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Abstract 
This thesis aims to investigate new functions for ciliopathy proteins and identify 
candidates for therapeutic application.  The ciliopathies form a class of genetic 
diseases whose aetiology lies in the primary cilium. Over 30 genes have been 
identified as mutant in ciliopathies and their proteins localise at the primary 
cilium.  When mutated they can cause kidney disease, obesity, polydactyly, and 
retinal degeneration. 
 
In this project, I have studied craniofacial dysmorphology related to Bardet-Biedl 
syndrome (BBS) in humans, mice, and zebrafish, and shown there to be consistent 
midfacial flattening and hypoplasia.  Bbs8, a causative gene of BBS, has a key 
role in neural crest migration and possibly in cell migration in general.  This 
accounts for the frequent observation of Hirschsprung’s disease, a gut immotility 
disorder, in BBS.  I identified new roles for BBS and other ciliopathy proteins in 
Sonic hedgehog (Shh) signal transduction and showed that they are important in 
the downstream processing of the transcription factor Gli3.  
 
I modelled ten different ciliopathy genes in the zebrafish and identified specific 
ciliary phenotypes, such as laterality randomisation, otic vesicle anomalies, and 
kidney cysts.  Administration of two drugs, Rapamycin and Roscovitine, were 
sufficient to rescue formation of kidney cysts and restore the filterative capacity of 
the kidney.  This paves the way for studies in mouse models and, ultimately, in 
humans, where no treatment for ciliopathic renal disease exists. 
 
I examined whether FTO, a gene associated with obesity in the general 
population, functioned in ciliary processes.  I provided some evidence that its 
protein was involved ciliary processes and glucose homeostasis.  I also showed 
that fto interacted with its neighbouring ciliary gene, ftm, in the zebrafish.  I 
performed similar interaction studies to show that a non-synonomous SNP in a 
gene associated with lipid accumulation in C. elegans had deleterious effects on 
protein function, explaining its high degree of association in BBS patients.
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PDGF   Platelet derived growth factor 
PFA   Paraformaldehyde 
pg   Picogram 
PKA   Protein kinase A 
PKD   Polycystic kidney disease 
PKD   Polycystic kidney disease 
PNS   Peripheral nervous system 
POMC   Pro-opio-melanocortin 
Ptc   Patched 
PTU   Phenolthiourea 
qRT-PCR  Quantitative real-time reverse transcription PCR 
QTL   Quantitative trait locus 
RA   Retinoic acid 
RNAi   RNA interference 
RP   Retinitis pigmentosa 
SDS   Sodium dodecylsulphate 
Shh   Sonic hedgehog 
shRNA  Short hairpin RNA 
siRNA   Small interfering RNA 
SLNS   Senior-Loken syndrome 
Smo   Smoothened 
SNP   Single nucleotide polymorphism 
ss   Somite stage 
Su(Fu)   Suppressor of fused 
TAP   Tandem affinity purification 
TEM   Transmission electron microscopy 
TPR   Tetratricopeptide repeat 
Tx-100  Triton X-100 
V   Volt 
VCFS   Velo-cardio-facial syndrome 
VEGF   Vascular endothelial growth factor 
VMH   Ventral medial hypothalamus 
ZPA   Zone of polarising activity 
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Chapter 1: Introduction 
History of the cilium 
The word “cilium” means eyelash in Latin and its use in Biology has been 
attributed to the eighteenth century Danish naturalist Otto Muller.  He was 
referring to the structure first observed by Antony Van Leeuwenhoek in 1675 
using a primitive microscope, when he observed the moving flagellum of a 
freshwater protozoon.  Leeuwenhoek went on to observe flagella beating on the 
mammalian spermatozoon and pondered “…how such an unbelievable motion is 
brought about” (Quoted in Frixione, 2000).   
 
Ever since then the motile cilium and flagellum1 have fascinated biologists 
because of their elegant structures and movement.  Over the next century, cell 
biologists observed motile cilia lining epithelia of the oviduct, respiratory tract, 
brain ventricles, and on spermatozoa.  Their interest in these organelles arose from 
the importance they attributed to the beating motion.  Disorders of motile cilia can 
result in human diseases such as Kartagener’s syndrome, in which cilia become 
immotile and are unable to beat.  This causes in bronchiectasis (inflammation of 
the bronchi) because the airway epithelium is unable to clear mucus, as well as 
causing situs inversus, or reversal of organ laterality. 
 
In contrast to the motile cilia which fascinated the early microscopists, primary 
cilia form a separate class of cilia and were not discovered until 1898, when 
Zimmerman first described them lining kidney tubules (Wheatley, 2005).  Primary 
cilia are immotile and so their function was unknown until relatively recently.  
They are ancient organelles and are present, at least at some point during the life 
cycle, on almost all eukaryotic cells (Davis et al., 2006). 
 
For the purposes of this thesis, I will concentrate on the biology of primary cilia, 
and not motile cilia, because my work concerns the ciliopathies, a group of 
                                                
1 The terms “cilium” and “flagellum” are often used interchangeably and refer to the same 
organelle.  In multicellular organisms, cilia beat in a wavelike motion and flagella beat in a 
whipping motion, such as on spermatozoa. 
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genetic diseases caused by mutations affecting proteins which function in the 
primary cilium.  It is first important to distinguish between the structure and 
function of the motile and primary (or immotile) cilia. 
 
Motile and primary ciliary cell biology 
Motile cilia tend to be concentrated in large numbers on the apical surface of 
cells, and beat in coordinated “Mexican” waves to clear mucus from the 
respiratory epithelium, drive sperm along the fallopian tube, and move 
cerebrospinal fluid in the brain ventricles and spinal cord.  In cross section, these 
cilia are constructed from a “9+2” arrangement of microtubules in which nine 
microtubule doublets surround a central inner pair.  These microtubules are stable, 
and not dynamic as they are in the cytoplasm.  This stability is achieved by 
acetylation of the tubulin monomers.  Figure 1 shows cross sections through 
motile and primary cilia (Fig. 1A and B), and scanning electron micrographs of 
these types of cilia in vivo (Fig. 1C and D). 
 
Each microtubule doublet consists of an “A” strand which is constructed from 13 
tubulin protofilaments, and a “B” strand made from 10 protofilaments (Alberts, 
2008).  In motile cilia, radial spokes connect the outer and inner doublets.  The 
inner doublet is used for generating shear forces needed to bend the cilium and 
induce motility.  Bending is achieved by dynein motor proteins shifting one 
microtubule doublet relative to the central pair, and is dependent on ATP 
hydrolysis.  When this beating is coordinated amongst cells lining an epithelium, 
the result is a unidirectional flow of fluid. 
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Figure 1.  The structure of motile and primary cilia 
Fig. 1A and 1B are TEM cross-sections through motile and primary cilia respectively.  
Fig. 1C shows motile cilia lining the oviduct, 1D shows primary cilia projecting from the 
surface of the node in a mouse embryo.  Taken from (Huangfu and Anderson, 2005). 
 
 
Primary cilia differ from motile cilia in their lack of the central microtubule 
doublet, so they are described as having a “9+0” arrangement.  9+0 cilia are 
immotile and do not beat, with the unusual exception of cilia covering the node 
(or organiser) of the mammalian embryo.  These nodal cilia do beat, and have 
been described as a third class of cilia.  The function of primary cilia, once 
disregarded as vestigial (Webber and Lee, 1975), is complex and variable.  In 
some cells they function as an antenna to respond to extracellular signalling 
molecules, in others they act as mechanosensors and bend in response to fluid 
flow, and they are also crucial for certain important developmental signalling 
cascades.  As such, primary cilia are crucial for development and maintenance of 
numerous organs and tissues, as will be discussed in detail later in this chapter. 
 
Motile 
cilia 
Primary 
cilia A B 
C D 
  22 
Chapter 1 - Introduction 
The anatomy of the cilium 
The ciliary axoneme (shaft) is only 0.25µm in diameter but its length can range 
from several microns to up to 2mm.  The basal body is a cylindrical structure 
measuring 0.4 by 0.2µm positioned perpendicular to the cell membrane, 
anchoring the cilium in the cytoplasm (Lodish, 2002).  It also acts as the 
nucleation point from which the cilium extends out from the cell.  The basal body 
consists of nine triplets of microtubules arranged in a ring from which extend 
three microtubules: A, B, and C.  All three fibres project from the basal body into 
the proximal region of the cilium known as the transition zone; this is the region 
from which a nascent cilium grows.  Further along the cilium is the middle zone 
composed of nine doublets consisting of just A and B filaments.  The axoneme 
terminates with the distal zone, comprised primarily of microtubule singlets.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Longitudinal section through a cilium 
At the proximal, cytoplasmic end of the cilium lies the basal body with microtubule 
triplets.  Distal to this is the transition zone where the microtubules are arranged in 
doublets.  The axoneme comprises the majority of the length of the cilium.  Taken from 
(Fliegauf et al., 2007). 
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Intraflagellar transport 
The ciliary matrix (cytoplasm) is devoid of ribosomes, meaning that any proteins 
needed for ciliary biogenesis or function must be transported into the cilium from 
the cytoplasm.  A system of ferrying proteins to (anterograde) and from 
(retrograde) the cilium is executed by a process called intraflagellar transport 
(IFT).  Anterograde transport involves the loading of cargo proteins bound for the 
cilium onto an IFT particle, which in turn is attached to a kinesin motor protein 
complex.  The motor complex consists of the motors KIF3A and KIF3B 
(Rosenbaum and Witman 2002), which slide along the axoneme.  The IFT particle 
consists of at least 17 proteins and is divided into two subcomplexes: subcomplex 
A with around 6 proteins, and subcomplex B with 11 proteins, outlined in Table 1 
(Lucker et al., 2005).  Retrograde transport back to the cytoplasm relies on the 
dynein motors, which also serves to recycle the kinesin motors. 
 
Subcomplex A Subcomplex B 
IFT43 IFT20 
IFT122A IFT27 
IFT122B IFT46 
IFT139 IFT52 
IFT140 IFT57 
IFT144 IFT72 
 IFT74 
 IFT80 
 IFT81 
 IFT88 
 IFT172 
Table 1.  A list of IFT complex A and B proteins. 
 
The two sub-complexes are coordinated by a bridge of accessory proteins.  The 
precise nature of the IFT particle is not completely characterised, but it is complex 
and the ciliary proteome consists of some 1,000 proteins, many of which are 
directly involved with IFT (www.ciliaproteome.org; (Gherman et al., 2006)).  No 
IFT particles accumulate in the distal tip of the cilium so the amount of retrograde 
transport always equals anterograde.  In fact, the rate of IFT remains constant 
throughout the cycle of cilium assembly and disassembly.  When the cilium is 
fully grown, many IFT particles enter the cilium without cargo and passage up 
and down the axoneme.  Loading of cargo is regulated at the basal body and the 
complex of proteins surrounding it, the pericentriolar material (PCM).  Many of 
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these cargoes derive from vesicles budded directly off the Golgi apparatus, so it is 
not surprising that the cilium usually forms apically to the trans-Golgi network 
(Davis et al., 2006).  Figure 3 depicts the process of IFT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  The mechanism of intraflagellar transport 
Cargo bound for the cilium is loaded at the basal body and attached to an IFT particle, 
which is propelled distal-wards along the axoneme, by the Kinesin-2 motor complex.  
The Dynein motor complex powers retrograde transport back to the cytoplasm.  Taken 
from (Scholey and Anderson, 2006). 
 
The ciliopathies form a new class of genetic syndrome 
Due to the importance of primary cilia in cell biology, physiology, and 
development, mutations in genes affecting proteins involved with ciliary function 
can have devastating effects on human development and health.  Since 2003, a 
growing list of ciliopathies has emerged – diseases in which genes encoding 
components of the cilium (including the basal body) are mutated (For review see 
(Badano et al., 2006)).  Understanding these diseases has been helped enormously 
by basic research into ciliated organisms, such as the unicellular alga 
Chlamydomonas reinhardtii and the nematode Caenorhabditis elegans, as well as 
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work done on vertebrate models.  In return, the ciliopathies have shed a huge 
amount of light on the functional importance of cilia and their proteins.  As such, 
the study of ciliopathies is a perfect example of how basic science can be 
transferred to understanding human disease, and vice versa.   
 
Several other ciliary genes are mutated in human diseases, such as polycystic 
kidney disease, but these proteins are not involved in ciliary function per se, they 
just localise to the cilium for their function.  In addition, they tend only to affect 
the kidney (although rarely can cause situs inversus too), whereas ciliopathies 
tend to involve multiple systems.  Ciliopathy proteins tend to be involved with the 
intrinsic function of the cilium, and lack of any one of them often causes the cilia 
to be malformed or absent.  Also, the ciliopathies are defined as affecting primary 
cilia, and the term is not extended to encapsulate motile ciliary dysfunction 
disorders such as heterotaxia and Kartagener’s syndrome.   
 
The ciliopathies currently include: Bardet-Biedl syndrome (BBS), 
Nephronophthisis (NPHP), Senior-Loken syndrome (SLNS), Alstrom syndrome 
(ALMS), Meckel syndrome (MKS), Joubert syndrome (JBTS), Oro-facial digital 
type I (OFD 1), Jeune asphyxiating thoracic dystrophy (JATD), Leber Congenital 
Amaurosis (LCA).  The list of ciliopathies is growing, and while it stands at 
around ten diseases, estimates are that there may be as many as 25 (P. Beales, 
personal communication). 
 
The core ciliopathies, whose ciliary origins are best studied, are NPHP, BBS, and 
MKS.  They exist in a phenotypic spectrum, with NPHP being considered the 
mildest, BBS as intermediate in severity, and MKS is pre- or perinatal lethal.  For 
each syndrome, there are many causative genes, reflecting the common 
underlying biological theme of the cilium uniting these diseases.  The different 
ciliopathies are clinically distinct and diagnosis is usually made based on 
phenotype and confirmed by genotype.   
 
Because of their common involvement in ciliary processes, the ciliopathies show a 
common denominator of clinical features.  In fact, these features are so 
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characteristic that they can be used as a way of predicting and identifying new 
ciliopathy syndromes, as Beales et al did for Jeune syndrome (Beales et al., 2007).  
This insight can then be used to discover new ciliary proteins and further our 
understanding of ciliary biology.  This table identifies the “hallmarks” of 
ciliopathy.  The features are listed in order or prevalence.   
 
 
Feature 
 
NPHP SLNS BBS MKS JBTS JATD OFD  
Kidney cysts        
Liver disease        
Situs inversus        
Polydactyly        
Agenesis of corpus 
callosum 
       
Mental retardation        
Dandy-Walker 
malformation* 
       
Retinal degeneration        
Encephalocoele        
Table 2.  Summary table showing common features of ciliopathies. 
Red shading indicates the feature is present in the syndrome. 
* This is a defect of the brain ventricles affecting the formation of the cerebellum.  Data 
taken from (Badano et al., 2006) and OMIM. 
 
From the table it is clear that cystic kidneys and liver disease are common to all 
ciliopathies.  Second to this is situs inversus, reversal of organ laterality.  
Polydactyly, agenesis of the corpus callosum, and mental retardation are a triad of 
features that seem to manifest together.  This possibly reflects common 
underlying signalling defects that will be discussed later.  Retinal degeneration is 
common to several ciliopathies and usually culminates in blindness.  
Encephalocoele is a neural tube defect (NTD) in which portions of the anterior 
neural tube fail to close, resulting in brain protruding through the skull and is 
always lethal.   
 
Table 2 also shows how NPHP has less multi-system involvement than the other 
diseases, and is considered phenotypically milder than BBS or MKS.  It primarily 
involves the kidney and is a common cause of kidney failure amongst children 
(Hildebrandt and Zhou, 2007).  When NPHP presents with retinal degeneration it 
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is called Senior-Loken syndrome (SLNS).  BBS involves more organ systems and 
has become the most studied ciliopathy, partly because it is informative about the 
role of cilia in so many different systems.  It also manifests a strong phenotype 
while not being lethal.  Meckel (MKS) and Joubert (JBTS) syndrome are both 
lethal and can be distinguished because JBTS presents a molar-tooth shaped 
cerebellum on MRI, and MKS causes NTDs.  MKS and JBTS can be considered 
at the extreme end of the ciliopathy phenotypic spectrum.   
 
Other ciliopathies affect different systems while preserving hallmarks such as 
kidney diseases, situs inversus, and polydactyly.  OFD1 and JATD both cause 
skeletal defects.  LCA only tends to affect the retina and so blindness is the main 
feature.  As such, it is debateable whether LCA should be considered a ciliopathy 
under the terms stated above. 
 
The relevance of studying ciliopathies 
Ciliopathies are rare diseases in the general population, although tend to be up to 
ten times more common in highly inbred populations such as in the Middle East; 
Pakistan; Newfoundland, Canada; and the Faroe Islands.  Data on prevalence are 
variable and hard to estimate due to low numbers of patients.  BBS is present at 1 
in 100,000 in the West and about 1 in 13,000 amongst Bedouin Arabs (OMIM 
209900).  MKS is more common at around 1 in 9,000 (OMIM 249000).   
 
Despite the rarity of these diseases, they are important to study for three reasons: 
first, they cause severe, multi-system pathology resulting in a very low quality of 
life and early death for most patients.  Currently there are no cures and few 
treatments and so understanding the disease is important for developing therapies 
to treat patients.  Second, the ciliopathies share some features common in the 
general population.  Kidney cysts are present in about 1 in 500 adults; retinal 
degeneration in 1 in 3,000; and polydactyly in 1 in 500.  One of the most 
prominent features of BBS is obesity, present in one third of adult Britons (Hyde, 
2008).  In BBS, this is combined with type 2 diabetes, hypertension, and 
cardiovascular disease, so it makes a good model for studying the poorly 
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understood metabolic syndrome, present in 25% of the American population 
(www.americanheart.org).  Third, studying the ciliopathies is informative about 
the basic biology of cilia and their role in cell signalling and development. 
 
The genetics of the ciliopathies 
The first ciliopathy gene, MKKS or BBS6, was identified simultaneously by two 
independent groups in 2000 (Katsanis et al., 2000; Slavotinek et al., 2000).  Since 
then, over 30 genes causing ciliopathy syndromes have been identified.  For some 
of these proteins, their function is being elucidated, while others remain elusive.  
Table 3 summarises the known ciliopathy genes and their protein products: 
 
Disease Causative genes Protein function Reference 
BBS1,2,3,4 BBS1 
BBS2 
BBS3/ARL6 
BBS4 
BBS5 
BBS6/MKKS 
BBS7 
BBS8/TTC8 
BBS9/B1 
BBS10 
BBS11/TRIM32 
BBS12 
Cilia function 
Cilia function 
Vesicle trafficking 
Microtubule transport 
Cilia function 
Cilia/chaperone 
Cilia function/IFT 
Cilia function/IFT 
Unknown 
Putative chaperone 
E3 ubiquitin ligase 
Type II chaperone 
(Mykytyn et al., 2002) 
(Nishimura et al., 2001) 
(Fan et al., 2004) 
(Mykytyn et al., 2004) 
(Li et al., 2004) 
(Katsanis et al., 2000) 
(Badano et al., 2003) 
(Ansley et al., 2003) 
(Nishimura et al., 2005) 
(Stoetzel et al., 2006) 
(Chiang et al., 2006) 
(Stoetzel et al., 2007) 
Alstrom1,3 ALMS1 Ciliogenesis (Hearn et al., 2002) 
Meckel/ 
Joubert2,3,4 
MKS1 
MKS2 
MKS3/TMEM67 
MKS4/RPGRIP1L 
MKS5 
MKS6/CC2D2A 
AHI1 
Unknown (cilium) 
Unknown (uncloned) 
Transmembrane (cilium) 
Basal body function 
Unknown (uncloned) 
Cilium/calcium binding 
WD repeats 
(Kyttälä et al., 2006) 
 
(Smith et al., 2006) 
(Arts et al., 2007) 
 
(Tallila et al., 2008) 
(Dixon-Salazar et al., 
2004) 
NPHP2,3 NPHP1 
NPHP2/INVS 
NPHP3 
NPHP4 
NPHP5 
NPHP6/CEP290 
NPHP7/GLIS2 
NPHP8/NEK8 
Cilium 
Cilium, laterality 
Unknown 
Cilium 
IQ domain/cilium 
Cilium/centrosome 
Transcription factor 
Nemo-like kinase 
(Hildebrandt et al., 1997) 
(Otto et al., 2003) 
(Olbrich et al., 2003) 
(Mollet et al., 2002) 
(Otto et al., 2005) 
(Valente et al., 2006) 
(Attanasio et al., 2007) 
(Otto et al., 2008) 
OFD Type I2,4,5 OFD1 Unknown (Ferrante et al., 2001) 
Jeune2,3,4,5 IFT80 IFT subcomplex B (Beales et al., 2007) 
Ellis van 
Creveld2,4,5 
EVC1  
EVC2 
Cilium 
Unknown 
(Ruiz-Perez et al., 2000) 
(Galdzicka et al., 2002) 
 
Phenotypic subgroups: 1) obesity as primary feature. 2)  kidney disease. 3) retinal 
degeneration. 4) polydactyly. 5) skeletal dysplasia 
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Table 3.  Table summarising the genes and their proteins mutated in human 
ciliopathies. 
 
This classification shows how, even within the ciliopathies, the diseases can be 
subcategorised contingent on the biological role of the protein involved.  I have 
classified ciliopathy features into five subgroups above.  Excluding kidney disease 
as a discriminator due to its ubiquity, this classification defines two groups: 
ciliopathies with skeletal involvement (JATD, OFD1, EVC), and those no skeletal 
involvement (BBS, NPHP, MKS/JBTS, ALMS).   
 
Most ciliopathies are autosomal recessive, with the exception of OFD1, which is 
X-linked dominant.  However, the inheritance pattern of some ciliopathies is more 
complex and sometimes involves more than one locus.  In 2001, it was suggested 
that BBS requires triallelic inheritance, consisting of homozygous mutations at 
one locus and a heterozygous change in a third allele at a different locus (Katsanis 
et al., 2001).  Evidence for this came from homozygous mutations in BBS2 not 
causing disease in one individual, but when present with a third mutation in a 
BBS6 allele, BBS features manifested (ibid.).  Since then, it has been reported that 
BBS4 and BBS1 may display triallelic inheritance (Beales et al., 2003).  Hoefele 
(2007) screened NPHP patients and found third alleles mutated in second NPHP 
loci, adding evidence that oligogenic, or triallelic, inheritance exists in other 
ciliopathies (Hoefele et al., 2007).  Meanwhile, several studies have performed 
mutation screening on large cohorts of BBS patients and found no evidence for 
triallelism (Hichri et al., 2005; Laurier et al., 2006; Nakane and Biesecker, 2005; 
Smaoui et al., 2006).  
 
Leitch et al (2008) found MKS1, MKS3, and CEP290 (NPHP6) mutations in BBS 
patients with mutations in BBS genes (Leitch et al., 2008).  The presentation of 
seizures in these patients suggested that this extra mutational load modified the 
phenotype to make it more severe.  Furthermore, mutations in ciliopathy genes 
have been shown to cause diseases not previously associated with that gene.  For 
example, mutations in CEP290 can cause NPHP, SLNS, or JBTS (Baala et al., 
2007; Helou et al., 2007); RPGRIP1L can cause MKS or JBTS (Delous et al., 
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2007), and AHI1 mutations can cause NPHP or JBTS (Wolf et al., 2007).  These 
findings suggest that the ciliopathies exist as a phenotypic spectrum modulated by 
the type, number, and position of underlying mutations.  Understanding these 
genotype-phenotype correlations is of importance in understanding the diseases.   
 
Furthermore, our thinking that all ciliopathies are caused by mutations in ciliary 
genes is being challenged.  In 2008, Attanasio et al identified mutations in the 
transcription factor gene GLIS2 in NPHP patients and recapitulated the phenotype 
in mouse (Attanasio et al., 2007).  Ciliary proteins have also been localised to the 
Golgi apparatus and to microtubules outside of the cilium (Follit et al., 2006); H. 
May-Simera, thesis).  Our study of ciliopathies may need to extend beyond the 
cilium and basal body to fully understand the mechanisms of disease. 
 
Bardet-Biedl syndrome as a “model” ciliopathy 
Basal body dysfunction was identified as a probable cause of BBS in 2003 
(Ansley et al., 2003).  The clue came from a patient with situs inversus who was 
then shown to have mutations in BBS8, whose protein localised to the basal body.  
Since then, almost all the BBS proteins have been localised to the primary cilium 
or basal body (for review see (Tobin and Beales, 2007)) (BBS11 localisation has 
not been reported yet).  BBS patients have all the common features of ciliopathies: 
polydactyly, cystic kidneys, retinitis pigmentosa, and situs inversus.  Nearly all 
BBS patients are obese, the precise reason being unclear, but thought to be linked 
to a defect in the satiety centre of the hypothalamus, whose neurons are ciliated 
(Berbari et al., 2008a; Berbari et al., 2008b).   
 
BBS patients are usually born with post-axial polydactyly (extra little finger or 
toe) of some or all limbs, and hypogenitalism.  In the first few years of life, they 
begin to put on weight and become obese.  By the age of eight, night blindness 
manifests proceeding to complete blindness by around fifteen years.  Kidney cysts 
usually appear in childhood and most patients require dialysis or transplantation to 
survive.  End-stage renal failure is the most common cause of premature death 
from BBS and is estimated to kill around 30% of patients (OMIM).  Most patients 
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survive until the third decade of life, but some patients have been known to live 
into their seventh decade (P. Beales, personal communication).  Complications 
often arise from overweight, including hypertension and type 2 diabetes.  Many 
patients also have congenital cardiovascular disease.   
 
The origin of most of these features relates to primary cilium dysfunction.  Rod-
cone dystrophy, or retinitis pigmentosa, is caused because the outer segment of 
the rod cell, which contains the photoreceptor pigments, is a modified cilium.  
This connecting cilium transports vesicles containing rhodopsin and structural 
proteins from the cell body to the outer segment via IFT, at a rate of 2,000 
vesicles per second (Sung and Tai, 2000).  The dysfunction of BBS proteins in 
this transport causes progressive degeneration of the outer segment, first resulting 
in night-blindness and then complete loss of vision. 
 
Post-axial polydactyly may be related to the fact that the apical ectodermal ridge 
(AER) of the developing embryonic limb bud is ciliated.  The AER is where the 
digits are patterned, and it receives the Sonic hedgehog (Shh) signal secreted from 
the zone of polarising activity (ZPA) in the posterior margin of the limb bud.  
Misinterpretation of the Shh signal can result in polydactyly, which might be the 
case in BBS.  Because the development of the external genitalia relies on similar 
signalling mechanisms to the limb extremities, it is thought that Shh signalling 
deficiencies could also result in the small genitalia seen in BBS patients.  
However, this has not yet been proven.   
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Table 4 shows the primary and secondary features of BBS and their incidence 
rates. 
Primary features % Prevalence      
(after Beales et al 1999) 
Comment 
Rod-cone dystrophy 93% Other ocular defects included: astigmatism, 
strabismus, cataracts, colour blindness, macular 
oedema and degeneration, and optic atrophy 
Post-axial 
polydactyly 
69% Present on all four limbs in 21% of patients, 
only hands in 9% and only feet in 21%.  
Brachydactyly present in 46% and syndactyly 
in 9% of patients 
Truncal obesity 72% Mean BMI in males was 31.5kg/m2, in females 
it was 36.6kg/m2 
Hypogonadism 98% Males had micropenis and 8% had 
maldescended testes.  Most women reported 
irregular menstrual cycles and genital 
abnormalities e.g. hydrometrocolpos 
Renal anomalies 24% (only 52% of 
patients had undergone 
renal exam) 
Renal parenchymal cysts (10%), calyceal 
clubbing (10%), fetal lobulation (12%), 
scarring (12%), dysplastic kidneys (5%), 
unilateral agenesis (4%), renal calculi (2%), 
vesicoureteric reflux (9%), bladder obstruction 
(4%), hydronephrosis (4%), horseshoe kidney 
(2%), ectopic kidney (2%) 
 
Secondary features 
 
  
Speech 
disorder/delay 
54%  
Developmental 
delay 
50% 52% showed delay in walking of up to one 
year, speech delayed by up to two years in 
47%, delay in pubescence in 31% (all males) 
Behaviour 33% Emotional immaturity, outbursts, disinhibition, 
depression and lack of social dominance, 
obsessive compulsive behaviour  
Ataxia/imbalance 40% Abnormal gait reported in 33% of patients  
Diabetes mellitus 6%  
Congenital heart 
defects 
7% Included: aortic stenosis, patent ductus 
arteriosis, cardiomyopathy 
Liver disease   
Hearing loss 
(Conductive and 
sensorineural) 
21%  
Facial features variable Deep-set eyes, hypertelorism, long philtrum, 
thin upper lip, anteverted nares, prominent 
forehead with male early-onset balding 
Situs inversus unknown  
Hirschsprung 
disease 
~10%  
Polyuria/polydipsia  May be present in the absence of renal 
abnormality 
Dental crowding  Also includes: high arched palate, hypodontia, 
small roots 
Anosmia ~60% See Kulaga et al. 2004 
Table 4.  Primary and secondary features of BBS. 
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The importance of cilia in kidney development is well known.  Cilia project into 
the lumen of the tubules in the kidney and act as flow sensors (Yoder, 2007).  
Dysfunction of the cilia here results in aberrant kidney development and cyst 
formation.  Figure 4 shows primary cilia in tissues whose development is 
defective in ciliopathy patients. 
 
 
 
 
 
 
 
 
Figure 4.  Primary cilia in ciliopathy contexts.   
Alterations to AER cilia can cause polydactyly; nodal cilia cause heterotaxia; and kidney 
luminal cilia, cystic kidneys.  Taken from (Marshall and Nonaka, 2006).  Scale bar 5µm. 
 
Diabetes in BBS patients may be secondary to obesity.  However, non-obese BBS 
patients who have had calorie-controlled diets are still hyperinsulinemic (P. 
Beales, personal communication).  This suggests that BBS proteins may have a 
primary role in glucose homeostasis.  This is a possibility in light of the fact that 
pancreatic β-cells, which secrete insulin, are ciliated, which may be important for 
reception of signals to secrete insulin (Ait-Lounis et al., 2007). 
 
BBS proteins are expressed in hair cells of the ear (H. May-Simera, thesis), which 
extend stereociliary bundles.  These bend in response to acoustic vibration and 
open ion channels that set off action potentials to the auditory nerve.  Early in 
development, the neat order of the stereociliary bundles is controlled by the 
kinocilium, a modified primary cilium.  BBS protein dysfunction may affect the 
function of the kinocilium, resulting in disordered hair cells and resultant hearing 
deficits.  Similarly, olfactory hair cells in the nose are ciliated and these are 
AER Node Kidney 
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required for detecting odours.  As such, over half of BBS patients are completely 
anosmic (unable to detect smells) (Kulaga et al., 2004). 
 
Functions of ciliopathy proteins 
Many ciliopathy proteins localise exclusively to the primary cilium (including the 
basal body) and/or the centriole, and so it is assumed that they function in ciliary 
processes.  However, the primary cilium is complex and is the location of many 
cellular processes.  These include, amongst others: loading and unloading of cargo 
on to IFT particles at the basal body, anterograde and retrograde transport along 
the axoneme, ciliogenesis, localising receptors and signalling molecules to the 
cilium, function of signalling pathways reliant on the cilium, positioning of the 
cilium on the cell surface, and control of the cell cycle.  Therefore, while ciliary 
localisation is a good clue as to ciliary function, it does not delineate what that 
function is.  This is harder to establish and so the precise function of many 
ciliopathy proteins at the molecular level remains unknown. 
 
Many ciliary genes have an X-box motif in their promoter sequence to which 
binds the transcription factor RFX3, which activates the transcription of many 
ciliary genes (Efimenko et al., 2005).  In addition, several ciliopathy proteins 
contain domains that give clues about their function by homology to other 
proteins.  A few examples are given below: 
MKS1: contains a B9 domain of unknown function.  In C. elegans there 
are three B9-containing proteins with mammalian homologues: MKS-1, TZA-1, 
and TZA-2 (Williams et al., 2008).  These form a trimeric complex at the cilium 
and only affect cilium formation when combined with mutations in nphp1 or 
nphp4.  As such, the B9 domain may be an effective bait for identifying new 
candidate ciliopathy proteins. 
MKS3: also known as Meckelin, this protein contains 7 transmembrane 
domains, a signal peptide, 4 N-linked glycosylation sites, and 2 cysteine-rich 
repeats (Smith et al., 2006).  This protein is structurally similar to the Frizzled 
receptor involved in PCP signalling.  It is not yet proven, but MKS3 could play an 
essential, direct role in transduction of the non-canonical Wnt signal. 
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BBS4 and BBS8: these proteins both contain tetratricopeptide repeats 
(TPRs), and the alternative name for these proteins are TTC10 and TTC8 
respectively (Ansley et al., 2003; Mykytyn et al., 2001).  TPRs are 34 amino acid 
motifs involved in protein-protein interactions.  In addition, BBS8 contains a 
predicted pilF domain present in proteins involved in bacterial flagellar motility 
and pilus formation.  This was used by Ansley et al (2003) to predict its role in 
cilia, flagellar, or pseudopodia function. 
BBS6, BBS10, and BBS12: these proteins make up a novel family of type 
II chaperonin proteins involved in protein folding.  Unlike any other BBS genes, 
they are specific to vertebrates, rapidly evolving, and may function redundantly 
(Stoetzel et al., 2006; Stoetzel et al., 2007).  It is unknown what the function of 
these chaperonins is, but they are not included in the interacting complex of BBS 
proteins, the BBSome (see Nachury et al. 2007), but may be involved in aiding 
the folding of other BBS or IFT proteins. 
 
No structural data from crystallographic studies has been obtained, largely owing 
to the fact that BBS proteins are insoluble.  However, function is better 
characterised for BBS4, BBS7, BBS8, IFT80, and NEK8, from which inferences 
about other ciliopathy protein functions have been made.  I will outline four 
studies that have illuminated functions of the BBS proteins. 
 
The first clues about function came from studies of BBS-7 and BBS-8 in C. 
elegans.  Blacque et al (2004) first showed that these two proteins localise to the 
base of the cilium in ciliated neurons, and GFP-tagged proteins could be observed 
participating in IFT (Blacque et al., 2004).  The average rate of anterograde 
movement was approximately 0.7µms-1, while retrograde was roughly 1.1µms-1; 
rates comparable with IFT motor proteins such as OSM-3 kinesin.  The authors 
found animals mutant for these two genes were defective in taxis towards two 
chemical attractants whose detection relies upon ciliated neurons.  They then 
showed that cilia structure was abnormal in these mutants, determined by the 
inability to uptake DiI.  GFP-tagged IFT proteins failed to localise and move 
properly along the cilium in bbs-7 and bbs-8 mutants.  The authors suggested that 
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these proteins facilitate the incorporation of the IFT particle onto the motor 
protein complex, and are selective for particular cargoes.   
 
Ou et al used the same C. elegans mutants to show that BBS-7 and BBS-8 
coordinate the movement of IFT subcomplexes A and B (Ou et al., 2005).  In the 
absence of these proteins, the subcomplexes moved separately, at different rates, 
because a different type of kinesin motor moves each subcomplex.  The authors 
proposed a model whereby BBS-7 and BBS-8 act as a bridge between the two IFT 
subcomplexes.  In the absence of these proteins, the two subcomplexes move 
independently and are unstable.  As such, IFT is not completely abolished in bbs 
mutants, but it becomes unstable and slow.  This explains why BBS phenotypes 
are less severe than complete IFT knockouts, and are not lethal.  Figure 5 shows 
how BBS-7 and -8 act together to coordinate IFT in C. elegans. 
 
 
 
 
 
 
 
 
 
Figure 5.  IFT functions of BBS-7 and BBS-8. 
BBS-7 and -8 act as a bridge to coordinate IFT subcomplexes A and B to stabilise 
microtubule transport.  In the distal zone where microtubules are monomers, speed of 
transport is higher than in the central portion of the axoneme.  Taken from Ou et al 
(2005). 
 
Kim et al performed a yeast two-hybrid screen to identify p150 and PCM1 
(pericentriolar material 1) as interactors of BBS4.  Silencing of Bbs4 resulted in 
abrogation of recruitment of PCM1 to the pericentriolar satellites, and a 
deanchoring of microtubules from the centrosome.  Figure 6 illustrates how BBS4 
aids retrograde IFT. 
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Figure 6.  Function of BBS4 
BBS4 interacts with PCM1 and p150glued, part of the dynein retrograde motor complex.  
It is thought to assist retrograde IFT and stabilise microtubules at the centrosome through 
its association with PCM1.  Taken from Kim et al (2004). 
 
Nachury et al provided the best insight to date as to how BBS proteins behave at 
the molecular level (Nachury et al., 2007).  They used tandem affinity purification 
(TAP) to isolate a complex of BBS proteins they termed the “BBSome”.  This 
438kDa complex consisted of stoichiometric ratios of BBS1, 2, 4, 5, 7, 8, and 9, 
with BBS9 acting as the central organiser, as it interacted with all other subunits.  
They found the most marked defects of ciliogenesis when cells were depleted of 
BBS1 and 5.  They conjectured that the BBSome is transported to the basal body 
by the centriolar satellites and it associates with the ciliary membrane.  They 
showed the BBSome to interact with Rabin8, a guanosyl exchange factor for 
Rab8, a small GTPase that regulates vesicle trafficking from post-Golgi vesicles.  
Rab8 enters the ciliary membrane and promotes ciliogenesis.  They proposed that 
pathogenesis in BBS might be caused by defects in vesicular transport to the 
cilium.  Figure 7 suggests how the BBSome is involved with vesicular transport to 
the cilium. 
 
In light of these studies, it seems there are two general, non-exclusive models for 
how BBS proteins might function.  One suggests that at least BBS4, 7 and 8 are 
necessary for microtubule-based transport along the cilium.  The other theory 
implies that BBS proteins function as a complex mediating vesicle transport from 
the cytoplasm to the cilium.  As such, no one clear model for the function of BBS 
proteins has been described and the proteins may function in numerous roles, 
including cytoplasmic transport. 
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Figure 7.  Proposed function of the BBSome. 
The BBSome associates with Rabin8, a small GTPase involved in vesicle transport from 
the trans-Golgi network.  Nachury et al proposed that the BBSome interacts with this to 
transport vesicles to the basal body and onto the IFT complex.  Taken from (Leroux, 
2007). 
 
Situs inversus in ciliopathies 
Situs inversus is a complete reversal of organ laterality, such that the positions of 
the heart, liver, stomach, and other internal organs are totally inverted – situs 
inversus totalis.  Often, only some of the body’s organs are inverted and this is 
referred to as situs ambiguous.  These laterality defects are defined under the 
umbrella of “heterotaxia”.  Heterotaxia occurs at a rate of 1 in 10,000 in the 
general population, but is frequently observed (precise figures unavailable, but 
thought to be <10%) in ciliopathy patients.   
 
Situs inversus in a patient with BBS8 mutations was responsible for identifying 
ciliary origins of the disease due to the canonical role for the cilium in breaking of 
embryonic symmetry early in development.  In the mouse embryo, the node 
appears during gastrulation at the anterior end of the primitive streak.  The centre 
of the node is covered in motile cilia, which beat in a clockwise direction and 
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establish the “nodal flow”, a current across the node (McGrath and Brueckner, 
2003; McGrath et al., 2003). Nodal flow was shown to be sufficient for deciding 
laterality by the classic experiment by Nonaka et al, where he showed that 
reversing the flow over a cultured mouse node reversed embryo laterality (Nonaka 
et al., 2002). 
 
There are two, non-exclusive, hypotheses about how nodal flow establishes 
asymmetry.  In the first, the motile nodal cilia are surrounded by a second class of 
peripheral immotile cilia which sense flow by bending in response to leftward 
flow and initiate calcium transients (McGrath and Brueckner, 2003).  In the 
second, nodal flow establishes a concentration gradient of morphogens including 
Shh, RA, and FGFs.  This is thought to happen by the asymmetric distribution of 
vesicles containing these molecules.  Tanaka et al (2005) fluorescently labelled 
these vesicles and showed them being absorbed by cells on the left side of the 
node in real time (Tanaka et al., 2005).  They named these vesicles “nodal 
vesicular parcels”.   
 
McGrath et al (2003) showed how Shh, RA, and FGFs were necessary to establish 
the left-sided accumulation of calcium ions.  This activates the nodal pathway on 
the left side of the embryo, driving expression of transcription factors such as 
Lefty2 and Pitx2.  This laterality information is then transmitted to the left-sided 
paraxial mesoderm, which develops left-sided character.  The mechanism of 
transmission is unclear, but is known to involve the Notch, Wnt, and FGF 
pathways. 
 
Situs inversus, or heterotaxia, are common amongst the ciliopathies compared to 
the general population but the incidence is still low (<10% situs inversus) 
compared to motile ciliary disorders where body situs is completely randomised 
(50% situs inversus).  NPHP2 was originally identified from the invs mouse, in 
which the gene encoding Inversin is mutated, so called because of the inverted 
laterality phenotype (Otto et al, 2003).  This protein functions at the node, where 
it is important for nodal flow (Watanabe et al., 2003).  Other ciliopathy proteins 
have also been localised to the node, including IFT80 (unpublished data, 
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molecular medicine unit, ICH).  It is not clear which class of 9+0 nodal cilia 
(motile or immotile) the ciliopathy proteins function at, but since they perturb 
flow, it is likely they affect both classes. 
 
The study of laterality is being facilitated by the zebrafish, in which asymmetry is 
established by a ciliated organ similar to the mammalian node, called Kupffer’s 
vesicle (KV).  This forms after gastrulation at the posterior end of the embryo and 
contains beating cilia, which drive fluid in a clockwise direction to establish left-
right identity in the paraxial mesoderm.   
 
Oishi et al (2006) identified a gene, duboraya (dub), essential for ciliogenesis and 
fluid flow in KV, with resultant randomisation of laterality in dub deficient 
embryos (Oishi et al., 2006).  They showed that its function was dependent on 
Frizzled-2 mediated phosphorylation, linking dub to the non-canonical Wnt 
pathway.  Several other ciliary mutants also show laterality defects observed by 
aberrant sidedness of expression of left sided markers such as southpaw (spaw) or 
lefty, or morphological phenotypes such as mis-sided heart or gut looping.  These 
studies show that establishment of asymmetry in fish and mammals is a 
homologous process reliant on the same molecules and cellular processes.  They 
also clearly link ciliary and ciliopathy proteins to asymmetry defects.  
 
The mechanism of Sonic hedgehog signalling 
The sonic hedgehog pathway is a widely deployed signalling pathway in 
development and its importance continues into adulthood.  As such, perturbations 
to the pathway, either genetic or teratogenic, cause congenital malformations and, 
in adults, can lead to cancer.  Shh has a role in the development of many organs, 
but I will restrict my discussion here to its canonical roles in dorso-ventral 
patterning of the neural tube, antero-posterior patterning of the digits of the limb, 
and control of midline development in the brain and face.  In the last five years, a 
growing body of evidence has shown that cilia and IFT are essential for Shh 
activity, which may help explain many of the ciliopathy phenotypes we observe. 
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The Shh pathway relies on a diffusible ligand, Sonic hedgehog (Shh), initially a 
45kDa protein that is cleaved into a 20kDa N-terminal isoform called Shh-N.  The 
C-terminal fragment has no known function.  Shh-N is then modified by addition 
of cholesterol moieties at the C-terminus that are thought to aid in secretion, 
trafficking, and receptor interaction.  Lastly, the molecule is palmitoylated which 
has been shown to increase its diffusion by 30-fold relative to unpalmitoylated 
forms (Pepinsky et al., 1998).   
 
The ligand is then secreted and is thought to be able to diffuse around 30 cell 
diameters in vivo (Zeng et al., 2001).  It binds to its membrane-bound receptor, 
Patched-1, on a nearby cell.  In the absence of Shh ligand, Patched-1 inhibits 
another membrane-bound protein, Smoothened (Smo), related to the G-protein 
coupled receptor family.  Patched is thought to do this by pumping oxysterols out 
of the cell, which inhibit Smo activity (Javitt, 2008).  When Shh binds Patched-1 
(Ptc), its sterol pumping function is inhibited, enabling Smo to accumulate sterols 
thought to be important for its membrane localisation.  Smo transduces the signal 
downstream. 
 
Several proteins are involved in the downstream transduction of the Shh signal, 
which ultimately results in the transcriptional activation of target genes by the 
Gli3 transcription factor.  Rab23 is a small GTPase involved in the endocytosis or 
targeting of vesicles containing Shh, Ptc, or Smo (Eggenschwiler et al., 2006).  
Downstream of Smo is a tetrameric complex made up of Fused (Fu), which 
positively regulates the pathway; Suppressor of Fused (Su(Fu)), a negative 
regulator of the pathway; Costal-2 (Cos2), a microtubule-associated kinesin-like 
protein; and Gli3, a transcription factor.  When the pathway is activated by 
intermediate levels of Shh, Fused phosphorylates Costal-2, causing the 
dissociation of the tetramer from the microtubules to which they were bound 
(Fukumoto et al., 2001).  Su(Fu) is a negative regulator of the pathway, as it binds 
to Gli transcription factors and inhibits their nuclear localisation (Ding et al., 
1999).  The interaction with Gli proteins is inhibited by high levels of Shh signal, 
enabling Gli proteins to enter the nucleus and activate downstream genes.   
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In the absence of Shh, promoted by Costal-2, PKA phosphorylates Gli3 and 
brings about its proteolytic cleavage from its full length, 190kDa transcriptionally 
active isoform (Gli3A) into an 83kDa transcriptional repressor (Gli3R).  Shh 
stimulation breaks up the tetramer in which Costal-2 functions, thereby stopping it 
from activating PKA and preventing the breakdown of Gli3A.  Gli3A enters the 
nucleus and activates downstream target genes.  Patched-1 is upregulated by the 
pathway to spatially restrict the spread of Shh far beyond its producing cells  
 
Figure 8.  Mechanism of Shh transduction. 
In the absence of Shh, Ptc inhibits Smo.  In the cytoplasm, the tetrameric complex of 
Su(Fu), Costal2, Fused, and Gli3 associates with microtubules and Gli3 is cleaved into its 
repressor form by PKA.  In the presence of Shh, the inhibition of Smo by Ptc is relieved.  
Smo acts to disassemble the tetrameric complex, preventing the action of PKA and 
leaving active Gli3 free to enter the nucleus.   
 
(Dessaud et al., 2007).  Many cell cycle genes are regulated by Shh, which is why 
over-activity of the pathway can result in tumour formation.  Figure 8 outlines the 
major players in the Shh transduction pathway. 
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Many genes respond to particular concentrations of Shh, and as such, it acts as a 
morphogen inducing a graded response.  This response is thought to be encoded 
by a gradient of Gli transcriptional activity, which is an intracellular correlate with 
Shh concentration (Stamataki et al., 2005).  In this way, different cell fates are 
induced depending on the level of Shh signalling they are exposed to, which in 
turn depends on their distance from the source of Shh secretion.   
 
In addition to Shh, there are two other Hedgehog pathway ligands in vertebrates: 
Desert hedgehog (Dhh) and Indian hedgehog (Ihh).  Dhh is expressed in the testis 
and is thought to be involved in spermatogenesis.  Ihh is expressed in developing 
bones and signals to the growth plate to induce cell division essential for bone 
growth.  Mutations in IHH in humans causes bone growth defects such as 
brachydactyly (short fingers) and dysplasia of the long bones such as the femur 
(Hellemans et al., 2003).  Downstream components of the pathway are the same in 
Dhh and Ihh signalling pathways, but the post-translational modifications of Dhh 
and Ihh differ from Shh, so their diffusion kinetics are not the same. 
 
In the developing neural tube, Shh is secreted from the notochord and diffuses 
dorsally.  The ventral-most cells are exposed to the highest concentration of Shh, 
and activate Nkx2.2 to become motor neurons (Briscoe et al., 1999).  In the middle 
of the neural tube, lower levels of Shh activate genes such as Nkx6.1 and Pax7; 
these cells become interneurons.  In the absence of Shh signal in the dorsal neural 
tube, cells differentiate into sensory neurons (Briscoe and Ericson, 2001).  In Shh 
mouse mutants, ventral neuronal cell types are not specified, and the neural tube 
becomes dorsalised.  In contrast, Patched mutants have an overactivation of the 
pathway due to constituent relief of Smo repression (Pazzaglia et al., 2006).  
These embryos have expanded ventral cell types. 
 
In the skull, Shh signalling is essential for normal craniofacial development (Hu 
and Helms, 1999).  Mutations in Shh in mice and humans cause 
holoprosencephaly (HPE), in which the lobes of the forebrain fail to split, leading 
to a single central eye (cyclopia) and the absence of a nose. Shh is essential for 
development of the frontonasal and maxillary processes of the upper and midface.  
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The lower face is much less severely affected.  Shh is secreted from the anterior 
neural tube and oral ectoderm, where it organises the patterned migration of 
cranial neural crest cells about the midline (Eberhart et al., 2006).  These cells 
form the bony features of the face.  Craniofacial dysmorphology is a notable 
feature of BBS and this may rely, in part, on Shh signalling. 
 
Ciliary involvement in Shh transduction 
In an ethyl-nitrosurea (ENU) based mutagenesis screen for embryonic patterning 
mutants, Huangfu et al identified two IFT genes: Ift172 and Ift88 (Huangfu et al., 
2003).  While these mouse embryos expressed Shh normally, Ptc1 expression 
level was markedly downregulated, a sign of reduced Shh pathway activity.  In 
the neural tube, ventral cell types were absent, while dorsal cell types, usually 
repressed by Shh, were expanded.  This indicated a loss of responsiveness to Shh 
stimulation.   
 
Liu et al generated a hypomorphic Ift88 allele and used it to study limb 
development, as the Ift88 null died at E10.5 before the limb bud is patterned (Liu 
et al., 2005).  These hypomorphs were polydactylous and the expression domain 
of Gli3 was expanded in the limb buds.  In wild types, the majority of Gli3 protein 
in the limb bud is proteolytically cleaved, giving a low ratio of Gli3A to Gli3R.  
In the hypomorphs, this ratio was increased, indicating less cleavage of Gli3 and 
an accumulation of the active isoform, which may induce the growth of extra 
digits in the limb.  This effect on Gli3 explains why embryos show loss of Shh 
phenotypes in the neural tube but not in the limb bud, where the Gli transcription 
factors are deployed differently.   
 
Corbit et al then showed that Smo localised to the cilium in response to 
stimulation by Shh, and that its ciliary localisation was essential for downstream 
signalling activity (Corbit et al., 2005).  Rohatgi et al localised Patched-1 to the 
cilium and showed this localisation to be antagonistic to Smo ciliary localisation 
in the absence of Shh (Rohatgi et al., 2007).  May et al showed that IFT was 
essential for Smo’s ciliary localisation (May et al., 2005).  Haycraft et al (2005) 
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then localised Su(Fu), Gli2, and Gli3 to the cilium, and showed this localisation to 
be abrogated in IFT mutants (Haycraft et al., 2005).  This supported a direct role 
for the cilium in Gli processesing and transport.  Several other ciliary proteins 
have since been shown to be essential for Shh signalling, including THM1 and 
RPGRIP1L, a causative gene of MKS (Tran et al., 2008; Vierkotten et al., 2007). 
 
The role of ciliary proteins in Shh signalling supports some of the clinical 
phenotypes observed in ciliopathy patients, including postaxial polydactyly, 
external genitalia anomalies, and craniofacial defects.  These are outlined below. 
 
Polydactyly  
A similar morphogen gradient to that in the neural tube exists in the developing 
limb bud.  Here, Shh is secreted from the posterior margin of the bud in the zone 
of polarising activity (ZPA).  This forms an antero-posterior gradient in the limb 
bud.  Loss of function mutations to SHH cause a loss of digits, while mutations in 
GLI3 cause a gain of digits resulting in polydactyly.  Polydactyly is present in at 
least 70% of BBS patients yet none of the mouse BBS mutants produced to date 
show any extra digits.  
 
Understanding why BBS patients develop polydactyly, and why it is always post-
axial (extra little finger or toe), will add to our knowledge of the role of ciliary 
proteins in Shh transduction, if indeed this is the cause of the polydactyly.  While 
some ciliary and IFT proteins are crucial for Shh transduction, there are 1,000 
proteins in the ciliary proteome, and these are not all involved with the pathway.  
Understanding which genes are involved, and which aren’t, will help delineate the 
precise role of ciliary components in the Shh pathway. 
 
Genital abnormalities 
98% of BBS patients have malformed external genitalia (Beales et al., 1999).  In 
males, this includes micropenis, small and undescended testes, and hypospadias 
(mispositioning of the urethral meatus).  Shh null mice fail to outgrow a genital 
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tubicle, the precursor to the penis (Haraguchi et al., 2001).  Perriton et al showed 
that transplanting the urethral epithelium to the limb bud in chick induced mirror-
image duplication of the digits, implying that Shh acts as a morphogen in genital 
development too (Perriton et al., 2002).  Also, it shows how Shh signalling in 
genital development is analogous to that of the limb.  The genital and limb 
phenotypes seen in ciliopathies such as BBS and MKS might have a shared 
aetiology in aberrant Shh signalling.  Evidence for this speculation comes from 
comparing BBS and Alstrom syndrome (ALMS).  ALMS is often misdiagnosed 
as BBS because the patients show obesity, blindness, deafness, and kidney 
disease.  However, ALMS patients tend not to develop polydactyly, genital 
anomalies, or mental retardation; the three features likely attributable, at least in 
part, to faulty Shh signalling. 
 
Ciliary involvement in Wnt signalling 
In addition to Shh signalling and platelet derived growth factor (PDGF – not 
described here) signalling, the cilium is also important for both canonical and 
non-canonical Wnt signalling.  The canonical Wnt pathway, like Shh, is involved 
in many contexts and employs secreted ligands which regulate cell fate and 
patterning during development, and can cause cancer in adulthood when 
overactivated.  The non-canonical Wnt, or planar cell polarity (PCP) pathway, is 
less well understood in vertebrates, but is important for patterning cells 
throughout an epithelial plane, such as in the lumen of the kidney tubule or hair 
cells in the inner ear. 
 
In the canonical Wnt pathway, extracellular Wnt ligands bind to the membrane 
receptor Frizzled, activating cytoplasmic Dishevelled (Dvl) protein.  Activated 
Dvl inhibits the β-catenin destruction apparatus, consisting of Axin, GSK3β, and 
APC.  β-catenin is then able to enter the nucleus where it binds its transcriptional 
co-factors TCF and LEF to induce transcription of downstream target genes 
(Widelitz, 2005).  These targets are often associated with cell proliferation, 
maintenance of stem-cell characteristics, and survival. 
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Non-canonical Wnt, or PCP, signalling relies on a slightly different mechanism, 
despite many shared pathway components.  While the canonical pathway is well 
characterised and mapped out in a linear pattern, PCP is much less clear-cut, and 
different pathway components are important in different tissue and developmental 
contexts.  Vertebrate PCP signalling also requires Wnt ligands, but uses different 
members of the family (e.g. canonical Wnt ligands include Wnt4, 6, and 8; while 
PCP ligands include Wnt5a, Wnt9, and Wnt11).  Dvl localises to the plasma 
membrane in PCP signalling via its DEP domain, where it is activated by Frizzled 
combined with a co-receptor, Knypek (Wong et al., 2003; Wong et al., 2000). Dvl 
then activates GTPases such as RhoA, which reorientate the cytoskeleton (Habas 
et al., 2003).  It can also activate the JNK pathway which can induce expression of 
downstream genes associated with cell polarity (Yamanaka et al., 2002).  Figure 9 
outlines the main steps in canonical Wnt and PCP pathways.  
 
PCP signalling has been well characterised in Drosophila, where it polarises the 
growth of bristles and hairs, as well as photoreceptors in the eye, throughout the 
plane of epithelia.  Its importance in vertebrates has only been considered more 
recently.  It plays a key role in the gastrulation movements of the early embryo, 
where it is essential for the convergent-extension movement of cells (Jessen et al., 
2002).  This involves mediolateral intercalation of mesodermal cells, which 
converge at the midline and then elongate along the anteroposterior (AP) axis.  
 
PCP signalling is involved in other areas of organogenesis where cells are 
polarised in the epithelial plane.  Examples include: alignment of the stereociliary 
bundles on the hair cells in the cochlea; closure of the neural tube, and orientation 
of the mitotic spindles of renal tubular cells (Fischer et al., 2006).  Saburi et al 
(2008) created a mouse mutant of the PCP gene Fat4, which developed cystic 
kidneys as a result of disoriented cell divisions and tubule elongation (Saburi et 
al., 2008). 
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Figure 9.  Wnt signalling pathways 
In the canonical pathway, Wnt binds to its receptor Frizzled (Fz) that activates 
cytoplasmic Dishevelled.  This inhibits the destruction complex consisting of Axin, APC, 
and GSK3β, preventing the destruction of cytoplasmic β-catenin.  β-catenin then enters 
the nucleus and activates transcriptional targets by association with TCF and LEF.  In the 
PCP pathway, Wnt binds to Fz, which recruits Dvl to the plasma membrane.  This then 
activates RhoA, which remodels the cytoskeleton, polarising the cell; or Dvl activates 
Rac1, which can activate JNK, which enters the nucleus and activates downstream targets 
associated with cellular differentiation. 
 
Mouse PCP pathway mutants, such as circle tail, loop tail, and Dvl1 and 2 
knockouts, display neural tube defects (NTDs) such as spina bifida (failure of the 
posterior neural tube to close), craniorachischisis (failure of the entire neural tube 
to close), and exencephaly (failure of the anterior neural tube to close).  These null 
mutants tend to be embryonic or perinatal lethal.  In humans, mis-sense mutations 
in VANGL1, a PCP gene related to VANGL2, whose homologue in mouse is 
mutated in loop tail, causes NTDs such as spina bifida (Kibar et al., 2007).  
 
Konig and Hausen (1993) were the first to implicate cilia in planar polarity when 
they showed that the polarity of Xenopus epithelial cells aligned with the direction 
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of ciliary beating, although they did not know at the time that this involved PCP 
signalling (König and Hausen, 1993).  Cano et al showed that the subcellular 
localisation of β-catenin was altered in Ift88 mutant mice, and that this affected 
tissue organisation in the pancreas (Cano et al., 2004).   
 
Simons et al (2005) showed that Inversin (NPHP2) localised to the cilium and 
acted as a molecular switch between the canonical and PCP pathways (Simons et 
al., 2005).  Inversin inhibits canonical Wnt signalling by facilitating the 
degradation of cytoplasmic Dishevelled (Dvl).  They showed that fluid flow in 
renal cells increased the level of Inversin in cultured kidney cells.  They 
speculated that urine flow in the developing renal tubule terminates canonical Wnt 
signalling in favour of PCP signalling, which then patterns the tubule to give it its 
filterative capacity.  In ciliopathy mutants, unopposed canonical Wnt signalling 
may suppress terminal differentiation of tubular cells, leading to cyst formation. 
 
Ross et al (2005) showed that BBS proteins were involved in PCP signalling 
(Ross et al., 2005).  A proportion of Bbs4 null mice phenocopied PCP mutants 
such as loop tail (Vangl2, PCP receptor, mutant).  These Bbs4 mutant mice had 
open eyelids at birth, exencephaly, and misorientated stereociliary bundles.  
Compound Bbs4+/-;Ltap+/- heterozygotes recapitulated these phenotypes, whereas 
either single heterozygote was not phenotypic, implying a genetic interaction 
between the two genes.  They also showed that Vangl2, a membrane-bound 
receptor involved in PCP signalling, localises to the cilium.  Park et al extended 
this by finding that mutations in two PCP genes, inturned and fuzzy, abrogated 
PCP signalling, as well as causing Shh-deficient phenotypes, which they 
attributed to a ciliogenesis defect (Park et al., 2006).   
 
Two papers have directly linked canonical Wnt signalling to the primary cilium.  
Gerdes et al showed that suppression of bbs1, bbs4, bbs6, and Kif3a resulted in 
stabilisation of β-catenin and upregulation of TCF-mediated transcriptional 
activity, indicative of over-active canonical Wnt signalling (Gerdes et al., 2007). 
Corbit et al showed that canonical pathway components β-catenin and APC 
localised to the cilium (Corbit et al., 2008).  They showed that Ofd1 null cells 
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were stimulated by exogenous Wnt ligand five times more than wild type cells.  
They attributed this to the absence of cilia in these cells, and proposed that the 
cilium acts to inhibit canonical Wnt signalling, in contrast to its role in Shh 
signalling.  This suggests that knocking out ciliary proteins relieves this brake, 
causing excess canonical Wnt pathway activity. 
 
Mechanosensory functions in the kidney 
In the developing kidney, cells divide rapidly to produce the branched tubules 
required for filtration.  As the embryo develops, urine begins to flow through the 
tubules as the kidneys begin to function as organs of excretion and 
osmoregulation.  The onset of flow is thought to reduce cell proliferation and 
begin to induce terminal differentiation of tubular cells.  This change of fate 
coincides with a shifting emphasis from canonical to non-canonical Wnt 
signalling (Simons and Walz, 2006).  Primary cilia projecting from tubular 
epithelial cells into the lumen bend as fluid flows over them (Yoder, 2007).  This 
bending opens calcium channels in the membrane and causes a flux of 
intracellular calcium as cytoplasmic stores of calcium are released by calcium-
induced calcium release.   
 
Li et al placed IMCD3 (inner medullary collecting duct) cells in a flow chamber 
and passed a fluid flow over the cells (Li et al., 2007a).  They found that cells 
expressing siRNA against ALMS1, the causative gene for Alstrom syndrome 
(blindness, deafness, obesity, diabetes, renal cysts), failed to produce a calcium 
spike, whereas calcium was released in control cells.  The kidneys of knockout 
mice were cystic, and had increased levels of proliferation and apoptosis, which 
resulted in impaired function, evidenced by proteinurea.   
 
Kidney disease is one of the most prevalent features of ciliopathies and is the most 
common cause of morbidity and mortality.  A fuller discussion of the aetiology of 
kidney disease is presented in Chapter 6, but I will briefly introduce the topic 
here.  Polycystic kidney disease (PKD) affects between 1 in 500 and 1 in 1,000 
people and results in the growth of large cystic lesions, mainly in the loop of 
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Henle, which impair the ability of the kidney to filter the blood.  This can result in 
chronic renal failure resulting in uraemia (accumulation of toxic waste products in 
the bloodstream), which poisons the brain and can result in coma and death.  
Currently, the only treatments are dialysis, which is time consuming, invasive, 
and expensive; and transplantation, but with a limited supply of organs and the 
risk of rejection, this is not an ideal treatment either.  Several drugs inhibiting 
cystogenesis are in preclinical and clinical development.  These are in Chapter 6.  
Figure 10 illustrates cystic kidneys in a foetus with MKS. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Cystic kidneys in an MKS foetus. 
MRI scan showing cystic kidneys (bracket) and encephalocele (arrow) in a foetus with 
MKS.  Taken from (Gupta and Jain, 2008). 
  
Obesity 
Obesity is one of the primary features of two ciliopathies whose diagnosis is often 
confused: BBS and Alstrom syndrome (ALMS).  The frequency of overweight in 
BBS varies by study from 72% (Beales et al., 1999) to 91% (Green et al., 1989).  
The differences likely reflect different criteria classifying obesity.  Beales et al 
found 52% of patients had a BMI (body mass index) of over 30 (classified as 
obese) and 16% had a BMI greater than 40 (morbidly obese).  Fat tended to be 
distributed around the trunk and hips.  Childhood obesity is present in 95% of 
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ALMS patients (Joy et al., 2007).  Therefore, obesity is a common thread amongst 
certain ciliopathies, but its precise cause is not clear.  
 
The causes of obesity in BBS are thought to arise from hyperphagia (overeating).  
This may stem from a defect in the satiety centre of the hypothalamus, in which 
ciliated neurons regulate the feeling of satiety and hunger, and control feeding 
behaviour accordingly (Davenport et al., 2007).  Anecdotal reports claim that BBS 
patients rarely feel full, even after a large meal, and so cannot avoid overeating.  
Strict caloric restriction is required to prevent morbid obesity ensuing.  
 
Grace et al found no difference in energy metabolism between BBS patients and 
controls matched for BMI, although patients tended to be much less physically 
active, likely contributing to their overweight (Grace et al., 2003).  Studies of 
mouse models of BBS have indicated that they consistently eat more than their 
wild-type littermates and develop obesity progressively from an early onset.  
Rahmouni et al found BBS2, 4, and 6 null mice to have low locomotor activity 
and increased levels of circulating leptin, a hormone that regulates satiety 
(Rahmouni et al., 2008).  Adding exogenous leptin to wild type mice reduced 
bodyweight by around 10% in a 4-day period, but it had no effect on BBS mutant 
mice, regardless of underlying mutation.  This suggested that BBS mice were 
leptin-resistant and the hypothalamic neurons were not responding to the signal, 
resulting in uncontrolled appetite and a persistent feeling of hunger.  They also 
showed that this leptin resistance contributed to hypertension in the mutant mice, 
another feature of BBS. 
 
A naturally occurring mouse mutant of Alms1 exists known as Fat aussie (Foz) 
(Arsov et al., 2006).  This mouse also had hyperphagia and obesity, as well as 
insulin insensitivity resulting in type 2 diabetes.  In addition, the sperm of males 
were aflagellate, causing infertility, as is the case for BBS null mice.  The 
subcellular localisation of Alms1 reveals that it has a ciliary and basal body 
distribution, although fibroblasts from affected individuals show no defects in 
cilia formation or the cytoskeleton (Hearn et al., 2005).  
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Berbari et al found that G-protein coupled receptors failed to localise to primary 
cilia in BBS mutant mice (Berbari et al., 2008b).  This included melanin 
concentrating hormone receptor 1, a protein involved in the regulation of feeding 
behaviour.  They suggested that this could result in hyperphagia-induced obesity.   
 
Romano et al found that Alms1 was expressed at highest levels in preadipocytes, 
but treating adipocytes with adipogenic factors had no effect on the gene 
expression of Alms1.  This suggested that Alms1 might have a role in the 
transition from preadipocytes to adipocytes.  Forti et al (2007) showed that BBS1-
9 and BBS11 were expressed in adipocytes, and that transcript levels increased 2- 
to 4-fold during differentiation of adipocytes (Forti et al., 2007).   
 
Davenport et al provided the first potential cell biological insight into the 
mechanism of ciliopathic obesity.  They knocked out Kif3a, thereby completely 
ablating cilia, specifically in hypothalamic neurons expressing POMC (pro-
opiomelanocortin), a type of neuron negatively regulating appetite (Davenport et 
al., 2007).  They found that these mice had one specific phenotype: uncontrolled 
eating leading to obesity.  While BBS knockout does not have as dramatic an 
effect on ciliogenesis as Kif3a, it is clear that cilia are important in this class of 
neuron for appetite regulation, and suggests a potential role for BBS and ALMS 
proteins in these neurons.  Currently, no conditional mouse models exist for BBS 
in which this can be tested.   
 
There seem to be potential roles for BBS proteins in appetite sensation and fat 
storage.  The data supporting a role for the proteins in the hypothalamus are more 
extensive and convincing, and fit with the observation of overeating. 
 
Other features of ciliopathies 
Skeletal dysplasia 
Earlier, I classified the ciliopathies with skeletal involvement into their own 
category, consisting of JATD, EVC, and OFD1.  JATD and EVC show similar 
skeletal and extra-skeletal features, as does short-rib polydactyly syndrome, 
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although the gene for this has not yet been identified.  JATD patients have a small 
rib cage and narrow chest, which obstructs the lungs and can cause death by 
asphyxiation in infancy.  In addition, the long bones, such as the femur, are short, 
as are the bones of the hands and feet.  EVC patients also have short limbs and 
short ribs, and have dental and craniofacial abnormalities.   
 
Ruiz-Perez et al showed that Indian hedgehog (Ihh) was expressed normally in the 
growth plates of developing bones, where it signals to induce prechondrocyte 
proliferation (Ruiz-Perez et al, 2007).  However, Patched1 and Gli1 were 
downregulated in the bones.  Similarly, Beales et al showed that these target genes 
were downregulated in zebrafish morphants for ift80, a gene mutated in JATD 
(Beales et al., 2007).   
 
The importance of cilia in Ihh signalling during bone development was confirmed 
by Koyama et al, who conditionally ablated Kif3a expression in cartilage 
(Koyama et al., 2007).  They showed mutant growth plates lacked proliferating 
cells seen in controls, and lacked expression of important downstream genes such 
as collagen X, VEGF, and matrix metalloproteinase (MMP).  Haycraft et al 
ablated Ift88 in the limb mesenchyme, which resulted in polydactyly and 
shortened limbs (Haycraft et al., 2007).  They showed that the polydactyly was 
due to Shh pathway disruption, while Ihh affected the extent of limb outgrowth.  
These data conclude that IFT is essential for normal skeletal development.  The 
fact that some ciliopathies affect bone growth more than others might reflect 
different expression patterns of these genes.  
 
Sensory deficits 
Retinitis pigmentosa (RP) involves progressive loss of vision, first manifesting as 
night blindness, then tunnel vision, before progressing to complete loss of sight.  
It is a primary feature of several ciliopathies, including BBS, ALMS, and SNLS.  
The average age of complete blindness in BBS patients is fifteen (Beales et al 
1999).  The connecting cilium in the rod cells carries rhodopsin molecules into the 
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outer segment of the rod cell.  Defects in ciliary transport cause these cells to die 
by apoptosis resulting in progressive loss of vision. 
 
Abd-El-Barr et al showed that rhodopsin is not transported from the cell body to 
the outer segment in Bbs4 null mice, and that these cells subsequently die (Abd-
El-Barr et al., 2007).  In addition, they noticed defects in synaptic transmission 
from the photoreceptors to the visual neurons.   
 
Bainbridge et al provided the first evidence of effective gene therapy for retinal 
degeneration caused by a ciliopathy – LCA (Bainbridge et al., 2008).  The 
underlying mutation was in RPE65, which encodes a ciliary protein expressed in 
the retina.  They were able to reconstitute the sight of three patients by injecting 
an adenoviral vector underneath the retina of the patients.  This raises the 
possibility of treating the sight of BBS patients using gene therapy. 
 
Deafness is also present in several of the ciliopathies, most notably Alstrom 
syndrome.  Most patients develop sensorineural hearing loss and about 10% 
become profoundly deaf (Marshall et al., 2007).  Ross et al found that half the 
Mkks null mice tested failed to respond to auditory stimuli, compared to none of 
the controls (Ross et al., 2005).  They found that BBS patients could not detect 
high frequency sounds, and adolescent patients had a hearing age of elderly 
individuals.   
 
Anosmia is another sensory deficit of BBS patients, reported by two separate 
groups (Kulaga et al., 2004; Nishimura et al., 2004).  Kulaga et al showed that 
BBS patients had partial or complete anosmia, with 50% being unable to detect 
odours at all.  Bbs4 null mice had a reduced ciliated border of the olfactory 
epithelium, which resulted in the trapping of olfactory receptor molecules in the 
cell bodies of olfactory receptors.   
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Hirschsprung’s disease 
Hirschsprung’s disease (HSCR) has been reported in up to 45% of BBS patients 
(de Pontual et al., 2007), but a more realistic estimate of prevalence is 5-10% 
(unpublished observations of P. Beales).  This incidence is extremely high 
compared to the general population where it only affects 1 in 5,000 children 
(0.02%).   
 
HSCR arises when neurons fail to colonise the intestine, usually the colon, 
resulting in a lack of peristaltic activity and blockage of the gut, leading to chronic 
constipation and megacolon at birth and during infancy.  The only treatment is 
surgical resection of the aganglionic segment, or colostomy.  Stem cell therapies 
to reintroduce neurons into the gut are underway in mouse models, but their 
efficacy is uncertain and translation to humans is a long way off (Gershon, 2007).   
 
Craniofacial dysmorphology and ciliopathies 
Craniofacial dysmorphology is variable and can manifest as obvious and extreme, 
or subtle and hard to distinguish.  OFD1 is an X-linked dominant lethal ciliopathy, 
meaning all patients are heterozygous females.  Patients present with severe 
craniofacial involvement, including cleft palate and a shortened, hypoplastic 
midfacial region.  Ferrante et al produced an Ofd1 mouse knock-out with severe 
cleft-palate and a disorganised brain, in addition to polydactyly, renal cysts, and 
randomised laterality.   
 
Abnormal craniofacial features have been reported in BBS patients by several 
independent investigators, as well as anecdotally by family members (Beales et 
al., 1999; Lorda-Sanchez et al., 2001).  In contrast to OFD1, the features are 
variable and subtle, and it often takes a trained dysmorphologist to accurately 
describe the face, even though there is often an obvious gestalt, or overall 
appearance.  Beales et al described the facies of BBS patients as having: “deep-set 
eyes, hypertelorism, downward slanting palpebral fissures, a flat nasal bridge with 
anteverted nares… a long philtrum and thin upper lip”.  Lorda-Sanchez et al came 
to similar conclusions with their analysis of the BBS face and added small mouth, 
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malar hypoplasia (small cheek bones) and retrognathia to the facial 
characteristics.  Figure 11 shows some photographs of adults and children with 
BBS. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  BBS patient faces. 
Four children (top row) and adults (bottom row) with BBS.  In addition to the excess fatty 
tissue, the patients have deep-set eyes, a small nasal bridge, retrognathia, thin lips, and a 
small jaw.  Taken from Beales et al (1999) and the LMBBS society pamphlet. 
 
The zebrafish as a model for studying human disease 
The zebrafish is a small (3-4cm long as adult), striped fish originally derived from 
freshwater lakes of the Himalayan foothills.  It has come to prominence in biology 
because of its embryos; each female can lay hundreds of eggs in a single 
spawning.  The embryos are optically clear and so development can be observed 
in real time, and because they develop ex vivo, it is possible to manipulate the 
embryo as it grows.  Development is rapid and all the major organ primordia have 
formed by 30 hours post fertilisation (hpf).  The embryo hatches from its chorion 
and becomes free-swimming at about 2.5 days post-fertilisation (dpf).  Until 5 
dpf, the embryo feeds on its yolk supply, after which it begins to feed on 
exogenous sources.  Figure 12 shows some stages of zebrafish development. 
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Figure 12.  Stages in zebrafish embryogenesis. 
A.  fertilised 1-cell stage; B. dome stage (5hpf); C. 12 somites (15 hours); D. 20 somites 
(19 hours); E. adult zebrafish.  Taken from http://www.zfin.org (July 2008) and 
http://www.bio.umass.edu/biology/kunkel/fish/zebra/devstages.html. Scale bars: A-D = 
200µm; E = 0.5cm. 
 
Genetic knockdowns can easily be made by injecting an antisense morpholino 
oligonucleotide (MO) against the gene of interest into the developing embryo at 
the 1 to 2-cell stage.  This oligo is inherited by each daughter cell and can provide 
efficient knockdown of expression for around 3 days.  Instead of ribose, the MO 
contains a 6-carbon morpholine ring in the oligonucleotide backbone.  This 
prevents it eliciting an exonucleolytic response by the host, and allows the MO to 
persist in the embryo to provide longer lasting knockdown than conventional 
RNAi.  MOs can be targeted to block translation by binding at, or just upstream 
of, the start AUG sequence of the mRNA.  Alternatively, they can block splicing 
by binding across a splice donor or acceptor site at an intron-exon boundary.  This 
produces a mature mRNA, either without an exon, or with a translated intron, both 
of which can lead to frameshifts resulting in a non-functional protein product.   
 
Zebrafish morphants have been used to model several human genetic diseases, 
including BBS.  Mouse models only exist for certain BBS genes and our lab only 
has access to Bbs4 and Bbs6 mutants, of which only Bbs4 nulls show any 
embryonic phenotypes.  These mutants breed very poorly and so reliably 
obtaining null embryos is difficult.  The zebrafish can generate knockout models 
of any gene quickly, and with the right control experiments, it is reliable.  The 
A B C D 
E 
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physiology of all the major organ systems is homologous to mammals, and the 
same signalling pathways are present and function in similar roles.   
 
There are several disadvantages to using zebrafish.  First, it is harder to 
extrapolate findings to humans.  Second, its rapid development means 
perturbations to the genetic program early on can have more devastating effects 
than in mammalian embryos, as there is less time for compensation by other genes 
or pathways.  Third, zebrafish lack limbs so studies of polydactyly cannot be 
performed.  Fourth, a lack of genetic mutants means only studies on embryonic, 
and not adult, phenotypes can be carried out. 
 
Zebrafish ciliary phenotypes 
Several zebrafish genetic mutants from mutagenesis screens have been identified 
in which the genes were subsequently found to encode ciliary proteins 
(Drummond et al., 1998; Zhao and Malicki, 2007).  Disruption to ciliary genes in 
zebrafish gives stereotypical morphological phenotypes, including a down-curved 
body axis, shortened and flattened somites (the segmented blocks of muscle in the 
body axis), kidney cysts, and randomised left-right asymmetry (heterotaxia).  As a 
group, these phenotypes are specific and can be used as a diagnostic toolkit if a 
gene has suspected ciliary involvement.  Figure 13 shows some of these 
phenotypes in ciliary mutants. 
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Figure 13.  Zebrafish ciliary mutant embryonic phenotypes. 
A and A’: wild-type zebrafish larva at 5dpf.  B: locke mutant showing down-curved body 
axis and, B’: kidney cyst (arrowhead).  C: control zebrafish showing right-sided ventricle 
and left-sided atrium in the heart.  C’ dub morphant with reversed heart looping 
compared to control (C).  Taken from Sullivan-Brown et al (2007) and Oishi et al (2007).  
Scale bars: A,B = 1mm; A’,B’ = 500µm. 
 
Objectives of this project 
The study of ciliopathies has intensified since discovering the aetiology of BBS in 
2003.  Many new ciliopathy genes have been identified since then, but their 
functions are, at best, poorly understood, and mostly completely unknown.  My 
investigations had the following objectives to discover some more about 
ciliopathy protein function, centering around the use of the zebrafish as a model 
system: 
 
1) To uncover the cellular and molecular basis for craniofacial 
dysmorphology in BBS patients.  In collaboration with Professor Peter 
Hammond, then at the UCL Eastman Dental Institute, I analysed data from 
facial scans of BBS patients and controls, and BBS null mice.  I then 
modelled these defects using the zebrafish. 
 
2) To examine the novel role of BBS proteins in neural crest migration.  I 
took the results from the facial data in humans, mice, and fish to 
investigate a potential new role of BBS proteins in neural crest cell 
development.  This led me to uncover an important role for BBS8 in cell 
migration. 
wild-type locke 
A 
A’ 
B 
B’ 
C 
C’ 
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3) To establish the molecular basis of these migration and patterning 
defects. I investigated the role of Bbs8 in two important signalling 
pathways: Shh and PCP. 
 
4) To use the zebrafish to develop a system for studying the kidney 
disease common to all ciliopathies and use this model to test candidate 
drugs. 
 
5) To use the zebrafish to investigate several genetic interactions of 
ciliopathy and non-ciliopathy proteins, and to test the function of 
putative ciliary proteins.  
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Chapter 2: Materials and methods 
Materials 
Reagents 
 
 
Tissue culture 
Cell lines used and culture conditions 
For Shh responsiveness assays NIH3T3 (immortalised mouse embryonic 
fibroblast) cells were used.  Some experiments were also performed on two 
primary fibroblast lines taken from two adult patients with null mutations in 
BBS8.  Cells were maintained in 75cm2 tissue culture flasks with 20ml of DMEM 
supplemented with 10% BCS and 1% Penicillin and Streptomycin.  Once every 3 
days cells were washed with PBS and detached from the flask using trypsin and 
EDTA.  Cells were replated at a dilution of 1:10.  For luciferase assays cells were 
cultured in 48 well plates at a seeding density of 50,000 cells per well.  For Gli3-
processing assays, cells were grown in six well plates. 
 
20x SSC 3M NaCl, 0.3M sodium citrate (pH 7.0) 
DNA ladder 0.1µg/µl DNA ladder (Invitrogen), 20% loading buffer in water 
dNTP mix (10x) 2mM each: dATP, dCTP, dTTP, dGTP 
Fish block 10% goat serum, 1% DMSO, 0.5% Triton X100, PBST 
Fish water UV illuminated, filtered through activated charcoal, 60µg/ml Instant Ocean 
salt mix 
Hyb solution Prehyb solution plus 5mg/ml yeast T-RNA, 50mg/ml heparin (pH 6.0) 
Hybridisation 
buffer 
50% formamide, 5x SSC, 0.1% Tween 20, 5mg/ml yeast RNA, 50mg/ml 
heparin, pH 6.0 
LB agar 2% agar, LB broth 
LB broth 1% bactotryptone, 0.5% bactoyeast, 1% NaCl 
Loading buffer 20% glycerol, 0.25% bromophenol blue 
Maleic acid buffer 150mM NaCl, 100mM maleic acid (pH 7.5) 
PCR buffer (10x) 100mM Tris-HCl, 400mM NaCl, 15mM MgCl2, 2.5mM spermidine 
Prehyb solution 50% formamide, 5x SSC, 0.1% Tween-20 (pH 6.0) 
RIPA buffer 25mM Tris-HCl (pH 7.6), 150mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS, protease inhibitor cocktail (Roche) 
Tail lysis buffer 100mM Tris (pH 8.5), 5mM EDTA, 0.2% SDS, 200mM NaCl, 100µg/ml 
Proteinase K 
TE buffer 10mM Tris-HCl, 1mM EDTA (pH 8.0) 
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To check that Bbs8 was knocked out in both primary and stably transfected cells, I 
performed quantitative real-time reverse transcriptase PCR (qRT-PCR).  This 
showed that BBS8 mRNA (normalised to GAPDH) was present at 5% of the wild 
type level in primary fibroblasts, and at 8% of the endogenous level in control 
stably transfected cells.   
 
For Smoothened immunolocalisation, IMCD3 (mouse inner medullary collecting 
duct immortalised cells) and HEK (human embryonic kidney) cells were used.  
IMCD3 cells were grown in DMEM:F12 1:1 media (Invitrogen).  MDCK cells 
were grown in DMEM.  10% FBS was used to supplement both media. 
 
shRNA silencing of gene expression 
In order to silence expression of Bbs genes in tissue culture cells we purchased 
constructs from Open Biosystems against BBS2,3,4,5,6,7, and 8, and IFT80, 
designed to target both human and mouse homologues of these genes.  These 
constructs use a modified form of the microRNA, mir-30, whose sequence-
specific binding region has been replaced with the sequence specific to the gene 
of interest.  This degrades mRNA by the Dicer/RISC pathway leading to effective 
knockdown of protein expression of around 90% (www.openbiosystems.com).  
The shRNA sequence is contained within the pSM2 plasmid and is under the 
control of the U6 upstream promoter and the plasmid contains Kanamycin and 
Chloramphenicol bacterial selectable markers, as well as a neomycin cassette to 
select stably transfected eukaryotic cells. 
 
In order to monitor the efficiency of shRNA uptake in transiently transfected cells 
the 110bp fragment containing the shRNA sequence and flanking regions was 
cloned into the LMP vector, a micro-RNA adapted retroviral vector.  This has the 
advantage of being integrated into the host genome and co-expressing GFP to 
monitor transgene expression levels.  See the “Cloning” section for details of how 
this was achieved.   
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The expression levels of the shRNAs were tested by the intensity of GFP 
fluorescence.  This was slightly variable between constructs but the constructs 
used extensively – Bbs8 and Ift80 – were both expressed at high levels in around 
90% of cells transiently transfected.  In order to assess functional efficacy of the 
shRNAs the constructs were transiently transfected into IMCD3 cells and 
immunostained for PCM1.  This protein normally localises to the basal body in 
cells but has been shown to be dispersed when BBS4 is knocked down (Kim et al 
2004).  This was expected to be the case for other BBS knockdowns.  
Unfortunately, this assay did not work and gave inconclusive results, even in 
untransfected cells.   
 
To validate the efficiency of knockdown in Bbs8 shRNA treated cells, RNA was 
extracted from the cells and used to generate cDNA using Trizol (Invitrogen) 
according to the manufacturer’s protocol.  cDNA was reverse-transcribed from 
total mRNA using SuperScript reverse-transcriptase (Invitrogen) primed with 
random hexamers (Invitrogen).  Quantitative RT-PCR was then performed using 
an ABI Prism 7000 (Applied Biosystems) to measure the level of Bbs8 transcript 
in cells.  Although this is not a direct assay, as the microRNA construct is thought 
to work partially by blocking translation and partly by causing RNA degradation, 
the results showed around 90% knockdown of Bbs8 transcript.  The Bbs8 
antibody is too unreliable to quantify knockdown by Western Blot but would be 
the best way to reliably measure shRNA efficacy. 
 
Transient transfection of cell lines 
Cell lines growing in 75cm2 flasks were trypsinised and plated onto 6, 24, or 48 
well plates.  If cells were to be immunostained, they were grown on glass 
coverslips.  HEK cells were grown on coverslips coated in 0.1% poly-L-lysine 
(Sigma) in PBS.  Cells were grown to 95% confluence and then transfected with 
plasmids using Lipofectamine 2000 reagent (Invitrogen) according to the 
manufacturer’s protocol.  After transfection, cells were kept in serum-free 
medium for 5 hours before replacing with normal media.  Cells transfected with 
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GFP-expressing constructs were visualised with an inverted fluorescence 
microscope 24 hours after transfected to monitor transfection efficiency. 
 
Production of stable cell lines 
In order to generate a cell line in which every cell constitutively expressed shRNA 
against Bbs8 and Ift80, I created stably transfected cell lines in both 3T3 and 
MDCK (Madin-Darby Canine Kidney) cell lines, both of which are ciliated.  Cells 
were transiently transfected with the shRNA construct in the LMP vector in 
100mm dishes.  Five days after transfection, the selectable marker Neomycin was 
used to select cells in which the shRNA cassette had inserted into the genome.  
Antibiotic selection continued for two weeks to ensure all transiently transfected 
cells were eliminated.  Neomycin was used at 2ng/ml for 3T3 cells and 2.5ng/ml 
for MDCK cells. 
 
Because the LMP vector expresses GFP linked to the expression of the shRNA, 
the intensity of GFP fluorescence is directly proportional to the amount of shRNA 
expressed.  Cells were then sorted using a Coulter Altra FACS machine into low-
GFP expressing and high-GFP expressing populations.  Cells expressing 
extremely high levels of GFP were discarded because of potential toxicity from 
over-expression of foreign DNA.  A single positive cell was sorted into each well 
of two 96-well plates for all samples.   
 
These cells were then incubated in 96 well plates until a sizeable colony had 
grown from the single sorted cell.  Viability after sorting was around 80% for both 
cell types.  Once colonies had established in the 96 well plates, the cells were 
trypsinised and replated in six well plates.  Twelve clones for each sample were 
grown and assessed for GFP fluorescence.  100% of these cells uniformly 
expressed GFP and so two clones for each sample (BBS8 GFP low and GFP high, 
IFT80 GFP low and GFP high, in both 3T3 and MDCK cell lines) were plated in 
75cm2 flasks and used for subsequent experiments.  High GFP expressing cell 
lines were used for most assays.  These cell lines will be referred to as: Bbs8 
shRNA and Ift80 shRNA.  
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Scratch wound healing assays 
3T3 cells stably transfected with either control or Bbs8 suppressing shRNA, or 
primary human fibroblasts taken from unaffected or BBS8 null patients were 
seeded on 16mm glass coverslips in 12 well plates.  Cells were grown to 
confluence and then starved overnight in medium supplemented with 0.5% serum.  
This was to prevent further cell proliferation, which could confound cell 
migration.   
 
After starvation, a scratch was made in a straight line through the cells using a 
sterile P20 pipette tip.  The cells were washed carefully once in PBS to remove 
detached cells and then re-immersed in low-serum growth medium.  Cells were 
fixed at 0, 6, 24, 48, and 72 hours post-scratching in 4% PFA for 15 minutes at 
room temperature.  Cells were blocked with 1% BSA in 0.1% TX-100 for 30 
minutes at room temperature before incubation in Phalloidin-594 (Invitrogen) for 
1 hour at room temperature to reveal the actin cytoskeleton.   
 
To measure the degree of cell migration, cells were imaged at low power (10x 
objective) and the distance between opposing cells was measured using Zeiss 
AxioImager 4.5 software.  An average of 10 measurements was taken and the 
width of the gap calculated at each time point for all cell types.  The differences in 
gap width between control and bbs8 mutant cells were analysed by t-test 
(Microsoft Excel).  
 
Shh agonists 
Three different agonists were used: 1) recombinant Shh peptide (R&D Systems) 
dissolved at 50µg/ml in PBS with 1% BSA.  This gave a strong transcriptional 
response but was too expensive to use for repeated experiments.  2) Shh-
conditioned media: this was made by transfecting COS-7 cells with a Shh-
expressing plasmid.  The cells then secrete the recombinant Shh into the overlying 
media, which, after five days, is removed and filtered.  The presence of Shh 
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peptide in the aspirated medium was confirmed by Western blot with an anti-Shh 
antibody (1:200, Santa Cruz Biotechnology, CA, USA) shown in Figure 14.  Shh 
protein was not present in untransfected COS-7 cells.  3) Purmorphamine is a 
synthetic molecule that binds directly to Smoothened (Smo) to activate 
downstream components of the cascade.  This method gave the most consistent 
and reliable results, and its concentration could be most easily regulated and 
reproduced, so it was more commonly used in subsequent assays.   
 
 
 
 
 
 
 
 
Figure 14.  Recombinant Shh western blot 
The arrow shows the position of the band corresponding to Shh protein (21kDa) in two 
independent batches of conditioned medium.  10µl of conditioned medium was taken 
from COS-7 aspirate (total medium produced was 10ml per batch) and mixed with an 
equal amount of 2x sample buffer. 
 
A dose-response curve to differing amounts of purmorphamine (dissolved in 1% 
DMSO) and Shh-conditioned media was performed by adding 0, 0.1, 0.2, 0.5, 1, 
2, or 5µM of purmorphamine, or 1:200, 1:50, 1:20, or 1:10 dilutions of Shh 
conditioned media to Shh-Light II 3T3 cells (see below) and performing a 
luciferase assay to assay Gli transcriptional activation.  These results are shown in 
chapter 5. 
 
From these results, it was ascertained that purmorphamine should be used at 
0.5µM and Shh-conditioned media at a 1:20 dilution.  This correlates with 
previously published work using these Shh pathway stimulants (Wu et al., 2004). 
 
1:1 1:10 1:100 1:1 1:10 1:100 10% 0.5% 0% 
FBS in DMEM Batch 2 Batch 1 
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Luciferase reporter assays 
For this assay, cells used were either transiently transfected with the luciferase 
reporter and an shRNA construct specifically knocking-down Bbs8 (or a control 
shRNA), or stably transfected cells were used, which constitutively express 
shRNA against Bbs8 (or control shRNA).  In addition, the assay was tried with 
Shh-Light II cells (gift of James Briscoe, NIMR).  These cells are stably 
transfected with the Gli-luciferase reporter and Renilla luciferase.  Most of the 
results presented here used the cells stably transfected with the Bbs8-shRNA 
construct and transiently transfected with the luciferase and Renilla constructs, 
unless stated otherwise.  This situation gave the most reliable results, as all the 
cells were deficient in Bbs8.  If the shRNA was to be transiently transfected, there 
would still be some cells (around 20%) not expressing Bbs8-shRNA which would 
confound the results.   
 
For the Gli activation luciferase assays, 50,000 cells were seeded on 48-well 
tissue culture plates to give 95% confluence 16 hours later.  At this point, cells 
were transfected with 0.8µg of the Gli luciferase reporter.  This construct consists 
of six Gli binding sites fused to the luciferase gene.  When the Sonic Hedgehog 
pathway is activated, Gli1 binds to these sites to initiate transcription of luciferase.  
25ng hCMV Renilla luciferase was co-transfected with the reporter to act as an 
internal transfection control.   
 
For transfections, the plasmids were mixed with Lipofectamine 2000 reagent 
(Invitrogen) according to manufacturer’s instructions.  Cells were then incubated 
in serum-free media for 5 hours to uptake the plasmids.  Serum-supplemented 
media was then added and the cells incubated overnight.  The next day, when the 
cells had grown to confluence, they were starved in serum-free media for 24 hours 
to induce the growth of primary cilia.  After this, the Shh-agonist was added to 
stimulate the Shh pathway.  Non-confluent, or non-starved cells that fail to ciliate, 
do not respond to Shh stimulation (Ocbina and Anderson 2008). 
 
Twenty-four hours later, the luciferase assay was performed using the Dual 
Luciferase assay kit (Promega, USA).  Cells were lysed in their wells by adding 
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50µl of lysis buffer with shaking for 15 minutes.  20µl of lysate was added to each 
luminometer tube containing 100µl of luciferase reporter substrate.  This substrate 
contains the luciferin that releases light in the presence of active luciferase 
enzyme.  The intensity of this light is measured by the luminometer and correlates 
with the level of transcriptional activation.  After the luciferase reading was taken, 
100µl of Stop And Glow reagent was added to quench the firefly luciferase 
reaction and allow the luminometer to measure the activity of the Renilla 
luciferase.   
 
The ratio of firefly luciferase activity to Renilla luciferase was then used to 
calculate the relative amount of transcriptional activity for each cell, controlling 
for differences in transfection level.  Each experimental condition was performed 
in triplicate and each experiment was performed three times.  The average of all 
runs was used and the standard deviation calculated.   
 
Western blotting 
Western blotting was performed on both cultured cells and embryo extracts.  For 
embryo extracts, the tissue was first treated with 0.25% trypsin-EDTA for around 
15 minutes to loosen cell contacts.  It was then triturated with progressively 
narrower fine gauge needles to dissociate the cells.  The trypsin was then 
inactivated by adding medium containing serum and the tissue was pelleted by 
centrifuging.  100µl of 2x Laemmli SDS-PAGE sample buffer containing 5% β-
mercaptoethanol was added and heated at 95°C for 5 minutes to denature the 
proteins.  For cultured cells, cells grown in 6 well plates were washed once in 
PBS and 100µl of 2x Sample Buffer heated to 100°C was added to each well.  
The cells were dislodged using a rubber stopper and decanted into 1.5ml 
eppendorf tubes.  These were then heated at 95°C for a further 5 minutes to 
denature proteins.   
 
The following protocol was the same for both embryo extracts and cultured cells.  
Samples were spun at 13,000 rpm for 5 minutes to pellet cell debris.  20µl of each 
sample was then loaded onto a 1mm thick 7.5% polyacrylamide SDS gel using 
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Rainbow molecular weight markers (Sigma).  Gels were run for 1 hour at 200V.  
The proteins were then transferred to a nitrocellulose membrane (GE Healthcare) 
using 200mA of current for 2 hours in the cold room.  The success of the Western 
transfer was assessed by staining with Ponceau Red solution.  The membranes 
were then blocked for 3 hours in 5% skimmed milk powder in TBST.  Primary 
antibody was diluted in block solution and the membranes were wrapped in 
plastic bagging and incubated overnight with rocking.  Primary antibodies used 
were: anti-Gli3 H180 (Santa Cruz, detects both long and short isoforms of Gli3, 
used at 1:200), anti-Gli3 C20 (Santa Cruz, detects C-terminal isoform only, used 
at 1:200 – could not get any specific signal), anti-Shh (Santa Cruz, used at 
1:1,000), anti-α-tubulin (Sigma, used at 1:5,000), anti-mTOR (Cell Signalling 
Technology, used at 1:1,000), anti-phospho-mTOR (CST, used at 1:1,000), anti-
S6K (CST, used at 1:1,000).   
Co-immunoprecipitation 
IMCD3 and 3T3 cells were plated at a density of 5x105 cells per well in six well 
plates.  Cells were transfected with N- or C-terminally GFP-tagged BBS8 
constructs using Lipofectamine 2000 reagent according to the manufacturer’s 
protocol.  Forty-eight hours later, cells were lysed in 1ml ice-cold RIPA buffer for 
15 minutes on ice before dislodging with a rubber syringe plunger.  Cells were 
transferred to an Eppendorf tube and spun at 13,000rpm for 5 minutes.  100µl of 
supernatant was removed to an Eppendorf.  This sample served as the pre-IP 
lysate.  900µl of supernatant was transferred to a second tube.  1.5µg of anti-Gli3 
antibody (Santa Cruz Biotechnology) was added to this tube and also to a separate 
tube containing buffer only.  20µl of protein A/G beads was added to these two 
tubes, which were then incubated overnight at 4°C on a roller.   
 
The next day samples were spun down and the supernatant discarded.  Pelleted 
beads were washed three times for one minute; vortexing, centrifuging and 
discarding the supernatant between each wash.  The final pellet was resuspended 
in 50µl of 2x protein loading buffer.  20µl of each sample was loaded onto a 7.5% 
SDS-PAGE gel with their corresponding lysate.  The membrane was probed with 
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an anti-GFP antibody to detect BBS8-GFP.  If a band was present, BBS8 must 
have been immunoprecipitated with Gli3. 
 
Immunocytochemistry 
For immunocytochemistry on cultured cells; cells were fixed in either 4% PFA in 
PBS for 15 minutes or cold methanol for 5 minutes.  Cells were blocked with 1% 
BSA in PBS with 0.1% Tx100 for 30 minutes before incubating with primary 
antibody in blocking solution for 1 hour at room temperature.  Secondary 
antibodies used were anti-goat, rabbit, mouse, and rat IgGs conjugated to 488, 
568, or 594nm fluorophores (all Invitrogen Alexa secondary antibodies).   
 
For immunohistochemistry on wholemount zebrafish, dechorionated embryos 
were fixed in 4% PFA overnight at 4°C before blocking in 1% BSA, 2% sheep 
serum, 1% DMSO, and 0.5% Tx-100 for 1 hour at room temperature.  Embryos 
were incubated in primary antibody overnight at 4°C, washed three times for 10 
minutes in 0.5% Tx100 and then incubated in fluorescent secondary antibody for 
1 hour at room temperature.  Primary antibodies used were: anti-acetylated tubulin 
(Sigma, 1:1,000), anti-gamma tubulin (Sigma, 1:1,000), anti HuC/D (Invitrogen, 
1:200), anti-GFP (Clontech, 1:500), anti-phosphohistone H3B (Millipore, 1:200). 
 
Polymerase Chain Reaction (PCR) 
PCR reactions were carried out in 96 well plates or tube strips.  For most reactions 
the following mixture was used: 
5-50ng DNA 
1x PCR buffer 
200µM dNTP mixture 
5pmol of each primer 
0.2µl Taq polymerase (Bioline) 
Make up to 25µl in sterile water 
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Most PCR programs were carried out using a touch down program.  Samples were 
denatured for 5 minutes at 95°C followed by ten cycles of amplification 
consisting of a denaturation step at 95°C for 30 seconds and an annealing step for 
30 seconds starting at 65°C and decreasing by 1°C per cycle.  This was followed 
by a 1 minute 72°C elongation step and a further 25 cycles with the annealing 
temperature at 55°C.  Finally, a 10-minute elongation step at 72°C. 
 
PCR products were checked on an agarose gel by electrophoresis.  For most gels, 
1% agarose was used dissolved in 1x TAE buffer by heating in a microwave 
followed by the addition of 0.5µg/ml ethidium bromide.  Samples mixed with 6x 
loading buffer were loaded onto the hardened gel and a size marker was run 
alongside the DNA samples.  DNA was visualised on a UV transilluminator. 
 
Cloning 
Cloning procedure 
Primers with intrinsic restriction sites designed to fit into the vector of interest 
were designed to amplify the full-length coding region of the gene of interest.  
The PCR product was checked on an agarose gel, cleaned up using a Qiagel 
QIAquick gel extraction kit, and eluted in 30µl of water.  This was then subject to 
restriction digestion to produce sticky ends.  The vector was cut using the same 
enzymes and treated with 1µl of calf intestinal alkaline phosphatase for 30 
minutes at 37°C to prevent recircularisation of the plasmid.  Enzyme activity was 
quenched by denaturing at 65°C for 15 minutes.  The insert and vector were then 
mixed in a 3:1 ratio and ligated for 3 hours at 14°C using T4 DNA ligase 
(Invitrogen).   
 
2µl of the ligation product was used to transform JM109 chemically competent E. 
coli cells.  For ligation products that would not transform with chemically 
competent cells, electrocompetent cells were used and electroporated.  
Transformations were left on ice for 10 minutes before heat shocking at 42°C for 
40 seconds, left to recover on ice for 2 minutes and then mixed with 1ml LB 
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broth.  This mixture was shaken at 37°C for 1 hour and then 50µl was spread onto 
antibiotic-containing LB agar plates.   
 
Ten colonies were then picked at random and minipreps generated.  Miniprep 
DNA was tested by restriction digest to check it had the gene of interest.  This 
miniprep culture was then used to inoculate a maxiprep culture from which up to 
500µg of plasmid DNA was recovered.  This was dissolved in sterile water to 
yield a final DNA concentration of 1µg/µl. 
 
Vectors used 
pBS2  This was used to clone ESTs to make antisense riboprobes for in situ 
hybridisation. 
pCS2+  This vector is designed for over-expressing genes in vertebrate embryos.  
It has a simian CMV promoter driving expression of the gene and a 3’ polyA 
sequence.   
pSM2  This vector expresses antisense shRNA under the control of a viral 
promoter. 
LMP  This vector is like pSM2 but contains a GFP cassette to identify transfected 
cells. 
 
Sequencing 
To check that plasmids contained the correct insert, and that it was in frame after 
PCR and cloning, the plasmids were sequenced.  200ng of plasmid DNA in 3µl of 
water was mixed with 5pmol of the forward or reverse sequencing primer, 1µl of 
BigDye premix containing the ddNTPs and polymerase, 2µl dilution buffer, and 
distilled water to 10µl.  The tubes were placed in a thermocycler for 35 cycles of a 
sequencing program consisting of a 95°C denaturing step for 2 minutes followed 
by a cycle of denaturing from 20 seconds, annealing at 50°C for 10 seconds, and 
extension at 60°C for 3 minutes.  The reaction mixture was topped up with sterile 
water to 20µl after PCR and desalted using a sephadex plate.  Samples were then 
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sequenced on a MegaBACE capillary sequencer and the sequences analysed using 
Sequencher software. 
 
Producing capped mRNA for injection 
For over-expressing constructs in the zebrafish, the full-length cDNA was 
obtained either from Gene Service (Cambridge, UK), or by PCR amplification of 
the full open reading frame from a zebrafish cDNA library made from fifty 24hpf 
zebrafish embryos.  PCR primers were designed to have restriction sites 
compatible for directional cloning into the pCS2+ expression vector.  PCR 
products were digested for 2 hours at 37°C with the appropriate enzymes and then 
purified using a Qiagen PCR clean-up column to remove enzymes.  The pCS2+ 
vector was cut with the same enzymes and purified with the same technique.  A 
3:1 molar ratio of insert to vector was ligated together using T4 DNA ligase 
(Promega) overnight at 14°C.   
 
The recombinant pCS2+ vector was then linearised with NotI downstream of the 
5’ end of the gene.  5µg of purified DNA was transcribed using SP6 RNA 
polymerase at 37°C for 2 hours.  A 5’methyl Guanine capping analogue (New 
England Biolabs) was added to the reaction mixture to add a 5’ cap to the RNA to 
make it more stable in vivo and enhance translation efficiency.  Free RNA 
nucleotides were removed at the end using a ProbeQuant G50 kit (GE 
Healthcare).  RNA in this eluate was precipitated using phenol-chloroform 
followed by ammonium acetate with ethanol at -20°C for 1 hour.  This was spun 
at 13,000rpm for 20 minutes and the resulting RNA pellet washed once in 70% 
ethanol.  This was spun for a further 5 minutes and the RNA was redissolved at 
1µg/µl in nuclease-free water.  RNA was injected at 50-100ng/µl into 1-2 cell 
stage zebrafish embryos.   
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Semi-quantitative RT-PCR 
In order to monitor relative expression of genes involved in Shh pathway 
signalling, I used semi-quantitative reverse-transcription PCR.  RNA was 
extracted from dissociated chick embryonic limb buds or cell cultures using Trizol 
reagent (Invitrogen).  The tissue was triturated and RNA extracted according to 
the manufacturer’s protocol.  Total RNA was resuspended in water and its 
concentration measured on a spectrophotometer.  Equal amounts of RNA were 
used to synthesise first-strand cDNA with random primers and the Superscript 
Reverse Transcriptase enzyme (Invitrogen).  PCR was performed on the cDNA 
using primers for Patched1 and Gli3, and Gapdh was used as a standard by which 
to compare expression of the genes in question. 
 
Quantitative real-time RT-PCR 
RNA was extracted from cultured cells or from pooled groups of fifty 24 hpf or 
ten 5dpf zebrafish embryos using Trizol.  cDNA was synthesised from the total 
RNA as above.  All experiments were performed in triplicate using three PCR 
reactions per sample to get an average of each gene expression.  5ng of cDNA 
was added to each reaction along with 2x SYBR Green reagent, which contains 
nucleotides, polymerase, buffer, and a fluorescent dye that glows when double 
stranded DNA is produced as a result of PCR amplification. 
 
The samples were run on an ABI7000 Prism real-time PCR machine.  Levels were 
normalised to a baseline and the ΔΔCt method was used to calculate gene 
expression for each gene relative to the control gene (Gapdh for cultured cells, β-
actin for zebrafish).   
 
Mouse husbandry 
Embryo collection 
Bbs4 and Bbs6 mutant mice were used for experiments on mouse embryos.  All 
mice were on a C57/Black 6 background.  To obtain embryos, heterozygotes for 
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both genotypes were crossed and the time when a vaginal plug was observed 
scored as E0.5.  On the day at which embryos were required, the pregnant female 
was sacrificed by cervical dislocation and the uterus removed from the abdomen.  
Embryos were dissected out of their deciduas into cold PBS using forceps and 
their yolk sacs were placed in a separate eppendorf tube for retrospective 
genotyping.  Embryos were fixed in 4% PFA at 4°C for 2 hours on rollers to 
ensure even fixation.  All mouse experiments were performed in accordance with 
Home Office guidelines on animal welfare. 
 
Mouse genotyping 
To determine the genotypes of mutant mouse embryos, the yolk sac was used for 
embryos and tail tips for P8-P10 juvenile mice.  The tissue was dissolved in 
100µg/ml Proteinase K solution in tail lysis buffer (100mM Tris-HCl, pH8.8; 
5mM EDTA, pH8.0; 0.2%SDS; 200mM NaCl) overnight at 55°C.  Remaining 
hard tissue was pelleted by centrifugation and the DNA precipitated by the 
phenol:chloroform method.  Approximately 50ng of genomic DNA was amplified 
by PCR using primers specific to either Bbs4 or Bbs6 gene traps.   
 
Mouse embryo cryosectioning 
In order to examine the expression of markers of Sonic Hedgehog activity in the 
neural tube, E10.5 mouse embryos were fixed in 4% PFA for 2 hours at 4°C on a 
nutator.  Embryos were equilibrated in 20% sucrose as a cryoprotectant overnight 
at 4°C before cutting the embryos transversely into three sections so that sections 
could be taken orthogonal to the neural tube at all axial levels.  Each embryo 
segment was embedded in OCT compound and frozen on a bed of dry ice.  Frozen 
blocks were stored overnight at -80°C before sectioning on a Leica cryostat at 
10µm thickness.  The tissue was then dried on a slide warmer and slides were 
stored at -80°C.  Excess OCT was washed off the slides with PBS before 
immunohistochemistry. 
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Mouse skull preparation 
For wholemount scanning of mouse skulls using a desktop laser scanner, the 
skulls had first to be defleshed.  Adult Bbs4-/-, Bbs6-/-, and wild-type mice were 
sacrificed and their weights and lengths measured to control for differences in 
weight.  These are presented below.   
 
The heads were removed and the skin cut away with forceps and scissors.  Major 
muscles were removed with forceps before fixing and dehydrating the head in 
95% ethanol overnight.  After fixation, the skulls were placed in a 2% potassium 
hydroxide solution for a week on a shaker.  The solution was refreshed every day 
and as the soft tissue dissolved away, it was removed with fine forceps, taking 
care not to damage the delicate zygomatic arch.  The skulls were then dehydrated 
again for 48 hours in 95% ethanol and left to air-dry overnight.  The dried skulls 
were then ready for laser scanning, which was performed by Matthew DiFranco at 
the Eastman Dental Institute’s Biomedical Informatics department.  Images of the 
scanned skulls were used to construct a three-dimensional model of the mean 
shape of control and Bbs mutant skulls. 
 
Chick culture 
Pluronic gel treatment 
Whilst the polydactyly phenotype is highly penetrant in human cases of BBS, to 
date polydactyly has not been reported in any of the five published BBS mouse 
models (Bbs1, Bbs1 M390R KI, Bbs2, Bbs4, Bbs6).  This could be due to the 
specific strain the mouse models are bred into or differences in the embryology of 
the mouse and human limb.  
 
To try to investigate the pathophysiology of polydactyly in the limb we tried to 
knock down Bbs8 in the developing chicken limb.  Bbs8 morpholino 
oligonucleotide (MO) specific to the chick Bbs8 orthologue (also called Ttc8) was 
dissolved in water to 1mM.  This solution was mixed with an equal amount of 
30% pluronic gel solution.  When cooled, pluronic gel liquefies and solidifies on 
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return to room temperature.  I tried to apply the gel to the chick limb bud at E2.5 
by making a hole in the vitelline membrane overlying the embryo with fine 
forceps.  Pluronic gel was cooled on ice and 5µl of gel was applied to the limb 
bud using a P20 pipette whose tips had been previously chilled on ice.   
 
Despite trying this experiment several times, it was extremely difficult to get 
consistent uptake of the gel into limb bud, evidenced by fluorescence in the limb 
bud 24 hours after application due to a fluoroscein label on the morpholino.  Most 
of the time this was due to the gel diffusing away from the site of application, 
coming unstuck from the ectoderm of the embryo, or only a limited amount of 
morpholino diffusing into the tissue.  As such, no convincing results were yielded 
with this strategy. 
 
In ovo electroporation 
To try to knockdown expression of Bbs8 in neural crest cells populating the gut, I 
electroporated the Bbs8 MO into chick embryos.  Hamburger-Hamilton stage 10-
12 chicken embryos were windowed using fine scissors after withdrawing 3ml of 
albumin with a syringe.  A 1.0mM solution of Bbs8 morpholino mixed with 
phenol red for visualisation was injected into the anterior neural tube with a fine 
needle and microinjector.  Platinum electrodes were then placed either side of the 
embryo at the axial level around the third somite.  This was to target vagal neural 
crest cells migrating away from the neural tube between the first and seventh 
somites into the foregut.  Five 50ms pulses of 12V were applied to the embryo 
before it was covered in tape and incubated for 24 or 48 hours at 37°C.   
 
Dissection and fixation of chick embryos 
Electroporated embryos incubated for either 24 or 48 hours after electroporation 
were dissected out of their egg by cutting around the blastoderm surrounding the 
embryo with fine scissors.  A square of blastoderm was cut out and pinned at each 
corner onto a silgard plate.  This was then bathed in 4% PFA for around 20 
minutes to fix the embryo in situ.  After this, the embryo was rigid and kept its 
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shape when the remaining blastoderm was cut off with fine scissors and the 
embryo fixed for a further two hours at room temperature.   
 
Immunohistochemistry of chick embryos 
Fixed chick embryos were equilibrated in a 15% solution of sucrose in PBS.  The 
embryos were then embedded in a mixture of 15% gelatin, 15% sucrose and PBS 
prewarmed to 37°C in a water bath.  Embryos were orientated in this embedding 
solution using forceps and left to harden on ice.  Blocks were then stored at -80°C 
to solidify fully.  Frozen blocks were sectioned transversely on a Leica cryostat 
making 15µm sections.   
 
The slides were blocked with 1% BSA in PBS for 30 minutes at room temperature 
before incubation with the primary antibody for one hour at room temperature 
(mouse anti-HNK1 (1:500) or mouse anti-p75 (1:1,000)) which both detect neural 
crest cells.  Following three washes in PBS, the secondary antibody was applied 
(anti-mouse IgG 594).  An anti-FITC antibody (Abcam, 1:1,000) was used to 
enhance the green fluorescence of the fluoroscein tag on the morpholino.  Images 
of the sections were taken on a Zeiss AxioImager microscope. 
 
Quail embryo explant culture 
As a quantitative measure of the effect of gene knockdown on neural crest 
migration, an ex-vivo quail assay was performed.  E1.5 quail embryos were 
electroporated with the chick Bbs8 MO using the same protocol as for the chicks.  
One hour after electroporation the embryos were dissected out of their eggs and 
the neural tube liberated using protease enzymes and fine forceps.  The dissected 
neural tubes were plated onto glass coverslips coated with 0.1% fibronectin and 
0.1% poly-L-lysine.  These were allowed to adhere before bathing in DMEM 
culture medium supplemented with 10% FBS and antibiotics.  The neural tubes 
were left overnight for the neural crest cells to migrate away.  Neural tubes were 
then examined under an inverted microscope and imaged.  The maximum distance 
the green fluorescent cells (morpholino-positive) had migrated away from the 
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neural tube was compared to the maximum distance migrated by the 
unelectrporated neural crest cells.  
 
Zebrafish husbandry 
Strains used 
Wild type Tubingen zebrafish were used for most zebrafish experiments.  Other 
strains used were:   
• Sox10::eGFP.  This line expresses eGFP in the neural crest cells and otic 
vesicle and so can be used to track migrating cells.  Two separate lines 
were used: one with 7.2Kb of the upstream Sox10 promoter sequence 
driving GFP expression, and one with 4.9Kb of promoter sequence.  Both 
lines gave exactly the same expression domains and levels of the 
transgene.  
• Pax2.1::eGFP.  This line expresses GFP in a subset of neurons, the optic 
nerve, and in the pronephros.  This was used to examine the development 
of the kidney. 
• Islet1::eGFP.  This expresses GFP in developing neurons and Rohon-
Beard (RB) cells.  This was used to determine localisation of RB cells in 
morphant embryos. 
 
Zebrafish morpholino injection 
Design of morpholino oligonucleotides 
Morpholino oligonucleotides were designed to knockdown the expression of 
genes in the developing zebrafish embryo.  For most genes studied, at least two 
different MO sequences were used for each gene to ensure specificity.  Usually 
one sequence blocking translation of the mRNA was used (ATG-blocking MO) 
and one blocking the splicing of one of the internal introns (splice-blocking MO).   
 
For each gene studied, the genomic sequence was obtained from the Ensembl 
zebrafish genome database.  A region of DNA sequence ranging from 75bp 
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upstream of the start ATG to 25bp downstream was used to design an ATG-
blocking MO.  For the splice blocking MO an intron-exon boundary (or an exon-
intron boundary) was selected which, when skipped, would yield an out-of-frame 
mRNA.  25bp either side of the boundary was used to design this MO, which 
would sterically hinder the activity of the spliceosome, yielding a dysfunctional 
protein product.  All MOs were manufactured by Gene Tools (Philomath, 
Oregon).  For some genes (ift80, bbs4, bbs8), control MO sequences were ordered 
consisting of the original MO for the gene with five mis-paired residues.  This 
was to exclude off-target effects of the MO.  
 
mRNA rescue experiments 
In order to validate the specificity of the MOs in question, full-length mRNA was 
injected alongside the MO to try to rescue the phenotype caused by the MO.  
Rescue of the phenotype indicates specificity of the MO sequence, and that the 
phenotypes were not caused by toxicity or non-sequence-specific effects of the 
MO.   
 
For ATG MOs the full-length cDNA of the human or mouse orthologue of the 
gene was obtained from Gene Service (Cambridge, UK).  The cDNA was cloned 
into the zebrafish expression vector pCS2+ from which mRNA was synthesised 
using SP6 RNA polymerase.  mRNA was injected into 1-cell embryos alongside 
its corresponding MO.  
 
For over-expression studies, a range of mRNA concentrations was injected alone 
into embryos to examine gain-of-function phenotypes.  Typically, 20, 50, 100, 
200, and 500pg of RNA were injected into the embryos.  For rescue experiments, 
if over-expression caused a phenotype, a dose below the threshold causing the 
phenotype was injected alongside the MO.  This is the case with many IFT 
proteins, which function in stoichiometric complexes, therefore, both over-
expression and loss-of-function lead to abnormalities. 
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In-situ hybridisation 
Probes used 
The following antisense probes were used for zebrafish embryos:  pax2.1, pax6, 
nkx6.1, nkx2.2, pax3, dlx2, dlx5, sox10, phox2b, foxd3, crestin, southpaw, sonic 
hedgehog, patched-1, gli1, gli3, ihha, wt1a, wt1b (gift of Wolfgang Driever, 
Freiburg), bbs8. 
 
The bbs8 probe was synthesised from a bbs8 expressed sequence tag (EST) 
obtained from Gene Tools.  It was cloned into the pBS2 KS+ cloning vector and 
antisense and sense (from control) mRNA strands were synthesised with T7 and 
T3 RNA polymerases respectively.  All probes were synthesised using 
Digoxigenin-labelled UTP residues in the in vitro transcription reaction. 
 
Wholemount in situ hybridisation 
Zebrafish embryos were fixed in 4% PFA in PBS overnight at 4°C.  Embryos to 
be used at stages later than 24hpf were treated with 0.03% PTU to inhibit 
melanogenesis at 24hpf.  This enabled clear visualisation of the in situ marker.  
Fixed embryos were washed in PBT (PBS with 0.1% Tween 20) and dehydrated 
in 100% methanol for 2 hours at -20°C.  Embryos were then rehydrated in a series 
of methanol/PBS dilutions before treatment with 2µg/ml Proteinase K (PK) 
solution.  The time of digestion in PK depended on the stage of the embryos.  
Embryos were washed and refixed in PFA for 20 minutes before incubation in 
prehybridisation solution for 2 hours at 65°C.  The probe was then diluted in 
hybridisation solution (prehybridisation solution plus heparin and yeast tRNA) at 
1ng/µl and the embryos were incubated in this overnight at 65°C.   
 
The following day the probe was removed and recycled for future reuse.  Embryos 
were washed once in prehybridisation solution for 5 minutes, once in 25% 
prehybridisation solution mixed with 75% 2xSSC, once in 2X SSC, and then three 
times in 0.2x SSC for 30 minutes each.  Embryos were then equilibrated in maleic 
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acid buffer (MAB) and blocked in MABI blocking reagent (MAB with 2% 
blocking reagent (Roche)) for at least 2 hours at room temperature.  Embryos 
were then incubated in horseradish-peroxidase conjugated anti-Digoxigenin 
antibody (Roche, 1:6,000) overnight at 4°C.  The following day embryos were 
washed 5 times in MAB to remove the primary antibody followed by two washes 
in Tris-HCl pH 9.5.  This was then replaced with BM Purple, used to develop the 
colour of the probe.  The reaction was stopped just before the emergence of 
background staining and washed 3x in PBS pH5.5 followed by re-fixing in PFA 
for 20 minutes.  The embryos were then mounted in 75% glycerol for imaging on 
a Zeiss Lumar stereomicroscope. 
 
Alcian blue staining 
Chondrocranial measurements 
Alcian blue (AB) was used to reveal the cartilage of larval zebrafish.  Zebrafish 
were injected with MO (bbs4, bbs6, bbs8, ift80, mks1, mks3, ofd1) and treated 
with PTU at 24hpf.  At 5dpf, embryos were fixed in 4% PFA overnight at 4°C and 
then bleached in 10% hydrogen peroxide in PBS for 1 hour on ice.  Embryos were 
washed and a 0.1% solution of Alcian Blue (Sigma, UK) in acidic alcohol (5% 
concentrated hydrochloric acid, 70% ethanol) was added to the embryos 
overnight.  Embryos were washed for at least 4 hours on a shaking platform with 
frequent changes of acidic alcohol to remove excess stain.   
 
For wholemounts, embryos were then mounted in 75% glycerol and imaged.  For 
flatmounts, the embryos were treated with 1% trypsin in a 35% sodium borate 
solution to loosen the tissues around the cranial cartilages.  The head was 
separated from the body with fine forceps and the notochord severed.  Head 
tissues were dissected away from the neurocranium carefully using sharpened 
tungsten needles.  Neurocrania were then flatmounted onto glass slides and 
covered with coverslips before imaging on a Zeiss AxioImager with phase 
contrast illumination. 
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Imaging neural crest migration 
Live imaging of NCC migration 
To track the migration of cranial neural crest cells in the zebrafish head, 
Sox10:eGFP transgenic zebrafish were injected with bbs8 or control MO.  At the 
12-somite stage, which is the time of the onset of migration of CNCCs into the 
head, embryos were selected for strong green fluorescence on a dissecting 
microscope.  Embryos were dechorionated, anaesthetised in 0.003% tricaine, and 
mounted in 1% low-melting point agarose and oriented with a mounted needle.  
Once the agarose had set, the embryos were bathed in embryo medium and 
mounted on a confocal microscope stage.  The Leica SP2 confocal microscope 
was used to create a time-lapse movie of the migrating CNCCs over a 4-hour 
period, capturing frames once a minute.  The total distance migrated during this 
time was measured by comparing the position of the migration front of the cells at 
12ss and 20ss, at the end of the time period. 
 
Imaging peristalsis in the zebrafish gut 
To visualise the peristaltic movements of the zebrafish gut, 5dpf control and bbs8 
MO-injected embryos were immobilised in 1% low-melting point agarose and 
their foreguts imaged on a Zeiss AxioImager with DIC optics.  Five-minute 
movies were captured at one frame per second.  The number of peristaltic pulses 
in the gut was quantified in five control and morphant embryos each and 
compared. 
 
Zebrafish cell transplants 
Transplantation involves grafting cells from a host embryo to a donor and tracking 
the migration of these cells to see if they behave differently in a non-native tissue 
environment to see if the function of the gene of interest is cell autonomous or 
not.  Around 100 sox10::eGFP embryos were co-injected with 3ng bbs8 MO and 
a 0.5% dilution of 10kDa rhodamine dextran (Invitrogen) at the 1-2 cell stage.  
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These were the donors.  Another batch of 100 control host embryos were 
untreated and incubated at the same time.   
 
After incubation at 28.5°C for 5 hours, the donor and host embryos were 
dechorionated on an agarose coated dish and mounted individually on a 1% 
agarose mould to hold each embryo in place for micromanipulation.  Around 20 
donor cells were aspirated into a fine-tipped glass micropipette.  To maximise the 
likelihood of targeting presumptive neural crest, the needle was positioned at an 
angle of 45° to the germ band.  These aspirated cells were then carefully 
reinjected into the host embryos at a roughly equivalent position on the embryo.  
About 60 transplants could be performed in one sitting before the donor and host 
embryos became too developed, and my patience too tried!  Transplanted embryos 
were then left to recover for 1 hour at room temperature before reincubating 
overnight at 22.5°C.  Incubating at this lower temperature meant the embryos 
were at the stage of the onset of NCC migration (10-12ss) at around 9am the 
following morning. 
 
Successful transplants were scored by the presence of GFP-positive cells in the 
host embryo.  This meant the engrafted cells had integrated into the neural crest 
and therefore the expression of Sox10 had been activated, driving GFP expression.  
Embryos in which the engrafted Sox10::eGFP-positive cells were surrounded by 
red-fluorescent cells were discarded as this meant the transplanted cells were 
surrounded by donor cells, and not host cells, which is the purpose of the 
experiment.  The success rate of transplants integrating into the neural crest was 
around 20%, however after screening for contamination with excessive donor 
cells, only around 5% of embryos were suitable for imaging.   
 
The successful embryos were carefully mounted in low melting point agarose to 
expose the lateral surface.  An image was taken at the onset of CNCC migration 
(12ss) showing the position of the engrafted NCC, this was called t=0.  Images 
were taken on a Leica compound microscope using a z-stack depth of about 30µm 
and maximum projection to get the whole image of the embryo’s head in focus.  
Images were taken in the DIC, FITC, and rhodamine channels.  Embryos were re-
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imaged 2 and 4 hours after, by which time the majority of CNCC migration into 
the head was complete.  The distance migrated by each individual NCC cell was 
calculated by comparing its positions at t=0, 2, and 4 hours. 
 
Drug treatment of embryos 
Drugs used in this study were: Rapamycin (Sigma), Roscovitine (Sigma), 
Mevenolin (Sigma), Paclitaxel (Sigma).  Compounds were dissolved in 1% 
DMSO in zebrafish water at the following concentration ranges based on previous 
studies and empirical trials: Rapamycin 2nM-100nM, optimum 10nM; 
Roscovitine 0.1µM-100µM, optimum 10µM; Mevenolin 25µM; Paclitaxel 10µM 
(only partially soluble, even when dissolved in DMSO).  Drugs were tested by 
dissolving in 5ml of fish water and adding to a group of 10 embryos in wells of a 
6 well plate at either 4hpf or 24hpf.  All subsequent experiments were performed 
adding drugs at 24hpf as it eliminated off-target effects.  For controls, embryos 
were treated with 1% DMSO alone. 
 
Embryos were incubated until 5dpf whereupon morphology was documented by 
immobilisation in 2.5% methylcellulose and imaged on a Zeiss Lumar stereo 
dissecting microscope.  The size of kidney oedema was measured by drawing a 
polygon around the swelling and calculating the surface area in microns squared 
using Zeiss AxioImager 4.5. 
 
Assessment of compounds on kidney function 
To functionally assess the effect of treating zebrafish morphants and controls with 
drugs, I adapted the protocol of Hentschel et al.  Zebrafish embryos were injected 
with MO at the 1-2 cell stage.  At 24hpf, PTU was added to prevent pigmentation 
forming and embryos were dechorionated at 48hpf.  At 96hpf embryos were 
anaesthetised in 0.003% Tricaine and immobilised by mounting ventral-side up in 
2.5% methylcellulose to expose the heart.  Using a fine-tipped glass needle and 
microinjector, 1nl of 10kDa rhodamine dextran (Invitrogen) was injected into the 
pericardium using a long pulse (800-1,000ms) of the microinjector.  This ensured 
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a smooth and even delivery of the dye into the heart, and enables a very fine 
needle to be used to puncture the heart cleanly, causing least trauma or damage to 
the embryo.   
 
Ten to 12 embryos were injected for each treatment and incubated in individual 
wells of a 24 well plate at 28.5°C.  Images of the amount of red fluorescence in 
the pericardium, as well as in the systemic circulation, were recorded using a 
Zeiss Lumar fluorescent stereomicroscope.  Images were recorded immediately 
after injection, 3 hours later, and 24 hours later.  The decrease in fluorescent 
intensity correlates with efficiency of renal filtration as the dye is selectively 
removed from the blood and excreted by the glomerulus.  The relative amount of 
fluorescence remaining in the embryo’s hearts after 24 hours was calculated by 
measuring the fluorescent intensity of the hearts using ImageJ.  A region 100x100 
pixels was drawn around the heart and the average intensity recorded.  An average 
and standard deviation of intensities was recorded for at least 10 embryos for each 
treatment.  Statistical analyses were performed using the paired T-test in 
Microsoft Excel. 
 
Single-cell dissociation of zebrafish embryos 
Approximately 200 control MO injected or bbs8 MO injected zebrafish embryos 
were incubated until the 14, 16, or 20 somite stage.  They were then washed in 
calcium-free Ringer’s solution (116mM NaCl, 2.9mM KCl, 5mM HEPES pH 7.2) 
for 15 minutes followed by trituration to remove yolks with a P200 Gilson pipette 
tip in which the end had been cut off.  These embryos were then transferred to a 
solution of 0.25% Trypsin in 1mM EDTA pH 8.0 for 30 minutes, triturating with 
a glass Pasteur pipette every 10 minutes.  Dissociation was monitored using an 
inverted microscope and when only single cells remained, the protease reaction 
was ceased by adding 5% FCS and 1mM CaCl2.  The cells were pelleted in a 
15ml Falcon tube by spinning at 300g for 3 minutes.  The supernatant was 
removed and the cells were washed with L15 media (Sigma) containing 1mM 
CaCl2 and spun down again.  The supernatant was removed again; cells were 
resuspended in 1ml of L15 and placed in 5ml FACS tubes.   
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Flow sorting GFP-positive cells from transgenic embryos 
Dissociated cells from bbs8 or control MO-injected Sox10::eGFP zebrafish 
embryos were sorted using a Beckman Coulter FACS machine, or, more recently, 
a MoFlo XDP.  A wild-type GFP-negative batch of embryos was used as a 
negative control to define the parameters of the GFP-positive cells.  Dead cells 
were excluded using the dye 7AAD.  Dead cells accounted for around 0.9% of 
total cells in both control and morphant embryos.  Cells accounted for 80-90% of 
total particulate matter entering the FACS machine.  Around 50,000 GFP-negative 
cells were analysed to set the gating position for the GFP-positive cells.  The 
Sox10:GFP positive cells were then fed into the machine and GFP-positive cells 
were collected in an eppendorf tube containing 0.5ml of RNAlater reagent 
(Ambion).  This stabilised the RNA inside the cells and prevented degradation 
prior to extraction.  Approximately 80,000 to 100,000 NCCs were obtained from 
100 16ss zebrafish embryos, giving around 800 to 1,000 NCCs per embryo.  This 
number was equivalent in controls and morphants.  Roughly 4% of the total cell 
count of the embryos was NCCs.  
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Chapter 3: Modelling craniofacial defects in Bardet-
Biedl syndrome 
Introduction 
Anecdotal reports of facial dysmorphism 
In addition to the well-characterised primary features of BBS (obesity, retinitis 
pigmentosa, kidney disease, polydactyly, mental retardation, and hypogonadism), 
parents of patients have anecdotally reported being able to spot another BBS 
patient “from a mile away” (P. Beales, personal communication; and reports from 
LMBBS Society meeting).  Historically, BBS was often misdiagnosed as Down’s 
syndrome due to a similar facial gestalt and mental impairment.  Whilst there are 
similarities between a typical BBS “face” and a Down’s “face”, such as small 
palpebral fissures, there are also numerous subtle differences that an experienced 
individual can identify.  
 
Published findings of craniofacial dysmorphology 
Beales et al (1999) was the first study to undertake a systematic analysis of the 
facies of BBS patients.  By examining the photographs of 76 patients they 
identified:  
 
“Considerable, inconsistent dysmorphism… a subgroup of patients showed facial 
similarities comprising deep set eyes, hypertelorism with downward slanting 
palpebral fissures, a flat nasal bridge with anteverted nares and prominent 
nasolabial folds, a long philtrum, and a thin upper lip.” 
 
This study was followed up by a paper in 2001 by Lorda-Sanchez et al entitled, 
“Does Bardet-Biedl Syndrome have a characteristic face?”  They examined a 
further 18 BBS patients’ faces and concluded similarly to Beales et al:  
 
“…Patients share a characteristic face with a wide forehead, mild downward 
slanting palpebral fissures owing to mild malar hypoplasia, a large nose, and a 
small mouth with a thin upper lip and slight everted lower lip. The mandible looks 
prominent on front view, but shows clear retrognathia on lateral view.” 
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In summary, the typical features associated with a BBS face are the following: 
 
Feature Frequency  
(As reported by Beales et al 1999, n=76) 
Short palpebral fissures (the size of the eyelid 
opening, normally 10mm high and 30mm in a 
healthy adult) 
92% 
Brachycephaly (flattened head) 92% 
Frontal balding 92% 
Long philtrum (space between upper lip and 
nose) 
82% 
Thin upper lip 54% 
Ptosis (closing of the eyelid) 29% 
Enophthalmia (deep-set eyes) No data but frequently observed 
Table 5.  Facial features and frequencies in BBS patients. 
 
The BBS “face” is dysmorphic, attributed by parents’ ability to recognise other 
patients with the disease from their faces, and published reports by clinicians.  
However, it is more subtle and variable than other canonical dysmorphic 
syndromes such as Down’s, Treacher Collins, Williams, and Noonan syndromes.  
This has led to some clinicians ignoring it as a feature of the syndrome, and has 
made formal characterisation confusing, although some descriptive attempts have 
been made.   
 
New technology in the form of 3D facial scanning has taken much of the 
subjectivity out of characterisation of facial dysmorphology.  Its use in the past 
was evaluated to see if it could be applied to BBS patients. 
 
Previous uses of 3D facial scanning 
Facial scanning involves using a laser scanner or 3D photogrammatic device to 
capture a three dimensional image of the face, whose surface is then populated 
with up to 100,000 3D points.  These points are used to reconstruct a wire mesh 
model of the face.  By combining many patients’ images together, the relative 
positions of the points of the face corresponding to specific facial landmarks can 
be used to construct a mean model of the face (Hammond, 2007).  By combining 
sufficient numbers of faces to obtain statistical power (usually n>50), 
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comparisons can be made between syndromic faces, and age, gender, and race-
matched controls.  Table 6 documents previous uses of 3D facial scanning for 
dysmorphology and Figure 15 shows previous uses of DSM modelling on four 
distinct dysmorphology syndromes. 
 
Syndrome Resolving power 
 
Conclusion Reference 
Autistic Spectrum 
Disorder 
Low Identified right-sided 
protrusion causing 
face asymmetry 
(Hammond et al., 
2008) 
Fragile X syndrome  Faces are longer than 
controls 
(Hammond, 2007) 
Cornelia de Lange 
syndrome 
 Able to discriminate 
between affected and 
unaffected 
(Bhuiyan et al., 2006) 
Fabry disease 85% for males, 67% 
for females versus 
controls 
Abnormalities in peri-
orbital region but low 
distinguishing power 
(Cox-Brinkman et al., 
2007) 
Williams-Beuren 
syndrome 
  (Hammond et al., 
2005) 
Noonan syndrome 94% between affected 
and controls 
 (Hammond et al., 
2005) 
Velo-cardio-facial 
syndrome 
95% between affected 
and controls and 
between VCFS and 
NS 
Could distinguish 
between the two 
syndromes 
(Hammond et al., 
2004) 
Binder syndrome Noses of patients are 
15-17mm retracted 
relative to contros 
Confirmed extent of 
nasal deficiencies 
(Kau et al., 2007) 
 
 
 
Table 6.  Published uses of 3D facial scanning to resolve dysmorphology. 
 
 
Using principle component analysis (PCA), the specific parameters by which the 
groups of faces differ can be defined.  For example, distance between the eyes, 
length to width ratio of the face, size of the nose, thickness of lips, and so on.  
These components can be partitioned to accurately differentiate between two 
groups of individuals and discern whether an individual has the syndrome or not, 
based on that parameter.  This technique overcomes the problems of subjectivity 
and the lack of expert dysmorphologists for any given syndrome.  Due to such 
rarity of many syndromes, it takes many years for a particular physician to see 
sufficient patients to recognise that syndrome’s gestalt. 
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Figure 15.  Discrimination between four dysmorphic syndromes by 3D DSM. 
Red shows relative decrease in inter-landmark distance relative to controls while blue 
shows an increase in distance.  Taken from Hammond et al (2005). 
 
Professor Peter Hammond has pioneered the use of this technique to study the 
facies of many genetic syndromes, as well as psychiatric disorders (autism), and 
fetal alcohol syndrome.  The first published use of this technique was in 2004 
where it was used to characterise the faces of 60 adults and children with Noonan 
syndrome and 90 with Velo-Cardio-Facial syndrome (Hammond et al 2004).   
 
Since then, this technique has been deployed for Cornelia de Lange syndrome, a 
growth deficiency where it characterised the faces of 20 patients.  It has been used 
to study the faces of human and mouse mutants of GFTIRD1.  Patients showed 
faces strikingly similar to those of Williams-Beuren syndrome and so identified 
this gene as a new candidate (Tassabehji et al., 2005).  More recently, it has 
uncovered hitherto unrecognised asymmetry in the faces of autism sufferers, 
underlying possible changes in forebrain structure. 
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Hammond et al (2005) showed the technology to be able to discriminate 
accurately between four dysmorphology syndromes (DiGeorge, Noonan, 
Williams, and Smith-Magenis).  In children, its accuracy at discriminating 
between individuals with each syndrome versus controls, or discriminating 
between any of the four syndromes, ranged from 90-98%.  Using only one of 
three facial features; the eyes, mouth, or nose, up to 96% accuracy could be 
achieved.  Accuracy was even higher for adults: 100% for adults with Williams 
syndrome versus controls.   
 
Whilst these results suggest the technique can be used for diagnosis, it is only 
discriminating between four syndromes, and not the hundreds that exist, some 
presenting subtly.  At present, it cannot be used to diagnose, de novo, a syndrome 
based purely on face alone.  However, it may be a useful training aid to expedite 
the dysmorphologist’s recognition of particular facies.  
 
Application of 3D facial scanning to BBS 
All the syndromes studied to date have had very pronounced dysmorphic features, 
well characterised and easily identifiable by clinicians.  The BBS face is subtle 
and there is no statistical proof that such a characteristic “face” exists, or whether 
it is simply a result of excessive fat around the face.  However, as there are 
numerous anecdotal and published identifications of the BBS face, and given the 
power of 3D scanning in resolving differences in facial morphology, BBS makes 
a good, albeit challenging candidate for the technology.  The ability to accurately 
identify BBS facies would be a quantum step forward in the application of the 
technology, as it would pave the way to study many more of the subtler 
dysmorphism syndromes.  
 
The aims of this study 
The first aim was to analyse the results of the scanning of BBS and control faces 
and characterise the identity of the BBS face performed by Peter Hammond.  This 
would give an idea about the parts of the face affected in BBS.  This could then be 
validated experimentally by analysing the faces of BBS mutant mice, and 
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furthermore, zebrafish.  The ultimate aim is to create a robust model system for 
craniofacial dysmorphology in BBS from which the biological basis of the 
phenotype could be determined.
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Results 
Characterising the facial gestalt with 3D photography 
Peter Hammond scanned 83 BBS patients, irrespective of underlying mutations at 
two of the annual Bardet-Biedl syndrome patient conferences in Northampton, 
UK, and also at a patient convention in Holland.  In addition, 230 controls were 
scanned.  All subjects were Caucasian and matched roughly for age with controls.  
Separate analyses were performed for subjects under 20 years old to control for 
the variability caused by growth of the face in children.  Peter Hammond and Matt 
DiFranco carried out analysis and statistics on the acquired images. 
 
From the 3D photographs, a dense-surface model (DSM) was constructed for each 
face.  Facial scans were annotated with landmarks according to Figure 16.  The 
distances between several landmarks were measured and compared between 
control and BBS faces.  Firstly, the n-gn to n-sn ratio was greater in BBS patients.  
This means the nose was relatively short compared to the face.  Secondly, the t-t 
to n-sn ratio was lower in BBS patients.  This means the face was relatively wide 
for the length of the nose.  Thirdly, the n-gn to t-t ratio was not significantly 
different in BBS children compared to controls.   
 
 
 
 
 
 
 
Figure 16.  Facial landmarks annotated on human and mouse faces. 
 
However, the problem with these two-dimensional analyses of interlandmark 
distance are three-fold: first is the arbitrary positioning of the landmarks, as they 
are input by the operator; second is that only 13 out of the possible c.25,000 
datapoints are used for each face; and third, most importantly, is that the excessive 
soft tissue on patient faces obscured an accurate analysis. 
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To overcome these problems, Peter Hammond performed analysis on colour-
distance-coded mean morphologies.  Here, the mean difference in position of the 
points on the DSM between control and BBS faces was colour-coded.  This 
analysis was performed in several orientations, but the most interesting 
differences were noticed when comparing the dorsal-ventral aspect of the face.  
Here, portions of the face sunken relative to the control face were rendered red, 
and protruding parts blue.   
 
In the first instance, analysis was performed on the nose alone, as this is the 
region of the face least covered in fat.  The DSM showed that in both children and 
adults the bridge and tip of the nose were relatively depressed in BBS patients 
compared to controls.  This indicates hypoplasia at the nasal bridge and nasal 
shortening.  A movie showing a dynamic morph between a control and BBS nose 
demonstrates differences in the nasal alae (edge of the nostrils) and columella 
(portion between the nostrils) (Figure 17A and B).  Using a pattern recognition 
algorithm known as “support vector machines”, a BBS nose could be 
distinguished from a control nose 91% of the time in children and 84% in adults, 
highlighting the degree of difference, which would otherwise go unrecognised 
(Tobin et al, 2008). 
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Figure 17.  Craniofacial dysmorphology revealed in man and mouse. 
A,B: comparison of noses of children (A) and adults (B) shows depression of the nasal tip 
and bony nasal bridge in patients.  C,D: rostro-caudal comparison between control and 
BBS adults (C) and children (D) shows a small lower jaw and upward displacement of 
the upper lip and nose.  E,F: dorso-ventral comparison shows relative flattening of the 
midface, consisting of a smaller chin, upper jaw, and nasal region than controls.   
 
Next, the full face was analysed.  Performing comparisons in the rostro-caudal 
axis, in both adults (Fig. 17C) and children (Fig. 17D), there was a relative 
upward displacement of the nose and upper lip (indicated by blue rendering) and 
reduced mandibular size (red rendering).  By performing comparisons in the 
dorsal-ventral axis, there was clear mid-facial hypoplasia in BBS adults (Fig. 17E) 
and children (Fig. 17F).  This consisted of a small chin, retrognathia (recession of 
 
C D 
E F 
A B 
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the mandible causing overbite), and a smaller maxilla and nose.  Midfacial 
flattening and facial flatness was used to differentiate clearly between control and 
BBS faces of children in 76% of cases (n=31), based solely on one measurement 
from the software.  Controlling for age produced a summary face with greater 
width, mid-facial flatness and retrognathia, and showed the technique can 
distinguish features unclear even to the trained dysmorphologist. 
 
Examination of Bbs mutant mouse faces reveals analogous facial 
defects 
We next investigated whether mouse BBS mutants displayed analogous 
craniofacial malformations.  This would show if the defect was conserved and 
therefore likely to have a consistent biological aetiology, rather than be a 
secondary effect due to excess fat, or particular to human BBS patients.  This 
work was performed mainly by Erica Eichers in James Lupski’s laboratory at 
Baylor College in Houston, Texas.   
 
Bbs4-/- (n=31), heterozygous (n=30), and wild-type (n=20) mice of the same strain 
(C57/black 6) were anaesthetised and their heads painted in cornstarch to improve 
the contrast with the background.  Heads were scanned using a 3D laser scanner.  
Although the craniofacial anatomy of mice and humans differs, there were 
significant similarities in key ratios for both Bbs4 and Bbs6 null mice, including a 
larger mid-face width to height ratio (P<0.01), and a shorter snout (P<0.01).  No 
landmark differences were seen in heterozygous mice (Tobin et al., 2008). 
 
3D laser scanning of Bbs mutant skulls determines bony origins of 
dysmorphology 
Next, we wanted to find out if the flattening of the midface had its origins in soft 
or hard tissue.  This was done in collaboration with Matt DiFranco, then at the 
UCL Eastman Dental Institute in London.  Heads were removed from Bbs6-/- 
(n=9) and wild-type (n=15) mice of C57/black 6 mice.  Skin and soft tissue were 
stripped from the heads and they were defleshed by immersion in potassium 
hydroxide for up to one week.  Cleaned and dried skulls were subjected to 3D 
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laser scanning on a desktop scanner.  Colour coded representations of the skulls 
were generated in a similar manner to the human faces. 
 
 
 
 
 
 
Figure 18.  3D scans of mouse skulls. 
A: dorsal view of BBS mutant skulls relative to controls showing hypoplasia of the snout 
(revealed in blue).  B: lateral view of the skull comparison. 
 
When viewed from the dorsal aspect (Fig. 18A), the colour-coded representations 
of the mean skull models showed shortening of the snout, specifically attributed to 
a hypoplastic pre-maxilla and maxilla (red shading).  The lateral view shows a 
higher cranial vault and depressed orbits, as well as the shortened snout (Fig. 
18B).  Enophthalmia, or sunken eyes, is a common feature noted in BBS.  The 
bones affected in these mice are homologous to the bones of the human upper jaw 
and nose, and so reduced size in humans will give rise to the gross phenotype 
observed.  This established that the defect in the human faces is most likely due to 
hypoplasia of the craniofacial bones contributing to the midface.  As these bones 
are entirely derived from the embryonic neural crest, this is an obvious cell type to 
examine in BBS models.   
 
Generation of bbs morphant zebrafish 
Because of the ease of making genetic models in the zebrafish using morpholinos 
(MOs), the relative homology of its craniofacial development with mammals, and 
its utility in studying neural crest cell migration, I decided to utilise this model.  In 
the first instance, I designed and injected ATG- and splice-blocking MOs against 
bbs4, bbs6, and bbs8.  bbs4 and bbs6 were chosen as these were the mouse 
models tested, and Bbs8 protein function is best understood, mostly from studies 
in C. elegans and is thought to serve as an adaptor protein for IFT.   
A B 
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In situ hybridisation shows that bbs8 is ubiquitously expressed at low level, with 
particularly strong expression in the eye and brain (Figure 19).  Because BBS 
proteins are present at very low copy number in cells due to their confinement to 
the basal body, they are often difficult to detect by wholemount in situ. 
 
 
 
 
 
Figure 19.  In situ hybridisation of bbs8 in zebrafish embryos. 
Anti-sense riboprobe shows that the bbs8 transcript is ubiquitously expressed in the 24hpf 
zebrafish but is enriched in the eye and brain.  Scale bar = 500µm. 
 
MOs were titrated over a range of doses.  It was found empirically that 4ng of 
bbs4 and bbs6 MOs gave a consistent, reproducible phenotype consisting of a 
convergent extension defect and kidney cysts by 3dpf.  The bbs8 MO gave a 
stronger phenotype, which was equally as penetrant, with 100% of embryos 
affected.  4ng of bbs8 MO gave a very severe phenotype and most embryos died 
before 5dpf.  As such, most experiments were performed with 2 or 3ng of bbs8 
MO that induced more moderate phenotypes without lethality. 
 
At the 8-somite stage (ss), all BBS MOs induce a mild gastrulation defect 
evidenced by shortening of the body axis and compressed, widened somites 
indicative of defects in the planar cell polarity (PCP) pathway.  This phenotype 
has been reported for all ciliopathy morphant models published to date (e.g. 
Gerdes et al., 2007, Ross et al., 2005).  bbs8 morphants consistently showed the 
most severe phenotypes.  At 24hpf, embryos showed U-shaped somites, similar to 
those of the Sonic Hedgehog mutants sonic you and smoothened you (so-called 
after the U-shape somites).  Morphants of all three genes had a down-turned body 
axis, most marked at 72hpf, a feature characteristic of other ciliopathy morphants 
and mutants reported previously (Drummond et al., 1998).  A detailed analysis of 
the specific phenotypes observed appears in Chapter 6.  
anti-sense sense 
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To test for toxicity of the specific MO sequences, I injected 5-base mispair MOs 
into wild type zebrafish embryos (see Appendix 2 for all MO sequences).  These 
oligos are similar to the gene of interest but are mispaired at 5 bases, sufficient to 
abrogate binding to the target, but with sufficient similarity to mimic any toxicity 
due to the chemical nature of the MO, and the surgical manipulation during its 
injection.  Mismatched MOs for both bbs4 and bbs6 conferred no visible 
phenotypes at 24hpf, nor later by 5dpf.   
 
To test the specificity of the bbs8 MO, I injected 100pg of full-length human 
BBS8 RNA (76% protein sequence identity) alongside 3ng of bbs8 MO.  Human 
mRNA was used as its 5’ sequence differed from the fish sequence sufficiently to 
render it incompatible with MO-mediated silencing.  By 24hpf, the convergent 
extension (CE) defect was greatly reduced, and the somites and notochord were 
straightened.  By 5dpf, embryos injected with MO alone had renal and cardiac 
oedema, a down turned body-axis, otolith defects, absence of pigmentation, and 
craniofacial anomalies.  Co-injection of 100pg of human BBS8 mRNA was 
sufficient to fully rescue the craniofacial, renal, pigmentation, and otolith defects. 
 
Craniofacial dysmorphology in bbs morphants 
Considering the conservation of craniofacial defects in humans and mice, and 
given the reproducible ciliopathic phenotypes in the zebrafish, making it a valid 
model of the human disease, I next investigated craniofacial morphology in the 
zebrafish.  Despite the size and shape differences between fish and mammalian 
skulls, many of the same signalling molecules are deployed, and its embryological 
ontology and anatomical organisation are well conserved higher up the chordate 
phylum. 
 
Cranial cartilages of control, bbs4, bbs6, bbs8, and bbs8-rescued embryos were 
visualised at 5dpf by staining with Alcian Blue.  Despite a severe convergent-
extension defect leading to pronounced curvature of the body axis at 5dpf, bbs4 
morphants had grossly normal craniofacial morphology, although the mandible 
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was wider and shorter (Fig. 20B,G).  The pharyngeal apparatus was intact with all 
branchial arches present.  Flatmount preparations of the neurocranium, which later 
develops into the skull, show no significant perturbations relative to controls (Fig. 
20K,L).   
 
 
 
 
 
 
 
 
Figure 20.  Craniofacial morphology of BBS morphant zebrafish. 
A: control larva at 5dpf showing jaws and branchial arches (arrowhead) in dorsal view.  
B: bbs4 morphant.  C: bbs6 morphant with disorganised and hypoplastic cartilages.  D: 
bbs8 morphant lacking branchial arches (arrowhead), and with cyclopia (inset).  E: 
complete rescue of bbs8 morphant craniofacial phenotype by co-injection of 100pg of 
human mRNA.  F-J: lateral views of alcian blue stained wholemounts.  K: control 
embryo chondrocranial flatmount.  L: bbs4 morphants have almost normal 
chondrocrania, but with a reduced ethmoid plate.  M: trabeculae of bbs6 morphants are 
shortened.  N: bbs8 moprhant trabeculae are fused at the midline.  O: rescue of trabecular 
defect with human mRNA.  Scale bars: A-J = 200µm; K-L = 100µm. 
 
Because of the shortened body axis resulting from the convergent extension 
defect, the ratio of jaw length to body length is slightly higher in bbs4 morphants 
than controls (Figure 21).  However, the neurocranial length to width ratio is 
slightly lower in these morphants (1.2 MO vs 1.3 control, P<0.05), mirroring the 
broadened face in human and mouse BBS mutants. 
 
bbs6 morphants showed a similar gross phenotype to bbs4 morphants, with renal 
and cardiac oedema, a down turned body axis and convergent extension defects, 
but their craniofacial dysmorphology was more pronounced.  Viewed ventrally, 
there was hypoplasia of the branchial arches; in some cases, arches were absent 
altogether (Fig. 20C).  The mandible was severely dysplastic, small and displaced, 
causing retrognathia, another feature observed in human patients (Fig. 20H).  
Flatmounts of the neurocrania show a similar gross morphology to bbs4 
  103 
Chapter 3 – Craniofacial dysmorphology in BBS 
morphants and controls, but the trabeculae, which connect the chondrocranium to 
the ethmoid plate, homologous to the premaxilla and maxilla in mammals, were 
much shorter in bbs6 morphants (160µm MO vs 260µm control, P<0.001) (Fig. 
20M).  The shape of the ethmoid plate was not affected but it was smaller than 
that of bbs4 morphants or controls.  The jaw (mandible) length to body length 
ratio was lower than controls (0.04 MO vs 0.05 controls, P<0.01) (Figure 21).  
This means that, even controlling for a shorter body axis, the jaws are still 
smaller.  Furthermore, the neurocranial length to width ratio was much lower than 
controls (0.95 MO vs 1.3 controls, P<0.01), correlating with the widened face 
seen in patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21.  Quantification of morphant crania. 
A: the ratio of neurocranial length to width in controls is 1.3.  This ratio decreases in 
bbs4, 6, and 8 morphants respectively, showing that the skull becomes relatively wider 
and shorter.  B: the ratio of jaw length (from the tip of the ethmoid plate to the base of the 
chondrocranium) controls for the CE defect in BBS morphants.  This shows that despite 
body length being reduced, particularly in bbs6 and 8 morphants, the jaw length is still 
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relatively shorter, implying that reduced body length is not responsible for the shortened 
chondrocranium. 
 
Bbs8 morphants consistently had the strongest phenotype, both in general and in 
the craniofacial skeleton, even with lower doses of MO than used for other BBS 
genes.  Mandibles were absent in almost all cases, as were branchial arches (Fig. 
20D,I).  In 20% of cases, the embryos exhibited synophthalmia; in some cases, 
incomplete cyclopia was observed (Fig. 20D inset).  In these embryos, 
craniofacial cartilage was often lacking altogether.  This tended to coincide with 
reduced cartilage condensation in the fin buds too.  Examination of the flatmounts 
revealed that the neurocranium was greatly reduced in size and the ethmoid plate 
failed to form normally (Fig. 20N).  In about 25% of embryos, the trabeculae 
fused at the midline resulting in a pointed ANC instead of the trabeculae 
terminating in the widened ethmoid plate.  Like bbs6 morphants, the jaw length to 
body length ratio and the neurocranium length to width ratio are decreased, albeit 
to a greater extent (Fig. 21).  
 
The fusion of the trabeculae at the midline of the skull bears striking resemblance 
to mutants of Sonic Hedgehog transduction, or embryos treated early in 
development with cyclopamine, an inhibitor of Shh signal transduction (Figure 
22).  This observation, coupled with the presence of other Shh-related phenotypes 
commonly observed in BBS patients, led to suspicions of disrupted Shh signalling 
in morphants and became the subject of further study, detailed in chapter 5. 
 
 
 
 
 
 
 
Figure 22.  Comparison of bbs8 morphant and syu crania. 
In both cases, the trabeculae are fused at the midline, a defect idiosyncratic to shh 
mutants.  tc = trabeculae, pbc = parabranchial.  syu image taken from Wada et al (2005).  
Scale bar = 100µm. 
bbs8 morphant syu 
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Discussion 
Validation of 3D scanning for subtle phenotypes 
Prior to this study, the technique of 3D scanning had been used for several 
conditions with obvious facial phenotypes, such as DiGeorge syndrome, Noonan 
syndrome, and Fragile X syndrome (Hammond et al., 2005).  It was unknown 
whether a syndrome with such variable and subtle phenotypes would register 
reproducible and significant differences in facial regions using this technique.  
However, BBS has proven to be a syndrome which computer modelling can 
identify as having a discrete and distinct set of distinct facial features.  This has 
confirmed the intuitive assessment of BBS faces by parents of patients and 
dysmorphologists experienced in the syndrome.   
 
Correlation of phenotypes in the mouse model 
The fact that the human facial patterns were reproducible in the mouse models, 
both bbs4 and bbs6 nulls, suggests a common biological aetiology.  Because the 
mouse skulls had shortened snouts, it was likely that these homologous bones in 
humans were disrupted.  However, it is unethical to expose humans to X-rays to 
perform non-essential scans, particularly it would involve many patients and CT 
scans would be the only way to get accurate 3D reconstructions.   
 
The mouse is a useful way to get an idea of what bony regions are affected.  
Considering the similarities in craniofacial embryogenesis and the signalling 
molecules employed in humans and rodents, the mouse model gives clues as to 
what might be awry in the human situation.   
 
The use of the zebrafish to model analogous defects 
Surprisingly, there is little published literature using animal models to study 
human craniofacial malformations.  This is partly due to lack of technology in 3D 
scanning of mice, and the fact that most groups are using zebrafish to study basic 
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developmental biology.  There is an increasing use of the zebrafish to investigate 
human genetic disease given its acceptance as a valid model organism, 
particularly for experiments inaccessible in the mouse.   
 
I showed here that regions of the presumptive zebrafish skull are shortened, 
similar to the human and mouse condition.  In some cases, elements such as the 
mandible and branchial arches are hypoplastic or altogether missing.  In the case 
of a proportion of bbs8 morphants, the trabeculae are fused at the midline.  This is 
a specific feature of Sonic Hedgehog pathway mutants and so provides clues for 
further experiments elucidating a possible connection between BBS proteins and 
the Shh pathway. 
 
It is often the case that gene knockdown in the zebrafish causes more severe 
effects than in mammalian models.  One possible reason for this could be the 
rapid development of the zebrafish; all major anatomical features have developed 
by only 36hpf.  This means any perturbation to genes expressed in early 
embryogenesis will be more pronounced than in mammals.  Following on from 
this, there is very little time for other genes or other mechanisms to compensate 
for early loss of a gene’s product.  Furthermore, ex vivo development means the 
embryo is more exposed to environmental pressures such as microbes in the 
water.  If loss of a gene even mildly affects embryonic hardiness by affecting, for 
example, the circulatory system, it might predispose the embryo to more 
environmental insults than in a mammalian embryo where the embryo is protected 
in utero.   
 
Whilst caution must be taken in interpreting extreme phenotypes in the zebrafish, 
as long as appropriate controls are made, such as RNA rescue, they are reliable.  
The phenotypes here serve as a useful method of revealing new roles for proteins 
which might otherwise be left uncovered as their mammalian phenotypes are too 
subtle to detect.   
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Determining the biological processes involved 
The majority of the head skeleton derives from the cranial neural crest (CNCC), 
from which cells migrate to the branchial arches and the frontonasal process 
where they form facial structures and eventually condense into cartilage and bone.  
The cells of the ANC, mandibles and branchial arches, which are hypoplastic or 
absent in Bbs morphants, are derived from neural crest cells that have migrated 
from the anterior neural tube.   
 
As such, the observation of shortened trabeculae, malformed ethmoid plate, 
hypoplastic mandibles, and reduced branchial arches points to a dysfunction of 
neural crest migration.  The possibility that BBS proteins are involved in NCC 
migration gave rise to a new set of questions.  Without performing the human, and 
subsequently mouse, craniofacial analysis, we would not have thought to examine 
the craniofacial region of the fish.  As such, examining facial dysmorphism in 
humans and then mapping these analyses to the zebrafish may provide an avenue 
by which to investigate the biological or molecular aetiology of the phenotype, 
and concurrently uncover new biological processes in which the protein takes 
part. 
 
The zebrafish has become a tool for studying embryological development, 
including that of the craniofacial region.  It is becoming increasingly acceptable as 
a model for human disease, given its versatility and the limitation of mouse 
models for performing functional studies, particularly involving cell migration.  
There is surprisingly little published work describing the use of the zebrafish in 
modelling craniofacial dysmorphology syndromes.  One study of a causative gene 
of Noonan syndrome, Shp2, (Jopling et al., 2007) showed craniofacial 
abnormalities which phenocopied those of the Wnt5 morphant, suggesting 
involvement of the non-canonical Wnt pathway.   
 
Li et al added 2% ethanol to the embryo medium of developing zebrafish to model 
craniofacial defects present in fetal alcohol syndrome (Li et al., 2007b).  They 
used the fish to show that the phenotype phenocopied that of Shh mutants, similar 
albeit more severe than the bbs8 morphants described here.  In addition, adding 
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cholesterol alongside the ethanol was capable of rescuing the alcohol-induced 
phenotype, implying that alcohol interferes with the cholesterol modification of 
the Shh ligand.  
 
These studies indicate the utility of the zebrafish in giving clues about the 
underlying biological basis of a human disease.  From this information, further 
functional experiments can be designed to tease out the precise role of the protein 
in question.   
 
Several zebrafish mutants have idiosyncratic cranial dysmorphologies associated 
with them.  A large-scale mutagenesis screen identified 48 mutations in 34 loci 
that caused a variety of craniofacial defects (Neuhauss et al., 1996).  Kimmel et al 
classified these into mutants with affected patterning at the midline, and those 
with defective antero-posterior patterning (Kimmel et al., 2001).  The midline 
group comprised genes involved in three separate signalling pathways: Sonic 
hedgehog, nodal, and non-canonical Wnt.   
 
These pathways raise some interesting questions in light of the phenotypes 
observed with bbs8 morphants.  Midline fusion of the trabeculae is reminiscent of 
Sonic hedgehog mutant zebrafish (syu), or embryos treated with cyclopamine 
early in development (Wada et al., 2005).  This observation became the basis for 
further analysis of the Hedgehog pathway and is covered in chapter 5.  BBS is 
also associated with polydactyly, another Sonic Hedgehog pathway phenotype.  
Nodal signalling controls laterality, a feature frequently perturbed in ciliopathy 
patients.  Finally, there are published associations between BBS, the cilium, and 
the non-canonical Wnt pathway (Ross et al., 2005, Park et al., 2006). 
 
  109 
Chapter 4 – Neural crest migration defects 
Chapter 4: Neural crest migration defects underlie 
craniofacial dysmorphology and Hirschsprung’s 
disease in BBS 
 
Introduction 
The neural crest in embryonic development 
The neural crest is an embryonic tissue which gives rise to a plethora of cell types, 
amongst which are included the bones of the face.  NCCs are multipotent 
migratory stem cells, whose fate depends upon where they migrate and where 
they settle, and the molecular cues they are exposed to en route and at their 
destination.  Their progeny include, amongst others: peripheral neurons, glia, 
enteric neurons, melanocytes, and craniofacial bones.  NCCs are responsible for 
some of the key anatomical features that have enabled vertebrates to become such 
successful predators, including a large cranium and paired sensory organs.  
Because of this, Peter Thorogood once famously quoted: “the only interesting 
thing about vertebrates is the neural crest”.  
 
Development of the neural crest can be broken down into four key steps: 
induction and maintenance, epithelial to mesenchymal transition (EMT), 
emigration from the neural tube, and differentiation.  NCCs migrate dorsally away 
from the neural tube, as shown in Figure 23.  There are four neural crest domains, 
which migrate in stereotypical patterns to give rise to specific cell types; these are 
outlined in Table 7. 
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Neural crest domain Cell types formed 
 
Cranial neural crest Facial structures: cartilage, bone, cranial nerves, glia, 
connective tissue of the face 
Pharyngeal arches: thymus, odontoblasts of teeth, 
bones of middle ear and jaw 
Trunk neural crest Early migratory pathway: dorsal root ganglia, sensory 
neurons, sympathetic ganglia, adrenal medulla, aortic 
nerves 
Late migratory pathway: melanocytes 
Vagal and sacral neural crest Enteric (parasympathetic) ganglia of the gut 
Cardiac neural crest Melanocytes, neurons, cartilage, connective tissue of 
the large arteries 
Table 7.  Domains of neural crest and their progeny. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23.  Embryonic origins of the neural crest. 
The neural crest is specified at the border between the neuroectoderm and non-neural 
ectoderm during neurulation in the vertebrate embryo.  The neural plate invaginates and 
then detaches from the overlying ectoderm.  The cells formed at this hinge point become 
neural crest.  After the neural tube has fully formed, the NCCs delaminate from the 
epithelium and migrate away.  Taken from (Gammill and Bronner-Fraser, 2003). 
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Induction and maintenance of the neural crest 
The neural crest is a transient population of cells that forms at the border between 
the non-neural ectoderm and the neuroectoderm during neurulation (see Figure 
23).  NCC specification relies on a gene regulatory network inducing cells where 
a combinatorial code of signals coalesce (Sauka-Spengler and Bronner-Fraser, 
2008).  These conditions exist at the border between the non-neural ectoderm and 
the neural plate, where high levels of neuroectodermally derived BMPs (bone 
morphogenetic proteins) meet high levels of ectodermal Wnt6 (Le Douarin and 
Dupin, 2003).  These proteins induce expression of Snail and FoxD3, which 
together specify the NCCs (LaBonne, 2002; LaBonne and Bronner-Fraser, 1999).  
In fact, expression of Wnt ligands is both necessary and sufficient to induce 
ectopic neural crest in Xenopus laevis (Saint-Jeannet et al., 1997). 
 
This cell population is then confined as differentiated from the neighbouring cells 
by Delta-Notch signalling (Endo et al., 2002).  These cells are maintained in this 
specified state by the intermediate concentration of BMP ligand until they receive 
a cue to migrate.  NCC survival is ensured by the expression of a cocktail of 
transcription factors, including: AP-2, c-Myc, Snail1 and Snail2, Sox9, Foxd3 and 
Id.  Expression of these genes marks the NCCs for EMT, the next step in neural 
crest development. 
 
Epithelial to mesenchymal transition 
EMT is essential before the NCCs can delaminate from the basement membrane 
to which they are tethered after they are specified.  The process of EMT involves 
several crucial steps: rearrangement of the cytoskeleton, loosening of cell 
junctions, and reduction of adhesion to the extracellular matrix (ECM).   
 
Firstly, the apical-basal polarity of the premigratory NCCs is lost and the tight 
junctions joining neighbouring cells are dissolved by breaking down structural 
proteins such as occludins, which hold cells together (Thiery and Sleeman, 2006).  
Secondly, cell adhesions are broken down by transcriptional repression of E-
cadherin, N-cadherin, and NCAM (neural cell adhesion molecule) (Nieto, 2001).  
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Repression of E-cadherin is mediated directly by Snail protein (Batlle et al., 
2000).  Thirdly, major changes in cytoskeletal organisation are brought about 
through the small GTPases RhoA and Rac1 (Alberts et al). 
 
Many of the same molecules are involved in NCC EMT as function in tumour 
metastasis, when the cancerous cells detach from their epithelium and become 
migratory, invading neighbouring tissues, or blood and lymphatic vessels, and 
spreading to distant sites.  NCCs, like tumor cells, are remarkable in the distances 
over which they can migrate, and they do this by crawling.  The NCCs require 
ECM over which to migrate and rely on interactions between laminin, integrins, 
and fibronectin.  Like invasive tumour cells, NCCs secrete, or express on their 
membranes, matrix metalloproteases (MMPs) to break down ECM as they move 
(Egeblad and Werb, 2002).  These MMPs, such as members of the ADAM family, 
are important in premigratory cells to break down their ECM attachments, and in 
migratory cells to destroy ECM in the path of travel. 
 
NCC migration 
Once fully delaminated, migrating NCCs extend protrusions in the direction of 
migration by polymerising actin microfilaments in a two-dimensional orthogonal 
mesh with most of the filaments parallel to the substratum in the direction of 
migration.  These lamellipodia then form focal contacts containing integrins, 
which adhere to the substratum, in this case the ECM.  Forward movement is 
accomplished by actin treadmilling, whereby actin is polymerised at the leading 
edge of the cell and depolymerised at the trailing edge.  This gives the illusion that 
the actin filaments are stationary as the cell moves.   
 
NCCs migrate in streams following stereotypical pathways, coordinated by 
diffusible and non-diffusible guidance cues.  Migration happens in a polarised 
manner and the centrosome often localises between the nucleus and leading edge 
of the cell to polarise the microtubules to assist persistent movement in a 
particular direction.  The positioning of the centrosome seems to reinforce the 
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strength of cell polarity established by the actin cytoskeleton, albeit by a poorly 
understood mechanism.   
 
The role of non-canonical Wnt signalling in NC migration 
Two papers by Roberto Mayor’s lab have demonstrated important roles for non-
canonical Wnt, or planar cell polarity (PCP) signalling in neural crest migration 
(De Calisto et al., 2005; Matthews et al., 2008).  The first paper used specific Dvl 
mutant constructs which either activated or repressed canonical Wnt signalling to 
show that, in Xenopus, canonical Wnt signalling is required for NCC induction, 
and non-canonical Wnt signalling is essential for NCC migration.  The 
requirement for non-canonical Wnt signalling was cell autonomous and depended 
on the Wnt11 ligand.  The second paper from Mayor’s lab showed that an ECM-
interacting protein, Syndecan-4, played a role in the PCP pathway and that PCP 
controlled the direction of cell migration by regulating the position of cell 
protrusion formation.  This was accomplished by activation of RhoA. 
 
Ross et al’s work of 2005 showed that BBS proteins play a role in the PCP 
pathway, suggesting PCP signalling via the primary cilium.  Subsequent work has 
confirmed this, particularly that of Park et al.  Park et al showed that Xenopus 
lacking expression of two PCP genes, either inturned or fuzzy, had ciliogenesis 
defects (Park et al., 2006).  Therefore, PCP seems to rely on cilium formation, 
while at the same time being important, in some contexts, for the formation of the 
cilium itself. 
 
The fact that BBS proteins and cilia are important for non-canonical Wnt 
signalling, which in turn is involved in NCC migration, forms the basis for a 
hypothesis whereby absence of BBS proteins affects NCC migration by inhibiting 
non-canonical Wnt signalling.  This can be put in the context of the neural crest 
origin of all the craniofacial bones disrupted in the human, mouse, and zebrafish 
BBS knockouts.  The craniofacial patterning of the human cases, recapitulated in 
mouse and fish, shows a mid-facial depression of these crest-derived features.  
Because these cells migrate rostrally to populate the frontonasal prominence, it is 
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feasible that these cells have failed to migrate as far in the absence of BBS 
proteins, thereby producing a shorter snout.  
 
The cranial neural crest 
Cranial neural crest cells (CNCCs) contribute to the majority of the structures of 
the vertebrate head.  These cells made possible some of the innovations that 
vertebrates have uniquely evolved, including the skull, which has allowed the 
vertebrate brain to expand.  CNCCs are unique amongst the four neural crest 
domains in being able to form cartilage and bone.  Fate mapping experiments by 
Noden et al showed that the majority of the vertebrate facial bones are NCC 
derived (reviewed in Hall, 1988).  
 
CNCCs migrate out of the brain in three streams (Graham, 2003).  The trigeminal 
crest arising from the midbrain and rhombomeres 1 and 2 contributes to the 
majority of the face.  These cells form the frontonasal prominence, which forms 
the forehead, middle of the nose, philtrum of the upper lip, and the primary palate 
(Helms and Schneider, 2003).  The ventral region of the first pharyngeal arch 
gives rise to the lower face: the mandibles, maxilla, and temporal bones.  The 
second stream of migrating cells, the hyoid crest, gives rise to neurons and the 
hyoid skeleton, while the third stream, the post-otic, forms the pharyngeal bones.  
Figure 24 shows how CNCCs contribute to the majority of facial structures in 
vertebrates.   
 
These streams derive their identity from the antero-posterior (AP) restricted 
pattern of Hox gene expression, which is in turn established by an AP gradient of 
retinoic acid (RA).  Later on in facial morphogenesis, dorso-ventral (DV) 
patterning is established by Dlx homeobox transcription factors, which give the 
pharyngeal arches their identities. 
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Figure 24.  CNCC contributions to the amniote skull. 
In birds, mice, and humans the CNCC migrating from the hind- and midbrains contribute 
to homologous structures: the lower and upper jaws, the nose, and structures around the 
upper face including the eye and forehead.  The back of the skull is primarily mesodermal 
in origin.  Taken from (Santagati and Rijli, 2003).   
 
These NCCs have an intrinsic, species-specific set of gene expression 
characteristics that give each species its stereotyped countenance.  Experiments by 
Schneider and Helms (2003) showed that transplanting frontonasal neural crest 
cells between quail and duck embryos resulted in a host with the beak of the 
donor.  This and further work showed that these cells do respond to cues from the 
local cellular environment, but the extent to which they do depends on the size of 
the cell population.  Therefore, it seems CNCCs have an intrinsic program of 
migration but they also respond to cues from the overlying ectoderm. 
 
Several different signalling pathways interact in a complex manner to pattern the 
face.  FGF8 is key for CNCC survival and patterning, particularly of the teeth and 
oral features.  FGF8 expression is inhibited by BMP4, which serves to spatially 
restrict FGF8 (Haworth et al., 2004).  FGF3 is important for pharyngeal arch 
polarity (David et al., 2002).  Endothelin-1 concentration, together with Hand2, 
control cartilage and bone differentiation (Thomas et al., 1998).  Sonic Hedgehog 
(Shh) is indispensable for frontonasal outgrowth (Hu and Helms, 1999).   
 
The interactions of these molecules and tissues in three dimensions make the 
morphogenesis of the face extremely complex.  Defects in initial NCC migration 
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and/or the molecules coordinating migration and differentiation, results in 
craniofacial dysmorphology associated with many genetic syndromes.  This 
includes Bardet-Biedl syndrome, so it is important to assess whether BBS proteins 
play a role in this elaborate process. 
 
Neural crest defects and craniofacial anomalies 
Craniofacial anomalies comprise roughly one third of all congenital 
malformations.  In some cases, defects are restricted to the head, in others; other 
parts of the body are affected too.  Some defects are genetic while others are 
caused by fetal exposure to teratogens, the most common being alcohol.  Because 
of the tight linkage between the development of the face and the forebrain, many 
craniofacial defects are associated with brain abnormalities, often causing mental 
retardation.   
 
Severe craniofacial malformations can result from anomalous anterior neural tube 
closure or gross mispatterning of the brain and face.  Table 8 summarises some of 
these extreme malformations and their causes: 
 
Malformation 
 
Features Syndromes/cause 
Holoprosencephaly (HPE) Failure of the forebrain to divide 
causing cyclopia, absence of 
olfactory bulbs at most extreme; 
agenesis of corpus callosum, 
single central incisor when mild  
Mutations in Shh or pathway 
components such as Patched 
and Gli2 
Or teratogens such as alcohol or 
retinoic acid 
Anencephaly Opening of the anterior neural 
tube leading to absence of the 
cerebral hemispheres and bones 
of the face 
Meckel syndrome, Acrocallosal 
syndrome, short-rib polydactyly 
syndrome 
Encephalocele Gap in the neural tube causing an 
opening in the skull 
Meckel syndrome, Joubert 
syndrome 
Craniosynostosis Premature fusion of cranial bones Mutations in FGF receptors, 
Msx2, Twist, and others 
Table 8.  Craniofacial deformations associated with neural tube defects. 
 
Although extreme, several of these malformations are features of ciliopathies.  
Exencephaly is a phenotype observed in some bbs4 null mice.  Encephalocele, a 
milder form of exencephaly, is a common feature of Meckel and Joubert 
syndromes.  Defects at the mildest end of the HPE spectrum (single central 
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incisor, agenesis of the corpus callosum) have been observed in BBS patients (P. 
Beales, personal communication).  
 
Genetic syndromes specifically affecting neural crest development, the 
“neurocristopathies”, cause more subtle craniofacial dysmorphology, usually 
arising from aberrant specification or migration of CNCCs (Figure 25).  Table 9 
lists several of these syndromes and demonstrates the ubiquity of craniofacial 
dysmorphology. 
 
Neurocristopathy Gene mutated 
 
Features Reference 
Waardenburg-Shah SOX10 
(transcription factor) 
Hirschsprung’s, 
frontonasal dysplasia, 
cleft lip and palate, 
piebaldism 
(Pingault et 
al., 1998) 
DiGeorge Deletion 22q11 (TBX1 – 
transcription factor) 
Craniofacial, dental, 
parathyroid, cardiac 
defects, schizophrenia 
(Merscher et 
al., 2001) 
Treacher-Collins TCOF1 (nucleolar 
phosphoprotein) 
Craniofacial, hearing 
loss 
(Wise et al., 
1997) 
Congenital Central 
Hypoventilation 
syndrome 
PHOX2B (transcription 
factor) 
Neuroblastoma, 
hypoventilation, facial 
dysmorphism, 
Hirschsprung’s.  Caused 
by failure of NCC to 
innervate the lung 
(Amiel et al., 
2003) 
Mowat-Wilson ZEB2 (transcription 
factor) 
Microcephaly, facial 
gestalt, Hirschsprung’s, 
mental retardation 
(Zweier et al., 
2002) 
Table 9.  Features of neurocristopathies showing the ubiquity of craniofacial 
defects. 
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Figure 25.  Facial features of some neurocristopathies. 
Photographs showing craniofacial defects in three neurocristopathies: Treacher-Collins, 
Waardenburg-Shah, and Mowat-Wilson syndromes.  Taken from 
http://www.emedicine.org; (Zweier et al., 2005); and (Read and Newton, 1997). 
 
The enteric nervous system and Hirschsprung’s disease 
The enteric nervous system (ENS) is part of the peripheral nervous system (PNS) 
(Heanue and Pachnis, 2007).  The ENS is highly complex and comprises a wide 
diversity of neurons and associated neurotransmitters.  ENS function is largely 
independent of CNS input, and the ENS makes autonomous decisions about 
stimulating targets.  The ENS innervates the smooth muscle lining the gut, thereby 
controlling the mixing and peristalsis of digested food in the intestines.  
Additionally, the ENS regulates intestinal secretions of enzymes, water, and 
electrolytes, as well as the blood flow to the gut.   
 
Enteric neurons are organised in two layers in the gut (see Figure 26).  The 
outermost layer consists of myenteric plexi sandwiched in between the outer 
longitudinal muscle and inner circular muscle layers.  These neurons control 
muscle contraction.  The inner layer of neurons lies in the submucosa and 
innervates the secretory cells and vasculature.   
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Figure 26.  Organisation of the ENS. 
The left-hand image shows streams of NCCs emigrating from the vagal region of the 
hindbrain through the branchial arches and into the foregut, where they migrate along the 
length of the gut to colonise it.  There is a minor contribution of cells to the hindgut from 
sacral NCCs derived from the posterior end of the neural tube.  The right-hand image 
shows a transverse section through the fully developed gut showing the two rings of ENS 
neurons: the outer myenteric plexus and the inner submucosal plexus.  Taken from 
Heanue and Pachnis (2007). 
 
Like the PNS, the ENS is neural crest derived.  It originates from the vagal NCC, 
which forms caudal to the hindbrain at the level of somites 1 to 7.  Cells from 
different axial levels of this region populate particular regions of the gut.  These 
cells delaminate and migrate into the gut, whereupon they are called enteric neural 
crest-derived cells (ENCCs), and have the potential to differentiate into mature 
neurons.  The ENCCs migrate in a rostral to caudal direction and colonise the gut 
in this order: foregut (oesophagus, stomach, duodenum); midgut (small intestine, 
caecum, ascending and transverse colon); hindgut (descending colon, sigmoid, 
and rectum).  In humans, this migration takes place between 4 and 7 weeks 
gestation. 
 
For the adult gut to function, the gut must be fully colonised from foregut to 
hindgut and contain the requisite number of neurons.  As such, three events are 
required: 1) complete migration of the ENCCs to the distal-most portion of the 
hindgut; 2) sufficient proliferation of ENCCs to ensure sufficient neuronal mass; 
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3) appropriate differentiation of particular ENCCs into the correct neuronal 
subtype. 
 
Failure of the enteric neurons to fully colonise the gut results in Hirschsprung’s 
disease (HSCR), a congenital malformation with a frequency of 1 in 5,000 live 
births.  In HSCR, there is an absence of neurons in the hindgut, causing tonic 
contraction of the circular muscles leading to obstruction of the gut lumen, 
causing megacolon, a massive enlargement of the colon.  It also means stools 
cannot pass through the gut, leading to chronic constipation and the risk of bowel 
rupture.  Standard treatment involves surgical resection of the affected segment of 
bowel, but several investigations involving the use of stem cells are underway as a 
potential alternative.  
 
Most cases of HSCR are sporadic, but in the few inherited cases, it is non-
Mendelian, suggesting a complex inheritance involving multiple loci.  In 70% of 
HSCR cases, incidence is isolated and there are no extra-intestinal manifestations.  
However, 30% of cases are syndromic and include involvement of other organs.  
Many of these syndromic cases are neurocristopathies such as Waardenburg-Shah, 
Mowat-Wilson, and Congenital central hyperventilation syndromes.  Amongst 
these syndromic cases, Down’s syndrome accounts for 10%.   
 
About 75% of all cases of HSCR are caused by mutations in RET, which encodes 
the receptor for glial derived neurotrophic factor (GDNF).  Other genes which can 
cause HSCR when mutated include the neurocristopthy genes: EDNRB (also 
causes piebaldism, or melanocyte defects), SOX10, PHOX2B, and ZFHX1B (See 
Table 9 for references).  Also, mutations in Sonic Hedgehog results in aganglionic 
colons in mice (Ramalho-Santos et al., 2000). 
 
While HSCR is present at 1 in 5,000 in the population at large, several 
investigators have noted a high frequency of the disease in BBS patients.  Maeda 
et al (1984) first noticed the association of BBS with HSCR.  This was followed 
by reports by six independent observations of the same phenomenon (Alter et al., 
2001; Beales et al., 1999; de Pontual et al., 2007; Işlek et al., 1996; Lorda-
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Sanchez et al., 2000; Radetti et al., 1988).  Cherian et al reported HSCR in two 
siblings with BBS (Cherian et al., 2008).  In one case, the whole ileum and colon 
was aganglionic and in the other, only the colon.  The fact that both siblings had 
HSCR and BBS suggests that the BBS mutation was responsible for the HSCR.  
de Pontual et al (2007) found that 45% (n=51) of BBS patients in their cohort, 
irrespective of underlying mutation, had HSCR.  This is an over-representation of 
over 2,000-fold relative to the general population, and therefore unlikely to be due 
to chance (p<0.001).  The incidence of HSCR in our BBS patient cohort is around 
10% (P. Beales, personal communication). 
 
de Pontual et al found that an allele of the RET gene predisposing to HSCR (TT) 
was present at higher frequency in patients with syndromic HSCR (including 
BBS, Mowat-Wilson, Waardenburg-Shah, Down Syndrome, and CCHS) versus 
those without (34.9% with HSCR vs 21% without, n=195 and 198 respectively).  
For BBS in particular the frequency of this TT allele increased from to 4% to 34% 
(n=23 and 28 respectively) for patients also manifesting HSCR.   
 
The frequency of this allele is estimated at 25% in the Caucasian population.  The 
authors suggest that the presence of the TT allele predisposes the patient to get 
HSCR.  However, the frequency of the SNP in BBS patients with HSCR is 34% 
compared to a wild type frequency of 25%.  This 9% increase cannot explain a 
2,000-fold increase in the frequency of HSCR and so does not serve to explain the 
clinical phenotype.   
 
The authors proposed that the disruption to PCP signalling caused by BBS 
mutation affected NCC migration which, in conjunction with a hypomorphic RET 
allele, leads to HSCR.  However, this is an oversimplified model, because 66% of 
BBS patients have HSCR, but lack the TT allele in RET, and 13% of BBS patients 
do not have HSCR but have the TT allele.  They also noted the expression of BBS 
genes in vagal NCCs in human embryos.   
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Zebrafish are a powerful means of investigating neural crest 
migration 
Current understanding of neural crest development comes from the study of the 
classical embryological models: mouse, chick, frog, and now fish (Halloran and 
Berndt, 2003).  Each model organism has its particular advantages: the mouse is 
most similar to humans, so is most relevant for study of disease; the chick is 
useful for grafting experiments, particularly transplants with quail tissue; the frog 
embryo is easy to manipulate, genes can easily be knocked-down or 
overexpressed, and fate mapping experiments can be performed.  
 
In the last ten years, the advantages of the zebrafish for studying neural crest 
development have become realised.  Firstly, the optical clarity means cell 
migration can be studied in real time in living embryos.  Secondly, the high 
fecundity and low cost of maintenance enables forward genetic screens that are 
impossible in other vertebrate species.  The mutants enable functional 
characterisation of genes involved in NCC development.  Third, the availability of 
transgenic lines expressing GFP in particular tissues enables precise and 
quantitative mapping of individual cell behaviour in vivo.  The latter point has 
been exemplified by the generation of the sox10::eGFP transgenic line that 
expresses GFP exclusively in the neural crest (Wada et al., 2005).  I have taken 
advantage of this for several experiments in this thesis. 
 
Several recent studies highlight the utility and power of the zebrafish in studies of 
neural crest migration.  However, the zebrafish still remains a tool largely used to 
answer fundamental questions about embryonic development and is only just 
emerging as a valid system in which to model human disease processes.  
Nevertheless, the ability to create knockout models in zebrafish that are not 
readily available in mouse, and the subsequent phenotypic and functional 
experiments possible, make the zebrafish a perfect model for investigating NCC 
migration in BBS models.   
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Development of the neural crest in zebrafish 
Zebrafish neural crest development is remarkably similar to higher vertebrates, 
although there are obvious anatomical differences between fish and mammals.  In 
both fish and mammals, trunk NCCs migrate in two pathways: the medial 
pathway between the neural tube and the somite, where cells form peripheral 
neurons and glia; and the later migrating lateral pathway between the somite and 
the ectodermal epithelium, where cells differentiate into melanocytes.  Similarly, 
the cranial neural crest consists of two main migratory streams. Streams of NCCs 
migrating from the hindbrain form the pharyngeal skeleton, while more anterior-
derived cells form the braincase, or neurocranium (Lumsden and Guthrie, 1991).   
 
In the zebrafish embryo, the head skeleton forms from CNCCs migrating rostrally 
from the hindbrain to populate the head and face.  The pharyngeal skeleton is 
entirely neural crest derived and consists of seven branchial arches (Schilling et 
al., 1996).  The anteriormost two become the mandible and ceratohyal 
respectively and form the lower jaws of the animal.  The posterior five arches 
form the branchial skeleton from which the gills derive and hence the fish’s 
breathing apparatus.   
 
The neurocranium comprises of the broad basal plate from which protrude the 
long, paired trabeculae which fuse at the anterior end into a condensation called 
the ethmoid plate.  Fate mapping experiments by Wada et al (2005) showed the 
trabeculae originate from dorsally-derived cells, while the ethmoid plate derives 
from more anterior positioned precursors (Wada et al., 2005).  This is shown in 
Figure 27.   
 
The fish skull is analogous to the mammalian skull and all the equivalent features 
are present.  The migration of the CNCCs in fish responds to the same signalling 
cues as the mammal.  Because of the complex three-dimensional geometry of the 
cranial skeleton, several signalling systems are deployed.  Kimmel et al (2001) 
studied the available data and concluded there was a separate signalling pathway 
for each of the three main axes: anteroposterior, dorso-ventral, and medio-lateral.   
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Figure 27.  CNCC migration in the zebrafish embryo. 
Posterior-derived CNCCs migrate dorsally around the eye and contribute to the 
trabeculae.  Anterior-derived CNCCs migrate on a ventral pathway and give rise to the 
ethmoid plate.  Taken from Wada et al (2005).   
 
The anteroposterior axis is the best understood, and is produced as CNCCs 
emerging from different axial levels in the neural tube migrate to stereotyped 
destinations to pattern the AP axis.  This regulates the order of the pharyngeal 
arches.  Nested expression of different Hox genes in the rhombomeres of the 
hindbrain specifies the axial level of these emigrating cells.   
 
Mutations in genes controlling dorsoventral polarity such as Dlx5 and Dlx6 result 
in rearrangements such as the homeotic transformation of lower jaw into upper 
jaw (Depew et al., 2002).  Furthauer et al showed that Fgf8 was also required for 
dorsoventral patterning in the zebrafish and ectopic Fgf8 expression leads to 
expansion of dorsal tissues at the expense of ventral ones (Fürthauer et al., 2004).  
They also concluded that Fgf8 had organiser-like properties in the developing 
head.   
 
The skull and pharyngeal skeleton also have a mediolateral polarity, with bones 
arranged in a symmetrical pattern about a midline (de Beer, 1937).  Details of the 
development of this axis are emerging from a group of “midline mutants” in 
which the mediolateral axis of the skull is anomalous.  The best understood 
molecule regulating midline polarity in the head is Sonic Hedgehog.   
 
This ligand is secreted from the midline of the prechordal plate and anterior neural 
tube (Strähle et al., 2004).  It also signals from the oral ectoderm to direct the 
polarised movement of cells at the midline of the embryo (Hu and Helms, 1999; 
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Marcucio et al., 2005).  Shh acts to keep streams of migrating crest cells separated 
at the midline.  Therefore, ablation of Shh or its downstream pathway components 
results in a fusion of the trabeculae, absence of the ethmoid plate, and 
synophthalmia, in which the eyes are closely spaced. 
 
The zebrafish enteric nervous system 
Just like the mammalian ENS, the zebrafish ENS derives from the vagal neural 
crest, whose cells migrate progressively along the gut to colonise the foregut, 
midgut, and hindgut.  The fish gut is much less convoluted than the mammalian 
and, like many fish, lacks a stomach (Wallace et al., 2005).  The anterior intestine, 
the intestinal bulb, has a wider bore than the posterior and is thought to act as a 
stomach-like reservoir for food.  The adult gut only has two kinks; one midway 
through the foregut, and one at the boundary between the foregut and midgut.  
The ENS controls the peristaltic activity of the smooth muscle lining the gut 
lumen as well as the secretory and vascular supply, just as in mammals. 
 
In mouse, the development of the ENS begins at around E9.5 and continues until 
around E14.5.  In zebrafish, this process happens much more rapidly: NCCs begin 
to migrate out from the vagal region at 36hpf and have begun to colonise the 
foregut by 48hpf.  By 72hpf, they have extended all the way along the distal 
portion of the gut to colonise the mid- and hindgut.  By 96hpf, these cells have 
already differentiated into mature neurons and are functional.  This can be 
observed by the coordinated peristaltic contractions in the gut, visible by time-
lapse DIC imaging of 96hpf embryos.   
 
The conservation of ENS developmental mechanisms, combined with the 
architectural simplicity of the gut make the fish a good model system for studying 
ENS development.  Kuhlman and Eisen performed an ENU-based mutagenesis 
screen to identify genes involved in ENS development.  They screened the 
phenotype by immunostaining with an anti-HuC/D-ElaV antibody, which 
identifies all differentiated neurons (Kuhlman and Eisen, 2007).  They identified 
13 mutant lines, four of which affected solely the enteric neurons, while the other 
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9 had pleiotropic effects.  These included: small head, neural tube defects, 
melanogenesis defects, mislocalised dorsal root ganglia, and rounded somites.  
Many of these phenotypes are reminiscent of neurocristopathy and it is likely that 
many of these loci are involved in NCC development, but are yet to be cloned. 
 
These authors then made time-lapse movies of the peristaltic contractions in 
5.5dpf wild type and mutant embryos.  They showed that the rostral to caudal 
peristaltic waves correlated perfectly with the degree of gut innervation.  This 
shows that the fish can be used to test the physiological, functional effects on the 
gut as well as the cellular effect.  As such, the fish makes a good model for 
studying the potential causes, both molecular, cellular, and physiological, for the 
high incidence of Hirschsprung’s disease in BBS patients.  This is valid since gut 
aganglionosis and immotility is what causes the symptoms of megacolon and 
chronic constipation in human patients. 
 
The aims of this investigation 
The human and mouse craniofacial defects discussed in the previous chapter were 
modelled in the zebrafish.  This revealed that while craniofacial deformities were 
common to all BBS morphants, the most striking phenotypes were consistently 
seen when bbs8 was knocked down.  Given the neural crest contribution to all the 
affected cranial regions: the mandible, maxilla, nasal bones, and pharyngeal 
skeleton, I aimed to determine whether BBS proteins, in particular Bbs8, had a 
role in NCC development.  Because NCC development comprises four main 
events (see above), I aimed to test these to see what role the proteins have in 
particular.  Because the sox10::eGFP transgenic zebrafish allows real-time 
imaging of NCCs in vivo, I aimed to take advantage of this facility in uncovering 
potential effects on NCC development.  In particular, I wanted to study how the 
contribution of the neural crest to the craniofacial skeleton was affected in bbs8 
morphants to see if craniofacial dysmorphology could be directly attributed to 
inhibition of migration. 
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In addition, I aimed to determine the effect of bbs8 knockdown on other crest-
derived cell types, in particular the melanocytes and enteric neurons.  While no 
BBS patients have been observed with piebaldism or albinism (splotchy or 
absence altogether of skin pigmentation), I have already discussed the prevalence 
of Hirschsprung’s disease.  Because these are both NCC derived cell lineages I 
also wanted to examine these cells in bbs8 knockdowns. 
 
Given the availability of primary cells taken from human patients with BBS8 null 
mutations, I also designed experiments to look at cell migration in vitro in 
fibroblasts to extend the study from NCCs.  Additionally, I tested the molecular 
basis for the NCC defect by manipulating the non-canonical Wnt signalling 
pathway in presence and absence of Bbs8 protein to see if Bbs8 was mediating 
migration via this mechanism.   
 
Finally, I wanted to further the study by examining the craniofacial morphology 
of other ciliopathy morphants such as mks3 and ofd1 to see if other ciliopathy 
proteins were potentially involved in NCC development.  This could raise the 
exciting possibility that the cilium, or IFT, in general, is important for NCC 
migration. 
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Results 
Induction and maintenance of neural crest cells are unaffected in 
morphants 
The craniofacial regions disrupted in BBS mutants and morphants derive from the 
neural crest.  These cells form at the edges of the neural plate and the dorsal 
aspect of the neural tube.  There are several stages in neural crest development 
and disruption in any of them could potentially lead to the phenotypes observed in 
the bbs8 morphants. 
 
A reduction in the neural crest derived structures of the craniofacial region could 
be due to one of several factors: 1) neural crest are not being specified correctly; 
2) the NCCs are not being maintained before migration; 3) NCCs are not 
migrating properly; 4) NCCs are differentiating inappropriately either along the 
course of migration or once they have reached their target sites.   
 
To begin with, I tested the first two hypotheses to see if NC induction or 
maintenance were affected.  To test NCC induction, I performed in situ 
hybridisation on 5ss embryos to examine foxd3 and Sox10 gene expression.  
These are two of the earliest markers expressed specifically in NCCs and so can 
be used to assess the extent of NCC induction in the neural tube.  Foxd3 
expression in controls and bbs8 morphants was comparable, suggesting that NCC 
induction is normal and a regular number of NCCs are being specified (Figure 
28).  
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Figure 28.  Induction and maintenance of NCCs. 
At 5ss expression of two NCC-specific markers, foxd3 and sox10, are equivalent in 
controls and bbs8 morphants, suggesting normal NCC induction.  At 12ss, immediately 
prior to migration, expression of sox10 shows a similar pattern in controls and morphants, 
suggesting that NCCs in the neural tube have been maintained and proliferated normally.  
Scale bar = 500µm. 
 
I next tried to determine whether NCC maintenance was affected in morphants.  
After specification, which occurs at the 5ss, there is a delay until the 12ss before 
the NCCs begin to migrate.  During this four-hour period, NCCs must be 
maintained before they emigrate from the neural tube, anteriorly into the head and 
dorsally into the trunk.  Embryos at 12ss were stained by in situ hybridisation for 
the marker Sox10, a pan-neural crest marker.  Again, there was no difference in 
the maintenance of NCCs, as the domain size and intensity of sox10 expression 
was unaffected in bbs8 controls (Figure 28).  It is possible that there may even be 
more pre-migratory NCCs in bbs8 morphants. 
 
The number and proliferation of neural crest cells is unaffected in 
morphants 
Given that induction and maintenance of NCCs is unaffected, as an extra control I 
tested whether the number and proliferation of NCCs was affected in bbs8 
morphants.  It may be that migrating NCCs either fail to proliferate, or die en 
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route during migration, which could potentially give rise to the craniofacial 
phenotypes observed.  
 
First, I examined the number of NCCs in zebrafish embryos during NCC 
migration at 16ss.  Sox10::eGFP embryos that express GFP specifically in the 
NCCs were injected with either control or bbs8 MO and 100 embryos of each type 
were dissociated into single cells.  These cells were sorted for GFP expression 
using wild-type embryos as GFP-negative controls to calibrate the cell sorter.  The 
number of NCCs in control and bbs8 morphants was not significantly different 
and in both cases ranged from around 800 cells for 14ss embryos to 1,200 for 20ss 
embryos.  This suggested that the number of NCCs was the same during the 
course of migration (Fig. 29A-D). 
 
Next, I tested whether proliferation of NCCs was affected.  To do this, I 
performed immunohistochemistry on wholemount Sox::10eGFP transgenic 
embryos at 24hpf and 72hpf using an anti-phosphohistone antibody.  At 24hpf, 
there was more cell proliferation in the brains of control embryos than morphants, 
particularly in the eye (Fig. 30A,B).  However, there was no difference in the 
number of proliferating NCCs.  In morphants, the NCCs had failed to populate the 
anterior portion of the head by 24hpf, whereas in controls the NCCs had migrated 
around the eye.  At 72hpf, there was greater proliferation in the brain regions of 
the morphants compared to controls, but again, there was no difference in the 
amount of proliferation in the NCCs themselves (Fig. 30C,D).   
 
Sox10:eGFP expression revealed a distinct lack of NCCs forming branchial 
arches in morphants, explaining why the arches were hypoplastic or missing.  
Examination of the expression of Sox10:eGFP in the trunk revealed a distinct lack 
of streams of migrating NCCs from the neural tube (Fig. 30E,F).  HuC/D is a 
neuronal marker and its expression was not increased in the bbs8 morphant NCCs 
trapped in the neural tube, suggesting that these cells were not inappropriately 
differentiating and that premature differentiation was not responsible for the 
observed migration defect (fig. 30G,H). 
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Figure 29.  FACS data on NCC abundance. 
A-C: FACS plots showing the proportion of events in control GFP-negative, uninjected 
sox10:eGFP, and morphant embryos is the same.  In each case around 80% of events are 
processed as cells.  A’: in GFP-negative embryos, only 0.3% of cells were sorted (non-
zero value likely due to autofluorescence).  B’ and C’: in uninjected and bbs8 morphant 
embryos, around 4.5% of cells were fluorescent.  D: quantification showing no significant 
difference between the percentage of NCCs as a total of all body cells in control and 
morphant transgenics, suggesting a similar amount of NCC proliferation. 
 
Neural crest migration is inhibited in bbs morphants 
In light of these results, I tested the extent of migration in the NCCs of morphants.  
In the first instance, wholemount in situ hybridisation was performed to examine 
the expression of crestin, a marker of neural crest cells.  This was performed at 
the 20ss when NCCs migrate in streams ventrally away from the neural tube into 
the trunk, with one stream per somite.  A crude quantitative measure of NCC 
migration is to count the number of migrating streams in each treatment.  In 
controls, there were an average of 13 streams of crest compared to about 9 for 
A 
A
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B
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bbs4 morphants, 3.5 for bbs6, and 1 for bbs8 (Fig. 31A-D).  The effect was almost 
completely rescued by co-injecting human bbs8 mRNA with the bbs8 MO (9 
streams), suggesting that the effect is specific to the MO (Fig. 31E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30.  Examination of NCC proliferation and migration in vivo.   
A-B’: expression of Sox10:eGFP (green) shows an inhibition of migration in bbs8 
morphants.  While there are more proliferating cells in the head of controls (red staining), 
the amount of proliferation in NCCs themselves is not changed in morphants.  C-D’: 
expression of Sox10:eGFP at 72hpf reveals a lack of branchial arch formation by NCCs 
in morphants.  It again shows no difference in proliferation of the Sox10-positive CNCCs 
in morphants.  E,F: examination of the trunk of 24hpf embryos reveals a lack of 
migrating streams of NCCs in morphants.  G,H: expression of the pan-neuronal marker, 
HuC/D, is not increased in morphant neural tubes, suggesting that the observed migration 
defect is not due to premature proliferation into mature neurons.  Scale bars: A-D’ = 
100µm; E-H = 50µm. 
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Figure 31.  Quantifying the extent of NCC migration in BBS morphants. 
A: control embryos at 20ss have around 13 streams of crestin-positive NCCs migrating 
ventrally from the neural tube into the trunk (also shown by expression of Sox10:eGFP).  
B-D: the number of streams of migrating NCCs is reduced in BBS morphants, most 
drastically in bbs8.  E: the number of streams of NCCs is almost completely rescued by 
mRNA co-injection.  F: the number of streams of migrating NCCs (bars) correlates with 
the reduction in ANC length to body length ratio.  This suggests the extent to which NCC 
migration is reduced is responsible for the severity of craniofacial deformity.  Scale bars: 
A-E = 100µm. 
 
This result shows that there is either a delay or severe inhibition of NC migration 
in the morphants, with bbs8 being the most severe.  The degree of migrational 
inhibition appears to correlate with the severity of skull defect.  This can be seen 
by comparing the graphs for skull length to width ratio, and body length to skull 
length ratio, with the number of streams of migrating crest cells in the morphants 
(Fig. 31F).   
 
To exclude the possibility that the reduced number of streams of migrating crest 
was due to possible transcriptional inactivation of crestin in the migrating trunk 
control bbs4 bbs6 bbs8 bbs8 + RNA 
A 
Sox10:eGFP 
B C D E 
F 
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NCCs, and to validate the previous results, I made use of the Sox10::eGFP 
transgenic zebrafish, which expresses GFP in NCCs.  I examined GFP expression 
at the 20ss and saw the same pattern of expression as the crestin in situ (Figure 
32).  This confirmed the observation of reduced trunk NCC migration.  I ensured 
that NCC migration itself was not affected by the sox10::eGFP transgene by 
performing an in situ hybridisation for crestin on uninjected sox10::eGFP 
transgenics.  This showed normal NCC migration. 
 
 
 
 
 
 
 
Figure 32.  crestin expression in sox10:eGFP embryos. 
Expression of crestin shows a lack of trunk streams in morphants while neural tube 
expression is unaffected in morphants.  This suggests that NCCs populating the neural 
tube have failed to emigrate.  It also shows in the control situation that NCC migration is 
not affected by the presence of the transgene in the sox10:eGFP transgenic zebrafish.  
Scale bar = 500µm. 
 
Pigmentation is lacking in bbs8 morphants 
The most striking phenotype of bbs8 morphants is their almost complete lack of 
pigmentation, mirroring published neural crest genetic zebrafish mutants such as 
colourless (sox10 null mutant).  Because melanocytes are derived from the trunk 
neural crest, which was observed not to migrate in bbs8 morphants, I next 
examined the expression of dopachrome tautomerase (dct), a marker of 
melanocyte precursors at 25hpf, about 5 hours before the appearance of 
pigmentation in the embryo.  The spotted pattern of expression in controls reveals 
where presumptive pigment will appear.  There is a complete lack of dct 
expression in the morphants, implying that the NCCs have persisted in the trunk 
and failed to migrate out to differentiate into melanocytes (Figure 33).   
 
 
control bbs8 
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Figure 33.  dct expression in bbs8 morphants 
There is a complete absence of dct expression, a pre-melanocyte marker, in morphants.  
Melanocytes derive from trunk NCCs and so their absence suggests a failure of these 
cells to reach their targets, as it is known that trunk NCCs fail to migrate in bbs8 
morphants.  This likely explains the lack of pigmentation in older bbs8 morphants.  Scale 
bar = 500µm. 
 
Time-lapse imaging of migrating cranial and trunk neural crest cells 
Evidence suggests that trunk neural crest fails to migrate in morphants and 
therefore does not give rise to differentiated cell types.  Because the cranial 
cartilages are NC-derived, I next tested whether the migration of the cranial NCCs 
was disrupted.  To do this, I mounted Sox10::eGFP control and morphant 
transgenic zebrafish in agarose and imaged the anterior portion of the embryo to 
visualise CNCC migration at timepoints between the 12 and 20ss (timepoints: 12, 
14, 16, 18, 20ss), a period of 4 hours during which cells migrate rostrally from the 
neural tube into the head.   
 
In control embryos, cells migrated rostrally in dorsal and ventral pathways around 
the eye to populate the whole head by 20ss (Fig. 34A and B).  In morphants, cells 
had not advanced as rostrally as controls by 12ss, and by 20ss, the cells had only 
reached the equivalent position in controls at 12ss (Fig. 34C and D).  
Developmental delay was controlled for by counting the number of somites in 
embryos before imaging.  The distance migrated by the CNCCs was calculated by 
comparing the position of the anterior-most cell at 12ss and 20ss.  In controls, 
these cells migrated, on average, 250µm compared to 80µm for morphants.  This 
result was confirmed by creating time-lapse confocal movies which showed 
inhibited migration of both the cranial and trunk NCC in morphants.   
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Figure 34.  CNCC migration in sox10:eGFP control and morphant embryos. 
A: at 12ss CNCCs in control embryos have begun to migrate around the eye and are 
about midway through the eye (arrowhead).  B: by 20ss CNCCs have colonised the 
anterior part of the head and have migrated in a stream around the dorsal aspect of the 
eye.  The white and red arrowheads show the relative positions of the migratory front at 
12 and 20ss respectively.  C: at 12ss morphant CNCCs have only migrated about a 
quarter of the way through the eye.  D: at 20ss these cells have reached the same position 
controls cells had at 12ss.  Scale bar = 100µm. 
 
Lack of neural crest cells in the ANC after 48 hours in morphants 
CNCCs migrating into the head converge at the midline and form the trabeculae, 
which terminate in a flattened condensation of cells called the ethmoid plate.  
Imaging the expression of Sox10 in transgenic zebrafish at 48hpf revealed the 
formation of the two trabeculae in controls, their convergence at the midline, and 
divergence into the ethmoid plate.  In morphants, the trabeculae failed to extend 
and the presumptive ethmoid plate was absent (Figure 35).   
 
 
 
 
 
 
 
Figure 35.  sox10:eGFP CNCCs at 48hpf. 
Confocal imaging of the CNCCs at 48hpf showed the rudimentary formation of 
trabeculae in controls, which have begun to coalesce at their terminal ends to form the 
ethmoid plate.  In morphants, the trabeculae have failed to extend by this stage, leaving 
  137 
Chapter 4 – Neural crest migration defects 
only the cells that will become the parabranchial cartilage.  The white line indicates the 
extent of the front of the head in the morphant embryo.  Scale bar = 100µm. 
 
These cells begin to differentiate into chondrocytes, which form cartilage at 
around 72hpf and so are markers of where the cranial skeleton will eventually 
develop.  Reduction in the extent of trabeculae at 48hpf, combined with the 
observed inhibition of CNCC migration at earlier stages, suggests that an NCC 
migration defect is responsible for the deficit in cranial cartilaginous structures at 
5dpf.    
 
Cell-transplantations show that the phenotype is cell-autonomous 
In bbs8 morphants, there is a typical convergent-extension phenotype universally 
penetrant amongst ciliary morphant and mutant embryos.  This results in 
shortened and widened somites, presumably resulting in compression of the 
somatic mesoderm tissue through which NCCs migrate.  As such, it is possible 
that the defect in NCC migration is a secondary effect of the compacted tissue 
environment through which the NCCs must migrate.  This scenario is less likely 
due to equivalent CE defects in both bbs4 and bbs6 morphants not resulting in 
NCC migration defects as severe as for bbs8.   
 
However, to test the possibility that non-cell autonomous factors contributed to 
the migration defect, I performed reciprocal cell transplantations.  To begin with, I 
transplanted 20-30 cells from control Sox10::eGFP embryos at 4hpf injected only 
with rhodamine-labelled dextran into wild-type hosts (figure 36A).  This tested 
that my transplantation technique in itself was not inhibiting migration of the 
NCCs and that transplanted cells were being targeted to the presumptive NC.  I 
then imaged the position of CNCCs at 12, 16, and 20ss and measured the linear 
distance migrated by the cells during this period.  This established a baseline for 
the distance migrated by control cells grafted into a normal cellular environment 
(Fig. 36A).   
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Figure 36.  Cell transplantations between control and morphant embryos. 
A and A’: between 12 and 20ss, labelled control cells transplanted into a control host 
migrated caudally, as evidenced by the advanced position of the leading cells 
(arrowheads).  B and B’: morphant sox10:eGFP cells transplanted into a wild-type 
control host failed to migrate and remained in the same position throughout the 4-hour 
test period.  C and C’: control donors transplanted into a bbs8 morphant host migrated as 
normal, suggesting that the tissue environment is not responsible for inhibiting migration 
in morphants, rather it is a cell-autonomous defect.  Scale bar = 100µm. 
 
I next transplanted bbs8 morphant Sox10::eGFP donors into control hosts.  These 
cells failed to migrate despite being transplanted into a normal cellular 
environment, suggesting the inhibition of migration in bbs8 morphants is cell 
autonomous (Fig. 36B).  In other words, lack of Bbs8 protein in NCCs 
intrinsically alters the capacity of the cells to migrate.  Finally, I tested whether 
control NCCs could migrate in bbs8 host embryos to test whether the CE defect 
was inhibiting migration.  Control NCCs transplanted into morphant hosts were 
able to migrate to the same extent as in a control host environment, implying that 
the CE defect in bbs8 morphants is not inhibiting CNCC migration in its own 
right (Fig. 36C).   
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Examination of cellular protrusions in migrating cells  
Migrating cells, particularly NCCs, extend fine protrusions, or filopodia, polarised 
in the direction of migration.  These are dynamic structures, which extend and 
collapse upon contact of an adjacent cell and are thought to be important for the 
cell to sense its neighbours to ensure an accurate migratory pathway.  The 
extensions of these protrusions are markers of polarity of the cell, and they can be 
inappropriately extended if the cell has lost its intrinsic polarity mechanisms. 
 
To see if morphant migrating CNCCs or trunk NCCs were extending polarised 
protrusions, I imaged cells at the leading edge of the rostral-most group of CNCCs 
migrating into the head as these migrated in the most stereotypical direction and 
so correlations could be made between direction of migration and cell protrusions.  
I also attempted to image streams of crest cells exiting the neural tube and 
migrating ventrally into the trunk.  The problem with this experiment is that the 
bbs8 morphants almost entirely lack migrating streams, making likewise 
comparison difficult. 
 
 
 
 
 
 
 
Figure 37.  Cell protrusions in migrating CNCCs. 
Control CNCCs extend fine projections (arrowheads) into the extracellular space as they 
migrate (the direction of migration is indicated by the arrow).  The majority of these 
projections are polarised in the direction of migration.  In bbs8 morphants, the CNCCs 
fail to extend these projections and remain tightly clustered, with more rounded, and less 
polarised, cell morphology.  Scale bar = 10µm. 
 
High-power confocal imaging of these CNCCs at 16ss, a period of active cell 
migration, revealed that control CNCCs extended many protrusions (Figure 37).  
However, protrusions were almost completely absent from morphant CNCCs and 
the cells were tightly clustered together (Figure 37).  This could be because the 
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cells have failed to migrate, but have proliferated, the cells are unable to detach 
from one another and migrate into open space.  It is possible that the lack of 
protrusions is due to contact inhibition, but the cells at the leading edge still failed 
to extend projections in their presumptive direction of travel.  
 
To investigate this further, I made time-lapse confocal movies lasting one hour to 
examine the behaviour of these protrusions in real time.  As expected, the control 
protrusions dynamically form and collapse over a very short time frame (5 
minutes) but the bbs8 morphants fail to do so.   
 
As the cell protrusions are formed by extensions of the actin cytoskeleton, and this 
is partly controlled by the planar cell polarity (PCP) (non-canonical Wnt) 
signalling pathway, it is possible that a defect in PCP signalling in morphants 
affects their ability to remodel the actin cytoskeleton in a polarised manner 
prerequisite for directed motility.   
 
Possible role of non-canonical Wnt signalling in the migration defect 
There are already published associations between Bbs proteins and the PCP 
pathway.  Bbs morphants have defective gastrulation movements (CE) 
reminiscent of PCP mutants, in the mouse they interact genetically with the PCP 
pathway, and Bbs suppressant cells show induction of canonical Wnt activity, 
thought to be antagonistic to the PCP pathway.  
 
Given the importance for PCP signalling for NCC migration in Xenopus, the 
genetic interaction of bbs8 morphants with trilobite, a PCP mutant (our 
unpublished data), and the lack of polarised protrusions on migrating CNCCs, I 
performed some experiments to test whether Bbs8 was potentially mediating PCP 
signalling in NCCs to control migration.   
 
Both induction and suppression of PCP signalling inhibits NCC migration.  I 
injected two different mutant Dishevelled constructs: Dvl-ΔN has an N-terminal 
truncation which eradicates the N-terminal region of the protein but maintains the 
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PDZ and DIX domains important for morphogenetic movements associated with 
PCP signalling.  Therefore, overexpression of Dvl-ΔN induces PCP signalling.  
The second Dvl construct contains sites for myristoylation and palmitoylation, 
which localises it constitutively to the membrane.  Cytoplasmic Dishevelled is 
associated with canonical Wnt signalling but membrane targeting activates PCP.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38.  Mutant dishevelled constructs can partially rescue the bbs8 
morphant NCC migration defect. 
A: control embryos at 20ss showing normal streams of NCC migration revealed by 
crestin in situ hybridisation.  B,F: injection of a dominant-negative form of dvl lacking 
the N-terminal region, or a membrane-targeted form of dvl, both caused inhibition of 
migration.  C: bbs8 morphants with reduced streams of migrating NCCs.  D,G: co-
injection of 3ng bbs8 MO with either the dominant-negative or membrane-targeted dvl 
constructs partially rescued the migration phenotype, as evidenced by a significant 
increase in the number of migrating streams of NCCs.  E: injection of 2ng bbs8 MO with 
the dominant-negative dvl construct did not rescue the phenotype, suggesting a dose-
dependent effect.  Scale bar = 100µm. 
 
Injection of either of the two mutant Dvl constructs inhibited NCC migration as 
shown by counting the number of migrating NCC streams in crestin stained 20ss 
embryos (Fig. 38B,F, and H).  Injection of 3ng of bbs8 MO also blocked 
migration (Fig. 38C).  However, combining either mutant Dvl construct with 3ng 
of bbs8 MO caused partial restoration of the migration inhibition (Fig. 38D,G, and 
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H).  Injection of 2ng of bbs8 MO with Dvl-ΔN did not rescue the phenotype (Fig. 
38E).   
 
These results suggest, but do not prove, that knockdown of bbs8 might be 
balancing the level of PCP signalling back to normal from the induced state of the 
mutant Dvl constructs.  This might mean PCP signalling is inhibited in bbs8 
morphants, which is, at least in part, causing the migration defect.   
 
As there are no validated direct quantitative read-outs for PCP signalling it is 
difficult to confirm these findings.  However, one role PCP is thought to play is in 
the localisation of the centrosome between the nucleus and leading edge of the 
cell in migrating cells.  
 
Attempt to visualise centrosome movements in migrating crest cells 
Because bbs8 is a centrosomal and basal body-expressed gene, and the position 
and function of the centrosome is important for the direction of cell migration, I 
next tried to investigate if the centrosome was mislocalised in CNCCs.  To do 
this, I injected sox10::eGFP transgenic embryos with H2B-RFP, which marks the 
nucleus with RFP.  I co-injected centrin-RFP which marks the centrosome with 
RFP.   
 
However, the Centrin localisation was unreliable and because the centrosome is so 
small, it tended to get obscured by the intense fluorescence of the nuclear RFP.  
Furthermore, both GFP- and RFP-tagged centrin were unreliable markers of 
centrosome position in vivo, as it was difficult to distinguish the centrosome from 
background fluorescence as it is a tiny organelle.  As such, no reliable data were 
obtained from this experiment but its optimisation would lead to potentially 
exciting mechanistic insights. 
 
The aim is to make real-time movies showing migrating CNCCs revealing the 
position of the centrosome in relation to the nucleus and the leading edge of the 
cell.  This is confounded further by the 3D quality of the embryo, which makes it 
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impossible to get a single fluorescent nucleus in focus at once, particularly as they 
migrate out of the field of view.  This confounds the region of interest with 
surrounding fluorescent, non-NCC nuclei. 
 
Neural crest cells are ciliated 
It is unknown whether NCCs are ciliated, and nobody has ever examined this.  
There are several lines of evidence to suggest that NCCs might be ciliated: 
1) There are several papers that show that cilia are crucial for PCP signalling, 
and in fact, conversely, that PCP signalling is involved in primary 
ciliogenesis.  If PCP is important for NCC migration, these cells should 
bear cilia. 
2) CNCCs are patterned at the mid-facial region by Shh-ligand secreted from 
the oral ectoderm.  Numerous reports have demonstrated the reliance of 
Hedgehog signalling on cilia. 
3) The observed role for Bbs8, a ciliary protein, in NCC migration. 
 
To investigate this possibility I fixed sox10::eGFP transgenic embryos at 20ss 
and performed immunohistochemistry using an anti-acetylated tubulin antibody to 
reveal the primary cilia.  Using confocal microscopy with a 63x water immersion 
lens, I was able to observe cilia on a large proportion of Sox10-positive cells (Fig. 
39A).  Confocal optical sectioning proved that these cilia emanated from the peri-
nuclear region of neural crest cells (Fig. 39B and B’). 
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Figure 39.  Primary cilia on NCCs. 
A: Sox10:eGFP expression demarcates NCCs while cilia are revealed by an anti-
acetylated tubulin antibody (in red).  B: a cilium (in red) on an NCC.  B’: confocal 
section through this cell showing the red cilium clearly extending apically from the 
perinuclear (nucleus stained in blue) from the green NCC.  Scale bars: A = 20µm; B = 
5µm. 
 
Examination of cell polarity in migrating NCCs in vivo  
The lack of polarised protrusions and migration defects in the morphants 
prompted me to examine the actin cytoskeleton in migrating NCCs, whose 
remodelling is essential for cell motility.  To do this, I fixed transgenic embryos at 
16ss and stained the embryos with Phalloidin to visualise the actin filaments.  
Unfortunately, it was very difficult to resolve the internal cytoskeleton in an 
individual NCC due to the confounding effect of all the surrounding cells stained 
with Phalloidin.  It was possible to get a clear outline of the cell, but not of the 
individual actin microfilaments within the cell.  
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Figure 40.  Actin cytoskeleton in migrating CNCCs. 
Control CNCCs migrating (green cells, dotted outline) showing phalloidin expressed at a 
higher level and seemingly with more intracellular microfilaments than morphant cells.  
Scale bar = 10µm. 
 
Some images suggested that there might possibly be an effect on the cytoskeleton 
in morphant migrating CNCCs but the images were not clear enough to say with 
any confidence (Figure 40).  As such, it was essential to examine the migration of 
cells in vitro where the actin cytoskeleton can be resolved much more clearly. 
 
Cell migration assays in immortalised and primary fibroblasts 
I used an in vitro model of cell migration for two reasons: firstly, to try to resolve 
the actin cytoskeleton in Bbs8 knockdown cells, even if they were not NCCs; and 
secondly to see if the migration defect applied to other migratory cell types.  To 
do this, I performed in vitro scratch wound healing assays on cultured 3T3 mouse 
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embryonic fibroblasts.  These had been stably transfected with either lentivirally-
expressed shRNA against Bbs8 or a scrambled sequence control.   
 
The actin cytoskeleton was examined immediately after scratching, and at 6, 24, 
48, and 72 hours afterwards.  A low-power view was taken to measure the gap at 
10 different positions between the two fronts of cells migrating into the gap.  In 
control-transfected cells, this gap had closed completely by 48 hours.  In Bbs8 
suppressants, the gap took longer to close and the cells migrated significantly 
slower (approx. 30µm/hour controls vs 10µm/hour Bbs8 suppressants) (Figure 
41).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41.  3T3 scratch wound healing cell migration assay. 
Immediately after the scratch (0hr), there is a large gap between the two fronts of cells.  
By 24 hours after the scratch, control cells have migrated into the gap and closed it by 
around 80%.  Bbs8 suppressant cells have only reduced the gap by around 40%, 
suggesting they are migrating at around half the speed of control cells.  By 48 hours, the 
gap is almost completely closed in the control but still only about 55% closed in the 
knockdown cells.  Scale bar = 200µm. 
0h
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High power imaging of the cells showed that the actin cytoskeleton in control 
cells was polarised, with microfilament stress fibres arranged in parallel rows 
aligned along the long axis of the cell.  Control cells had begun to polarise 
themselves orthogonal to the scratch line 6 hours after the wound simulation (Fig. 
42A,B).  However, in Bbs8 knockdown cells, the cells were disordered and the 
microfilaments tended not to be aligned in parallel rows (Fig. 42C,D).  Often, the 
actin bundles criss-crossed each other and formed a disorganised array in the 
cytoplasm, not elongated along the axis of the cell.   
 
Examination of the cells migrating across the gap between the two frontiers of 
cells 24 hours after scratching showed that the control cells formed an organised 
array with the long axes of the cells pointing orthogonal to the line of the scratch, 
in the direction of cell migration, and their microfilaments aligned along this axis.  
In contrast, knockdown cells were scattered in an uncoordinated pattern across the 
gap, and their microfilaments did not appear to align in any particular direction 
(Fig. 42E,F).  Examination of these cells crossing the gap at higher power 
revealed the extent of the mispolarisation of actin microfilaments (Fig. 42G,H).   
 
The extent of microfilament mispolarisation was quantified using the high-power 
images such as Fig. 42G and H.  The angle of each microfilament in eight to ten 
different cells from separate images was measured relative to the horizontal.  For 
each cell, the average angle was calculated and the standard deviation of the 
angles was calculated.  The average standard deviation, and the deviation of the 
standard deviations were calculated to give a crude measure of the degree of 
disorder of microtubules in control and suppressant cells.  A value of 0 would 
mean that all the microfilaments in all cells were parallel, whilst a high value 
shows their orientation to be more randomised and less ordered.  Indeed, Fig. 43A 
shows the high degree of disorganisation of suppressant microfilaments relative to 
controls. 
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Figure 42.  Actin cytoskeleton in migrating 3T3 cells. 
A: control cells 6 hours after wounding are polarised orthogonal to the wound edge and 
are beginning to project into the gap.  B: higher power imaging shows the polarisation of 
microfilaments in these cells.  C: bbs8 knockdown cells fail to project into the gap 6 
hours after wounding.  D: the microfilaments of these cells are less aligned than controls.  
E: control cells 24 hours after wounding crossing the middle of the gap intercalate and 
polarise in the direction of migration, orthogonal to the direction of the scratch.  F: Bbs8 
knockdown cells do not align across the gap and appear disorganised and chaotic.  G: 
high magnification image of control cells migrating into the gap shows polarisation of the 
actin stress fibres in the direction of migration.  H: suppressant cells have a random, 
disordered array of actin filaments, with nucleations and clustering inside the cytoplasm.  
Scale bars: A,C = 20µm; B,D = 5µm; E,F = 20µm; G,H = 5µm.  Arrow indicates 
direction  orthogonal to wound gap (direction of migrating cells). 
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For eight different cells, the deviation in angle of each microfilament from the 
average orientation was plotted on a radar diagram.  In controls, this shows how 
the microfilaments deviate very little from the average, meaning that most 
microfilaments are parallel within a given cell (Fig. 42B).  In Bbs8 knockdown 
cells, the microfilaments deviate widely in angle from the average (Fig. 42C).  
Each line represents a different cell and each point a different microfilament from 
that cell. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43.  Quantification of microfilament organisation. 
A: graph showing the average standard deviation of the angle of microfilaments in each 
of ten cells.  This shows that the control cells; microfilaments are mostly parallel, or show 
a small deviation from parallel, whereas Bbs8 suppressant microfilaments are much more 
randomly aligned.  B: radar diagram showing deviation of 8 microfilaments in 8 different 
cells from the average angle of alignment.  This shows the extent of mispolarisation in 
suppressant cells.  See text for a description of how this statistic was calculated.   
 
I repeated this set of experiments using primary fibroblasts taken from skin 
biopsies from an adult patient with BBS8-/- null mutations, or a healthy, unaffected 
adult control.  Again, the mutant fibroblasts tended to migrate slower, not 
completely closing up the gap by 48 hours post-scratching, unlike the controls, 
A 
B 
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which had completely closed the gap by this stage (Figure 43).  Also, the mutant 
primary cells had a disorganised actin cytoskeleton compared to the controls, 
where the microfilaments were ordered parallel to the long axis of the cell (Figure 
43).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44.  Migration of primary fibroblasts. 
Immunofluorescence shows that the control cells completely fill the gap by 48 hours 
whereas fibroblasts from a patient with BBS8 null mutations fail to migrate as fast.  
Again, mutant cells migrate at approximately half the speed of controls.  Like the Bbs8 
knock-down immortalised fibroblasts, the actin cytoskeleton in mutant primary cells is 
disordered compared to the highly ordered “harp-string” like organisation of the primary 
cells’ actin cytoskeleton.  Scale bars: top = 200µm; bottom = 5µm. 
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The number of enteric neurons is reduced in bbs8 morphants 
Bbs8 protein seemed to be important in the migration of many different cell types, 
so I next tested whether it was important for the development of the enteric 
nervous system.  This is also derived from NCCs migrating from the vagal and 
sacral regions of the neural tube to colonise the gut.  This cell type is highly 
pertinent given the published association of BBS with Hirschsprung’s Disease, 
caused by aganglionosis of the colon.   
 
I performed immunohistochemistry using the pan-neuronal marker 
HuC/HuD/ElaV, with a modified protocol to prevent labelling neurons outside the 
gut and DRGs (Kuhlman and Eisen, 2007).  Control embryos contained, on 
average, 120 neurons along the entire length of the hindgut, terminating at the 
anus (Figure 45).  Embryos injected with 2ng of bbs8 MO only contained an 
average of about 20 neurons and they typically only colonised half the length of 
the gut.  Using 4ng of MO prevented any neurons from migrating along the gut, 
resulting in almost complete absence of gut innervation (Figure 45).   
 
A detailed molecular analysis of enteric nervous system 
development in morphants 
The next aim was to try to establish a time course of events giving rise to the 
miscolonisation of the gut.  I first analysed the expression of the NCC marker 
crestin at 36hpf, a time point when NCCs migrate out of the vagal region of the 
hindbrain and converge at the midline in two parallel streams.  Expression was 
comparable in both controls and morphants indicating that early exit from the 
hindbrain was not affected in morphants (Fig. 46A,B).   
 
At 48hpf, expression of phox2b in lateral views of controls indicated that the 
NCCs had migrated through the branchial arch region and begun to migrate into 
the proximal region of the foregut (Fig. 46C,E arrowhead).  In morphants, the 
dorsal-most strand of cells migrating into gut was absent, despite expression 
(albeit attenuated) in the branchial arch region (Fig. 46D,F arrowhead).  This 
suggested the onset of the gut migration deficit stemmed from around this stage.  
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Figure 45.  Enteric neurons in bbs8 morphants. 
HuC/D wholemount immunofluorescence reveals colonisation of the entire length of the 
gut by enteric neurons in controls (asterisk indicates position of anus).  Injecting 2ng bbs8 
MO caused enteric neurons only colonise the most proximal region of the gut, while 4ng 
MO completely abolished migration into the gut.  This was quantified by counting the 
number of neurons in the gut from midway along the yolk sac to the anus.  The graph 
shows a massive reduction in enteric neurons in morphant embryos.  Scale bar = 200µm. 
 
At 72hpf, phox2b effectively labels the NCCs that have migrated along the gut 
and will differentiate into mature neurons.  By this stage, the whole gut is 
colonised in controls, evidenced by a band of phox2b expression stretching along 
the entire length of the gut tube (Fig. 46G).  In 2ng MO-injected embryos, phox2b 
expression only extends halfway along the gut to the anus, correlating with the 
expression of HuC/D in mature neurons 24hpf later (Fig. 46H).  In 4ng MO-
injected embryos, expression of phox2b in the gut is lacking altogether, 
confirming the results seen with the HuC/D immunostaining (Fig. 46I). 
 
 
 
 
control 2ng bbs8 MO 4ng bbs8 MO 
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Figure 46.  Molecular analysis of the time course of ENS migration. 
A,B: crestin expression at 36hpf is comparable in controls and morphants showing exit 
from the vagal region is unaffected.  C,D: phox2b expression at 48hpf shows reduced 
expression in the presumptive branchial arches (bracket) but equivalent expression in the 
hindbrain, just caudal to this.  E,F: the stream of NCCs entering the gut tube in controls 
(arrowhead in E) is missing in the lateral view of the morphant (arrowhead in F).  G: 
phox2b expression at 72hpf delineates the NCCs colonising the entire gut.  The 
arrowhead indicates the position of the extent of migration and the asterisk identifies the 
anus.  H,I: in bbs8 morphants with low and high doses, there is limited to no colonisation 
of the gut by NCCs respectively.  Scale bars: A,B = 100µm; C-F = 500µm; G-I = 200µm. 
 
Time-lapse imaging of gut motility in zebrafish embryos 
To see if this lack of neurons affected gut motility, I performed high-speed time-
lapse imaging, capturing 5-minute movies of control and morphant 4.5dpf 
embryos’ guts.  In controls, there were regular, spontaneous waves of peristalsis 
occurring in the proximal region of the gut (Figure 47).  In 2ng MO-injected 
A B 
C D 
E F 
G H 
I 
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embryos, no peristalsis was ever observed in any portion of the gut, despite 
imaging several different embryos (Figure 47).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47.  Gut motility in zebrafish embryos. 
Stills taken from high-speed time-lapse microscopy of the gut region analysed.  Counting 
the number of peristaltic waves in a 5-minute period in 5 separate 5dpf embryos showed a 
significant reduction in gut motility in morphant embryos, correlating with the lack of gut 
innervation.  Scale bar = 200µm. 
 
Attempting to analyse neural crest migration in morphant chicken 
and quail embryos 
Despite being a relatively new model organism, the zebrafish is generally 
regarded as a valid system for investigating mechanisms of human development 
and disease.  However, to try to corroborate the phenotypes observed in the 
zebrafish, and given the lack of a Bbs8 mutant mouse, I chose to try to generate 
morpholino-based knockdown of Bbs8 in the chick neural crest. 
 
The chick embryo is a classical system for studying neural crest migration, and 
the migratory pathways of neural crest cells emerging at all axial levels of the 
neural tube are stereotypical and well characterised.  Much of what we know 
about the migratory pathways of different NCC populations comes from studies of 
control bbs8 
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the chick, and it has been particularly illuminating through use of grafting 
experiments.   
 
A translation (ATG) blocking morpholino specific to the chicken Bbs8 (also 
called Ttc8) sequence was designed and ordered from Gene Tools (Oregon, USA).  
The MO was tagged at its 5’ end with FITC to act as a fluorescent marker to 
monitor the efficiency of uptake after electroporation.  The MO was diluted to 
1mM in water and 0.5% phenol red was added to visualise the solution in ovo.  It 
was found that Fast Green, often used to visualise plasmids for electroporation, 
inhibited the activity of the MO.   
 
HH stage 10-12 chicken embryos were electroporated with the MO into the neural 
tube at the level of somites 3 to 7.  This drives the construct into the vagal region 
of the neural tube from which emigrate the NCCs.  Because electroporation only 
drives the construct into one side of the neural tube, there is a contralateral 
control.   
 
Embryos were sectioned 24, 48, and 72 hours after electroporation and stained 
with HNK1, a marker of NCCs.  Unelectroporated sides of the neural tubes, or 
embryos injected with a GFP-expressing plasmid as a negative control, had 
streams of neural crest cells beginning to migrate ventrally out of the dorsal aspect 
of the neural tube.  By 48hpf, these cells had migrated further ventrally to 
populate the sympathetic chains of neurons in the trunk and the foregut.  By 
72hpf, HNK1-positive cells were observed in the hindgut as well (Figure 48A,B: 
right-hand side of embryos).   
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Figure 48.  NCC migration in electroporated chick neural tubes. 
A: 24 hours post electroporation (hpe) the electroporated side (left) can be determined by 
the presence of green fluorescence due to the FITC-tagged MO.  Migrating NCCs are 
visualised in red with an anti-HNK-1 antibody.  The arrowhead shows the curtailment of 
the stream of migrating NCCs in the electroporated side.  B: 48hpe there appears to be a 
lack of a migrating stream on the electroporated side.  However, this could well be a 
sectioning artefact due to the streams not migrating in the plane of the section and then 
re-emerging ventral to the neural tube.  Scale bar = 100µm. 
 
In the sides of the neural tube electroporated with 1mM of Bbs8 MO, there 
appeared to be consistently shorter, or even absent, streams of NC migrating from 
the neural tube 24 hours after electroporation (Figure 48A arrowhead).  By 48hpf, 
it was impossible to tell if there was a deficit of cells populating the gut because 
cells from the contralateral uninjected side compensate by contributing to the gut.  
Also, it is possible that this observation, in some cases, was due to sectioning 
artefact.  This can be seen in Figure 48B, where there appears to be no stream 
emigrating from the electroporated side of the neural tube, but there are cells more 
ventrally (arrowhead).  As such, the chick assay is inconclusive.  The other 
problem is that the MO is electroporated at around, or after, the time the NCCs 
begin to delaminate and migrate, and so may only start working once the cells 
have already begun to move away from the neural tube. 
 
A second assay was performed to try to measure the degree of inhibition of 
knockdown cells in avian embryos.  The same Bbs8 MO was electroporated into 
DAPI  HNK-1  MO 
A B 
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quail embryos.  The neural tubes of the quails were removed 24 hours later using 
pancreatin and cultured on glass coverslips coated with fibronectin and laminin.  
Images of the neural tubes were taken 24 hours later and the distance that the 
leading front of cells had migrated from the neural tube was calculated (Fig. 
49A,A’).  It appeared that the electroporated cells had not migrated to the NCC 
front (Fig. 49B).  However, it was difficult to distinguish as the FITC-positive 
morphant cells were surrounded by unelectroporated cells.  Also, the distance the 
cells had migrated varied greatly depending on the time they exited the neural 
tube.  As such, this assay proved inconclusive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49.  Ex vivo quail neural tube culture. 
A: the electroporated cells are clearly visible in green (FITC) amongst the total cell 
population in blue (DAPI).  A’: this shows the cultured whole quail neural tube with the 
NCCs migrating away from the neural tube 24hpe.  B: high-power image of the neural 
tube (bottom of image) with the FITC-positive electroporated cells amongst the NCC 
population.  The electroporated cells do not extend to the front of NCC migration, but this 
is inconclusive as the starting position and time of emigration from the neural tube are 
unknown.  Scale bars: A,A’ = 100µm; B = 100µm. 
 
A 
A’ 
B  
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Aberrant craniofacial cartilage morphology in other ciliopathy 
morphants 
Given the importance for BBS proteins in neural crest migration, and the 
observation of cilia on NCCs, I reasoned that other ciliopathy morphants might 
also show craniofacial dysmorphology.  To investigate this, I examined Alcian 
blue-stained 5dpf Ofd1, Mks1, and mks3 morphants.   
 
 
 
 
 
 
 
 
 
 
Figure 50.  Ciliopathy morphant cranial cartilages 
A: control embryos at 5dpf.  B: mks1 morphant embryo with cyclopia and lacking cranial 
cartilages.  C: mks1 morphant with a slightly less severe phenotype, but also having a 
drastically reduced cranial cartilage.  D: mks3 morphants have hypoplastic cranial 
cartilages.  E: ofd1 morphants also have smaller cranial cartilages, although all the 
branchial arches are present.  Scale bar = 200µm. 
 
mks1 morphants often lacked craniofacial cartilage altogether (Fig. 50B).  
Embryos that had developed cartilage had hypoplasia, absence of branchial 
arches, and reduced or absent mandibles (Fig. 50C).  Trabeculae were often fused 
at the midline and synophthalmia (convergence of the eyes) was common.  These 
morphants resembled a more severe form the bbs8 morphants, in keeping with 
Meckel Syndrome being considered as a phenotypically extreme form of BBS.   
 
Mks3 morphant cranial cartilages also resembled those of bbs8, but were much 
less severely disrupted than mks1 Fig. 50D).  The cartilages are much smaller than 
controls, despite the body being of a comparable size.    
 
A B C 
D E 
control mks1 mks1 
mks3 ofd1 
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Ofd1 morphant embryos had very small craniofacial cartilage elements compared 
to controls (Fig. 50E).  The jaws and branchial arches were narrower, not filling 
the full width of the head as they did in controls.  Despite the severe hypoplasia of 
these cartilages and the strong phenotype elsewhere, such as renal oedema and 
kinked body-axis, the gross morphology and patterning of the craniofacial 
cartilages was normal.  All the branchial arches were present, albeit narrower than 
in controls.   
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Discussion 
Novel roles for Bbs proteins in neural crest cell migration 
Here, Bbs proteins, in particular Bbs8, were shown to be important for migration 
of NCCs into the head, trunk, and gut.  This has implications for our 
understanding of the pathomechanisms of disease and helps explain the aberrant 
craniofacial morphology and Hirschsprung’s disease common amongst BBS 
patients.   
 
Tan et al observed mechano- and thermosensory deficits in humans, mice, and C. 
elegans BBS mutants, and showed erroneous localisation of key receptor proteins 
in dorsal root ganglia (DRG) of Bbs1-/- and Bbs4-/- mice.  The innervation of the 
paws by the peripheral neurons was also faulty.  DRG and peripheral neurons are 
neural crest derived cells and so it is possible that lack of BBS proteins affects 
their development or migration to the correct targets.  Tan et al also showed that 
DRGs are ciliated, a previously unrecognised phenomenon (Tan et al., 2007). 
 
Pigmentation defects in bbs8 morphants 
The most striking neural crest phenotype of bbs8 morphants is their overt lack of 
pigmentation.  These cells are neural crest derived and are the last lineage of cells 
to emigrate from the neural tube.  Pigmentation defects such as piebaldism (but 
not albinism) exist in some neurocristopathy syndromes, such as Waardenburg-
Shah syndrome (SOX10 mutation).  However, this is likely due to 
hypoproliferation of NCCs and so insufficient numbers of melanocytes are 
produced.  Sufficient numbers of NCCs are induced and they proliferate normally 
in bbs8 morphants, but their migration is inhibited, albeit not completely. 
 
No patients with BBS have been reported with piebaldism or other pigmentation 
defects.  In fact, the first patients to be identified with BBS8 mutations were 
Pakistani and so had highly pigmented skin.  However, abundant naevi have been 
reported in a large proportion of BBS patients (Beales et al., 1999, 22% had 
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naevi).  These are caused by the benign hyperproliferation of melanocytes in the 
skin, and can predispose to skin cancer if they become invasive.   
 
Karaman (2008) described one such patient who he reported as having a 
dysmorphic face (micrognathia, thin philtrum, thin upper lip) and multiple 
pigmented nevi (Karaman, 2008).  It is possible that the melanocytes in some 
BBS patients proliferate inappropriately because they migrate later, or slower, 
than they should in the embryo and so become exposed to different signals when 
they differentiate into melanocytes.  One way to test this would be to take a 
melanocyte cell line, such as CRL-2811, derived from a primary melanoma, and 
knock down BBS genes.  Then, one would analyse cell cycling, proliferation, and 
cell behaviour in response to differentiation stimuli. 
 
Hirschsprung’s disease 
Hirschsprung’s disease is commonly associated with BBS (estimates range from 
5% to 45% of the total patient cohort, but are likely to be around 10% (findings 
from our own patient cohort)).  HSCR is to neurocristopathy what kidney cysts 
are to ciliopathy – it is the common denominator.  Not all neurocristopathies 
present with other NCC development phenotypes such as facial dysmorphism, 
piebaldism, and pharyngeal arch defects, however all have HSCR.  The high 
incidence of this disease in BBS patients (around 1000 times more common than 
the general population), in addition to the ENS development and functional data 
from the zebrafish, gives a good idea that this may be due to NCC migration 
defects.  This work suggests that there might be an overlap between certain 
ciliopathies and neurocristopathies, and provides a cell biological rationale for 
this.  
 
Ciliation of neural crest cells 
Previously, it was not known whether NCCs were ciliated, and I have shown clear 
primary cilia emanating from NCCs.  It is impossible to tell whether these cells 
were actively migrating when they were observed, and not all NCCs appeared to 
bear cilia.  To see if there is a difference in ciliation between migrating and static 
  162 
Chapter 4 – Neural crest migration defects 
NCCs, one would need to label cilia in vivo by expressing a tagged marker such as 
acetylated tubulin.  However, because the NCCs are migrating in such a dense 
matrix of cells, the cilia of the NCCs are difficult to distinguish from 
neighbouring cells.   
 
In vivo NCC assays will inform on the mechanics of PCP-dependent 
migration 
In the future, it will be useful to perform in vivo assays on migrating NCCs.  This 
will have to be performed in Xenopus, as it is far easier to explant and culture the 
NCCs.  This would also enable a thorough molecular analysis in which the 
localisation of PCP intermediates, such as Dishevelled, could be monitored in 
real-time.  Matthews et al (2008) showed that Dishevelled localises to the 
membrane of the leading edge of the migrating cell, and that this localisation was 
perturbed by knockdown of Syndecan 4, a PCP intermediate.  They performed in 
vivo FRET analysis on Rho, Rac, and cdc42 - PCP-mediated modulators of the 
cytoskeleton, and showed them to regulate the direction of cell protrusions in 
migrating cells.   
 
Park et al (2008) have demonstrated that Dishevelled is necessary for localisation 
of the basal body, and hence correct positioning of the cilium (Park et al., 2008).  
Given the importance of PCP for NCC migration, and the role of Bbs8 in PCP, it 
would be interesting to examine the position of the basal body in migrating NCCs.  
Dawe et al found that MKS3 is important for centrosome migration prior to 
ciliogenesis (Dawe et al., 2007).  This might explain the craniofacial defects in 
mks3 morphant zebrafish.  If the cilium fails to form on migrating NCCs, or forms 
in the wrong place, they may fail to migrate properly in response to the 
extracellular cues, such as Shh.  I tried to perform examine the position of the 
basal body in migrating NCCs in vivo, but found it extremely hard to differentiate 
the basal body from the red fluorescent nuclei.  To improve this, one could have 
to develop a blue-fluorescent centrin construct to mark the basal body.  
Alternatively, one could perform the experiment in vivo on Xenopus NCCs and 
label the nucleus, Golgi apparatus, and basal body.  One would then compare the 
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alignment of these three organelles with the directionality of migration and see if 
Bbs8 knockdown perturbed it. 
 
Bbs proteins tend to be ubiquitously expressed at low levels during zebrafish 
development, with stronger expression in the eye and brain.  The exact level of 
expression in the NCCs is almost impossible to determine, but Bbs8 expression in 
NCCs is important for their migration as cell transplantations demonstrated a cell 
autonomous role for this protein.   
 
A potentially more general involvement of Bbs8 in cell migration 
The finding of a role for Bbs8 in NCC migration was extended to include other 
cell types after it was observed that cultured fibroblasts and primary cells deficient 
in Bbs8 protein showed reduced migration in in vitro scratch wound healing 
assays.  Furthermore, the actin cytoskeleton of these cells was mispolarised 
relative to the direction of migration.  The finding that skin cells from BBS 
patients had migration and polarity defects might have implications for possible 
wound healing or scarring defects in patients.  These have never before been 
reported, but it might be something for clinicians to be aware of in future. 
 
Because PCP signalling is important for the positioning of the basal body and the 
correct polarity of the actin cytoskeleton in migrating cells, it would be interesting 
to analyse the position of the basal body relative to the axis of migration in these 
cells.  A future experiment would be to perform time-lapse imaging of these 
migrating cells to determine whether the directionality or just the velocity of 
migration was affected.   
 
Matthews et al noticed that knocking down syndecan 4 appeared to completely 
inhibit NCC migration, but when they traced the paths of these NCCs, they found 
that the cells moved in tortuous paths and regularly doubled back on themselves, 
whereas control cells moved in straight, persistent paths.  As such, the velocity of 
migration was only slightly reduced, rather the persistence and directionality of 
the cells was disrupted.   
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Craniofacial dysmorphology in other ciliopathies 
Knockdown of ofd1, mks1, and mks3 also produced craniofacial dysmorphology 
in the zebrafish, albeit differently to Bbs knockdown.  Mks morphants show very 
severe craniofacial disruption, and given the severity of the patient phenotype and 
similarity to BBS, it is possible that MKS proteins are also involved in NCC 
migration.  Because MKS3 is so similar in structure to the PCP receptor Frizzled 
(Dawe et al., 2007), one could envisage PCP-mediated NCC migration defects if 
this gene was knocked out.   
 
Craniofacial dysmorphology in OFD1 patients is well documented and the facial 
hypoplasia is repeated in zebrafish morphants.  However, cartilaginous elements 
are not missing, nor is pigmentation, as in BBS morphants.  This suggests that the 
craniofacial defects in OFD1 are not due to aberrant NCC development, but rather 
to defects in cartilage and bone formation. 
 
Aberrant bone development in the skeletal ciliopathies, such as EVC, JATD, and 
OFD1, confounds an analysis of facial dysmorphology attributable to NCC 
development.  Extending the facial analysis to other non-skeletal ciliopathies such 
as NPHP might determine which genes are involved in craniofacial development, 
and possibly NCC migration.  Performing in vitro assays on cell migration for all 
ciliopathy proteins might reveal differential and specific roles for different 
ciliopathy proteins in cell migration, such as microtubule transport outside the 
cilium, IFT, signalling, and cytoskeletal remodelling. 
 
The results from these experiments were published in the Proceedings of the 
National Academy of Sciences, USA in July 2008 (Tobin et al., 2008).
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Chapter 5: Involvement of ciliopathy proteins in 
Sonic Hedgehog signal transduction 
 
Introduction 
The features of different Shh pathway mutants 
The mechanics of the Shh signalling pathway were outlined in the introduction.  
Due to the complexities of the pathway, there is not simply a “loss of function” or 
“gain of function” phenotype associated with Shh mutants.  Because Shh 
functions in so many anatomically disparate systems in the developing embryo, 
mutations to the pathway cause complex and widespread phenotypes.  
Nevertheless, there are three systems in which Shh pathway dysfunction is well 
characterised and has a stereotypical role: control of digit identity, neural tube 
patterning, and craniofacial morphology.   
 
Several different missense mutations exist in the SHH gene in humans, which 
affect different regions of the gene thereby affecting its protein’s post-
translational modification, kinetics, or receptor binding.  These mutants show 
differing severity of HPE, hence a spectrum of the disorder exists which, at its 
mildest (e.g. the I111F mutation), may consist of a single central incisor, possibly 
combined with hypoplasia of the corpus callosum, a feature that can only be 
detected by MRI of the brain (OMIM).  Extreme forms of HPE can be formed by 
nonsense alleles such as E284X (OMIM). 
 
Null mutation in the Shh gene in mice causes complete loss of function of the 
signalling pathway, as the ligand is crucial for activation (Litingtung et al., 2002).  
When this happens, digits fail to form in the limb, and instead a single, stumpy 
digit with no joints is produced at the end of the limb.  A single eye forms at the 
midline of the face with a proboscis instead of a nose – characteristic of complete 
holoprosencephaly, whereby midline structures are lost.  The neural tube loses its 
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ventral cell-types and the forebrain fails to divide into two hemispheres (Rallu et 
al., 2002).   
 
In contrast, addition of exogenous Sonic Hedgehog to chick limbs causes growth 
of ectopic limbs, while increased Shh in the face causes widening of the face and 
duplication of midline structures such as the nose and jaw (Hu and Helms, 1999).  
Transgenic over expression of Shh in the mouse also causes tumorigenesis, 
particularly in the skin and brain, and overactive Shh signalling is associated with 
tumour growth (Oro et al., 1997). 
 
Null mutation of the downstream transcription factor Gli3 results in polydactyly.  
Double knock-out of Shh and Gli3 still results in polydactyly suggesting that Gli3 
acts independently of Shh to mediate repression of target genes, cell survival, and 
digit growth in the limb (Litingtung et al., 2002).  Gli3+/- Shh-/- embryos do not 
exhibit polydactyly but do grow some digits, unlike the Shh nulls which lack 
digits altogether.   
 
Haploinsufficiency, often caused by microdeletion, of GLI3 results in Greig 
cephalopolysyndactyly (GCPS) in humans.  This consists of pre-axial polydactyly 
with fused digits, a wide face with hypertelorism, and agenesis of the corpus 
callosum.  This human phenotype closely matches the mouse Extra toes (Xt) 
mutant, in which the 5’ end of the Gli3 gene is deleted (Schimmang et al., 1992).   
 
In contrast to GCPS , a mutation truncating or frame-shifting the GLI3 protein 
causes Pallister-Hall syndrome (PHS) (Johnston et al., 2005).  PHS causes more 
severe features including: post-axial polydactyly, hamartomas in the 
hypothalamus, macrocephaly, cleft palate and craniofacial dysmorphism such as 
retrognathia, and genital abnormalities such as hypospadias and micropenis.  
Johnston et al showed that mutation in the first third of GLI3 cause GCPS while 
mutation in the second third causes PHS.  The molecular mechanisms responsible 
for causing either pre- or post-axial polydactyly, depending on the type of 
mutation, are not understood. 
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Mutations to intermediate members of the Shh pathway have varying effects, 
depending on their position in the pathway.  Mutating Smoothened, the 
membrane-bound receptor to which Patched binds, phenocopies the Shh null 
condition (Zhang et al., 2001).  Conversely, null mutation in Patched1 leads to 
constitutive de-repression of Smoothened resulting in inappropriate activation of 
Smoothened.  This leads to ectopic induction of the Shh pathway and results in 
gain of function phenotypes such as neoplasia and hypertelorism (Goodrich et al., 
1997).  In humans, PATCHED1 mutation causes Gorlin, or basal cell nevus 
syndrome.  Mutation of Suppressor of Fused (SuFu) also causes ligand-
independent activation of the Shh pathway resulting in tumours (Svärd et al., 
2006).   
 
The Shh pathway consists of a series of agonistic and antagonistic steps and so 
mutation to each of these causes different phenotypes.  Interpretation of 
phenotypes is confounded by the graded response to differing concentrations of 
Shh ligand, which is translated into a gradient of Gli3 transcriptional activator to 
repressor ratio.   
 
The features of BBS that are reminiscent of Shh mutants are as follows: 
 
BBS feature attributable to Shh  Similar Shh pathway mutant  
 
Post-axial polydactyly GLI3 (PHS) (Gain of function phenotype) 
Craniofacial abnormalities: 
Mid-facial hypoplasia with retrognathia 
Single central incisor 
Agenesis of the corpus callosum 
 
Mild loss of function mutations in SHH 
 
Genital abnormalities: 
Hypospadias 
Micropenis 
 
GLI3 mutations (PHS) (Gain of function 
phenotype) 
Table 10.  Comparison of BBS features to Shh pathway mutants. 
 
Table 10 demonstrates the apparent paradox that in BBS, Shh pathway activity is 
reduced in the head at the same time as being increased in the limb.  This can be 
reconciled by considering the now accepted role for IFT in Shh signalling. 
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The ciliary basis of Shh signalling 
Huangfu et al (2003) performed a large-scale ENU-based mutagenesis screen for 
embryonic patterning mutants and identified two IFT mutants, IFT88 and IFT172, 
both with hallmarks of Shh pathway dysfunction.  These mutants lacked ventral 
cell types in the neural tube and were polydactylous.  The authors showed that the 
IFT proteins were acting downstream of Patched, but upstream of transcriptional 
targets of Shh, and so were playing a role in the intermediate stages of the 
pathway. 
 
Liu et al (2005) then showed that IFT proteins in general were essential for 
regulating the balance of Gli3 repressor and activator isoforms.  Corbit et al 
(2005) made the surprising discovery that Smoothened localises to the primary 
cilium in response to stimulation by Shh ligand, and that this localisation was 
essential for downstream activity of the pathway.  Further weight was added to 
this assertion when Rohatgi et al (2007) showed ciliary localisation was also 
essential for Patched activity – only in this instance, Patched left the cilium upon 
activation by Shh, freeing up the repression of Smo in the cilium.  It has also been 
shown that SuFu, Gli2 and Gli3 also localise to the cilium (Haycraft et al., 2005).   
 
Processing and transport of Gli3 from the cilium to the nucleus is dependent on 
IFT.  Tran et al (2008) identified a new mutant encoding a protein called THM1 
(tetratricopeptide hedgehog modulator 1) in which retrograde IFT was impaired.  
This caused sequestration and accumulation of IFT proteins in the tips of cilia and 
resulted in over-activated Shh signalling.  They proposed that anterograde IFT 
was necessary for Gli3 activation.  The subsequent fate of this Gli3 is unclear 
from this model. 
 
Ocbina and Anderson (2008) showed that primary cilia were required for primary 
fibroblast cells from mice to respond to stimulation by exogenous Shh (Ocbina 
and Anderson, 2008).  As such, only fully confluent cells would respond to 
stimulation by upregulation of Gli1 because only confluent cells ciliate.  They 
concluded that IFT-dependent trafficking of Shh pathway components through the 
cilium was essential for Shh pathway activation.  It is also observable that 
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unciliated cell lines, such as Cos7, fail to respond to stimulation with Shh 
(personal observation and communication with J. Briscoe). 
 
This growing body of evidence suggests that the cilium is indispensable for Shh 
signalling and that IFT proteins are important in regulating the processesing of 
Gli3 from its full-length activator isoform to its repressive form.  Exactly how this 
happens, and the precise role for IFT proteins, is not clear.  What is also not clear 
is at precisely which point in the pathway the IFT proteins intersect, just that they 
function somewhere around the level of Gli3 but do not function in the nucleus.   
 
The Shh-like phenotypes of BBS outlined above are consistent with the 
phenotypes of other bona fide IFT mouse mutants.  Ift88 and Ift172 null mutants 
show very severe phenotypes and die at E9.5, before digit patterning can be 
investigated.  However, the downregulation of Patched and lack of ventral cell 
types in the neural tube is indicative of downregulated Shh signalling.  However, 
embryos with a hypomorphic Ift88 allele survive until E12.5 – long enough to 
examine digit patterning.  These embryos are polydactylous and show expanded 
expression domains of downstream Shh genes such as Gli3 in the limb bud 
(Huangfu and Anderson, 2005).  Furthermore, Ift52 hypomorphic embryos 
showed midline fusion of the olfactory pits, another loss-of-function Shh feature.   
 
Therefore, it is clear that BBS shows a similar pattern of phenotypes, albeit not 
quite so severe.  This apparently concurrent loss and gain of Shh function 
phenotypes probably represents a defect in Gli3 processesing.  The fact that facial 
and limb tissues are affected differently reflects the differential outcome of Gli3 
activation or repression in different developmental systems.   
 
Mouse models of BBS do not exhibit polydactyly 
Despite faithfully reproducing all the cardinal features of BBS, none of the six 
mouse models (Bbs1, Bbs1 M390R KI, Bbs2, Bbs3, Bbs4, Bbs6) produced to date 
exhibit polydactyly, a feature present in 70% of patients at birth.  The reasons for 
this are perplexing because other mouse IFT mutants show polydactyly, as do 
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Gli3 mutants.  The reason could be that the effect of lack of BBS proteins on the 
limb is subtle.  Because the mouse limb bud is much smaller than the human limb 
bud, lack of BBS protein may not perturb the response to the gradient of Shh 
morphogen sufficiently to induce polydactyly.  It may also simply be due to the 
particular genetic background of the mouse strains used. 
 
Nobody has ever checked if mouse mutants have brain abnormalities associated 
with Shh signalling, such as agenesis of the corpus callosum, but they do have 
ventriculomegaly.  Due to the striking lack of polydactyly in the mouse, and my 
aim to see if BBS proteins were involved in Shh signalling, the zebrafish became 
a more tractable model organism to use.  
 
Using the zebrafish to explore the involvement of ciliopathy proteins 
in the Shh pathway 
The zebrafish has never been used to model Shh signalling in ciliopathy mutants 
or morphants.  Many ciliary genetic mutants in zebrafish exist from large-scale 
mutagenesis screens for renal phenotypes but Shh signalling has never been 
investigated in these.  The Shh signalling pathway in the fish is identical to the 
mammal and the pathway components are conserved.  It is involved with 
homologous developmental processes, including neural tube and brain patterning, 
and outgrowth of the paired fins.   
 
Corbit et al (2005) used the zebrafish to show that a ciliary localisation defective 
mutant allele of smoothened was unable to rescue the phenotype of Smo-/- 
embryos while the wild type allele could. Tayeh et al (2008) found an expanded 
domain of shh expression in the fin bud of bbs1 and bbs7 morphant embryos and 
altered fin cartilaginous elements (Tayeh et al., 2008), although the data are 
difficult to interpret. 
 
Given the physiological relevance of the zebrafish BBS models generated, 
including the craniofacial deformities, renal cysts, convergent-extension defect, 
and neural crest migration phenotype, I aimed to use the fish to examine Shh 
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signalling in the absence of Bbs proteins.  The bbs8 morphant craniofacial 
phenotype is strikingly similar to that of the shh and smoothened mutants, as well 
as embryos treated with cyclopamine, a potent inhibitor of Smoothened, between 
4 and 8hpf (Wada et al., 2005).  This specific midline trabecular fusion is not seen 
in any other craniofacial mutant zebrafish and so is indicative of Shh signalling 
defects.   
 
Responses to Shh can be quantified with in vitro assays 
While the zebrafish can be used to show phenocopy of Shh-like phenotypes and 
analyse gene expression levels of downstream pathway components, it cannot be 
used to quantify the level of signalling response.  Because of the relative subtlety 
of the BBS phenotype compared to Shh-pathway mutants or bona fide IFT null 
mutants, I expected that any putative defects in Shh signalling would not be as 
striking as they are in these knockouts.  In order to reveal subtle, possible 
secondary effects on Shh signalling, a quantitative output can be achieved using in 
vitro cell-based assays, analysing the response of cells to exogenous Shh 
stimulation.   
 
Because IFT proteins and the cilium have been shown to function downstream of 
Patched, upstream of transcriptional activation, and are involved with Gli3 
processing, I did not expect to see a complete loss or gain of pathway function.  
Instead, I wanted to see if the response to graded morphogen signalling was 
affected.  This would more likely explain the subtle phenotypes seen in patients. 
 
To do this, a luciferase reporter construct has been developed which expresses 
luciferase under the control of six Gli1 binding sites.  When the pathway is 
activated, the Gli3 protein binds to these sites to activate Gli1 transcription.  The 
amount of luciferase expressed is directly proportional to this downstream 
transcriptional response and can be measured luminometrically.   
 
Additionally, cell lines can be used to assess the ratio of active to repressive Gli3 
isoforms in the absence and presence of exogenous Shh stimulation.  Wu et al 
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discovered a molecule, purmorphamine, which binds directly to smoothened and 
agonises it (Wu et al., 2004).  It is therefore a potent activator of the Shh pathway 
and is more reliable than using recombinant Shh peptide which is unfeasibly 
expensive and whose dose-response can be variable.  In addition, purmorphamine 
is capable of stimulating the pathway more powerfully even than ShhN itself, and 
so can be used to test fine and coarse responses to stimulation. 
 
The aims of this study 
The phenotypic clues from humans and zebrafish suggest that Shh signalling is 
defective in some form.  In this section, I aimed to answer the following 
questions: 
 
1) Do BBS proteins have a role in the Shh pathway? 
2) How significant is this role, and are different BBS proteins differentially 
involved? 
3) If there is involvement in the pathway, at what level in the pathway do 
BBS proteins act? 
4) Are BBS proteins involved in Gli3 processesing?  
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Results 
Cursory analysis of Bbs6-/- mouse embryo neural tubes shows no 
evidence of altered Shh signalling 
Human BBS patients show several features consistent with defective Shh 
signalling, such as: post-axial polydactyly, frequent agenesis of the corpus 
callosum, and infrequent single central incisor.  Surprisingly, none of these 
features has ever been detected in mouse models of the disease (including bbs1, 2, 
4, and 6).  However, nobody has ever examined molecular readouts of disrupted 
Shh signalling.   
 
In the neural tube, Shh ligand is secreted from the notochord where it diffuses 
dorsally to the neural tube and induces expression of motor-neuron precursor 
markers such as Nkx2.2 and Mnr2 in the ventral neural tube.  I aimed to see if 
expression of these genes was affected in BBS mouse mutants.  Bbs4 null mice 
have the strongest phenotype, but these mice were sub-fertile and so I was unable 
to obtain any null embryos of this genotype.  The Bbs6 mice reproduced normally 
and so were used despite having an extremely mild phenotype, which suggests 
that the model is a hypomorph and not a true, null allele.   
 
 
 
 
 
 
 
 
Figure 51.  Expression of Shh markers in mouse neural tubes 
A,B: Nkx2.2 is a marker of ventral cell-types in the neural tube and is activated in 
response to high-levels of Shh.  Its expression is unaffected in Bbs6 null embryos.  C,D: 
Mnr2 is a marker of motor neurons in the ventral neural tube.  Again, its expression is 
comparable between wild type and null embryos.  Scale bar = 100µm. 
Nkx2.2 Mnr2 
A B C D control Bbs6-/- Bbs6-/- control 
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Bbs6 null embryos and wild-type littermates were fixed at E10.5 and sectioned 
transversely.  The serial sections were stained with either Nkx2.2 or Mnr2 
antibodies, which stain motor neuron precursor cells.  Inhibited Shh signalling 
might lead to a down regulation of these markers, while induction of the pathway 
would lead to upregulation.  No difference in the expression of these markers was 
observed between null and control embryos (Fig. 51A-D).  Furthermore, no 
difference in the expression of the dorsal neural tube marker, Pax7, was noted 
between mutants and controls (data not shown).  This could be for a number of 
reasons:  1) there is no defect in Shh signalling in the neural tube; 2) because of 
differences in embryology between mouse and human which also results in the 
mouse lacking polydactyly; 3) the possibly hypomorphic nature of the Bbs6 allele.   
 
Attempts to model polydactyly in the developing chick limb 
Mutations in BBS8 in human patients only accounts for around 2% of total 
mutations but the clinical manifestations of their phenotype tend to be most 
severe.  Because no mouse model for Bbs8 exists, I tried to apply a Bbs8 
morpholino to the developing limb bud of chick embryos to see if I could induce 
limb defects.   
 
To begin with, I tested to make sure Bbs8 was expressed in the limb bud.  I 
removed limb buds and divided them into anterior and posterior, and proximal 
and distal halves from stage 18 and stage 24 chick embryos.  I extracted total 
RNA using Trizol, of which I used 500ng to synthesise cDNA and performed 
semi-quantitative RT-PCR to determine the presence and relative abundance of 
Bbs8 (and Bbs11 – as it was newly discovered at the time as an E3 ubiquitin 
ligase).  Bbs8 and Bbs11 are both expressed in the limb bud.  It seems that both 
genes are expressed at higher level in the posterior portion relative to anterior. 
(Figure 52).  Expression of both genes is equivalent in proximal and distal halves 
(not shown).  This could be interesting in light of the fact that Shh signals from 
the posterior margin of the limb bud. 
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Figure 52.  RT-PCR expression of BBS genes in the chick limb bud. 
Bbs8 and Bbs11 are both expressed in the developing chick limb bud.  It is possible that 
both genes are expressed at higher level in the posterior  half of the limb bud, in which 
Shh is secreted.  (Ant. = anterior, Post. = posterior). 
 
The limb bud of a chick consists of mesenchyme overlaid by epithelial tissue and 
as such does not contain a lumen convenient for introduction of genetic material 
for electroporation.  I tried to electroporate the limb bud by injecting 1mM of 
bbs8 MO at various sites in the limb bud followed by electroporation, but this 
failed and the MO only entered very small foci around the points of injection.   
 
To deliver MO systemically to the whole limb bud I tried a different approach, 
dissolving the MO in 30% pluronic gel.  This substance liquefies when cooled on 
ice but sets into a gel when the temperature is raised.  To administer the gel, 
pipette tips were cooled on ice to keep the gel liquid.  A tear was made in the 
vitelline membrane overlying the limb bud of 2dpf chick embryos to expose the 
embryonic tissue.  The MO dissolved in pluronic gel was then expelled over the 
limb bud whereupon it set on contact with the warm tissue.  The eggs were then 
covered over with tape, incubated, and examined 24 hours later for evidence of 
incorporation of the MO into the tissue, evidenced by green fluorescence of the 
FITC-tag on the MO.   
 
Fluorescence was inconsistent and tended to be at very low level, often not 
focussed in the limb bud itself, implying that the gel had diffused away from the 
site of delivery.  This was a problem before the MO had even permeated into the 
limb tissue, and precluded any worthwhile assessment of the subsequent limb 
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morphology, whose cartilaginous elements do not begin to appear until 2 days 
after MO administration. 
 
Localisation of Smoothened in fibroblasts 
A paper published in Nature at the start of this PhD described how the localisation 
of Smoothened to primary cilia was necessary for proper activation of the Shh 
signalling cascade (Corbit et al., 2005).  Because BBS proteins are involved in 
ciliary transport, I reasoned that mutations abrogating the function of BBS 
proteins could potentially prevent the ciliary localisation of proteins by affecting 
transport into, or along, the cilium.  Consistent with this hypothesis is the fact that 
all bona fide IFT mouse mutants show Shh signalling phenotypes, including 
polydactyly and misexpression of downstream proteins in the neural tube.   
 
I used primary fibroblasts taken from the skin of a healthy adult to examine 
Smoothened localisation.  These were stained with an antibody detecting 
Smoothened, which revealed its localisation in a highly punctate pattern in 
unstimulated cells (Fig. 53A).  The movement of Smo into cilia in response to 
Shh stimulation reported by Corbit et al was recapitulated in adult primary 
fibroblasts.  When recombinant Shh was added to these cells, Smo was 
redistributed from puncta around the cell to become concentrated in the cilium 
(Fig. 53B).   
 
However, because the Smoothened was observed dispersed in puncta around the 
membrane, it was impossible to say with any confidence whether its ciliary 
localisation was affected in the case of primary cells taken from BBS8 null adult 
humans.  Also, these primary cells were taken from the skin of adults, which may 
not signal via Sonic hedgehog in the same manner as embryonic cells, particularly 
when cultured in vitro.  To make this experiment more accurate, one would have 
to look at Smoothened localisation in vivo, or at least in response to stimulation by 
exogenous Shh ligand in vitro. 
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Figure 53.  Localisation of Smoothened in primary fibroblasts. 
A: In the absence of exogenous Shh, Smo localises in puncta throughout the cell and is 
excluded from the cilium (inset).  B: in response to Shh stimulation, the Smo is 
redistributed from the dispersed puncta to the cilium, where it becomes concentrated 
(inset).  Scale bar = 5µm. 
 
Localisation of Gli3 in fibroblasts 
Gli3 is the downstream transcription factor effecting the transcriptional response 
to upstream Shh signalling.  In the absence of Shh signal, Gli3 is cleaved into a 
shorter 83kDa repressive fragment (Gli3R), and in the presence of Shh it exists as 
a full-length, 190kDa transcriptional activator (Gli3A).  These proteins must be 
translocated from the cilium, where the Shh signal is perceived, to the nucleus.  
This process is reliant upon both IFT and on microtubule-based transport in the 
cytoplasm.  Because BBS proteins are thought to be important for both of these 
processes, I examined the localisation of Gli3 in primary fibroblasts.   
 
 In wild-type fibroblasts, the Gli3 protein localised in puncta along the 
microtubule cytoskeleton (Fig. 54 A,B).  Gli3 was absent from the nucleus in 
controls.  In BBS8 mutant cells, Gli3 was present on the microtubules but seemed 
to be present in large puncta inside most of the nuclei (Fig. 54C).  This is a 
surprising finding and may be artefactual, or may represent an accumulation of 
either full-length or cleaved Gli3 in the nucleus.  Also, the Gli3 antibody could be 
staining the microtubules non-specifically and so the only way to check this 
would be to test the antibody on some primary cells taken from a Gli3-null mouse 
A B 
-Shh +Shh 
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embryo.  Even so, the inclusion of the Gli3 from the nuclei of mutant cells was 
consistent.  To determine whether there was a gross difference in distribution of 
Gli3 activator or repressor isoforms, I stained cells with an antibody only 
recognising the repressor form.  However, this antibody failed to work on either 
immunofluorescence or Western Blot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54.  Gli3 localisation in primary human fibroblasts. 
A: Gli3 is localised in puncta in the cytoplasm but is excluded from the nuclei (blue).  B: 
co-staining with an anti α-tubulin confirmed that the Gli3 protein was localised on the 
microtubules.  C,D: in BBS8 mutant fibroblasts, Gli3 persisted on the microtubules but 
was also present in large puncta inside the nuclei.  Scale bars = 5µm. 
 
Cellular fractionation 
The next experiment aimed to see if there was a difference in the amount of 
activator and repressor isoforms of Gli3 in the nuclear versus the cytoplasmic and 
membrane fractions of the cells.  This aimed to determine whether the Gli3 puncta 
observed in the BBS8 null nuclei consisted of Gli3R or Gli3A.  To do this I 
fractionated wild type and mutant primary fibroblasts, extracted the total cellular 
protein, and performed a Western Blot with a Gli3 antibody recognising both 
active and repressive isoforms.  
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By blotting the nuclear fraction for Gli3 protein, it appeared that there was more 
Gli3R in the mutant (blue arrow) than wild-type cells.  This might suggest that 
Gli3 was being cleaved more in BBS8 mutants than in wild types (Fig. 56A).  To 
control for protein levels, I blotted for α-tubulin and showed there to be 
comparable levels in each sample (blue arrow, Fig. 56B).  To be sure that the 
nuclear and cytoplasmic fractions were distinct, I blotted the proteins from each 
fraction with an antibody against C23, a nucleolar marker.  This was convincingly 
present in the nuclear fraction and absent from the cytoplasmic fraction (blue 
arrow, Fig. 56C).  Because Gli3A cleavage is repressed by Shh signalling, this 
suggests a possible lack of response to Shh pathway stimulation in the null 
fibroblasts. 
 
Figure 55.  Gli3 protein levels in cellular fractions. 
A. Nuclear fractions of control and Bbs8 suppressed 3T3 cells blotted with an anti-Gli3 
antibody showing greater levels of Gli3R in the nucleus of Bbs8 suppressants.  B. Anti-α-
tubulin shows a comparable level of protein between control and suppressed nuclear 
fractions.  C. anti-C23 blotting for a nucleolar protein proves the efficacy of the cellular 
fractionation as it is present in the nuclear fraction (blue arrow), but absent from the 
cytoplasm. 
  
To determine if Bbs8 protein might be interacting with Gli3 in an IFT process, I 
performed co-immunoprecipitation experiments by transfecting cells with full-
length GFP-tagged Bbs8.  I then immunoprecipitated with an anti-Gli3 antibody, 
ran the protein out on a gel and blotted with an anti-GFP antibody to detect tagged 
Bbs8.  When cells were transfected with a C-terminally tagged Bbs8 construct, a 
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faint band was observed, corresponding to a physical interaction between Bbs8 
and Gli3 (Figure 55, lane 1).  This band was observed in the lysate at the same 
size – around 90kDa, which corresponds to the size of Bbs8 (55kDa) plus GFP 
(38kDa).  This band was not observed in the absence of anti-GFP antibody, nor 
using N-terminally tagged Bbs8, so it is possible that the interaction occurs at the 
N-terminus of Bbs8, as the N-terminal GFP could sterically abrogate an 
interaction (Figure 55).  Endogenous Gli3 protein was used for this IP.  Elevating 
Gli3 levels by transfection may yield a stronger interaction, confirming the result, 
but is more of an artificial system. 
 
 
 
 
 
 
 
 
 
 
 
Figure 56.  Co-immunoprecipitation of BBS8 and Gli3. 
Gli3 was immunoprecipitated and then BBS8 tagged with GFP at the C-terminus was 
detected on the blot.  A single feint band at around 90kDa corresponds to GFP-tagged 
BBS8 protein (blue arrow) (Lane 1).  The lysate from the transfected cells shows a strong 
band at 90kDa corresponding to tagged BBS8 (Asterisk is a non-specific band in all 
lysate lanes) (lane 3).  No Gli3 antibody added to the immunoprecipitation and then 
blotted to detect BBS8 revealed no band at 90kDa, suggesting that IP and interaction in 
Lane 1 is specific.  Cells were transfected with an N-terminally tagged BBS8 construct.  
IP with anti-Gli3 followed by blotting to detect BBS8 failed to detect an interaction (lane 
5).  The N-tagged BBS8 construct was expressed at the same level as the C-tagged 
revealed by blotting the cell lysate with anti-eGFP (lane 6).  Lack of Gli3 antibody also 
failed to pull-down any N-terminal tagged BBS8 protein (lane 7).  GFP alone did not 
interact with Gli3 (lane 9). 
 
* 
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Luciferase assays show Bbs8 and Ift80 mutant cells have a blunted 
response to Shh stimulation 
It appeared that there were some defects in localisation and abundance of Gli3 in 
mutants, but the effect this was having on the cells was unknown.  To investigate 
this, I performed luciferase assays using a reporter construct comprising six Gli1-
binding sites driving expression of the luciferase reporter gene.  To determine the 
optimum concentration of Purmorphamine, I treated Shh-Light2 cells with a range 
of purmorphamine concentrations from 0 to 5µM, dissolved in 1% DMSO.  
Figure 58 shows a dose-response to purmorphamine with a maximum response 
reached by 2µM.  These values are comparable to those reported in (Sinha and 
Chen, 2006).  As 2µM is more stimulatory than physiological conditions, I chose 
to treat cells with 0.5µM, where the pathway is stimulated around 2.5 to 3-fold, a 
range more in keeping with high-level Shh signalling in vivo (Dessaud et al., 
2007). 
Figure 57.  Purmorphamine gradient assay. 
3T3 Shh-Light cells were treated with varying amounts of purmorphamine and their 
response measured by luciferase assay.  Unstimulated cells were given a baseline value of 
1.  Addition of increasing amounts of purmorphamine stimulated the pathway 
progressively, with maximal activity being reached with 2 or 5µM purmorphamine.  This 
                                                
2 Shh-Light cells are stably transfected with the Gli-luciferase reporter construct 
and a Renilla internal transfection control. 
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shows that the assay works and is reproducible and can sensitively distinguish between 
different levels of pathway activation. 
 
I then co-transfected 3T3 cells with shRNA targeted against Bbs8, Bbs7, and 
Bbs4, as these are the proteins whose roles have been most closely associated with 
IFT.  In each case, three samples of each cell type were treated with DMSO 
(vehicle) alone, and three were treated with 0.5µM purmorphamine, the Shh 
pathway agonist.  The relative luciferase assay value was calculated by dividing 
the result for the firefly luciferase activity by the result for the Renilla luciferase 
activity.  This normalises the luciferase values by controlling for the transfection 
level in each sample.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 58.  Luciferase assays of Shh response in BBS knockdown cells. 
The top graph shows how addition of 0.5µM purmorphamine to control cells induces the 
Shh pathway.  This response is dulled in all BBS shRNA-treated cells tested.  The bottom 
graph shows the fold increase in pathway activity in response to Shh relative to untreated 
cells.  This is significantly lowered (by around 75%) in Bbs8 knockdown cells relative to 
controls.  The response is around 50% lower in Bbs7 knockdown cells.  Knockdown of 
both Bbs7 and Bbs8 failed to show any synergistic effect on response to Shh. 
A 
B 
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In control cells, addition of purmorphamine resulted in approximately 2.3-fold 
induction of Shh signalling.  The graphs show how this induction is attenuated in 
cells transfected with all the BBS shRNA constructs (Figure 58).  Knocking down 
both Bbs7 and Bbs8 together does not reduce signalling level below either 
knockdown alone, suggesting that they do not act synergistically in modulating 
Shh transduction, and may be redundant.  Bbs4 knockdown produced the most 
dulled response to Shh stimulation suggesting it has an important role in 
transduction of the pathway.   
 
In all cases, the baseline level of Shh signalling activity in the absence of 
purmorphamine was slightly reduced in suppressant cells.  However, this 
reduction was not statistically significant.  These results imply that BBS proteins 
are important for the cell’s response to Shh stimulation, but do not significantly 
interfere with the function of the pathway in the absence of ligand stimulation. 
 
To confirm these results further, I performed the same luciferase assay on cells 
that had been stably transfected with the Bbs8 shRNA construct to ensure that all 
cells were knocked-down for the gene, and that the result was not skewed by cells 
not expressing the construct.  I recapitulated the same results as previously and the 
Bbs8 suppressant cells showed an attenuated response to stimulation with 
purmorphamine. 
 
Bbs8 may be important for the graded response to the Shh 
morphogen 
Purmorphamine is a powerful agonist of the Shh pathway and is not as 
physiologically relevant as recombinant Shh, the natural ligand.  I next performed 
a luciferase assay on control and Bbs8 knockdown in mouse embryonic 3T3 
fibroblasts using a range of concentrations of Shh peptide derived from the 
conditioned medium of Shh-transfected COS7 cells.  These results showed that 
controls were stimulated in a similar manner with Shh as they were with 
purmorphamine (Figure 59).  Stimulation of Bbs8 suppressant cells failed to 
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activate the pathway, especially at low levels of Shh signalling (Figure 59).  These 
results suggest that Bbs8 is most important in the cell’s response to lower 
concentrations of Shh ligand.  As such, lack of BBS8 may impair a cell’s ability 
to discriminate between the fine-grained concentration gradients of Shh 
morphogen in the developing embryo.  This might result in polydactyly due to an 
inability to interpret the morphogen gradient at the posterior end of the limb bud. 
Figure 59.  Stimulation of 3T3s with recombinant Shh protein. 
Adding recombinant Shh to the media of control cells stimulates the Shh pathway, even 
with relatively small amounts of Shh-conditioned media (around 1 in 2,000).  Adding 
recombinant Shh to Bbs8 suppressant cells fails to stimulate the cells at low levels (10µl), 
and there is a dulled response at higher levels of Shh (200µl). 
 
Quantitative RT-PCR analysis of downstream Shh components 
For a finer analysis of the effect of BBS knockdown on the Shh pathway, I used 
qRT-PCR to analyse the expression level of several genes downstream of Gli3, 
upregulated by Shh signalling.  Ptc1 and Gli1 are all direct transcriptional targets 
of Gli3A.  In control transfected 3T3 cells, all these targets were upregulated by 
addition of purmorphamine.  This was most pronounced in the case of Gli1 which 
was upregulated 6-fold by purmorphamine in controls (Figure 60).  In the Bbs8 
knockdown cells both Ptc1 showed absolutely no increase of expression upon 
stimulation, and Gli1 was only upregulated 2-fold (Figure 60).   
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Figure 60.  qPCR expression levels of downstream Shh targets. 
Adding purmorphamine to controls caused the upregulation of ptc1 mRNA by around 
2.3-fold compared to almost nothing by Bbs8 suppressants.  Gli1 expression was 
increased around 6-fold in controls but only by 2-fold in bbs8 suppressants. 
 
An involvement for Bbs8 in the processing of Gli3 
Of all the BBS proteins identified, BBS8 has the most characterised function as a 
regulator of IFT particles, and is important for transport of IFT complexes along 
the cilium.  I have shown that BBS8 is important for transduction of the Shh 
signal but it is unknown at what point in the pathway BBS8 is involved.  Given 
that IFT is essential for processing and transport of Gli3 to the nucleus, I next 
designed an experiment to see if processing of Gli3 into its active and repressive 
isoforms was affected in BBS8 knockdown cells.  
 
To do this, I added 0.5µM purmorphamine to control or Bbs8 knockdown cells, 
extracted the protein, and blotted it with the anti-Gli3 antibody.  I then used 
Fold-induction of gene expression 
relative to unstimulated cells 
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densitometry to compare the ratio of Gli3A to Gli3R.  When the control cells were 
stimulated with purmorphamine, the ratio of Gli3A to Gli3R increased 
approximately four-fold (Figure 61).  This is due to inhibition of the proteolytic 
cleavage of Gli3A.  When Bbs8 knockdown cells were stimulated with 
purmorphamine, the ratio of Gli3A:Gli3R was only increased by about 1.4-fold, 
and this difference was not statistically significant.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 61.  Gli3 processing in response to Shh stimulation. 
The image of the blot shows that addition of 0.5µM purmorphamine to control cells 
results in the abolition of Gli3R, and therefore an increase in the ratio of Gli3A:Gli3R by 
approximately 4-fold.  In Bbs8 suppressant cells, addition of purmorphamine had less of 
an effect on reducing Gli3R levels, resulting in an attenuated level of Gli3A to Gli3R. 
 
Markers of Sonic Hedgehog signalling are misregulated in bbs 
morphant zebrafish 
The data from the cell culture experiments revealed that, at least in vitro, BBS8 
protein is important for transduction of the Sonic Hedgehog signal, and that a lack 
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of this protein, and other BBS proteins, impairs the response of the cell to Shh 
stimulation.  To see if this effect persisted in vivo, I turned to the zebrafish 
embryo to study markers of Shh signalling activity and to try to dissect the point 
at which Bbs8 intersects the pathway.   
 
bbs8 morphants show phenotypic signs of Shh pathway misregulation.  These 
include: cyclopia, U-shaped somites, and midline fusion of the trabeculae of the 
ANC.  I next wanted to investigate molecular readouts of Shh signalling.  
Previous work done by a colleague in our laboratory has shown that expression of 
shh transcript itself is unaffected in bbs8 morphants (H. May-Simera, thesis).  If 
the Shh transduction mechanism is defective, as indicated by the cell culture data, 
it is possible that direct transcriptional targets of the pathway could be 
misregulated in bbs8 morphants.  
 
To investigate this possibility, I performed in situ hybridisation to examine the 
expression of two genes positively regulated by Shh signalling: ptc1, and nkx2.2.  
Despite ptc1 being a negative regulator of the pathway by inhibiting Smoothened, 
it is autoregulated by the pathway in a negative feedback loop that prevents over-
activation of the pathway.  It is for this reason that loss of ptc1, when mutated, 
causes hyperactivity of the pathway and results in malignancy.  nkx2.2 is 
responsive to high concentrations of Shh signalling in the ventral neural tube.   
 
ptc1 was downregulated in bbs4, 6, and 8 morphants relative to controls, but most 
markedly so in bbs8 morphants (Fig. 62A-D).  pax6, a gene negatively regulated 
by Shh, was upregulated in the neural tubes of bbs8 morphants relative to controls 
(Fig. 62E and H).  The reduction in expression of Shh target genes ptc1, gli1, and 
shh was shown by qRT-PCR of whole embryos (Fig. 62I).  Focussing on the head, 
nkx2.2, a direct target of high-level Shh signalling, was downregulated in bbs8 
morphants, as was ptc1 (Fig. 62J-M).  The neural tube, revealed by nkx2.2 in situ 
hybridisation, was kinked in bbs8 morphants.  This was reminiscent of mutants 
with defects in the PCP pathway (Fig. 62N and O). 
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Figure 62.  Expression of Shh target genes in morphant zebrafish. 
A-D: expression of ptc1, a direct target of the Shh pathway, was downregulated in bbs4, 
bbs6, and bbs8 morphants.  E-F: expression of pax6 in these morphants; it was distinctly 
upregulated in the bbs8 morphant neural tube (arrow).  I: qRT-PCR analysis showing 
downregulation of three downstream Shh pathway targets in bbs8 morphants.  J-M: 
downregulation of expression of both nkx2.2 and ptc1 in the heads of bbs8 morphants.  
N,O: kinking of the neural tube (arrowhead in O) in bbs8 morphants relative to controls 
(arrowhead in N).  Scale bars: A-H = 500µm; J-M = 100µm; N,O = 200µm. 
 
I next examined the expression of nkx6.1, a gene expressed in the middle of the 
neural tube, in between the ventral domain responsive to high-level Shh 
signalling, and the dorsal domain, whose patterning genes are inhibited by Shh.  
As such, nkx6.1, like pax7, represents a gene that is responsive to low levels of 
Shh signalling.  Expression of nkx6.1 in morphants was not obviously different 
between control and morphant embryos (Figure 63).  This suggests that genes not 
reliant on high-levels of Shh transduction are unaffected by loss of Bbs8. 
 
 
 
A 
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Figure 63.  Expression of nkx6.1 in morphants. 
Expression of nkx6.1 was comparable in control (A) and morphant (B) neural tubes 
(arrowheads).  Scale bar = 500µm. 
 
Epistasis analysis to determine the point at which Bbs8 intersects 
the pathway 
To try to examine the point at which Bbs8 was interacting with the Shh pathway, I 
performed some epistasis experiments.  As mentioned earlier, Ptc1 negatively 
regulates Shh signalling, and so knockdown of ptc1 causes induction of the 
pathway.  I injected ptc1 MO either alone or in combination with bbs8 MO.  
When 1ng ptc1 MO was injected, it caused induction of ptc1 expression due to 
upregulation of the Shh pathway and consequential activation of ptc1 transcription 
(Fig. 64A).  Co-injection with the bbs8 MO restored the expression level of ptc1 
to the control level, but not to the low level seen in bbs8 morphants alone (Fig. 
64B).  This suggested that Bbs8 was functioning downstream of Ptc1 in the 
pathway but was not absolutely required for signalling to take place, due to the 
intermediate expression level of ptc1 after induction of the pathway.  
 
 
 
 
 
 
 
 
Figure 64.  Epistasis experiments to determine the level of Bbs8 activity. 
A: injection of ptc1 MO induces the Shh pathway seen by increased amount of ptc1 
mRNA.  B: co-injection with bbs8 MO partially rescues this pathway induction.  C: 
injection of dnPKA mRNA also induces the Shh pathway by preventing cleavage of 
A B 
control bbs8 
A B 
C D 
ptc1 MO ptc1 + bbs8 MO 
dnPKA mRNA dnPKA + bbs8 
  190 
Chapter 5 – Cilia in Shh signal transduction 
Gli3A into Gli3R.  D: co-injection with bbs8 MO is also able to rescue the dnPKA-
mediated pathway induction.  Scale bar = 500µm. 
 
I next modulated the downstream end of the pathway at the point at which Gli3 is 
processed.  Protein Kinase A (PKA) negatively regulates the Shh pathway by 
phosphorylating components of the pathway that targets Gli3 for proteosomal 
degradation into its repressive form.  I injected the mRNA of a dominant negative 
form of PKA (dnPKA).  Injection of 100ng of this RNA caused ectopic induction 
of the Shh pathway, manifested by ubiquitous, high-level expression of ptc1 (Fig. 
64C).  Co-injection of bbs8 MO was, again, able to partially rescue this induction 
(Fig. 64D).  This suggests that bbs8 is functioning at or downstream of the level 
of Gli3 proteolytic processing.  While the precise mechanism is unclear, there is 
good evidence that IFT is essential for proper processing of Gli3.  It is likely that 
Bbs8 is intersecting the Shh pathway at the level of Gli3 transport.  This is also 
consistent with the co-IP data. 
 
ift80 knock-downs also show signs of Sonic Hedgehog signalling 
defects 
Because Bbs8 is an IFT-associated protein that perturbs the Shh signalling 
pathway, I decided to perform some of the same assays on Ift80 null models.  This 
was because patients with Jeune Syndrome show some of the same Shh-related 
phenotypes as BBS, and given IFT80’s central role in IFT, known to be key in 
regulating Shh transduction.   
 
Firstly, I performed the Gli3 processing assay on 3T3 cells stably transfected with 
an shRNA construct suppressing Ift80 expression.  The cells showed the same 
indifference to stimulation by purmorphamine as did the Bbs8 suppressants.  This 
implied that the defect in Gli3 processing reported for other bona fide IFT 
proteins, such as IFT88, IFT172, and IFT57, also applied to IFT80, and most 
likely to IFT proteins in general.   
 
I next performed wholemount in situ hybridisation for ptc1 expression in ift80 
morphant zebrafish embryos.  As with bbs8 morphants, ptc1 was expressed at 
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lower level throughout the body, particularly in the head (Fig. 65A,B).  To 
confirm this, I extracted RNA from control and morphant embryos and performed 
quantitative RT-PCR to measure the amount of ptc1 mRNA.  In morphant 
embryos, it was expressed at 43% of the control level.  The same epistasis 
experiment involving co-injection with a ptc1 MO also showed that ift80 lies 
downstream of Ptc1 in the pathway, as it was able to rescue the induction of the 
pathway (Fig. 65C,D). 
 
The Gli3 processing assay showed a similar defect to Bbs8 suppression in 
response to Shh stimulation.  The ratio of Gli3A to Gli3R did not increase in ift80 
knockdown cells as it did in controls (around 4-fold) (Fig. 65E,F). 
 
I then prepared flatmounts of the neurocranial cartilage from controls and ift80 
morphants at 5dpf.  These demonstrated midline fusion of the trabeculae, again 
reminiscent of the Sonic Hedgehog pathway mutants, or early cyclopamine 
treated embryos (Fig. 66).  The branchial arches and mandibles were present in 
ift80 morphants and the degree of hypoplasia of the chondrocranial cartilages was 
much less than the bbs8 morphants.   
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Figure 65.  Shh pathway activity in response to ift80 depletion. 
A,B: ptc1 expression is reduced in ift80 morphants.  C,D: co-injection of ift80 MO with 
ptc1 MO rescues the induction of the pathway brought about by suppression of ptc1, 
suggesting ift80 lies downstream of ptc1 in the Shh pathway.  E,F: addition of 
purmorphamine to Ift80 suppressant cells fails to induce the pathway by preventing Gli3 
cleavage as it does in controls.  Asterisk represents non-specific band detected by the 
anti-Gli3 antibody.  Scale bar = 500µm. 
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Figure 66.  The chondrocranium of ift80 morphants. 
Midline fusion of the trabeculae in ift80 morphants (right) is reminiscent of syu mutant 
embryos (left).  Scale bar = 500µm. 
 
Although I did not check with specific NCC markers, the ift80 morphants showed 
no signs of aberrant NCC migration, such as depigmentation.  Despite a severe 
convergent-extension phenotype and the hypoplasia of the cranial cartilages, the 
pigmentation was entirely normal.  This implies that the midline fusion of the 
trabeculae is due to a faulty response to Shh signalling, whilst the mandibular and 
branchial hypoplasia is largely a result of inhibited NCC migration.   
 
Investigating a possible role for ift80 in Indian Hedgehog signalling 
Indian Hedgehog (Ihh) is a homologue of Shh which functions as a ligand that 
binds to patched in a similar manner to Shh, albeit with different kinetics, due to 
different post-translational cholesterol modification.  Ihh is important for bone 
development by encouraging the proliferation of chondrocytes in the growth plate 
of developing bones.  JATD patients’ most prominent and fatal feature is the 
failure of bones to grow properly, resulting in a small rib cage that causes 
asphyxiation.   
 
Considering the importance of IFT in Shh signalling, the role of the ciliopathy 
protein Bbs8 in Shh signalling, the necessity for Ihh signalling in bone growth and 
the similarity between Ihh and Shh transduction, I tried to discover if Ihh 
signalling was affected in ift80 morphants. 
 
ift80 MO syu 
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Firstly, I performed wholemount in situ hybridisation for ihha, one of two ihh 
paralogues in zebrafish, on 5dpf embryos.  It should be expressed in the 
developing cartilaginous elements of the face and fin buds.  The probe failed to 
yield a distinct signal, possibly because ihh expression was obscured by overlying 
tissue in the head.   
 
Because there is almost no literature on Ihh signalling in the zebrafish, save for 
one paper describing its expression pattern in chondrocytes of the jaw, I designed 
a MO to investigate the effects of its knockdown on embryonic development.  At 
24hpf, morphants were indistinguishable from controls, showing that the MO 
caused no toxicity.  Also, ptc1 expression was indistinguishable from controls, in 
keeping with the fact that Ihh is involved specifically with cartilage development, 
a later-onset process (Fig. 67A).  By 5dpf, morphants almost completely lacked 
any cartilage in the head, despite the rest of the body looking morphologically 
normal (Fig. 67B,C).  This suggests a conserved and very specific role for Ihh in 
the zebrafish, and suggests that the critical role of Ihh during bone development in 
fish and mammals is conserved.  This model should enable study of the 
mechanisms of Ihh signalling further.   
 
 
 
 
 
 
 
 
 
 
Figure 67.  Indian hedgehog knockdown phenotype. 
A: knockdown of ihha has no phenotype at 24hpf and ptc1 is normally expressed.  B and 
C: alcian blue stained 5dpf embryos injected with 4ng ihha MO showed a massive 
reduction in cranial and fin cartilage.  Only a rudimentary ANC was retained. 
 
A 
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Discussion 
The first demonstration that Shh signalling is defective in Bbs and 
JATD patients 
Numerous IFT proteins (IFT52, IFT57, IFT88, IFT172) have been implicated in 
Shh signal transduction.  Several ciliopathies show gross features that one 
typically sees when components of the Shh pathway are mutated, such as 
polydactyly, agenesis of the corpus callosum, single central incisor (rare), midface 
defects, and genital anomalies.  Zebrafish bbs8 morphants show clear Shh-like 
phenotypes: synophthalmia, midline fusion of the trabeculae, and U-shaped 
somites.  This is the first time it has been demonstrated that Shh signalling is 
perturbed in ciliopathy models.   
 
The results showed that Bbs8 and Ift80 both had significant effects on the 
pathway and likely acted downstream of Patched at the level of Gli3 processing 
and transport.  It is possible that Bbs8 is important for shuttling Gli3A and Gli3R 
to the nucleus where they activate their transcriptional targets.  Cells deficient in 
Bbs8 are less responsive when stimulated with exogenous Shh protein or Smo 
agonist than control cells.  The likely meaning of this is a failure to process the 
Gli3 transcription factor.  In epistasis experiments in the zebrafish, bbs8 MO was 
able to rescue induction of the pathway induced by ptc1 knockdown and partially 
rescue the phenotype caused by PKA inactivation.  Because the pathway is so 
complex, it is difficult to produce an exact pinpoint of where Bbs8 functions in 
the pathway.  To do this, one would have to perform proteomic assays on cells 
unstimulated and stimulated with different concentrations of purmorphamine to 
see with which proteins Bbs8 interacts.   
 
Another useful experiment would be to perform real time imaging of Shh 
transduction at the cilium.  To do this, cilia of control and Bbs8 suppressant cells 
with long cilia (such as MDCK) would be labelled with fluorescently tagged 
acetylated tubulin (or other ciliary marker such as Polaris).  I performed some 
feasibility studies on MDCK to show that they respond well to Shh signalling, and 
also created a line stably expressing shRNA against Bbs8.  GFP-tagged Smo or 
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Gli3 would be transfected into the cells.  A time-lapse movie would be recorded 
after photobleaching a portion of the cilium to visualise the movements of Shh 
pathway components in response to stimulation with Purmorphamine.  This would 
enable real-time monitoring of the behaviour of Shh pathway components in the 
absence of Bbs8.  This could be extended for other ciliary and IFT proteins to 
dissect the roles of each ciliary protein in Shh signalling. 
 
A proposed model for the role of Bbs and IFT proteins in Shh 
signalling 
From these experiments, it is clear that Bbs8 and Ift80 are not essential for Shh 
signalling, although Ift80 may be more important, particularly for Ihh 
transduction.  Immunoprecipitations showed some evidence for a possible weak 
interaction between the C-terminus of Bbs8 (which bears the TPR motifs) and 
Gli3.  Further experiments will have to be performed to validate this result 
convincingly.  These could include: GST-pulldown experiments with GST-tagged 
Gli3 or BBS8 proteins, yeast 2-hybrid interactions, and FRET between BBS8 and 
GLI3 reporter proteins.  This suggests that Bbs8 might have an accessory role in 
transporting Gli3 between the cilium and the cytoplasm.  It is conceivable that 
Bbs8 aids in the transport of Gli3 along the cilium towards the nucleus.  This is 
highly speculative and, at present, the molecular-scale function of IFT proteins in 
Shh transduction is completely unknown.  Proteomic analysis will be useful in 
understanding this.  A simple method of doing this might be to perform pairwise 
yeast-two hybrid interaction assays for proteins such as Bbs8 with each key 
protein in the Shh pathway, and then test these interactions in cell culture and then 
by FRET (fluorescent resonance energy transfer). 
 
The functions of Shh and Ihh overlap and the downstream signalling components 
are shared.  If a protein important for Shh transduction is expressed in the Ihh 
signalling domain, it is likely to perturb Ihh signalling and cause bone growth 
defects, as Ift80 does.  Defining the precise spatial expression pattern of Ift80 will 
be important in determining its potential role in Ihh signalling, and whether Ihh 
and Shh have different reliance on the cilium.  Also, Bbs8, which is highly 
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expressed in the testis, might mediate Desert hedgehog (Dhh) signalling, which is 
expressed exclusively in the testis, where it is essential for male germline 
development (Bitgood et al., 1996).  This raises the possibility that Bbs proteins 
might be important in testis development, as hypogonadism (small and 
undescended testes) is highly penetrant in the BBS cohort. 
 
Possible cross-talk between the Shh and Wnt signalling pathways at 
the cilium 
Several high-profile papers have linked Shh and Wnt signalling.  Alvarez-Medina 
et al showed that Gli3 expression is controlled by Wnt activity, likely by Tcf 
binding sites surrounding human GLI3 (Alvarez-Medina et al., 2008).  They also 
showed that Gli3R transcriptional repression in the dorsal neural tube restricted 
graded Shh signalling to the ventral neural tube.  Lei et al showed that Nkx2.2, a 
ventrally expressed gene responsive to high-level Shh signalling, is repressed by 
Tcf (Lei et al., 2006).  They showed that canonical Wnt signalling opposes 
positively regulated Shh gene targets to spatially restrict downstream genes to 
discrete domains.  Ulloa et al found that Gli3R inhibited canonical Wnt activity 
and showed a physical interaction between the C-terminus of Gli3R and β-catenin 
(Ulloa et al., 2007).  Furthermore, Glis2 (Gli-like 2) interacts with p120 catenin, a 
transcriptional regulator of canonical Wnt signalling (Hosking et al., 2007).  
GLIS2 mutations have been found to cause NPHP in humans, linking Shh and 
Wnt signalling to the primary cilium in ciliopathies.   
 
The importance of the cilium as a nexus for signalling was also highlighted by 
Park et al, who showed that it mediated both non-canonical Wnt and Shh 
pathways concurrently.  Clearly, more work is needed in elaborating the precise 
roles for individual ciliary proteins in the control of these pathways. 
 
A model for craniofacial dysmorphology in BBS morphants 
Shh is not necessary for NCC migration per se.  However, Shh derived from the 
oral ectoderm in the head patterns the migrating CNCCs and keeps the two 
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streams migrating to form the two trabeculae and also separates the eyes.  This is 
why Shh signalling defects cause midline fusion of the trabeculae and cyclopia.  
Evidence for this came from the fact that inhibiting Shh signalling in embryos by 
administration of cyclopamine to sox10::eGFP embryos between 4 and 24hpf did 
not affect NCC migration but clearly resulted in cyclopia and midline craniofacial 
patterning defects.  Meanwhile, it is known that PCP is essential for early 
migration of the CNCCs into the head.  We also know that both pathways are 
perturbed when bbs8 is suppressed.  
 
I propose a model to account for the craniofacial dysmorphology in BBS whereby 
disrupted PCP signalling slows migration of CNCCs, which populate the face, 
leading to hypoplasia (Figure 68).  Because these cells have a dulled response to 
Shh ligand, when they arrive in the head they are mispatterned about the midline.  
In the bbs8 morphants, the CNCC streams fail to separate at the midline.  This 
happens in a minority of BBS patients, who lack a corpus callosum and have a 
single central incisor.  The ENS is also patterned by Shh, and Shh mutant mice 
lack an ENS.  It is possible that the same phenomenon is contributing to 
aganglionosis in BBS. 
 
 
 
 
 
 
 
 
 
Figure 68.  Model describing craniofacial perturbation in BBS. 
With Bbs8 knockdown, early CNCC migration into the head is inhibited or retarded by 
reduced PCP signalling.  When cells finally reach the head they fail to respond properly 
to Shh ligand secreted from the oral ectoderm and rostral neural tube.  This leads to 
midline patterning defects in the fish reminiscent of Shh mutants, and features concordant 
with subtle HPE in humans. 
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Chapter 6: Restoration of renal function in zebrafish 
models of ciliopathies 
 
Introduction 
Renal disease is a common denominator in ciliopathies 
All of the nine diseases currently considered “ciliopathies”: BBS, MKS, JBTS, 
ALMS, OFD1, SL, NPHP, and JATD, share renal disease in common.  While 
other phenotypes are hallmarks of ciliopathies, such as polydactyly, brain 
abnormalities, and situs inversus, these are not represented amongst every single 
ciliopathy.  In addition, it is the renal component that is the commonest cause of 
death from ciliopathies such as BBS and NPHP.  Therefore, it is important to 
develop models to understand the progression of this disease and develop 
therapeutics.  
 
In general, ciliopathy patients’ renal disease involves cystic kidneys, but it is more 
complex than this in reality, and the different ciliopathies present differential renal 
pathology.  In BBS, O’Dea et al found that, in a Newfoundland cohort of 38 
patients, 96% had fetal lobulation, clubbing, or calyceal cysts (which form in the 
inner region of the kidney in the region just before the urine enters the renal 
pelvis) (O'Dea et al., 1996).  These authors also reported that 70% (n=20) of BBS 
patients were unable to produce concentrated urine, even after vasopressin 
treatment.  Alton and Macdonald reported that 30% of BBS patients die from 
uraemia, the condition caused by kidney failure when urea and other toxic waste 
enters the blood stream and leads to coma and death (Alton and McDonald, 1973).  
This fate can only be offset by chronic renal dialysis or transplantation.  Due to a 
greater susceptibility to infection, many BBS transplantees become septic or reject 
their transplant.   
 
In NPHP the renal involvement can be more severe and results in death between 4 
and 15 years of age (Fanconi et al., 1951).  Many patients develop medullary 
cysts, and interstitial lymphohistiocytic cell infiltration is common.  Later on, 
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these features develop into sclerosing tubulointerstitial nephropathy, which is 
what causes kidney failure.  Senior-Loken syndrome, described as NPHP with the 
addition of retinitis pigmentosa, manifests similar cystic and dysplastic kidneys.   
 
Meckel syndrome results in massively enlarged cystic kidneys, which cause 
distension of the abdomen in the fetuses that bear them.  Polycystic kidneys are 
also observed in OFD1 patients.  Biopsy of ALMS patients showed mesangial cell 
(basement membrane cells surrounding the glomerular blood vessels) proliferation 
(Ozgül et al., 2007).  In summary, cystic kidneys are the most common cause of 
renal disease, but also present are renal dysplasia, sclerosis, fibrosis, lobulation, 
and divertiula. 
 
Current theories explaining cyst formation 
Most of what we know about cyst formation comes from studies of polycystic 
kidney disease (PKD), of which there are two types.  Autosomal dominant 
(ADPKD), which is adult onset, occurs at a frequency of 1 in 1,000, and causes 
fluid-filled cysts.  Autosomal recessive (ARPKD), which is juvenile onset, is less 
common at 1 in 20,000, and is more serious, frequently leading to infant 
mortality.   
 
The formation of cysts in both types of PKD is thought to arise by the same 
mechanism, involving increased proliferation and apoptosis in renal epithelial 
cells, loss of epithelial cell polarity, dysregulation of cell/ECM interactions, and 
transformation from an absorptive epithelial cell phenotype to a secretory 
phenotype.  Cysts then separate from their tubule of origin once they have grown 
over 200µm in diameter and begin to fill with fluid, as chloride channels pump 
chloride into the cystic lumen, lowering the osmotic potential and causing water 
to enter via aquaporins.   
 
The proteins that cause PKD, Polycystins 1 and 2 (PC1 and 2) in the case of 
ADPKD, and fibrocystin for ARPKD, localise to the primary cilium, leading 
some to call PKD a “ciliopathy”.  Cilia on the tubular epithelium project into the 
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lumen where they act as mechanical flow sensors, bending in response to urine 
flow through the tubule (Yoder et al., 1998).  This triggers an influx of Ca2+ into 
the ciliary membrane, mediated by PC1 and 2.  This calcium flux is intrinsically 
linked to cell cycle regulation via the cilium and the ciliopathy proteins.  It is 
thought that the transcription factor STAT6 dissociates from its binding to PC1 
when the cilium is sheered by fluid flow, whereupon STAT6 translocates to the 
nucleus and activates downstream targets associated with cell proliferation (Low 
et al., 2006).  This is summarised in Figure 69. 
 
Another role for the cilium in regulating kidney development comes from the 
discovery that the cilium acts as a switch between the canonical and non-
canonical/PCP Wnt signalling pathways.  The β-catenin-dependent canonical Wnt 
pathway is associated with cell proliferation and is important for the branching 
morphogenesis associated with embryonic kidney development.  Transgenic 
overexpression of β-catenin in mouse kidneys caused cystogenesis (Saadi-
Kheddouci et al., 2001).  Inversin, a ciliary protein, targets cytoplasmic 
Disheveled for degradation, thereby inhibiting the canonical Wnt pathway.  
Therefore, knockdown of Inversin, for example in NPHP2 patients, causes 
unopposed activity of the Wnt pathway leading to overproliferation in the kidney.  
This is also the case in both mouse and zebrafish Inversin knockdown models 
(Simons et al., 2005).  
 
The PCP signaling pathway, known to be disrupted in BBS mutants, is essential 
for asymmetrical distribution of the cytoskeleton, thereby modulating cell 
polarity.  If the molecular “switch” model is correct, an excess of the canonical 
Wnt pathway results in a downregulation of the PCP pathway at its expense 
(Simons et al., 2005).  This is true in BBS where the canonical Wnt pathway is 
known to be hyperactivated, and the PCP pathway downregulated.   
 
PCP signaling is known to control the orientation of the mitotic spindle (Gong et 
al., 2004).  During tubular development, cell proliferation lengthens the tubules 
without widening their bore.  As such, the spindle axis of dividing tubular cells 
aligns with the tubular axis (Fischer et al., 2006).  In the rodent model of PKD, 
  202 
Chapter 6 – Restoration of renal function 
pcy (Pkhd1 mutant), the mitotic spindles are misorientated, even before the onset 
of cyst formation.  This suggests that any subsequent cell divisions will not be 
parallel to the tubule, resulting in an increased girth of the tubule.  Mispolarised 
cell division will lead to disordered growth in the tubule and cystic enlargement.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 69.  Signalling at the cilium in the kidney. 
A: Urine flow through the kidney tubule causes an influx of Ca2+ ions through polycystin 
2 (PC2), while polycystin 1 (PC1) anchors the transcriptional complex of P100 and 
STAT6 in the cilium. Concurrently, inversin is translocated to the nucleus, where it 
 
A  wild type + flow B  wild type no flow 
C  BBS mutant 
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targets cytoplasmic Disheveled for destruction, activating the non-canonical pathway and 
causing cells to differentiate. The ciliary localisation of PC1/2 and inversin may be 
dependent on BBS proteins.  B: Absence of urine flow reduces Ca2+ influx and causes 
release of P100 and STAT6, allowing them to enter the nucleus to activate transcription. 
It also prevents translocation of inversin to the cytoplasm, maintaining the cytoplasmic 
pool of Disheveled, which activates the canonical Wnt pathway and causes proliferation. 
C: A lack of BBS protein function may inhibit proper transport of PC1/2 to the distal tip 
of the cilium and also prevent translocation of inversin to the cytoplasm. This would 
cause inappropriate activation of STAT6 target and maintenance of cytoplasmic 
Disheveled, leading to unregulated cell proliferation. Additionally, lack of BBS protein 
function could disturb planar cell polarity (PCP). The combination of disorganised cell 
polarity and cell division could cause the various abnormalities seen in BBS.  Taken from 
(Tobin and Beales, 2007) 
 
At present, the precise mechanism by which PCP regulates the orientation of the 
spindle is not known.  However, PCP signaling relies on ciliary function and the 
basal body at the proximal end of the cilium, together with the second centriole, 
produces the microtubule spindle during mitosis after resorption of the cilium.  
The orientation of the cell is controlled by the alignment of the actin cytoskeleton, 
which is modeled by Rho, Rac, and cdc42, which are, in turn, regulated by PCP 
signaling.  As such, it can be hypothesized that absence of ciliopathy proteins is 
affecting downstream PCP signaling, which, in turn, affects the polarity of the cell 
and subsequently the centrioles do not align along the axis of the cell.   
 
Current therapies for cystic kidney disease 
ADPKD is one of the most common genetic diseases, with an incidence of around 
1 in 1,000.  The onset of the disease is much later than ARPKD, with a median of 
around 15 years (Zerres et al., 1993).  Cysts grow progressively larger and kidney 
mass has been reported to reach up to 20kg (Germino and Somlo, 1993).  As such, 
therapies to slow the development of the cysts prolong symptom-free status, as the 
health only becomes compromised when the cysts impair the filtering capacity of 
the kidney.  This results in end stage renal failure (ESRF) in approximately 50% 
of patients with ADPKD. 
 
Currently there is no treatment for PKD, there are only drugs that slow cyst 
development, with some promising molecules in preclinical development in the 
mouse, but no compounds have entered the market to treat humans yet.  Present 
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treatment involves a low protein diet to offset renal failure.  Current advances in 
understanding the mechanism of cystogenesis will inform drug discovery 
strategies.  Several important mouse models are being used as PKD models: the 
orpk mouse (Oak Ridge PKD) is a polaris mutant which encodes IFT88; the inv 
mouse in which Nphp2 is mutated; and conditional knock-out of Kif3a in the 
kidney causes cysts. 
 
Current pathways targeted for therapy include the Ras pathway, a mitogenic 
signalling pathway upregulated in PKD.  Ras signals via Raf to translocate the 
MAP kinase ERK to the nucleus, whereupon it phosphorylates transcription 
factors associated with cell division.  Another pathway involved in cyst 
progression is the G-protein coupled receptor (GPCR) pathway where cAMP 
activates Raf kinase activity to drive cell proliferation.  Therefore, cAMP 
inhibitors are another option for therapy.   
 
This table summarises the drugs which have been shown to work in rodent models 
of PKD adapted from (Torres, 2004): 
 
Treatment Mode of action 
 
Model used 
Acetazolomide Carbonic anhydrase inhibitor; diuretic Han:SPRD rat (PKD model).   
Did not work in PCK rat 
Amiloride Diuretic Han:SPRD rat.   
Did not work on PCK rat 
Batimastat Matrix metalloprotease inhibitor, anti-
cancer drug 
Han:SPRD rat 
c-myc antisense Prevents excess cell division Cpk mouse 
c-Src inhibitor Prevents excess cell division Bpk mouse (ARPKD model) 
EGFR inhibitor Inhibits receptor for epidermal growth 
factor 
Han:SPRD rat 
Lovastatin HMG-CoA reductase, lowers 
cholesterol level 
HAN:SPRD rat 
Methylprednisolone Corticosteroid, blocks inflammation Han:SPRD rat and pcy mouse 
Paclitaxel Stabilises microtubules to prevent cell 
division.  Used in cancer chemotherapy 
Cpk mouse (ARPKD model).   
Did not work on pcy (Nphp3) 
mouse, orpk mouse, or 
Han:SPRD rat. 
Rapamycin Inhibits mTOR, antiproliferative 
compound 
Bpk and orpk mice 
Roscovitine CDK-inhibitor; prevents cell division Jck (Nek8) and cpk mouse 
V2R antagonist Vasopressin receptor antagonist PCK rat, cpk, pcy, Pkd2 mice 
Table 11.  Drugs previously used on rodent models of polycystic kidney 
disease. 
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Of these drugs, only Rapamycin (also called Sirolimus) has entered clinical trials 
in humans (Serra et al., 2007).  In mouse models, Rapamycin caused apoptosis 
and shedding of cystic cells, reducing the size of the kidneys from 16% of total 
body weight to 4%, compared to 0.7% in wild types (Shillingford et al., 2006).  
This had the effect of completely restoring renal function, as measured by the 
concentration of blood urea nitrogen.  These authors suggested that inappropriate 
activation of mTOR is common to all forms of cystic kidney disease, because 
addition of Rapamycin ameliorates cysts in several different mouse models.  
Furthermore, because Rapamycin alone rescued the kidney phenotype, they 
asserted that the mTOR pathway was the predominant cause of cystogenesis in all 
PKD models.  
 
mTOR is a kinase that controls cell proliferation.  It is regulated upstream by two 
centrosomal proteins, TSC1 and TSC2, whose genes, when mutated, cause renal 
cysts.  mTOR also interacts with the cytoplasmic tail of PC1 and so functions, at 
least in part, at the cilium.  Because Rapamycin specifically interferes with 
signalling at the cilium to restore diseased kidneys, and given its proven function 
in a range of polycystic kidney models involving ciliary gene mutations, it is a 
valid candidate to test on ciliopathy models.   
 
Bukanov et al (2006) reasoned that because cilia function in cell cycle regulation, 
and this is disrupted in PKD, this would be the most proximal target for 
preventing cyst growth (Bukanov et al., 2006).  Roscovitine is a cell cycle 
inhibitor that acts by binding to cyclin dependent kinases (CDK), and is currently 
in clinical trials to treat cancer.  They showed that administration of Roscovitine 
to jck mice reduced the kidney to bodyweight ratio from 9% to 4%, while blood 
urea nitrogen was also lowered.  Bukanov et al also showed that administration of 
150mg per kilogram bodyweight for 3 weeks, followed by 2 weeks off treatment 
was sufficient to reduce cyst size.  This shows that Roscovitine has long lasting 
effects, and daily administration is not required.   
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Bukanov et al also showed Roscovitine to be effective on the more aggressive 
ARPKD mouse model, cpk.  Roscovitine reduced the kidney to bodyweight ratio 
from 25% to about 18% and reduced cystic volume by around 25%.  Therefore, 
Roscovitine is not as effective at treating very severe disease, and Rapamycin may 
be more effective.  
 
Bukanov et al showed an increase in proliferating cells lining the tubule of human 
and jck mouse kidneys, which was reduced by Roscovitine treatment.  They 
attributed this excessive activation to upregulation of the Ras/Raf/ERK pathway, 
which was demonstrated by upregulated components of the pathway, such as 
Erk2, by Western blot.  They also showed that Cdk7 and 9 were upregulated, 
which were the likely targets of Roscovitine.  These Cdks activate RNA 
polymerase II to drive transcription and cell division.  Roscovitine simultaneously 
reduces the amount of apoptosis in the jck kidney.  The relevance of this model is 
that jck contains a mutation in Nek8, a gene mutated in the ciliopathy NPHP, and 
whose protein functions at the cilium and interacts with PC1 and 2 (Sohara et al., 
2008).   
 
Because Roscovitine and Rapamycin have been shown to work on specific ciliary 
models of PKD, and have well characterised modes of action with appropriate 
targets, they are likely to be useful candidate drugs for testing on ciliopathy 
models for potential use in humans.  Because ciliopathies are so rare, it is not 
economically viable for pharmaceutical companies to develop orphan drugs, nor 
perform clinical trials for them.  However, because the mode of cystogenesis is 
likely to be similar to that of the more common PKD models tested, these drugs 
can be trialled as candidates for ciliopathy treatments such as BBS, NPHP, and 
OFD1.   
 
Because of the time taken to breed mice, section them, and analyse the kidneys, 
plus the requirement for genetic models, I have been exploring the utility of the 
zebrafish in screening drug candidates for ciliopathic renal disease. 
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Kidney development in the zebrafish 
Despite its small size, rapid development, and relative anatomical simplicity, the 
zebrafish kidney functions in almost exactly the same way to the mammalian one.  
The main difference is that while the adult human kidney comprises some one 
million nephrons, the embryonic zebrafish pronephros contains just two.   
 
Two glomeruli are fused at the midline just ventral to the aorta from which the 
blood is filtered.  These glomeruli are anatomically similar to mammals, 
containing fenestrated epithelial cells and podocytes for ultrafiltration, and 
polarised epithelial cells.  Two pronephric tubules connect the glomeruli to the 
pronephric ducts, which run caudally and fuse before connecting to the cloaca, 
which secretes waste to the outside world (Figure 70).  Despite the anatomical 
similarity with mammals, the zebrafish pronephros is primarily for 
osmoregulation, rather than excretion, as the animal contains salty blood but lives 
in a fresh water environment.  Disruption to kidney function causes oedema, as 
animals fail to expel water, so become oedematous, and die. 
 
 
 
 
 
 
Figure 70.  Kidney development in the zebrafish. 
Two pronephric tubules link the midline glomerulus, which overlies the dorsal aorta, with 
the lateral paired pronephric ducts.  The zebrafish glomerulus functions in a manner 
similar to the mammalian kidney and so is a good model for kidney development and 
function.  From (Drummond, 2005). 
 
Pronephric development begins at around 24hpf, when mesodermal fibroblasts 
form a polarised epithelial tube to produce the pronephric duct, homologous to the 
collecting duct of the mammalian kidney.  The glomerular primordia and ducts 
then fuse and blood vessels invade the podocytes to form a functional glomerulus.  
This process is complete and functional by about 40hpf (for review, see 
Drummond, 2005).  Kidney function can be assessed by injection of fluorescent 
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tracer dyes into the systemic circulation of the animal.  The presence of 
fluorescent endosomes in the cytoplasm of pronephric duct cells shows that the 
dye has passed through the glomerulus into the duct.   
 
Modelling cystogenesis in the zebrafish 
The zebrafish is a good model for studying cystic kidneys, because the presence 
of a large bubble-like cyst can easily be seen from outside the animal from 3dpf.  
Drummond et al (1998) took advantage of this to perform a large-scale 
mutagenesis screen in which they identified 15 separate mutants with pronephric 
cysts.  12 of these mutants also had a curved body axis and presented the most 
rapid and severe cyst development.  Sun et al (2004) performed a separate screen 
using retroviral mutagenesis and identified 10 more cystic mutants (Sun et al., 
2004).  They then cloned these genes and found 4 of the 10 to encode IFT 
proteins.   
 
Zebrafish ciliopathy models that show cystic kidneys have been produced in the 
past.  Liu et al (2002) knocked down nek8 with MO and found kidney cysts (Liu 
et al., 2002).  Nek8 is mutated in the mouse model jck and was later found to be a 
causative gene of NPHP.  Knockdown of polycystin 2 in zebrafish also causes 
cysts.  This table summarises all the mutants and morphants, published to date, 
with renal cysts.  Ciliary genes are marked in bold. 
 
 
 
 
 
 
 
 
 
 
 
  209 
Chapter 6 – Restoration of renal function 
Gene 
 
Phenotype Reference 
Mutants   
Double bubble, bazuka joe, 
dizzy, junior, mr bubble, blow-
up, fusion, bubbleicious, big 
league chew, hubba bubba, 
inflated 
Pronephric cyst, down-curved 
body axis 
Fleer, elipsa As above with eye 
degeneration 
Pao pao tang, cyster Cyst 
(Drummond et al., 1998) 
Vhnf1 Pronephric cyst, gut and 
hindbrain abnormalities 
(Sun and Hopkins, 2001) 
Locke Cyst, axis asymmetry, axis 
curvature 
(Sullivan-Brown et al., 2008) 
Scorpion, pontin, qilin, 
seahorse, pkd2 
Cyst  
Ift57, ift81, ift172 Cyst (Sun et al., 2004) 
Plce1 Cyst (Hinkes et al., 2006) 
 
Morphants 
Nek8 Pronephric cyst, down curved 
body axis 
(Liu et al., 2002) 
Inversin Cyst, body curvature and 
asymmetry 
(Simons et al., 2005) 
Nphp6 Cyst (Sayer et al., 2006) 
Arhgef11 Cyst, mispolarised epithelium (Panizzi et al., 2007) 
Wt1a and wt1b Cyst (Perner et al., 2007) 
Lrrc50 Cyst (van Rooijen et al., 2008) 
Ift80 Cyst, down curved body (Beales et al., 2007) 
Table 12.  Zebrafish mutants and morphants published to date with renal 
cysts.  Many of these gene products are involved with the primary cilium. 
 
At present, zebrafish models for three ciliopathy genes have been generated 
(inversin - NPHP2, nek8 - NPHP8, ift80 - JATD) and all show cystic kidneys.  
While the mechanism of cystogenesis in the mammal is generally accepted as 
being hyperproliferation, dysplasia, and mispolarity, it is much less clear in the 
zebrafish and several mechanisms have been proposed.  
 
Kramer-Zucker et al showed that, unlike mammalian renal tubular cilia, zebrafish 
pronephric cilia are motile, beat with a frequency of about 20Hz, and drive a fluid 
current through the duct (Kramer-Zucker et al., 2005).  They suggested that 
mutations in ciliary proteins result in reduced ciliary motility causing a back-up of 
fluid and increase in pressure which causes the cysts to form.  They showed that a 
cyst could form in 30 minutes if the cloaca is obscured with forceps.   
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Sullivan-Brown et al (2007) examined the mechanism of cyst formation in a 
number of mutants.  They found tubule dilation to onset as early as 48hpf, and 
excess cell proliferation in the tubule was a secondary effect of this.  They also 
showed that, despite the three mutants tested having differing degrees of ciliary 
motility, the mechanism and extent of cyst progression was the same.  This 
suggests that a motility defect is not the cause of cystogenesis.   
 
Further confounding this body of work is a paper by Kishimoto et al (2008), who 
characterised the cystic mutant seahorse.  They showed that seahorse is 
dispensable for ciliogenesis and motility, yet mutants still develop cysts.  In 
seahorse mutants, Wnt signalling is ectopically induced at the expense of PCP 
signalling.  Seahorse physically interacts with the DEP domain of Dishevelled, a 
region of the protein essential for membrane localisation and PCP signalling.  
Abrogation or mutation of critical residues of the DEP domain abolishes PCP 
signalling (Axelrod et al., 1998).   
 
These data therefore suggests that increased canonical Wnt signalling could be 
responsible for cyst formation in this mutant.  Because canonical Wnt signalling is 
known to be increased in ciliopathy knockdowns (bbs1, bbs4, bbs6, and kif3a) 
(Gerdes et al., 2007), this could be the route of cystogenesis in ciliopathy patients.  
The three studies outlined here present somewhat contradictory evidence of the 
mechanism of cyst formation in the zebrafish.  As such, no clear conclusions can 
be drawn about the precise aetiology of the cysts, only that they are recapitulated 
in all ciliary knockdowns tested so far, and their morphology is consistent. 
 
Use of the zebrafish in pharmacological screening 
Given the penetrance of the cystic phenotype in ciliopathic zebrafish and the 
rapidity with which one can screen for the presence of the cyst, I examined the 
possibility of using the zebrafish to test compounds to restore renal structure and 
function.  As well as being a useful vertebrate model for large-scale mutagenesis, 
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the zebrafish is emerging as a tool for screening drug compound libraries for 
efficacy.   
 
In contrast to traditional drug discovery, where the target is known and bioassays 
are performed to identify a molecule that binds to it, zebrafish drug screening 
usually involves unknown targets.  Rather, the desired phenotype is scored for.  
The advantage of this approach is that the full signalling mechanism does not 
need to be understood a priori to drug screening.  As such, this is a perfect system 
in which to test drugs on zebrafish ciliopathy models, as there is much confusion 
and misunderstanding about the precise molecular mechanism of cystogenesis, but 
there is a clear and scoreable phenotype.  
 
The utility of the zebrafish as a small molecule screening system was first 
identified by Peterson et al who used it to identify small molecule modulators of 
embryonic development (Peterson et al., 2000).  They placed 3 wild-type embryos 
into each well of a 96 well plate with 200µl of water.  1,100 small molecules from 
a commercially available library were diluted in DMSO and fish water and 
robotically added to the embryo water at the 8-16 cell stage.  Embryos were 
examined at 1, 2, and 3dpf.  They identified molecules that specifically affected 
the development of the CNS, heart, pigmentation, ear, and otolith.  This study 
provided proof of principle that it was feasible to perform high throughput studies 
on zebrafish embryos.  Moon et al subsequently used the fish to successfully 
screen a library for microtubule polymerisation inhibitors (Moon et al., 2002).   
 
Behra et al used the fish for a toxicological screen of several acetyl cholinesterase 
inhibitors (Behra et al., 2004).  They used it to specifically identify one compound 
out of four that was active.  Chan et al used zebrafish in a cancer model to test 
anti-angiogenic molecules and showed that a human VEGF-inhibitor also worked 
in zebrafish (Chan et al., 2002).  
 
The use of transgenic zebrafish models coupled to robotic drug administration, 
high-throughput imaging systems and computer algorithms has enabled real in 
vivo high-throughput screening to take place in zebrafish.  Peterson et al (2004) 
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screened 5,000 compounds and found two which suppressed the aortic blockage 
phenotype of the hey2 mutant (gridlock) (Peterson et al., 2004).  This mutant is a 
model for aortic coarctation, a common congenital defect in humans and so the 
identification of drugs in zebrafish is potentially of major clinical benefit.   
 
Burns et al (2005) developed a transgenic zebrafish expressing GFP in the 
myocardium (Burns et al., 2005).  They developed computer software to 
automatically identify individual fish hearts arrayed in a 96 well plate and count 
the heart rate.  They then added compounds that slowed the heart rate and showed 
how the technique could rapidly generate dose-response curves for the effect of 
different concentrations of the drug on heart rate.  This is the first time an 
automated technique has been used for phenotypic analysis of vertebrate organs.  
 
Tran et al (2007) arrayed fli1:gfp transgenic zebrafish which express GFP in blood 
vessels in 384 well plates (Tran et al., 2007).  They generated an algorithm to 
quantify the number of angiogenic blood vessels in the fish and used this to screen 
a 1,280-molecule library.  From this they identified two molecules with known 
anti-angiogenic properties as well as a third novel compound.  They then tested 
this new compound in an in vitro assay on human umbilical endothelial cells 
(HUVECs) and showed it be effective at inhibiting angiogenesis. 
 
While screens in zebrafish are lower throughput than for cell lines, specific, 
physiologically relevant disease models can be tested, in which cell-cell and cell-
matrix interactions are present.  The scalability of the system for studying disease 
models may improve in the future.  For instance, a fully robotic system for 
injecting morpholinos into embryos which can exceed the capacity of a human 
investigator has been reported (Wang et al., 2007).   
 
In summary, while the use of zebrafish is not as high-throughput as isolated 
protein targets or cell lines, it is now possible to screen several thousand 
compounds, given an assay amenable to automation.  It has benefits in that it is 
physiologically relevant and phenotypes can be readily scored.  Disadvantages 
include different mechanisms of absorption, distribution, metabolism, and 
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excretion, making bioavailability and pharmacokinetic comparisons to humans 
difficult.  However, the main advantage is that it is a cheaper, quicker, and more 
physiologically relevant technique for “pre-pre-clinical” drug discovery. Lead 
compounds can then be tested on a mouse model with more confidence of 
efficacy, while gaining knowledge of dosage and toxicity. 
 
The aims of this study 
Given the phenotypes of the plethora of non-ciliopathic and ciliopathic zebrafish 
models of renal cysts and the potential to perform drug compound screening on 
the zebrafish, I made the following aims: 
 
1) To create zebrafish models of all the major ciliopathy syndromes: BBS, 
NPHP, SNLS, JBTS, MKS, OFD1, and JATD. 
2) To examine the kidney morphology of these morphants 
3) To try to determine some of the molecular mechanism behind the 
pathology and see if cellular proliferation was increased in the morphant 
kidneys. 
4) To test known anti-cystic compounds on these morphants and develop a 
quantitative assay for morphological rescue. 
5) To develop a functional assay to see if these compounds ameliorated renal 
function. 
 
The ultimate aim of this project was to try to develop a physiologically relevant 
way of testing compounds known to work on common rodent models of 
ciliopathy (such as orpk and jck) on zebrafish ciliopathy morphants.  Because only 
a few mouse models of ciliopathies exist (currently only for a few BBS genes), I 
wanted to create zebrafish models of genes for which no mouse models had been 
made.  I then wanted to identify compounds that could subsequently be tested on 
our available mouse models of BBS (Bbs4 and Bbs6), which develop renal cysts. 
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Results 
Validation of the morpholino oligonucleotides 
In order to perform a study representing the whole spectrum of ciliopathy genes 
and phenotypes, I designed and ordered MOs directed against both start ATG and 
splice sites of the following genes (see Appendix 2 for sequences): 
 
Bardet-Biedl syndrome: bbs4, bbs6, bbs8 
Meckel syndrome: mks1, mks3 
Nephronophthisis: nphp2, nphp5  
Joubert syndrome: nphp6 
Oro-facial-digital Type I: ofd1 
Jeune syndrome: ift80 
 
These ten different genes represent the ciliopathies from their most mild clinical 
phenotype (NPHP), to the most extreme (Meckel syndrome), with BBS, OFD, and 
Jeune syndrome as intermediates. 
 
Initially, I performed a series of injections at different doses: 1, 2, 3, 4, 6, and 8ng 
of MO.  For most MOs, the phenotypes were consistent between both ATG and 
splice blocking sequences, but often the effective dosage was different.  As such, 
this had to be determined empirically and was taken as the concentration of MO 
inducing a consistent phenotype in over 90% of embryos, without signs of 
toxicity, non-specific cell death, or lethality.  For each dose of each MO, I injected 
50-60 embryos and then scored each embryo at 3dpf for no, mild, and strong 
phenotypes, and also lethality.  In general, most MOs were used in the range of 2-
4ng per embryo.   
 
As controls, some of the MOs were tested against 5-base mispairing MOs in 
which five of the 25 residues are altered to abrogate binding to the target.  This 
checks that the MO itself is not causing toxicity.  None of the mispairing MOs 
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caused any gross phenotypes or developmental delay, even when injected at a 
relatively high dose (8ng).   
 
Injection of the ift80 MO gave highly reproducible phenotypes consistent with 
ciliopathy.  At 24hpf, embryos had a down-curved body axis relative to control 
MO injected embryos (Fig. 71A,B).  At 3dpf, morphants had a highly down 
curved body axis, cardiac oedema, and a palpable pronephric cyst (Fig. 71C,D).  
By 5dpf, the curvature of the body axis persisted but the cyst had swelled in size 
due to abdominal oedema (Fig. 71E,F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 71.  ift80 morphant phenotypes. 
A,B: ift80 morphants have a down turned tail at 24hpf relative to controls.  C,D: At 3dpf, 
a kidney cyst is clearly visible and the curvature of the body-axis has become more 
pronounced.  E,F: by 5dpf the kidney has swollen due to oedema (arrowhead in F).  Scale 
bars: A,B = 500µm; C-F = 1mm. 
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For two of the MOs (bbs8, ift80), I checked the specificity of the phenotype by 
co-injecting the MO with a human (bbs8, 71% sequence identity with zebrafish) 
or mouse (ift80, 61% sequence identity with zebrafish) full-length mRNA.  In 
both cases, the mRNA was able to almost completely rescue the phenotype (Fig. 
72A and C).  A minority of the rescued embryos retained a very moderate 
phenotype such as mild cardiac oedema, very mild tail kinking, and a small 
kidney cyst.  This may be because the precise dose of mRNA injected did not 
perfectly match the degree of knockdown and the endogenous expression level.  
The other problem with injecting mRNA is that it is expressed constitutively in all 
cells, not in the spatially and temporally regulated manner in normal conditions.  
In addition, Bbs8 and Ift80, similar to other ciliary and IFT proteins, have gain-of-
function phenotypes as well, consisting of CE defect.  Gain-of-function 
phenotypes here are likely due to the disruption of stoichiometric ratios important 
for proper assembly of complexes in which they participate.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  217 
Chapter 6 – Restoration of renal function 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 72.  Rescue of ift80 morphant phenotypes. 
A: co-injection of 50pg mouse ift80 mRNA rescues the morphant phenotype.  B: RT-PCR 
showing a strong band in controls in the two exons flanking the exon-intron boundary 
against which the MO is designed.  This band is missing in morphants and is replaced by 
a 3.5kb band due to the inclusion of an intron in the mRNA.  α-tubulin mRNA products 
are the same in control and morphant embryos showing that non-specific mRNAs are not 
affected.  Lack of reverse transcriptase (-RT) has no band when used with control cDNA 
and ift80 primers, showing the band is a specific product. 
 
For splice-blocking MOs, the efficiency of splice blocking, and by inference the 
proportion of mis-translated protein, could be determined by designing PCR 
primers in the exons flanking the splice site targeted by the MO.  In the case of the 
ift80 splice-blocking MO, this blocked the removal of a 3kb intron resulting in a 
much higher mass band on the PCR gel.  This processed 100% of the ift80 mRNA 
at 24hpf (Fig. 72B).  Over time during development, the amount of MO inherited 
into each daughter cell decreases as the MO becomes diluted, and also can diffuse 
out of the tissue or become degraded.  
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Specific ciliary-related phenotypes in the fish 
All the ciliopathy MOs trialled in this experiment showed phenotypes consistent 
with their human counterparts, in addition to convergent-extension, which is 
ubiquitously associated with zebrafish ciliary mutants and morphants.   
 
The most dramatic phenotype associated with ciliary dysfunction is situs inversus.  
In zebrafish this can be easily scored by examining the direction of heart looping, 
or at earlier stages, by determining the sidedness of south paw (spaw) expression.  
This marker is a downstream component of the Nodal signalling pathway and in 
normal conditions, its expression domain is restricted to the paraxial mesoderm of 
the left-hand side of the embryo.  Situs inversus is manifest by right-sided 
expression of spaw, while bilateral expression indicates randomisation of 
laterality (Fig. 73A-C).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 73.  Sidedness of spaw expression in ift80 morphants. 
A,D: left-sided expression of spaw is normal and present in 100% of control embryos.  B: 
22% of ift80 and 46% of bbs8 morphants show bilateral expression of spaw but controls 
do not.  C: 8% and 7% of ift80 and bbs8 morphants, respectively, show right-sided, or 
inverted, spaw expression.   
 
A B C 
left-sided spaw bilateral right-sided 
Side of spaw expression D 
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In control embryos at 15ss, the expression of spaw is restricted to the left side of 
the body axis in 100% of embryos (n=31).  In 30% (n=52) of ift80 morphants, the 
sidedness of spaw expression is anomalous: 22% of embryos showed bilateral 
expression and 8% right-handed (or inverted) expression.  In bbs8 morphants, 
spaw expression was anomalous in 53% (n=43) of embryos: 46% showed bilateral 
expression and 7% right-handed expression (Fig. 73D).  This phenotype is 
specific and, whilst not conclusive in its own right, suggests that there is a 
problem with cilia function in Kupffer’s Vesicle (KV), a ciliated organ 
functionally analogous to the mammalian node.   
 
The beating of cilia in this organ drives leftward fluid flow resulting in 
asymmetric distribution of signalling molecules and activation of the Nodal 
signalling pathway only in the left-hand side of the embryo.  This breaks the 
symmetry of the embryo and gives each side either left or right sided character.  
Unpublished data from another member of our laboratory has shown that the 
length of KV cilia is reduced in bbs8 morphants and this results in misdirected 
movement of vesicles suspended within the lumen of the vesicle.  These 
phenotypes suggest defective ciliary structure and function in these ciliopathy 
morphants and support the efficacy and specificity of the gene knockdown. 
 
Otolith defects are another ciliary phenotype 
Zebrafish ears are remarkably similar in function to the mammalian ear, albeit 
much simpler.  They function for both auditory perception and balance, important 
for coordinated swimming.  Each ear contains two otoliths, small crystallisations 
of calcium carbonate that are analogous to the otoconia in the vestibular apparatus 
of the mammalian ear.  They function in balance and maintenance of an upright 
swimming posture.  Underneath the otoliths lie bundles of sensory hair cells that 
are deflected when the otoliths move about in response to the body position of the 
fish.  These deflections inform the brain as to the position of the body axis so the 
animal knows which way is “up”.  Mutations in genes important for otolith 
formation, such as starmaker, cause malcoordinated swimming and imbalance. 
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Gross examination of several of the ciliopathy morphants revealed anomalous 
numbers, sizes, and shapes of the otoliths present in the ears of the embryos.  In 
control embryos, 100% (n=42) have two otoliths at 72hpf, one large and one 
smaller, in each ear (Fig. 74A,D).  In bbs8 morphants, only 7% of otic vesicles 
(n=56) contained normal otoliths.  In 43% of cases the otoliths were fused, 
producing one large otolith with two distinct lobes (Fig. 74B).  In 35% of cases, 
there was only a single otolith present, and in 15% there were three or more 
otoliths present (Fig. 74C).  Some otic vesicles contained up to six small otoliths.  
In ift80 morphants many embryos had fused or only one otolith, but never more 
than two, as is the case in some bbs8 morphants.  Otolith defects were widespread 
in bbs4, bbs6, ofd1, mks1, mks3, and nphp2 morphants as well.  These results 
suggest randomisation of otolith number likely arising earlier in development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 74.  Otolith numbers in bbs8 morphants. 
A,D: normal arrangement of otoliths in an otic vesicle; one large and one small otolith as 
present in 100% of controls.  B: 43% of bbs8 otic vesicles contained fused otoliths.  C: 
35% of bbs8 otic vesicles contained only a single otolith.  Scale bar = 50µm. 
 
A B C 
D 
Normal Fused One 
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Formation of the otoliths begins at around 18hpf when kinocilia, which are 
specialised primary cilia of hair cells in the otic vesicle, entrap seeding particles, 
which cause the accretion of the otolith.  Motile cilia beating in the otic vesicle 
agitate the fluid in the otic vesicle and prevent premature formation of ectopic 
otoliths (Riley et al., 1997).  After 24hpf, these motile cilia recede, leaving the 
two bundles of kinocilia tethering the accreting otoliths and by 30hpf, the motile 
cilia are completely absent.   
 
I examined the cilia in the otic vesicle by immunostaining wholemount embryos 
with an anti-acetylated tubulin antibody.  In control embryos at 24hpf, there exist 
two discreet bundles of long kinocilia projecting into the lumen of the otic vesicle 
(Fig. 75A).  These will later become the nucleation sties of the two distinct 
otoliths.  In bbs8 morphants at this stage there do not appear to be any discreet 
bundles of kinocilia, rather all the cilia are of uniform length and are likely to be 
motile cilia (Fig. 75B).  In 27hpf controls, the motile cilia had receded and 
appeared as dots surrounding the otic vesicle.  In morphants, however, there was 
no recession of these cilia and the motile cilia appeared to persist long after they 
had disappeared in controls (Fig. 75C).  The persistence of the motile cilia in bbs8 
morphants, and the absence of the primary kinocilia, might suggest the abnormal 
numbers of otoliths observed in these morphant embryos. 
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Figure 75.  Otic vesicle cilia. 
A: in controls the otic vesicle contains many short motile cilia, which have regressed, and 
two long patches of kinocilia (arrowheads), which tether the nascent otoliths.  B: in 
morphant otic vesicles, the motile cilia remain long and there are no clear patches of 
motile cilia.  C: at 27hpf these long motile cilia persist and have failed to regress.  Scale 
bar = 50µm. 
 
Renal cysts are common to all morphants 
Renal disease, consisting of either dysplastic, hypoplastic, or cystic, kidneys is a 
common denominator of nearly all ciliopathies described, and is one of the 
hallmarks used to identify potential new ciliopathy candidates.  I aimed to see if I 
could recapitulate some of these renal phenotypes in zebrafish.  Zebrafish have 
been developed as a valid model for mutagenesis screens identifying novel genes 
causing cystogenesis in the kidney.  Amongst many genes discovered, several 
have been shown to encode bona fide ciliary proteins. 
 
MO-mediated knockdown of every one of the ten ciliopathy genes tried in this 
study caused renal cysts to develop by 3dpf.  This phenotype was most penetrant 
in ift80 morphants, where 100% of embryos developed a round cyst in the kidney, 
identical to those seen in zebrafish mutants such as double bubble and bazuka joe.  
By 5dpf, this cyst had swollen into an oedematous bulge.  The most severe renal 
phenotypes were always seen with ift80 morphants, despite their relatively mild 
phenotype at 24hpf.  All the other MOs also induced this renal oedema by 5dpf, 
although to differing degrees. 
A B 
C 
control bbs8 24hpf 
bbs8 27hpf 
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Rapamycin ameliorates cyst formation 
Rapamycin is an antiproliferative drug that has been shown to slow cyst 
progression in rodent models of polycystic kidney disease and has entered clinical 
trials for some indications in humans.  Drugs can easily be dissolved in DMSO 
and applied directly to the zebrafish’s embryo water, where they pass through the 
skin to act on their target tissues.   
 
I first tested Rapamycin on ift80 morphants as these had the most penetrant and 
extreme renal phenotype.  Because Rapamycin has never been used on the 
zebrafish to target the kidney before, I had to determine appropriate 
concentrations empirically.  I used a range of dilutions: 0, 1, 10, 100, and 
1,000nM dissolved in 1% DMSO.  In addition, I tested adding the drug at 
different stages of development: 4hpf (just before gastrulation) and 24hpf.  
Addition of the compound to control embryos produced no adverse effects at or 
below 100nM, and adding it early or later in development made no difference.   
 
Addition of between 2 and 100nM of the drug to ift80 morphants completely 
ameliorated the renal oedema by 5dpf.  The lowest dose at which at least 95% of 
embryos were rescued was 10nM, so I chose to use this dose for subsequent 
experiments.  Addition at either 4hpf or 24hpf made no difference to the outcome 
and so I chose to add the drug at 24hpf to minimise off target effects before the 
onset of kidney development.  The Rapamycin had no effect on the other affected 
tissues in the ift80 morphants: the body axis was still curled down, the heart 
oedema persisted (albeit slightly less so, presumably due to better kidney 
function), and the cranial cartilage defect persisted (Fig. 76G,G’). 
 
Because the Rapamycin was so effective on ift80 morphants, I added it to all the 
other ciliopathy morphants developed during this study.  The same effect was 
recapitulated in every morphant tried upon treatment with 10nM Rapamycin (Fig. 
76A-G’).   
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95% (n=64) of mks1 morphants had died by 5dpf without addition of Rapamycin, 
and the fry were necrotic.  At 4dpf, the embryos all had renal oedema, as did the 
few surviving embryos at 5dpf (Fig. 76F).  When Rapamycin was added at 24hpf 
only 25% of the embryos were dead at 5dpf.  None of the 75% surviving embryos 
had renal oedema – it had been ameliorated by the Rapamycin (Fig. 76F’).   
 
This increase in survival correlating with a morphological rescue of the kidney 
oedema suggests that the cystic kidney in the mks1 morphants is pathological and 
ultimately lethal, and that addition of Rapamycin might be rescuing renal function 
to ameliorate this pathology.  It is possible that the Rapamycin was rescuing 
lethality via another, unknown mechanism.  However, as with the other 
morphants, the other phenotypes, such as curved body-axis, persisted in the 
surviving morphants treated with Rapamycin, again suggesting that its effects are 
confined to the kidney. 
 
Quantifying the surface area of renal oedema in morphants showed a consistent 
increase in size without Rapamycin and this was rescued back to control levels by 
the addition of Rapamycin (Fig. 77A). 
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Figure 76.  Addition of Rapamycin to ciliopathy morphants. 
A,A’: Addition of 10nM Rapamycin has no effect on controls (* represent the swim 
bladder absent in morphants).  B-G’: renal cyst (dotted outline) is rescued by addition of 
Rapamycin in all morphants tested: bbs6, bbs8, nphp2, nphp6, mks1, ift80.  Scale bar = 
500µm. 
 
The effect of Roscovitine on the renal phenotype 
Based on the effectiveness of the Rapamycin, I extended the study to include 
other compounds with published success at restoring polycystic kidneys in rodent 
models.  Roscovitine is a CDK-inhibitor previously shown to alleviate cyst 
development in two rodent models: jck (juvenile cystic kidney, nek8 mutation) 
and cpk (congenital polycystic kidney, cystin mutation).  Continuous 
  226 
Chapter 6 – Restoration of renal function 
administration of Roscovitine is not required to yield these effects; a single dose is 
sufficient to provide long lasting arrest of cyst progression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 77.  Quantifying the size of untreated and treated morphant kidneys. 
A: in every case, addition of 10nM Rapamycin restores the size of the kidney to control 
levels.  The asterisk in mks1 morphants represents the lethality precluding measurement 
of the kidney.  B: a dose-response curve shows that addition of Roscovitine has no effect 
on controls, but reduces the size of the ift80 morphant kidney by about 50%.  
 
I tested the effect of adding Roscovitine to ift80 morphants.  There were no 
published uses of Roscovitine on zebrafish before, only its use on cultured cells as 
a cell cycle inhibitor where it was used in the micromolar range.  As such, I tested 
a range of Roscovitine concentrations: 0, 1, 10, and 100µM.  1µM had no effect 
on the embryos and 100µM caused the same effect as 10µM, so I used 10µM to 
be conservative (Fig. 77B).  Addition of the drug either before, (4hpf) or during 
A 
B 
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(6hpf), gastrulation caused massive cell death and killed the embryos before 
somitogenesis had begun.  This is not surprising as Roscovitine functions as a cell 
cycle inhibitor.   
 
Adding the Roscovitine to ift80 morphants at 24hpf did not cause any lethality.  It 
partially rescued the size of the oedematous bulge to about half the size without 
treatment.  It was not as effective at reducing the size of the oedema as 
Rapamycin and had to be used at 1,000-times the concentration.  While 
Rapamycin had no effect on the extra-renal phenotypes associated with the 
morphants, Roscovitine was able to partially rescue the size of the pericardial 
oedema in ift80 morphants (Fig. 76H).  Also, the degree of body axis curvature 
was reduced in Roscovitine treated embryos.  There is no clear explanation of 
why this should be so.   
 
Functional assays to test the therapeutic potential of these 
compounds 
The morphological rescue of the renal oedema suggested that Rapamycin was 
preventing the development of cysts in the morphants.  Mks1 knockdown caused 
lethality by 5dpf, which was rescued by Rapamycin, suggesting, not conclusively, 
that it was restoring the function of the kidney, thereby preventing death.  I next 
wanted to see if Rapamycin could restore the functional capability of the kidney 
by improving its filtering capacity.   
 
I employed a modified protocol of Hentschel et al, where it was used to quantify 
the rate of renal filtration in a model of acute renal failure induced by 
administration of the nephrotoxic antibiotic, Gentamicin.  I injected the pericardial 
cavity of embryos at 3dpf with approximately 50pg of rhodamine-labelled 10kDa 
dextran.  This perfused rapidly into the systemic circulation and within 5 minutes 
the whole embryo glowed red when viewed on a fluorescent dissecting 
microscope.  This dextran is then filtered by the glomerulus and excreted from the 
body in the urine.  The rate of filtration can be determined by measuring the 
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intensity of fluorescence in a defined region of the heart immediately after 
injection, and 24 hours post-injection (hpi).   
 
An absence, or decrease in the amount, of fluorescence in both the heart and 
peripheral vasculature indicates that the kidney has effectively removed the 
dextran.  By comparing the difference in the decrease in fluorescence over this 
time period between controls and morphants, one can evaluate how effectively the 
kidney is filtering the blood in morphants.   
 
In control embryos, most of the fluorescence is removed from the body within 24 
hours of injection of the dye (Fig. 78A,A’).  In ift80 morphants, fluorescence 
persists in the body, suggesting impaired renal function (Fig. 78B,B’).  The degree 
of kidney function can be measured by calculating the percentage of fluorescent 
intensity remaining in the heart 24hpi.  In controls, it almost vanishes (Fig. 
78C,C’).  In ift80 morphants, residual fluorescence can be seen in the heart and 
pronephric duct (Fig. 78D,D’ arrowhead).  Addition of Rapamycin reduces the 
amount of this residual fluorescence (Fig. 78E,E’).  Roscovitine also reduces the 
residual fluorescence but to a lesser extent than Rapamycin (Fig. 78F,F’). 
 
In control embryos, 9% of fluorescence persists in the heart 24 hpi; meaning 91% 
of the dextran has been removed by the kidney (some of this 9% residual 
fluorescence could in fact be background or autofluorescence).  In both ift80 and 
bbs4 morphants only about 55% of the dextran is excreted leaving residual 
fluorescence in the embryo (Fig. 78G).   
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Figure 78.  Renal function assay. 
A,A’: cardiac and systemic fluorescence 3hpi in controls.  24 hours later, the fluorescence 
has been eliminated as the dextran has been filtered out of the bloodstream.  B, B’: At 
3hpi, the amount of systemic fluorescence is comparable to controls, but it persists at 
24hpi.  C,C’: fluorescence in the heart is eliminated within 24 hours in controls.  D,D’: 
residual fluorescence persists in the morphant, particularly in the kidney where it is 
getting backed up (arrowhead). E,E’: administration of Rapamycin reduces the level of 
residual fluorescence in ift80 morphants.  F,F’: roscovitine partially ameliorates the 
kidney dysfunction but is not as effective as Rapamycin as some fluorescence persists in 
the kidney (arrowhead).  G: the percentage of fluorescent signal remaining in the heart 
24hpi was used to quantify the degree of functional impairment and restoration in ift80 
morphants.  Scale bars: A-B’ = 1mm; C-F’ = 200µm. 
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As well as causing changes to renal morphology, the ciliopathy morpholinos also 
impair renal function, and so the renal cysts are likely to be responsible for the 
impaired filtration.  Considering that Rapamycin is able to rescue the morphology, 
I next tested if it rescued the function.  To do this, I performed the same assay as 
above, but adding Rapamycin, and in separate experiments, Roscovitine, to the 
controls and morphants.  Adding Rapamycin to controls has no effect on filtering 
capacity.  When it is added to either ift80 or bbs4 morphants filtering capacity of 
the kidney is improved by roughly 2.3-fold and 3-fold respectively relative to 
vehicle treated morphants.  In other words, only about a half to one third of the 
fluorescent dextran persisted in the treated embryos 24hpi.  This effect was 
greater when the Rapamycin was added at 24hpf than when it was added at 4hpf. 
 
Roscovitine was also tested and shown to have consistent, but milder, 
amelioration of renal function.  In ift80 morphants, filtering was improved by 1.2-
fold, and in bbs4 morphants by 1.8-fold.  In the cases of both drugs, bbs4 
morphants were restored more fully than ift80.  This might be because the ift80 
renal phenotype is more severe.  Also, the Rapamycin always restored renal 
filtering capacity to a greater extent than Roscovitine, just as it also improved 
renal morphology better, suggesting that the renal cysts are directly responsible 
for impaired filtering capacity, in keeping with renal disease being the most 
common cause of premature death in ciliopathy patients. 
 
Hyperproliferation may be responsible for cyst formation 
I then turned to try to understand the cellular basis of the cyst development in 
morphant zebrafish.  In mice and humans, it is widely regarded that over-
proliferation of tubular cells, often at the expense of differentiation, is responsible 
for cyst formation.  In zebrafish, there are a few theories for why cysts form.  One 
theory is simple overproliferation, as in mammals.  Some authors have suggested 
that it is due to a lack of polarity of renal tubule cells, resulting in disrupted flow 
causing blockage.  Others have suggested that abnormal beating of cilia lining the 
tubule disrupts fluid flow and causes fluid to back up.  Yet another theory 
suggests that the lumen of the pronephric duct gets blocked.   
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It is unlikely that a single one of these causatory factors occurs in isolation; it is 
more likely that they occur in combination.  Unfortunately, the sequence of events 
is complex and difficult to elucidate.  Sullivan-Brown et al showed that over-
proliferation of cells was a secondary consequence of tubular dilation in cilia 
motility mutants.  However, they also show that knockdown of pkd2 does not 
affect cilia motility but still causes cysts by a different, uncharacterised, 
mechanism.   
 
Any of the above factors might be responsible for the cyst formation in the 
morphants studied here.  However, the fact that antiproliferative drugs, 
particularly the CDK-inhibitor Roscovitine, are able to rescue the cysts, suggests 
that they might have their origin, at least in part, in hyperproliferation.  It is 
difficult to determine conclusively whether this is the first stage of cystogenesis or 
secondary to fluid blockage, or something else.  To investigate this, I 
immunostained embryos with the mitotic marker phosphohistone 3 (PH3) at 
60hpf, before the cysts become visually palpable in wholemount.  
 
 
 
 
 
 
 
 
Figure 79.  Phosphohistone 3 immunofluorescence in morphant kidneys. 
A: PH3 staining in an uninjected kidney in transverse section shows no fluorescence in 
the pronephric duct (PD, surrounded by dotted line).  The two bright PH3-positive spots 
lateral to the ducts are probably the lateral line organs.  B: PH3 positive cells are seen 
lining the medial sides of the pronephric ducts in ift80 morphants.  Scale bar = 100µm. 
 
In ift80 morphants, there were distinct clusters of PH3-positive cells around what 
is anatomically concordant with the pronephric duct (Fig. 79A and B).  Without a 
pronephric duct specific marker to reliably identify these cells, it is hard to be 
PD PD PD PD A B 
control ift80 
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absolutely sure they are the ducts.  These cells seem to cluster around the medial 
edge of the duct and there do not appear to be any proliferating cells at the lateral 
boundaries of the ducts.  In contrast, control embryos lacked PH3-positive cells 
entirely in this region.   
 
The expression of PH3 in other regions of the embryo at this axial level were the 
same in controls and morphants, showing the effect is confined to, what appears 
to be, the pronephric duct.  PH3 expression is particularly strong in the neural tube 
where the developing nervous system is undergoing rapid expansion.  To prevent 
this region overpowering the much weaker fluorescence from the pronephric 
region I excluded it from the frame during imaging.  These data suggest, but do 
not prove, that there is excess cell proliferation in the pronephric duct of ift80 
morphants.  To prove this more conclusively, one would have to co-stain for PH3 
with a marker that specifically labelled pronephric duct cells, or use a transgenic 
expressing GFP in this tissue.  A possible marker could be the Na+/K+/ATPase. 
 
Attempts to examine activity of the mTOR pathway in zebrafish 
Rapamycin is an anti-proliferative compound that acts by inhibiting the protein 
mTOR, a central component of the mTOR pathway.  Because Rapamycin 
ameliorated cyst formation, I tried to analyse whether mTOR signalling was 
affected by knockdown of ift80.  It has been shown that TSC1 and TSC2 
(Tuberous Sclerosis 1 and 2), which are key intermediates in the mTOR pathway, 
physically interact with Polycystin, a ciliary protein whose gene is mutated in 
polycystic kidney disease.   
 
To examine the function of the pathway, I performed Western Blots to determine 
the protein level of three key pathway components: mTOR, phospho-mTOR, and 
S6-kinase.  Of the three antibodies, only mTOR gave a signal.  This is probably 
because the antibodies used were raised against mouse antigens.  There did not 
appear to be a difference in the gross level of mTOR protein in ift80 zebrafish 
lysates.  However, activation of the pathway results in phosphorylation of mTOR 
and so one expects to see an increase in phospho-mTOR.  Unfortunately, the 
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antibodies for phospho-mTOR and S6-kinase failed to work.  Also, the Western 
Blots only examined whole-embryo lysates and were not specific to the kidney, 
which represents only a small fraction of total embryonic protein.  To resolve this, 
I tried to perform immunofluorescence to detect the levels of the proteins within 
the renal cells themselves.  The antibodies failed to detect any of the proteins.  
Another method to resolve the problem is to perform Western blots on proteins 
isolated from the renal cells by flow sorting pax2a::eGFP transgenic zebrafish, 
which express GFP only in the kidney and optic nerve.   
 
Because post-translational modification is critical in mTOR signalling, in situ 
hybridisation is useless in discriminating expression levels.  As such, to resolve 
this problem one would have to either obtain anti-zebrafish specific antibodies, or 
perform the experiments on mouse tissues or cultured cells.   
 
Attempting to examine markers of renal patterning 
While some evidence suggests that pronephric duct cells of the morphants may be 
hyperproliferative, there is also a possibility that the renal tissue is mispatterned, 
which could affect filtration and therefore cause cysts to develop.  To investigate 
this I performed in situ hybridisation for two kidney markers: wt1a, which marks 
the glomerulus, and pax2a, which marks the pronephric ducts.  It is difficult to get 
a clear view of the expression pattern in wholemount, as the tissue lies deep 
within the mesoderm, underneath the yolk.  However, there were no obvious 
differences in the overall patterning of these renal tissues.   
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Figure 80.  Renal patterning markers in ift80 morphants. 
A: expression of wt1a demarcates the glomerulus (arrowheads) in controls at 56hpf.  B: 
expression of wt1a in morphants is comparable.  C: pax2 expression demarcates the 
pronephric tubules.  D: expression of pax2 in morphants is similar to controls.  Scale bar 
= 100µm. 
  235 
Chapter 6 – Restoration of renal function 
 
Discussion 
A recapitulation of human ciliopathy phenotypes in zebrafish 
The phenotypes observed in the ciliopathy morphants are a testament to how 
reliable and useful the zebrafish can be in modelling human genetic syndromes.  
Ift80 morphants show several features specific to ciliary knockdown and human 
ciliopathy.  These include: heterotaxia, down-curved body-axis, renal cysts, eye 
development abnormalities, and bbs8 morphants have stunted cilia in the KV 
(unpublished data from our lab).   
 
As mentioned earlier, the phenotypes are exaggerated in the zebrafish which has 
advantages and disadvantages: it makes screening for phenotypes easier, but on 
the other hand, it can make it harder to distinguish between toxic and artefactual 
effects, and real phenotypes.  The presence of all of the above phenotypes in a 
single embryo, clear structural abnormalities in the fish, combined with effective 
rescue of the phenotypes (bbs8 and ift80 morphants) shows that these phenotypes 
are specific and not due to toxicity or developmental delay.  This provides a 
reliable platform on which to examine the function of ciliopathy proteins. 
 
A potentially novel role for ciliopathy proteins in the development of 
the vestibular apparatus 
Several of the ciliopathy morphants had aberrant numbers of otoliths in the otic 
vesicle.  This was most evident in bbs8 morphants, where instead of two distinct 
otoliths, between one and six otoliths were present.  This seemingly random 
production of otoliths suggests a defect in their embryonic formation.  The 
number of otoliths is established by the presence of two long bunches of kinocilia 
(primary cilia) in the otic vesicle, surrounded by motile stereocilia.  Otoliths 
accrete at the end of these kinocilia, which tether them in position while they 
develop.  In bbs8 morphants, these kinocilia fail to form but the stereocilia persist.  
It is possible that the otoliths form at random, as they do not have any defined 
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nucleation or tethering point.  This likely arises due to a specific ciliary defect 
induced by loss of Bbs8.   
 
BBS patients are known to have problems with coordination and balance.  Beales 
et al (1999) wrote that many patients “complain of clumsiness, incoordination, 
and poor balance, and cite the latter as their main mobility problem, far 
outweighing the inconveniences of blindness”.  MRI scans of the cerebella of 10 
patients failed to find any structural abnormalities.  As such, it is possible that 
balance defects are due to anomalies of the vestibular apparatus.   
 
In zebrafish, the two otoliths react to gravity to maintain an upright position in the 
water – equilibrioception.  In humans, otoliths are present in the utricle and sacule 
of the inner ear.  These rest on a viscous gel layer and respond to acceleration by 
moving relative to the gel.  This induces a neural output by an unknown 
mechanism that translates into information regarding linear acceleration and 
direction of gravitational pull.  This combines with visual information to produce 
the ocular-vestibular reflex, which results in muscular responses to changes in 
body position.   
 
BBS patients have poor sight combined with possibly poor vestibular function 
resulting in malcoordination, imbalance, and poor posture.  This may be 
associated with ciliary-dependent developmental defects in the vestibular 
apparatus. 
 
Functional restoration of renal phenotypes 
Zebrafish morphants representing all the main ciliopathy genes were created and 
all developed kidney cysts, in keeping with their human and mouse counterparts.  
These cysts manifested as a small bubble in the kidney at 72hpf.  By 5dpf, this 
had massively expanded, as the body cavity became oedematous due to osmotic 
imbalance caused by impairment of renal function.  Administration of two drugs, 
shown to reduce cyst growth in mice, Rapamycin and Roscovitine, were able to 
restore the kidney back to its normal size.  Rapamycin was particularly effective.  
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Its failure to rescue other elements of the phenotype suggested a kidney-specific 
effect.   
 
These drugs were also able to restore filtering function in the kidney, evidenced 
by restored ability to excrete fluorescent dextran from the circulation.  Because 
the functional assay is quantitative, the relative efficacy of each compound can be 
evaluated.  Also, the zebrafish is amenable to toxicology studies and so poisonous 
side effects can be rapidly detected.  In the case of Rapamycin and Roscovitine, 
addition of the drugs to control embryos had no effect, suggesting no toxicity.  
This is the first study to use the zebrafish to identify drugs that can restore renal 
function.  It is also the first study to trial any drug compounds on ciliopathy 
models. 
 
The potential to extend this study to mammals 
The encouraging data from the zebrafish has prompted researchers in our 
laboratory to extend the study to mouse models of BBS.  Other useful mouse 
models to test would include: the jck mouse, which affects Nek8/Nphp8; the pcy 
mouse affecting Nphp3; and the Wistar polycystic kidney (Wpk) mouse mutant for 
Mks3.  Because the mouse models take up to several months (in the case of Bbs4 
nulls) to develop cysts, it is useful to have preliminary in vivo data on the efficacy 
of the drug on that genetic model in question.   
 
Because of the rapidity with which the zebrafish model can be screened, obtaining 
functional data in one week, compounds can enter pre-clinical testing in the 
mouse with a lower attrition rate.  This increases the likelihood of success in the 
mouse, with the possibility of identifying compounds and dosages to trial in 
human patients.  This is important to do, as currently kidney disease is the major 
cause of early mortality in ciliopathy patients and is untreatable without dialysis 
or transplantation. 
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Expanding the study to screen small-molecule libraries  
This study provides proof of principle that: 1) the zebrafish can reliably model 
human genetic disease phenotypes; 2) these phenotypes can be ameliorated by 
compounds known to work on mouse models of similar conditions; 3) functional 
restoration can be quantified with simple assays.  Using this approach, a medium-
throughput screen of several hundred candidate compounds could be employed.  
In order to scale up the operation to a high-throughput screen, more automation is 
needed.  To do this, one could use the transgenic zebrafish line, which expresses 
GFP in the kidney (Na+/K+ATPase:eGFP).   
 
If fluorescence was expanded in a cystic model due to renal expansion, one could 
automatically quantify the reduction in cyst size using a fluorescent plate reader.  
Using robotic drug dispensing, embryos grown in 96 well plates could be rapidly 
screened and several thousand compounds could be tested.  To do this one would 
need to use genetic ciliopathy mutants such as obtained from TILLING (targeting 
induced local lesions in genomes) projects.  
 
Investigating mTOR pathway signalling in ciliopathies 
At present, the aetiology of kidney cysts in humans and mice is thought to result 
from hyperproliferation, apoptosis, and dysplasia.  This is thought to rely, in part, 
on increased canonical Wnt signalling at the expense of PCP, resulting in a 
disordered, hyperproliferative, cystic kidney.  The cause of cysts in zebrafish is 
controversial and several models have been proposed, involving blockage of the 
duct, hyperproliferation, and altered cell polarity.   
 
Because Roscovitine, a CDK inhibitor, is able to rescue the zebrafish cysts, it 
suggests that the cyst is formed by hyperproliferation of cells.  What causes this 
proliferation is less clear.  Rapamycin is an antiproliferative that specifically 
inhibits mTOR to prevent overproliferation.  Overactive mTOR signalling has 
been implicated in kidney cyst formation and it interacts with the ciliary protein 
PC1.   
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Because Rapamycin is able to prevent cyst formation in the ciliopathy morphants, 
this suggests that overactive mTOR signalling is responsible.  The complete 
rescue of the cyst suggests that this is the primary cause of cystogenesis.  
Canonical Wnt signalling upregulates the mTOR pathway by inhibiting TSC2, a 
protein that normally inhibits mTOR (Inoki et al., 2006).  Inoki et al therefore 
suggested that Rapamycin could be used to treat cancers arising as a result of 
hyperactive Wnt signalling.  As such, the induction of the canonical Wnt pathway 
observed in BBS and Kif3a mutants might be responsible for activation of mTOR 
in the kidney and hyperproliferation of cells (Gerdes et al., 2007).  Future work 
will dissect the activity of the mTOR pathway in the fish and mouse kidney in 
BBS mutants to determine if this hypothesis is correct. 
 
The renal phenotype of BBS and NPHP patients is more complex and variable 
than that of AD or ARPKD patients.  In addition to cysts, the kidney is dysplastic 
and often fibrosed with connective tissue.  The calyces are often clubbed and 
lobed and the appearance of the kidney is disorganised.  Concurrently with 
activated Wnt signalling, knockdown of BBS proteins causes deficits in PCP.  
This is known to cause mispolarisation of tubular epithelial cells resulting in a 
disorganised, dysplastic kidney with inefficient filtering capacity.  It is possible 
that these two effects combined are the cause of the kidney phenotype in BBS 
patients.   
The results of these experiments were published in Pediatric Nephrology in July 
2008 (Tobin and Beales, 2008). 
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Chapter 7: Characterising the functions of the 
obesity and diabetes-related gene FTO 
 
Introduction 
The genetic component of obesity 
Obesity is one of the most serious public health problems facing the developed 
world, with 30% of the British adult population being affected, as defined by a 
BMI (body-mass index; weight divided by height squared) of over 30.  Obesity is 
associated with some serious clinical sequelae:  
• Cardiovascular disease: atherosclerosis, embolism 
• Endocrine dysfunction: polycystic ovary syndrome, infertility 
• Gastrointestinal disease: colon cancer, fatty liver syndrome 
• Kidney and liver failure 
• Back pain and immobility 
• Asthma, sleep apnoea, depression 
 
Monogenic obesity accounts for around 7% of cases, is caused by mutations in 
around 75 genes, and includes the diseases: BBS, ALMS, leptin receptor and 
melanocortin deficiencies.  In addition, 5% of obese children carry mutation in the 
melanocortin-4 receptor (MC4R), a membrane-bound receptor for the appetite-
controlling hormone melanocortin (Loos et al., 2008).  In these cases, age of onset 
of weight gain is very young, often before two years.   
 
The majority of obesity cases are not monogenic and weight gain begins later in 
life.  This has been attributed to life style factors such as overeating and being 
sedentary.  The thrifty gene hypothesis suggests that our genome has evolved to 
make the most of scarce resources in the past, when food has not been abundant.  
In our current times of plenty, these genes that once provided a survival advantage 
may predispose to obesity in a sedentary, gluttonous society. 
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Obesity is more complex than simply excess calorie intake, as the question arises 
as to why some people overeat in the first place, and why some people who eat 
moderate amounts tend to put on more weight than others.  Neurobiological 
explanations for obesity reside in the control of appetite and satiety, rooted in the 
hypothalamus.  Here, the arcuate nucleus outputs to the lateral hypothalamus 
(LH), which controls feeding, and the ventromedial hypothalamus (VMH), which 
controls satiety.  The hormone leptin is produced by adipocytes and signals an 
increase in appetite when fat reserves are low, and vice-versa.  Leptin stimulates 
the pro-opiomelanocortin (POMC) expressing neurons, which normally stimulate 
the VMH, increasing satiety and decreasing the desire to feed.  It is thought that 
obese people may be resistant to leptin signalling, meaning it takes more to satisfy 
their appetites.   
 
Studies on monozygotic twins reveal a 77% heritability of non-monogenic 
obesity, suggesting a strong genetic component to the disease.  As such, obesity is 
a complex and heterogeneous condition in which several factors, both genetic and 
environmental, contribute to the phenotype.  Over the past twenty years, 
epidemiological studies using quantitative trait loci (QTL) and genome-wide 
linkage have identified around 15 QTLs linked to obesity, but these are not 
powerful at resolving the effects of individual genes, and the sample sizes are too 
small to draw conclusions about risk factors for the population at large.   
 
Recently, genome-wide association studies have been used as an unbiased means to 
identify candidate genes predisposing to obesity in the adult population.  It is a useful 
means of generating hypotheses, which can then be tested functionally, with the ultimate 
aim of finding ways to treat, or control, obesity.  The Wellcome Trust Case Control 
Consortium (WTCCC) was set up in 2005 to undertake genome-wide association for major 
common complex diseases including: Type 1 and Type 2 diabetes, Crohn’s disease, breast 
cancer, coronary heart disease, hypertension, bipolar disorder, rheumatoid arthritis, 
multiple sclerosis, malaria, and tuberculosis (http://www.wtccc.org.uk).   
 
In each study, 500k Affymetrix chips were used to provide SNP data on 2,000 
affecteds and 3,000 healthy controls.  These chips capture about 80% of the 
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genetic variation in the human HapMap, which details all the common genetic 
variation in the human population.  Statistical analysis is then used to calculate the 
significance of the association of particular regions of the genome with the disease 
in the affected group versus the controls.  This then identifies candidate loci and 
can be used to calculate risk factors of particular SNP genotypes for the disease in 
question.   
 
The discovery of FTO as an obesity-associated gene 
The first association study carried out by the WTCCC was for type 2 diabetes 
(non-insulin dependent) and identified a group of SNPs in the first intron of a 
novel gene, FTO, associated with this disease.  After adjusting for variation in 
BMI, the association between FTO and type 2 diabetes was abolished, implying 
that FTO was actually mediating body weight, which in turn predisposes to type 2 
diabetes (Frayling et al., 2007).   
 
Since then, association of obesity with FTO has been recapitulated in Chinese, 
Korean, Japanese, Oceanic, and African populations in at least 10 additional 
studies (For review, see Loos and Bouchard, 2008).  Homozygotes for the risk 
allele had a 67% greater chance of being obese and weighed an average of 3kg 
more than individuals with no risk allele (Frayling et al., 2007).  16% of 
Europeans are homozygous for the risk allele.  These data conclude that having 
the “AA” genotype in two FTO alleles is a major factor contributing to the 
development of obesity.  The question arising is: is the FTO gene responsible for 
the obese phenotype?  If so, what is the function of FTO and how does it 
contribute to obesity? 
 
Functions of the FTO protein 
Considering the number and strength of genetic association studies linking FTO 
with obesity, very little is known about the structure or function of the FTO 
protein.  FTO is a novel gene with no homology to other known genes and no 
obvious motifs giving clues about putative function.  In wild type mice, Fto 
mRNA is most abundant in the pancreas and brain, and in particular, the region of 
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the hypothalamus regulating energy-expenditure.  Tschritter et al (2007) 
suggested that FTO may affect insulin sensitivity, as homozygous individuals 
exhibited a reduced insulin sensitivity in the brain (Tschritter et al., 2007).  
Fredriksson et al (2008) found that Fto was upregulated by 41% in the 
hypothalami of wild type rats deprived of food for 48 hours (Fredriksson et al., 
2008).  Wahlen et al (2007) showed that the level of FTO mRNA increases with 
BMI, suggesting a peripheral role for FTO protein (Wåhlén et al., 2008).   
 
Only two studies have revealed any clues about the molecular-level function of 
FTO.  Sanchez-Pulido et al (2007) used bioinformatics to place FTO as a novel 
member of the non-haem oxygenase superfamily, requiring 2-oxoglutarate and 
iron to function (Sanchez-Pulido and Andrade-Navarro, 2007).  Other members of 
this family, such as hypoxia-inducible factors (HIFs), function as metabolic 
sensors and nuclear effectors in response to low oxygen.   
 
Gerken et al (2007) used bioinformatics to reach the same conclusion as Sanchez-
Pulido’s study.  They also performed a biochemical assay to show that 
recombinant FTO protein could demethylate single-stranded DNA in a Fe2+ and 
2-oxoglutarate dependent manner (Gerken et al., 2007).  They demonstrated a 
nuclear localisation of recombinant FTO and that its mRNA in mice was 
expressed in the arcuate nucleus of the hypothalamus and was regulated in 
response to feeding and fasting.  They suggested that FTO alters DNA 
methylation status, which somehow regulates energy balance and fat storage. 
 
The Fused toes mutant mouse 
Before its discovery as an obesity-associated gene, Fto was known as one of six 
genes deleted in the Fused toes (Ft) spontaneous mouse mutant.  Ft was first 
identified in 1994 as a dominant mutation causing fusion of the toes, thymic 
hyperplasia, and random body situs (van der Hoeven et al., 1994).  It was 
generated serendipitously during the integration of a retroviral transgene into the 
mouse genome.  Homozygous Ft embryos die at midgestation with craniofacial 
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defects, polydactyly, ventral neural tube defects, and random left-right 
asymmetry. 
 
In 1999, Peters et al cloned the Fatso gene (Fto) from the Ft mutant and showed 
that Fto had a predicted mass of 58kDa but had no motifs indicating putative 
function (Peters et al., 1999).  They ascribed the function of Fto to control of left-
right asymmetry and craniofacial development.  In 2002, Peters et al showed that 
Fto was part of a 1.6Mb region comprising six genes deleted in Ft: Fto, Ftm, Fts, 
Irx3, Irx5, and Irx6 (Peters et al., 2002).  Gotz et al (2005) ascribed the lack of 
ventral cell types in the Ft neural tube to a loss of Shh signalling (Götz et al., 
2005).   
 
In 2007, Anselme et al described how anteroposterior and dorsoventral patterning 
of the Ft brain was affected, and that these were the likely cause of the 
craniofacial deformities including small eyes, hypoplastic facial features, and 
anterior neural tube closure defects (Anselme et al., 2007).  They also showed that 
cranial neural crest cell migration was delayed in Ft embryos and the branchial 
arches were smaller. 
 
The problem with studying protein function in the Fused toes mouse is that six 
genes are deleted, so attributing function to any one gene is problematic and 
exacerbated by the possibility of genetic interactions and epistasis amongst the six 
genes.  This is likely given the fact that the Ft heterozygotes also display a 
phenotype, whereas mice heterozygous for individual genes from the Ft interval 
are not phenotypic.   
 
Reasons for considering  Fto as a candidate ciliary-associated 
protein 
Vierkotten et al (2007) generated an Ftm knockout mouse.  They showed that 
homozygotes had polydactyly, neural tube patterning defects, left-right 
asymmetry defects, and the ratio of activator to repressor Gli3 was affected.  
Ftm+/- embryos were unaffected.  They localised Ftm to the basal body of cilia 
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and suggested it was a novel ciliary protein involved in Shh signalling.  Mutations 
in RPGRIP1L, the human homologue of Ftm, were found in patients with Joubert 
and Meckel syndromes, and the RPGRIP1L protein interacted with NPHP4 and 
NPHP6 (Arts et al., 2007).  This firmly established Ftm as a ciliopathy protein. 
 
Ftm and Fto are adjacent on chromosome 8 in mice and chromosome 16 in 
humans, and are transcribed in opposite directions.  Stratigopoulos et al (2008) 
examined the expression of Fto and Ftm in several obese mouse mutants such as 
Tubby and Obese.  They showed Fto and Ftm expression was indistinguishable in 
response to under or over feeding, and hypothermia (Stratigopoulos et al., 2008).  
They suggested that the two genes were therefore coregulated.  The overlapping 
putative regulatory region between the two genes contained binding sites for 
Cutl1, a gene product with a SNP associated with human obesity.  Knockdown of 
CUTL1 in human fibroblasts dramatically downregulated both FTO and FTM 
(Ibid.).   
 
Because the Ft heterozygotes have phenotypes reminiscent of Ftm homozygous 
nulls, it is possible that Fto and Ftm interact, as haploinsufficiency of both genes 
is sufficient to give the phenotype.  The similarity between phenotypes, regulatory 
mechanism, and chromosomal position of FTO and FTM, hint at the fact that 
FTO, like FTM, might play a role in the cilium. 
 
Aims of this project 
Alleles of FTO predispose to obesity in the population at large, while null 
mutations in the mouse might give phenotypes reminiscent of ciliopathy including 
craniofacial dysmorphology, polydactyly, situs inversus, and Shh signalling 
defects.  Obesity is a major feature in several ciliopathy nulls (BBS and ALMS).  
I aimed to test whether Fto might have a role in ciliary biology by performing the 
following experiments: 
 
1) Generate a zebrafish model of fto knockdown.  Because there are common 
phenotypes associated with ciliary protein knock-down in zebrafish, 
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including: convergent-extension defect, down-turned body axis, otolith 
defects, kidney cysts, and laterality defects, it is possible to get a clue 
about whether a gene product is involved with cilium function. 
2) Investigate the localisation of Fto in ciliated cells in vitro and in vivo. 
3) Test pancreatic function and development in fto morphants 
4) Examine signalling pathway activity in fto morphants 
5) Test to see if there is a genetic interaction between fto and ftm in vivo.   
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Results 
Fto morphant zebrafish show some characteristics of ciliopathy 
To determine the possible cellular functions for the FTO protein, I generated a 
zebrafish morphant model and designed MOs against translation and splice sites 
(see Appendix 2 for MO sequences).  The splice-blocking MO gave a phenotype 
at 24hpf showed the common convergent-extension defect ubiquitously associated 
with ciliopathy knockdowns (Fig. 81A,B).  The embryos had a down-curved body 
axis with squashed somites.  Examination at 48hpf showed that this down-curved 
axis persisted and the embryos did not show any signs of MO-induced toxicity 
(Fig. 81C,D).   
 
Because the SNP in FTO associated with obesity is of unknown function, I next 
tested the effect of over-expression of the protein to explore the possibility that 
this might result in phenotypes.  Consistent with many of the ciliopathy proteins, 
over-expression of Fto with 200pg of zebrafish mRNA amplified from a cDNA 
library, phenocopied the knockdown phenotype (Fig. 81E,F).  This included the 
CE defect and flattened somites.  The body axis was distorted in a manner very 
similar to the knockdown situation.  Injection of 50pg or 100pg of mRNA caused 
no phenotype suggesting that a high degree of over-expression is necessary to 
induce the morphological phenotype.  To test if the effect of the mRNA and MO 
were specific, I co-injected 4ng of the splice-blocking MO with 100pg of 
zebrafish fto mRNA and saw complete rescue of the phenotype (Fig. 81G).  This 
confirmed specificity of both mRNA and MO, and that the observed phenotypes 
were real effects. 
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Figure 81.  fto morphant phenotypes. 
A: control embryos at 24hpf.  B: fto morphant embryos have a convergent extension 
defect, squashed somites, and a down-curved tail.  C,D: at 48hpf morphants have a 
curved body-axis.  E: injection of 100pg of Fto mRNA has no effect on morphology.  F: 
200pg Fto mRNA yields a similar phenotype to the morphant.  G: co-injection of the MO 
with 100pg mRNA rescued the morphant phenotype. 
 
A B 
E F 
G 
control fto MO 
Fto mRNA 100pg Fto mRNA 200pg 
MO + Fto mRNA 100pg 
C 
control 48hpf 
D 
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At 5dpf, both ATG and splice-blocking morphant embryos showed more signs of 
ciliary features: the kidney was oedematous and swollen like other ciliopathy 
models (Fig. 82A-E).  More tellingly, otic vesicles frequently contained a single 
otolith, a defect often prescribed to aberrant cilia form or function (Fig. 84F,G).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 82.  Phenotypes of fto morphants at 5dpf 
A: control embryos at 5dpf.  B,C: both ATG and splice-blocking MOs produced renal 
oedema.  D: close-up of the kidney of fto ATG MO.  E: swelling of the pronephric duct 
of fto splice-block morphants.  F: presence of a single otolith in the otic vesicle of 
morphants.  G: close-up of morphant otic vesicle showing fused otoliths. 
 
Despite these phenotypes, the structure of the cilia lining the pronephric duct 
appeared grossly normal in fto morphants (Figure 83).  
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Figure 83.  Pronephric cilia in fto morphants. 
Cilia in fto morphant pronephric ducts at 27hpf appear grossly similar to controls.  Scale 
bar = 50µm. 
 
I next performed in situ hybridisation for southpaw to see if laterality was affected 
in morphants.  At 15ss, spaw expression was left-sided in 100% of controls 
(n=35) (Figure 84).  Using the ATG-blocking MO, spaw expression was left-sided 
in 80% (n=35) of embryos while 1% of embryos showed right-sided expression 
and 19% were bilateral.  In splice-blocking morphants, 64% (n=50) of embryos 
had left-sided expression of spaw, 4% were right-sided and 32% were bilateral 
(Figure 84).  These figures are comparable to the degree of laterality abnormality 
associated with bbs and ift80 morphants.   
 
Bilateral expression of spaw suggests complete randomisation of body situs, 
whilst right-sided expression suggests, but does not prove, reversal of ciliary 
beating and therefore interpretation of the signal is reversed.  Because bilateral 
expression is much more common than inverted expression, it is possible that 
there is disorganised or reduced ciliary beating in the Kupffer’s Vesicle (KV) in 
these morphants.  There was no change to the gross structure of the KV cilia in 
morphants compared to wild types (not shown), but it is possible that their 
function is affected.  While these phenotypes are suggestive of ciliary 
involvement, phenocopy of ciliary-like phenotypes is not conclusive proof that the 
protein is involved in ciliary function.   
 
 
 
 
 
A 
B 
control 
fto 
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Figure 84.  spaw localisation in fto morphant embryos. 
In controls, all embryos had left-sided expression of spaw.  In both ATG and splice-
blocking MOs, there was significant mislocalisation of spaw expression, suggesting 
incomplete randomisation of laterality and heterotaxia. 
 
Fto protein localises to the nucleus in cultured cells and in zebrafish 
embryos, but to the basal body in cultured cells 
The zebrafish phenotypic analysis suggests a possible role in ciliary function.  To 
see if Fto protein localised to the cilium, I injected Myc-tagged fto mRNA into 
one-cell stage zebrafish embryos and examined the localisation of the tagged 
protein at gastrulation stage (5hpf), because the sheet of cells on the top of the 
animal pole is easy to visualise.  In all cells, the Fto protein localised clearly to the 
nucleus and there was no cytoplasmic, basal body, or ciliary localisation observed.  
Nuclear localisation was expected, given the later report (Sanchez-Pulido et al., 
2007) that the protein contains a bipartite nuclear localisation signal (Figure 85). 
 
 
 
 
 
Side of spaw expression 
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Figure 85.  Fto protein localisation in zebrafish embryos. 
GFP-tagged Dvl protein is visualised in green and Myc-tagged Fto (in red) shows nuclear 
localisation in gastrula stage (5hpf) zebrafish embryos.  Scale bar = 10µm. 
 
To extend these studies, another person in the lab transfected ciliated 3T3 and 
IMCD3 cultured cells with a Myc-tagged mouse FTO construct.  Here, the FTO 
protein colocalised with gamma-tubulin, indicating a basal body and centrosomal 
localisation.  It is unclear why the localisation data differed between the zebrafish 
and cultured cells.  One explanation could be the rare, but misleading, 
mislocalisation of tagged proteins to the basal body, where they are sequestered 
by gamma- or acetylated-tubulin.   
 
Shh signalling is not affected in Fto morphants 
The data suggested that FTO might be a nuclear and possibly a ciliary protein.  
Because the bbs and ift80 morphants tested previously had Shh signalling defects, 
and given the fact that fused toes mouse mutants have polydactyly and mid-facial 
anomalies, I tested this in FTO morphants by in situ hybridisation of ptc1 mRNA.  
This revealed no change in expression compared to controls and gave a rough 
indication that Shh signalling was not affected in fto morphants (Figure 86).   
 
Dvl-GFP  Fto-Myc 
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Figure 86.  ptc1 expression in fto morphants. 
ptc1 expression is comparable in control and fto morphants. 
 
Glucose homeostasis may be disrupted in Fto morphants 
In addition to obesity, genome-wide association studies have connected FTO with 
Type II diabetes.  FTO is expressed in many tissues, but is at the highest levels in 
the brain and pancreatic islets cells, including insulin-secreting β-cells.  To test 
the expression of endogenous protein in pancreatic cells, I raised a proprietary 
polyclonal antibody (Sigma, UK) to detect FTO protein in cultured mammalian 
cells raised against two peptides; N-terminal and C-terminal, common to both 
human and mouse sequences.  This antibody failed to yield any signal when tested 
on human or mouse cells for either Western Blot or immunocytochemistry. 
 
Given the possible role for FTO in ciliary function, its expression in pancreatic 
cells, association with diabetes, and the known importance for cilia in pancreas 
development and function, I next tested the glucose homeostasis of fto morphants.  
To do this, I adapted the protocol of Elo et al (2007) where they used zebrafish 
larvae to test anti-diabetic compounds on models of glucose metabolism.  By 
4dpf, larval zebrafish begin to run out of nutrition supplied by the yolk and so 
model the effects of starvation and therefore hypoglycaemia.   
 
Addition of 40mM of glucose at 4dpf to embryonic water results in the 
upregulation of the pre-pro-insulin gene, insa, to induce glycogenesis.  
Concomitantly, embryos downregulate the gene encoding Phosphoenolpyruvate 
carboxykinase (PEPCK), an enzyme essential for gluconeogenesis, which 
control fto 
ptc1 
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converts oxaloacetate into phosphoenolpyruvate and carbon dioxide.  The 
expression level of these genes was determined 24 hours later in 5dpf larval 
zebrafish by quantitative real-time PCR performed in triplicate using cDNA 
generated from mRNA extracted from 10 embryos per batch. 
 
I performed three repeat experiments using triplicate batches of embryos, testing 
glucose concentrations of 40mM and 100mM.  The results were slightly variable 
because, in the first run, the control embryos showed no response to glucose 
stimulation.  However, I repeated the experiment dissolving the glucose in 1% 
DMSO in case it had failed to enter into the zebrafish tissue.  In this case, addition 
of 40mM glucose caused a 2.5-fold increase in insa expression.  Addition of 
100mM glucose caused a 1.5-fold increase in insa expression but had deleterious 
effects on the morphology of the embryo, particularly the morphants.  Addition of 
40mM glucose had no effect on insa expression in fto morphants, while the 
relative expression of insa, normalised to β-actin expression levels, was similar to 
controls (Fig. 87A).  gapdh was not used to normalise expression levels as it is a 
metabolically regulated gene.   
 
Adding glucose to controls reduced pepck expression to 20% of the unstimulated 
level (1% DMSO alone), presumably as a result of less gluconeogenesis.  In 
morphants, relative pepck expression was reduced to around 70% of control levels 
in unstimulated embryos, possibly indicating lower metabolic activity.  
Stimulation with glucose did not cause downregulation of pepck expression; 
rather, it was slightly upregulated, although this change is unlikely to be 
biologically significant (Fig. 87B).  This supports the insa expression data 
suggesting that glucose homeostasis is aberrant in fto morphant zebrafish.   
 
 
 
 
 
 
 
  255 
Chapter 7 – Functions of FTO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 87.  Glucose responsiveness assay in fto morphants. 
A: addition of glucose to control embryos stimulated the expression of insa by 2.5-fold.  
This upregulation failed to take place in fto morphants.  B: pepck was downregulated in 
controls upon addition of glucose.  This downregulation did not occur in fto morphants. 
 
These results must be interpreted cautiously, as morphant embryos show a very 
strong phenotype by 4dpf, including renal oedema, probably resulting in impaired 
function.  The general ill health of the embryos might be a contributory factor in 
their lack of cellular response to glucose stimulation.  However, the results of 
these experiments have led to studies on insulin secretion and response performed 
on RNAi models in cultured mouse pancreatic β-cells.  As yet, a mouse model for 
FTO knockout has not been published and so the cultured cells are a substitute 
system. 
 
To investigate the zebrafish phenotype further, I attempted to visualise the size 
and shape of the pancreas by in situ hybridisation using the markers insa for the 
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mature pancreas and pdx1 as a marker of early, presumptive pancreas.  
Unfortunately, no reliable data was obtained from these studies as the probes 
failed to hybridise specifically to the pancreas in several, repeated attempts, 
despite published examples of their efficacy. 
 
Investigating potential involvement of Fto with the non-canonical 
Wnt pathway 
Fto morphants show the CE-defect reminiscent of several ciliopathy morphants 
showed to be important in non-canonical Wnt signalling.  Non-canonical Wnt 
signalling is important for the development of vertebrate islet cells in the 
pancreas.  Disruption of TCF7L2, a downstream transcription factor in the Wnt 
pathway, is highly associated with Type II diabetes and obesity in human 
genome-wide studies.  Considering these facts, I decided to try to determine if Fto 
was involved in non-canonical Wnt signalling.  Despite the published finding that 
type 2 diabetes in humans appears to be secondary to obesity, strong and specific 
expression of FTO in the pancreas suggests it is having a role here. 
 
To do this, I took advantage of the fact that over-expression of Frizzled-7 (Fz7), a 
seven-pass transmembrane receptor of Wnt ligands, induces a change in 
localisation of Dishevelled from the cytoplasm to the plasma membrane.  I 
performed analyses on gastrula-stage embryos, because non-canonical Wnt 
signalling is important during gastrulation and the cells are easy to visualise at this 
stage.  
 
Injection of 100pg fz7 mRNA induced the membrane localisation of GFP-tagged 
Dishevelled.  To see if this response was affected by expression of fto I co-
injected 50pg Myc-tagged fto mRNA, 100pg fz7 mRNA, and 100pg Dvl-GFP 
mRNA.  I then visualised the localisation of Dishevelled by confocal microscopy.  
When Dvl-GFP and Fz7 mRNA were co-injected, Dvl localised at the plasma 
membranes of 5hpf zebrafish cells due to induction of the non-canonical Wnt 
pathway by Fz7 (Fig. 88A).  When these constructs were injected alongside a 
Myc-tagged fto mRNA, the Dvl became more diffusely cytoplasmic, and less 
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strongly expressed at the plasma membranes (Fig. 88B).  Fto protein could be 
detected in the nuclei.  This suggested that over-expression of Fto induced the 
canonical Wnt pathway at the expense of PCP, consistent with the CE defect seen 
in Fto over-expressing embryos.  However, this assay is crude and may not be 
sensitive enough to reveal subtle effects on the signalling pathway.  However, 
knock down of fto failed to affect the subcellular localisation of Dvl-GFP in the 
absence of Fz7. 
 
 
 
 
 
 
 
 
 
Figure 88.  Dishevelled localisation upon Fto over-expression. 
A: co-injection of fz7 and dvl-GFP mRNA caused membranous localisation of Dvl-GFP.  
B: co-injecting these constructs with myc-tagged Fto mRNA showed nuclear localisation 
of Fto and more cytoplasmic localisation of Dvl-GFP.  Scale bar = 10µm. 
 
An epistatic relationship between Fto and Ftm 
Ftm is a gene directly adjacent to Fto in the 1.6Mb interval containing the six 
genes deleted in the fused toes mouse mutant.  Ftm (Rpgrip1L) is a bona fide 
ciliary protein, localising to the basal body.  Mouse mutants have laterality, limb, 
and neural tube defects.  Ftm plays a role in Shh signalling by regulating the 
processing of Gli3, just like other ciliary and IFT proteins.  Fused toes 
homozygous mutants die during gestation but the heterozygote embryos survive 
and show similar phenotypes to the Ftm null, suggesting that Ftm might be the 
major contributor to the phenotype.  However, Peters et al (1999) found that 
expression of Fto was absent in fused toes homozygous mutants and concluded 
that this gene was the major contributor.  
 
A B 
Dvl-GFP + Fz7 Dvl-GFP + Fz7 + Fto-Myc 
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Ftm is transcribed in the opposite direction to Fto and it has been suggested that 
the intronic SNPs in Fto associated with increased fat mass might regulate the 
expression of Ftm.  These intronic SNPs are of unknown function, but it is 
feasible that they may alter splicing and it is known from work in our lab that 
there exist both long and short isoform in humans, which are differentially 
expressed in the brain and pancreas (our unpublished data).  Given the clues that 
Fto might be involved with ciliary function, Ftm’s ciliary localisation, FTM 
mutation causing Joubert syndrome, and the chromosomal proximity of Fto and 
Ftm, I aimed to test if there was any interaction between the two genes, to see if 
they functioned in the same pathway.   
 
To do this, I performed double injections of fto and ftm MOs.  A range of MO 
concentrations were tested, each time quantifying the percentage of embryos with 
a morphological phenotype consisting of a shortened body axis at 24hpf. Injection 
of 1.5ng of each MO individually caused no phenotype in any of the embryos 
(Fig. 89A,B).  Injecting 4ng of either fto or ftm MO caused severe shortening and 
downward curvature of the body axis in both cases (Fig. 89C,D).  Ftm morphants 
were more severely affected, with misshapen, flattened somites, and a malformed 
head.  
 
 
 
 
 
 
 
 
 
 
Figure 89.  Co-injection of fto and ftm MOs. 
A,B: injection of 1.5ng of fto and ftm had no observable phenotype.  C,D: 4ng of either 
MO caused a severe phenotype.  E,E’,E’’: co-injection of 1.5ng of fto and ftm MOs 
caused a severe phenotype reminiscent of the 4ng single MO injections.  Scale bar = 
500µm. 
fto MO 1.5ng 
Ftm 1.5ng 
fto 1.5ng + ftm 1.5ng 
ftm MO 1.5ng 
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When 1.5ng of each MO were co-injected, embryos exhibited the downward 
curved body axis and widened somites of the individual morphants (Fig. 
89E,E’,E’’).  The phenotype more closely resembled the fto single morphants, as 
the head patterning was not affected and the somites and yolk stalk were not as 
misshapen.  These data suggest that fto and ftm function in the same pathway and 
that Ftm might lie upstream of Fto as the double knockdown revealed the fto 
phenotype. 
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Discussion 
Functional characterisation of Fto 
FTO is the first gene to be identified as a potential cause of complex obesity in the 
general population.  While the genetic association between an intronic SNP in 
FTO and increased fat mass and type 2 diabetes is unquestionable, the function of 
the FTO protein is less well characterised.  Evidence suggests that it functions in 
DNA methylation, but how this influences fat deposition is unknown.  Its 
expression in the satiety centre of the brain and pancreas suggests that it could 
serve to regulate appetite or energy metabolism, but it could function in the 
pancreas to regulate insulin secretion.  It is possible, but unlikely, that it can cause 
obesity by all three mechanisms.  
 
The effect of the intronic SNP on protein function is also not known.  It could 
affect splicing of the protein as is the case for TCF7L2 (Douglas et al., 2001).  It is 
likely that any alteration to the peptide will cause a loss of function to the protein, 
evidenced by homozygotes being more severely affected than heterozygotes for 
the SNP.   
 
No in vivo data exist on the function of FTO, but clues can be derived from the Ft 
mutant mouse and other data, which suggest possible co-regulation with the 
adjacent Ftm gene, a bona fide ciliary gene involved in Shh signalling.  Because 
genetic changes in an intronic SNP are difficult to model in vivo, I took a simple 
approach and used the zebrafish to produce both gain- and loss-of-function fto 
models.  Both loss- and gain-of-function models produced a phenotype, but the 
morphant phenotype was more severe, suggesting that fto is important in 
development.  Human Fto mRNA was able to fully rescue the morphant 
phenotype. 
 
The localisation studies on zebrafish showed a ciliary localisation of Fto in 
gastrula stage embryos.  However, the tagged protein localised to the basal body 
in the ciliated cell lines 3T3 and IMCD3.  It is known that some tagged proteins 
artefactually localise to the basal body and so this data may be spurious.  We 
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produced a proprietary Fto antibody to recognise mouse and human epitopes and 
it will be important to characterise sub-cellular localisation in mammalian cells 
and tissues.   
 
FTO is associated with type 2 diabetes, in which the body is insulin-resistant.  It is 
possible that this is secondary to obesity, wherein the body over-produces insulin 
in a response to overeating after which the receptive cells become progressively 
less responsive to it.  The best way to manage this type of diabetes is through 
dietary control, as administration of exogenous insulin is ineffectual.   
 
To test if fto morphants had defects in glucose homeostasis, I treated 4dpf 
embryos with glucose adapting the protocol of (Elo et al., 2007).  In controls, this 
resulted in the upregulation of the preproinsulin gene and the downregulation of 
pepck.  fto morphants failed to respond to glucose treatment, suggesting a defect 
in glucose homeostasis, or at least transcriptional response to glucose stimuli.  
Baseline levels of preproinsulin were unaffected, suggesting there was not a 
problem with pancreatic production of insulin.  To test if this was due to a 
defective pancreas, I tried to examine expression of pancreatic markers but failed 
to get reliable data. 
 
Upregulation of the preproinsulin gene in response to glucose is a long-term 
effect.  What normally happens in physiological conditions is that insulin self-
cleaves and is secreted from cells in response to the hypothalamic detection of 
increased blood glucose concentration.  Measuring serum insulin levels in 
zebrafish embryos is almost impossible, and so to do this a mouse model, or at 
least a cell line, would be used.  In the absence of a mouse model, a member of 
our lab has used siRNA to knockdown Fto in a pancreatic β-cell line.  Glucose is 
then added to the cells and insulin secretion measured by ELISA.  At the time of 
writing, no data were available from these experiments, but it will be interesting 
to see if Fto knockdown affects pancreas function. 
 
The Wnt pathway is known to play an important role in pancreatic development.  
Canonical Wnt signalling induces proliferation of islet cells (Rulifson et al., 
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2007).  Conditional expression of Axin3, a potent inhibitor of canonical Wnt 
signalling in β-cells, resulted in a reduction of insulin production.  Kim et al 
(2005) showed that knockdown of wnt5a, a non-canonical Wnt ligand, and fz-2 – 
a noncanonical pathway receptor, both yielded hypoplastic pancreas because of 
impaired cell migration (Kim et al., 2005).  Wnt5a-/- also had reduced pancreatic 
mass. 
 
In light of this, I tried to see if Fto perturbed canonical Wnt signalling in a 
Frizzled-dependent manner.  Overexpression of myc-tagged Fto protein abrogated 
the membrane localisation of Dvl in response to Fz7.  This suggests that 
overexpression of Fto is capable of inhibiting the non-canonical Wnt pathway.  To 
test to see if there is an interaction between FTO and the non-canonical Wnt 
pathway in development, fto MO could be injected at sub-phenotypic doses into 
PCP mutant zebrafish embryos, such as trilobite and strabismus, to see if this 
enhanced the mutant phenotype.  A similar approach was carried out by Ross et al 
(2005) to show a genetic interaction between bbs4 and the PCP pathway.  This 
has also been used to demonstrate genetic interactions between ciliopathy genes 
such as bbs1, bbs4, bbs6, and bbs8 (H. May-Simera, thesis) with the PCP pathway 
(Gerdes et al., 2007).  
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Chapter 8: Determining the functional importance of 
the interaction between ACAT1 and BBS1 
 
Introduction 
The association of a metabolic enzyme and BBS1 in C. elegans fat 
storage 
Obesity is the most persistent feature of BBS, yet its molecular aetiology is 
unknown.  Understanding the mechanism of lipid accumulation in monogenic 
diseases will be informative about non-syndromic obesity prevalent in the 
population in general, whose basis is complex and under the control of many loci.   
 
Mak et al (2006) performed a screen for mutants which enhanced the fat 
accumulation phenotype of the nematode orthologue of Tubby, a mouse mutant 
with BBS and ciliopathy-like features: obesity, retinal degeneration, and hearing 
loss (Mak et al., 2006).  They proved that this increase in lipid accumulation was 
not due to reduced movement, reproduction, or increased food consumption or 
retention.   
 
They isolated a single gene that consistently enhanced lipid accumulation and 
found it to encode a 3-ketoacyl-coA thiolase (encoded by kat-1), a conserved 
member of the mitochondrial fatty acid β-oxidation pathway.  Tub-1 or kat-1 
single mutants both showed 50-100% increase in fat accumulation relative to wild 
types.  However, double knockout enhanced fat accumulation to 9-times wild type 
levels, indicating a genetic interaction, or synergism.  They then showed that kat-1 
activity, in the gut in particular, contributed to lipid accumulation and suggested 
that tub-1 function in ciliated neurons was controlling the release of a 
neuroendocrine signal regulating fat storage in the gut. 
 
They then performed another screen for mutants that enhanced the kat-1 single 
mutant phenotype, and isolated bbs-1.  They narrowed down the site of control of 
lipid accumulation to a subset of 15 out of the total 60 ciliated neurons in C. 
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elegans, possibly linked to these neurons’ requirement in sensation of external and 
internal nutrient level and their control of the β-oxidation pathway. 
 
β-oxidation is the biochemical process by which fats are broken down into acetyl-
coenzyme A molecules, the entry molecule for the Krebs cycle.  β-oxidation takes 
place in the peroxisome or mitochondria and occurs via four recurring steps: 1) 
the fatty acid is oxidised by a dehydrogenase; 2) the newly formed double bond is 
hydrated, forming a hydroxyl group; 3) this new hydroxyl group is oxidised by 
NAD+ to form a ketone group; 4) a thiol group (containing sulphur) is inserted 
between two acetyl groups to yield two molecules of acetyl coA.  The last step is 
catalysed by the β-ketothiolase encoded by kat-1. 
 
The human orthologue of kat-1 is ACAT1 (acetyl coA thiolase, also called T2) and 
has 41% identity with the C. elegans sequence at the protein level.  Mutations in 
ACAT1 cause 3-ketothiolase deficiency, a rare autosomal disease affecting only 
50-60 patients worldwide.  It manifests clinically with dehydration, tiredness, 
seizures, ketoacedosis, damage to the CNS, and possibly coma.  Mutations in 
humans do not cause obesity but lead to accumulation of ketones (ketoacedosis) in 
the bloodstream when fats are broken down.  As such, it is intriguing that 
mutations in this gene should modulate the severity of the fat accumulation in 
ciliopathy-derived obesity. 
 
Testing the association in BBS patients 
Mak et al showed that kat-1 genetically interacted with several obesity-related 
ciliary genes, particularly bbs-1.  In light of this, scientists from our group tested 
if there were changes in ACAT1 in patients with BBS1 mutations, common in the 
Caucasian cohort and accounting for approximately 20% of all BBS patients.  
They found a highly significant over-representation of a non-synonymous SNP 
resulting in an alanine to proline substitution at amino acid position 5 (A5P).  This 
is present at a frequency of around 20% in BBS1 mutant patients, compared with 
5% in the general population.   
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Collaborators at Johns Hopkins University repeated this screen for the other BBS 
genes and found similar over-representations of the ACAT1 SNP (unpublished 
data).  This increase in allele frequency amongst BBS patients is too great to be 
due to chance and so is likely to have some functional relevance modifying 
obesity presentation, as it did in C. elegans.  
 
The aims of this study 
Given the functional epistatic relationship between bbs-1 and kat-1 in C. elegans, 
and the genetic association in humans, I wanted to test if the A5P substitution had 
an effect on protein function by modelling the mutation in the zebrafish.  Japanese 
collaborators tested the enzymatic activity of the mutant protein and showed it not 
to be affected in in vitro assays.  This may be because the substitution occurs well 
outside of the catalytic domain.  A member of our lab also showed that tagged 
mutant protein still localised to the mitochondria like the wild type protein, but the 
data was not fully conclusive due to indistinct staining and high levels of 
background immunofluorescence.  
 
I aimed to perform the following experiments: 
1) Test whether acat1 and bbs1 interact in the zebrafish 
2) Test whether the mutant allele of ACAT1 could rescue the morphant phenotype 
 
Results 
ACAT1 and BBS1 genetically interact in the zebrafish 
Mak et al (2006) showed that kat-1 and bbs-1 functionally interacted in C. 
elegans.  The human orthologue of kat-1 is ACAT1, acetyl co-enzyme A 
transferase 1 (also called acetyl coA thiolase T2).  Sequence analysis performed in 
our laboratory identified a non-synonymous SNP in the human ACAT1 gene 
highly over-represented in patients with BBS1 null mutations (20% vs 5% in 
controls).   
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To see if this association between BBS1 and ACAT1 had functional consequences, 
I performed double knock-down experiments in the zebrafish and assessed the 
severity of the phenotypes by counting the number of embryos morphologically 
normal, with a CE defect (phenotype), or dead.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 90.  acat1/bbs1 MO double injections. 
A: control embryo at 24hpf.  B: 8ng bbs1 MO yields a mild phenotype with 43% of 
embryos affected.  C: 16ng bbs1 MO gives a more severe CE defect and a higher 
percentage (89%) are affected.  D: 1ng acat1 MO gives a moderate phenotype, 13% of 
embryos are affected.  E: 2ng acat1 MO gives a severe phenotype with 45% affected.  F: 
co-injection of the lower doses of bbs1 and acat1 MOs gives a synergistic phenotype with 
93% of embryos affected and the phenotype is much more severe than either MO alone.  
G: injecting 8ng bbs1 MO with 2ng acat1 MO gives an extremely strong phenotype 
where the tail fails to extend at all.  H: graph quantifying the effects of the MOs showing 
that the double injection demonstrates an interaction between the two genes. 
control bbs1 MO 8ng bbs1 MO 16ng 
acat1 MO 1ng 
bbs1 8ng acat1 1ng 
1ng 
acat1 MO 2ng 
bbs1 8ng acat1 2ng 
A B C 
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H 
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In controls, 96% of embryos were normal at 24hpf and 4% were dead (n=47) (Fig. 
90A,H).  Injection of 8ng or 16ng of bbs1 MO led to 43% (n=28) and 89% (n=36) 
respectively of embryos showing a phenotype or being dead (Fig. 90B,C,H).  
Injection of 1ng acat1 MO caused 13% (n=48) of embryos to be affected (dead or 
phenotype) (Fig. 90D,H).  Co-injection of 8ng bbs1 MO with 1ng acat1 MO led 
to 93% of embryos being affected (Fig. 90F,H).  If these effects were additive one 
would expect approximately 57% of embryos to be affected by the co-injection.  
The fact that 93% were affected suggests that the two genes function 
synergistically to give a multiplicative effect.  These data suggests that Bbs1 and 
Acat1 functionally interact in an unknown cellular process.   
 
The obesity-related SNP in ACAT1 fails to rescue acat1 knockdown 
I next wanted to test if the SNP found in the human gene affected the function of 
the protein.  To do this I generated a wild type and mutant human constructs and 
used these to create wild type and mutant mRNA.  I then injected these into 
zebrafish acat1 morphants and tested the potential of each transcript to rescue the 
acat1 morphant phenotype.  
 
Knocking down acat1 with 2ng of MO resulted in 96% of embryos being either 
phenotypic or dead (Fig. 91A).  100pg of wild type mRNA was insufficient to 
rescue this, but co-injection with 200pg reduced the number of affected embryos 
to 63% and the severity of the embryos with the phenotype was much less (Fig. 
91B).  It is difficult to quantify this objectively, but the images show a 
representative group of rescued embryos, some of which are still classified as 
having a phenotype, but are clearly much less severely affected than when MO 
was used alone.   
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Figure 91.  Rescue of the acat1 morphant phenotype with mutant mRNA. 
A: 2ng acat1 MO causes a severe morphological phenotype at 24hpf.  B: co-injection of 
2ng MO with 200pg wt human mRNA rescues the phenotype in a large proportion of the 
embryos.  C: co-injection of the MO with the A5P mutant mRNA fails to rescue the 
phenotype and arguably makes it worse.  D: 200pg of human mRNA alone causes no 
phenotype.  E: 200pg mutant (A5P SNP) mRNA gives a phenotype with a misshapen 
body-axis and poorly extended yolk stalk.  F: quantification of the phenotype shows 
partial rescue with the wt human mRNA but not with the mutant mRNA. 
 
When the mutant mRNA was co-injected with 2ng of MO, the phenotype was not 
even partially rescued, rather it was slightly exacerbated with the number of dead 
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embryos increased from 59% (MO alone) to 77% (Fig. 91C).  The morphology of 
the mutant rescue embryos shows severe shortening of the body axis and 
significant amounts of cell death.  The fact that the mutant mRNA made the 
phenotype worse suggests that it is having a dominant negative effect.  Indeed, 
injection of 200pg of mutant mRNA alone caused a phenotype in its own right, 
while the same amount of wild type mRNA had no effect (Fig. 91D,E). 
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Discussion 
The original paper by Mak et al showed the nematode kat-1 gene to genetically 
interact with bbs-1 to enhance lipid accumulation.  Work performed in our 
laboratory showed that a non-synonymous SNP (A5P) in the human orthologue of 
kat-1, ACAT1, is highly associated with patients with homozygous mutations in 
BBS1.  The frequency of this SNP in BBS1 patients is around 20% compared with 
<1% in the general population.  Elaboration of this study by collaborators in 
Baltimore showed this SNP to be associated with all BBS patients, regardless of 
underlying mutation.   
 
This is a surprising result, since it is difficult to imagine why this allele should be 
so enriched in patients with mutations in ciliopathy genes.  Furthermore, the most 
promising current hypothesis to explain obesity in BBS patients is a defect in the 
satiety regulating neurons of the hypothalamus.  ACAT1 is a metabolic enzyme 
involved in fat metabolism.  It is thought that metabolic rate and energy 
metabolism is normal in BBS patients.  It is possible to speculate that output from 
the hypothalamus regulates the activity of ACAT1’s fat metabolism by signalling 
to adipocytes in which ACAT1 potentially functions.  Why genetic changes in 
ACAT1 should be associated with BBS mutations is unknown. 
 
It is known that the ACAT1 SNP is reproducibly associated with BBS.  The SNP 
is not thought to abolish enzyme activity, but it might alter mitochondrial 
localisation of the protein.  I found that knockdown of acat1 in the zebrafish 
produced a very dramatic phenotype, even with moderate amounts of MO.  I 
titrated the dose down to a level where almost no phenotype was seen and co-
injected this with an equally low amount of bbs1 MO.  The re-emergence of a 
phenotype suggested that bbs1 and acat1 functionally interact in some way, 
suggesting that they act in the same biological pathway.  What the epistasis 
experiments in the zebrafish show is that the nematode-based relationship 
between BBS-1 and ACAT-1 is conserved in vertebrates.  What the biological 
mechanism underpinning this relationship might be remains a mystery. 
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The acat1 morphant phenotype could be rescued by co-injecting wild-type ACAT1 
human mRNA.  However, co-injecting the A5P mutant mRNA failed to rescue the 
morphant phenotype.  This shows that the A5P substitution negatively affected 
the function of the protein.  Whether this is due to affects on enzyme activity, 
subcellular localisation, or something else is unknown.  It will be important to 
understand the exact effect of the A5P allele on subcellular localisation and 
biochemical activity.  It is also important to determine if the A5P mutant protein 
is stable or degraded in the cytoplasm.  This could explain the loss-of-function 
phenotype associated with it.  This could be done by Western blotting the wild 
type and mutant proteins.  Enzymatic assays for the activity of the mutant enzyme 
should also be performed. 
 
To extend these studies, it would be worth screening all other known obesity- and 
non-obesity related ciliopathies to see if the genetic association persists.  If the 
association is present only in obesity-related ciliopathies, it might be that the 
ACAT1 allele is contributing to the obesity phenotype.  If it is present in all 
ciliopathies, it might mean that ACAT1 is in someway associated with the cilium, 
or reliant on microtubule transport.  It is important to combine genetic, 
hypothesis-generating experiments with functional studies on proteins in order to 
understand the biological significance of the genetic phenomena observed.  
Potential mitochondrial roles for BBS proteins are the subject of current further, 
ongoing investigation in the laboratory.
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Chapter 9: Conclusion 
Summary of findings 
This work aimed to understand more about the basis of ciliopathies.  This resulted 
in the following findings being made: 
1) Craniofacial dysmorphology in man, mouse, and zebrafish BBS knockouts 
was modelled and attributed to midfacial bone hypoplasia. 
2) A new role for Bbs8 in NCC migration was established, possibly via a role 
in PCP signalling and regulating actin cytoskeletal dynamics.  This is the 
first time ciliary proteins have been directly linked to cell migration. 
3) Bbs8 and Ift80 are involved in Shh signalling, at the level of Gli3 function. 
4) Rapamycin and Roscovitine are able to restore renal function in zebrafish 
models of ciliopathies, providing proof of principle for pre-clinical studies 
in mouse models. 
5) The possibility of Fto as a new cilia-related protein was explored using the 
zebrafish as a model. 
6) The genetic association of  an ACAT1 SNP with BBS mutations was 
modelled in zebrafish and shown to have functional relevance to 
development. 
 
Together, these findings add to our, at present, scant knowledge of ciliopathies.  
The craniofacial investigation is the first time characterisation of human 
dysmorphology has been used to elucidate novel biological roles for a protein.  
This approach is a model for the study of other malformation syndromes.  
Modelling the ciliopathies in zebrafish provided, for the first time, potential 
therapeutic avenues to treat the kidney disease associated ubiquitously with all 
ciliopathies.  This is the first time a therapeutic investigation has been carried out 
for ciliopathies.  It is also the first time the zebrafish has been used as a model to 
test drugs to treat renal disease. 
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Characterisation of craniofacial dysmorphology 
The facial gestalt of BBS patients has been reported before in the literature, 
(Beales et al., 1999, Lorda-Sanchez et al., 2001) but it has been difficult for 
clinical dysmorphologists to characterise it, due to its variability.  Peter Hammond 
has performed dense-surface modelling to show statistically significant midfacial 
flattening and hypoplasia of the nasal bridge, maxilla, and retrognathia.  Skull 
preparations from BBS mutant mice showed homologous bones in the snout were 
hypoplastic, resulting in a shortened snout and a higher cranial vault.   
 
Zebrafish morphants of three BBS genes: bbs4, bbs6, and bbs8 showed shortening 
of the trabeculae, which are structures homologous to the upper jaw of mammals.  
Mandibles and branchial arches were hypoplastic, and sometimes absent from 
bbs8 morphants.  These embryos also had cyclopia and midline fusion of the 
trabeculae with absence of the anterior ethmoid plate.  These defects were 
strikingly similar to Shh pathway mutants, or embryos treated with chemical 
inhibitors of Smo.  Midline defects in the zebrafish skull were extreme examples 
of two mild HPE phenotypes infrequently observed in BBS patients: fusion of the 
maxillary incisors, and hypoplasia or agenesis of the corpus callosum. 
 
The application of dense surface modelling to a syndrome with subtle and variable 
features, such as BBS, is novel, as previously it has only been used to characterise 
obvious facial deformities.  This application provides proof of principle for its use 
in other syndromes with previously undocumented facial features.  The use of 3D 
laser scanning on mouse skulls has not been reported before this work, and its 
application provides a way of validating the biological significance, and exploring 
underlying cellular and molecular aetiologies, of a condition.  Further extension of 
the analysis to the zebrafish allows a finer scale resolution of the underlying 
pathways potentially involved. 
 
Discovery of a new role for BBS proteins in neural crest migration 
The bony regions of the face affected by BBS knockdown all derive from the 
cranial neural crest, a migratory population of cells deriving from the anterior 
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neural tube.  I showed that the degree of CNCC migration inhibition was 
correlated with the severity of the craniofacial phenotype, and was consistently 
most pronounced in bbs8 morphants.  Neural crest induction, maintenance, or 
proliferation was unaffected in bbs8 morphants and the number of crest cells was 
similar to controls.  However, the cells failed to emigrate from the neural tube, 
and the distance migrated was around one quarter of controls.  At later stages, 
cells did populate the head, but failed to extend into the most anterior portions to 
extend the trabeculae and form the ethmoid plate.  A similar mechanism would 
also account for the craniofacial defects also seen in humans and mice. 
 
Evidence that Bbs8 might play a role in pan-NCC migration came from the clear 
observation that bbs8 morphants lacked pigmentation and melanocyte precursors, 
a trunk NCC-derived lineage.  Furthermore, these embryos had incomplete 
colonisation of the gut by enteric neurons, which correlated with a loss of gut 
peristalsis.  This finding offers a likely explanation as to why Hirschsprung’s 
disease is so common amongst BBS patients.   
 
The function of Bbs8 in NCC migration was shown to be cell autonomous. 
Higher-power images of CNCCs at the leading edge of the dorsal stream of cells 
migrating caudally around the eye, showed morphant cells to lack filopodial or 
lamellipodial protrusions.  In contrast, these protrusions were generally aligned in 
the direction of migration in controls.  This hinted at a loss of cell polarity, and 
Bbs4 and Bbs8 have previously been implicated in the PCP pathway (Ross et al, 
200, H. May-Simera, thesis).  Epistasis experiments with two different mutant 
Dishevelled constructs suggested that downregulation of PCP by bbs8 knockdown 
might be responsible, at least in part, for the inhibition of migration.  These 
findings are in keeping with results from Roberto Mayor’s laboratory, where they 
have shown PCP to be important for NCC migration in both Xenopus and 
zebrafish (De Calisto et al., 2005, Matthews et al., 2008). 
 
Because PCP signalling controls cell polarity by organising the actin cytoskeleton, 
I attempted to visualise actin microfilaments in migration CNCCs.  No clear data 
was obtained due to the confounding effects of surrounding cells.  To get a clearer 
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view, I cultured mouse cell lines and human primary cells both deficient in Bbs8.  
To induce directional cell migration I performed a scratch assay.  Surprisingly, 
both types of cultured fibroblast migrated significantly slower than their 
respective controls.  Furthermore, the actin cytoskeleton was disordered and 
mispolarised in both cases.  This finding is interesting in light of work by Park et 
al (2006), who showed that disrupting the actin cytoskeleton by perturbing PCP 
signalling resulted in mispositioned basal bodies and intracellular cilia, in which 
the axonemes projected into the cytoplasm.  As such, this opens up a completely 
unexplored area of research whereby BBS proteins could also regulate the actin 
microfilaments, possibly via PCP signalling, and this could determine basal body, 
and hence ciliary, position. 
 
These experiments highlight two findings to follow up: firstly, the possibility that 
BBS8 is important for cell migration in general, not just in the neural crest, and 
possibly for wound healing; and secondly, that the actin cytoskeleton is 
mispolarised in these knockout cells.  Future work in this area will be to further 
elucidate the role of BBS proteins in cytoskeletal arrangement in vivo, as well as 
the potential role for BBS proteins in wound healing.   
 
To better understand how Bbs8 is involved in NCC migration, preliminary work 
has been performed to elucidate differential gene expression profiles in NCCs at 
stages of active migration in control and morphant zebrafish embryos using gene 
expression microarrays.  Protocols have been optimised for cell purification by 
FACS and RNA recovery.  So far, no expression data has been obtained but this 
will be the next piece of work to carry out.  
 
Involvement of ciliopathy proteins in Shh signalling 
The high penetrance (70%) of post-axial polydactyly in BBS and other 
ciliopathies (MKS, JATD, OFD1), as well as evidence from published IFT mutant 
mice and the known role for cilia in Shh signalling, suggest that this pathway is 
disrupted in BBS.  Further clues come from the craniofacial abnormalities, 
particularly the midline defects in bbs8 morphants.  Downstream Shh target 
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genes, nkx2.2, and ptc1 were downregulated in all morphants, but particularly 
bbs8, especially in the head.  The result was confirmed by the upregulation of the 
negatively regulated gene, pax6 in morphants.  Epistasis experiments showed that 
bbs8 functions downstream of Ptc1 and is likely to be involved at the level of Gli3 
processing and transport.   
 
Cellular assays showed that Bbs8 knockdown cells were insensitive to high levels 
of exogenous Shh ligand, but zebrafish data suggested that the cells could respond 
to medium levels, as seen by normal expression of nkx6.1.  These data suggest 
that Bbs8 is not essential for Shh pathway activity, but is needed for maximal 
signalling activity.  Gli3 processing in response to Shh stimulation was shown to 
be defective in Bbs8 knockdowns.  Immunofluorescent and cell fractionation data 
hinted that Gli3 may be mislocalised in Bbs8 mutant cells, and co-
immunoprecipitations suggested a potential physical interaction between Bbs8 
and Gli3.  However, uncertainties about the reliability of the Gli3 antibody for 
immunofluorescence confound the reliability of these results.  Proteomics could 
reveal potential interactions between other ciliopathy proteins and Shh signalling 
pathway molecules. 
 
Future work will involve examining pathway activity at the cilium in real time.  
To do this, the ciliary axoneme will be fluorescently labelled and the localisation 
of tagged Shh proteins, such as Smo and Gli3, will be visualised.  Fluorescent 
recovery after photobleaching (FRAP) will be used to bleach a small region of the 
cilium, and the rate of movement of the signalling molecules will be measured in 
response to exogenous stimulation with purmorphamine.  This is a highly 
ambitious project with many technical hurdles to overcome, but will be more 
revealing than the indirect luciferase and Gli3 processing assays currently 
performed. 
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Development of the zebrafish as a tool to test drugs for kidney 
disease 
I then turned to expanding the repertoire of zebrafish ciliopathy models and 
created morphants of ten ciliopathy genes, chosen to be representative of the 
whole spectrum of diseases.  All of these morphants developed kidney cysts, 
followed by renal oedema.  In addition, I observed several other cilia-specific 
phenotypes: laterality defects and unusual numbers of otoliths in the ear.  This has 
implications for understanding the malcoordination and balance problems BBS 
patients have. 
 
The renal oedema could be specifically rescued by two drugs previously shown to 
be efficacious on mouse models of PKD: Rapamycin and Roscovitine.  In 
addition to reducing the size of the kidney swelling back to control levels, 
Rapamycin was able to restore the filtering function of the kidney from around 
10% of control levels to around 50%, therefore improving kidney function by 
about 5-fold.  Roscovitine was also able to reduce swelling size and restore some 
function to the kidney, but was never as effective as Rapamycin.   
 
The functional assay was able to differentiate quantitatively between the efficacies 
of the two treatments.  This validates it as a tool to evaluate compounds to 
progress to trials on mouse models of ciliopathies.  If data are promising from 
these experiments, it paves the way to perform trials in humans.  This might have 
the potential to alleviate the need for ciliopathy patients to spend the rest of their 
lives on renal dialysis or be reliant on transplantation.  However, more work needs 
to be done to reveal the precise molecular and cellular aetiology of the complex 
renal phenotype in diseases like BBS and NPHP. 
 
Future work will involve scaling up the proof of concept experimental system 
developed here.  This will involve developing medium to high-throughput small 
molecule screens to test kidney disease drugs.  In future, this might be a valid 
method to identify candidate molecules in vivo, as it is more physiologically 
relevant than using isolated recombinant protein targets or cell-based bioassays.  
In addition, the zebrafish assay has the advantage of in-built toxicological 
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screening.  Any candidates identified in the zebrafish can then be tested on mouse 
models and, ultimately, humans. 
 
Determining the function of the FTO protein 
While numerous genes have been identified as candidates for monogenic 
syndromic obesity, the genetic aetiology of complex, polygenic obesity is not so 
well understood.  FTO was the first gene to be associated with obesity in the 
general population.  An intronic SNP increases the risk of obesity by around 70%.  
FTO protein function is not clear, although some data suggests a role in DNA 
methylation, although how this contributes to weight gain is unknown.   
 
To try to gain some insight into potential function, I created knockdown and over-
expression models of Fto in the zebrafish.  Both treatments caused phenotypes, 
but the SNP in humans is likely to produce a hypomorphic allele, if it does affect 
protein function, but is hard to model as it lies in an intron.  These morphants 
show some phenotypes usually associated with ciliary dysfunction: aberrant 
otolith numbers, convergent-extension defect, kidney cysts, and laterality 
randomisation. 
 
Subcellular localisation studies on over-expressed, tagged Fto protein in zebrafish 
showed nuclear localisation.  However, Myc-tagged Fto in ciliated cell lines 
revealed a basal body localisation.  An FTO-specific antibody failed to resolve the 
discrepancy in localisation, as it produced no immunofluorescent signal.  The only 
way to resolve this to observe endogenous, untagged protein would be to raise 
another antibody to a different FTO epitope. 
 
A ciliary function would account for features seen in the Fused toes mouse 
mutant, which shows laterality, polydactyly, and craniofacial anomalies.  These 
features manifest in the heterozygote, which is haploinsufficient for six genes.  
However, Ftm null mice phenocopy the Ft heterozygotes.  Given evidence that 
Ftm and Fto might be coregulated, it is possible that the two genes interact in the 
same pathway, and so haploinsufficiency for both genes gives the Fused toes 
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phenotype.  As Ftm is known to be a ciliary protein (Vierkotten et al, 2007), it is 
possible that Fto is as well, or it could be a downstream nuclear effector of Ftm. 
 
To test this, I performed double MO injections with fto and ftm MOs and found 
there to be a genetic interaction between the two genes.  This supports the 
proposition that the two genes function in a common biological process.  Ftm is a 
ciliary protein that functions in Shh transduction.  It is possible that Fto acts 
downstream of Ftm at the cilium and in the nucleus.  More experiments will be 
needed to understand how Fto function relates to Ftm. 
 
FTO is associated with type 2 diabetes in humans.  I tested the transcriptional 
response to glucose stimulation in zebrafish, an indirect measure of glucose 
homeostasis, by quantifying the level of two genes regulated by increased blood 
glucose concentration.  Preproinsulin was upregulated in response to glucose in 
controls, but not in fto morphants.  Concurrently, pepck was downregulated in 
controls but not changed in morphants.  These data suggest that fto morphants 
have defective glucose homeostasis.  However, these data cannot be readily 
transferred to mammals because the morphant zebrafish show other phenotypes 
that might indirectly compromise their pancreatic function and general health.  
Cultured cell assays are being performed to follow up on this result in the absence 
of an Fto knockout mouse. 
 
Testing the association between BBS1 and ACAT1 
ACAT-1 is the human homologue of the C. elegans kat-1 gene, a metabolic 
enzyme involved in β-oxidation of fatty acids.  kat-1 was identified in a screen for 
mutants that enhanced the lipid accumulation phenotype of the tub mutant, also a 
ciliary protein.  When a screen for genes enhancing the kat-1 phenotype was 
performed, bbs-1 was identified as the top enhancer.  Work in our laboratory 
found a nonsynonomous SNP, A5P, to be more than 5-times over-represented in 
patients with BBS1 mutations, than in controls.  Extending this analysis revealed a 
similar enrichment for the SNP in all BBS patients, regardless of genetic 
background.  The reason for this enrichment is unclear. 
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To test whether the A5P allele was affecting the function of the ACAT1 gene, I 
performed knockdown of acat1 in zebrafish and showed it to genetically interact 
with bbs1, confirming the C. elegans results.  I then co-injected acat1 MO with 
both wild type and mutant ACAT1 human mRNA.  This showed that the human 
mRNA was able to rescue the phenotype, but the SNP was not.  In fact, the A5P 
mutant mRNA made the phenotype worse, suggesting it might have a dominant 
negative effect.  This domain of the protein is outside of the catalytic domain but 
may be involved in protein targeting to the mitochondrion, or may be important in 
overall stability of the tertiary structure.  This suggests that the ACAT1 SNP might 
modify the phenotype in BBS patients.  It would be interesting to see if the SNP is 
association with obesity in the general population.   
 
These experiments fail to illuminate how the ACAT1 SNP might enhance the 
obesity phenotype of human patients.  To do this, more experiments would need 
to be performed on the subcellular localisation, enzyme activity, and potential 
interaction with ciliary processes. 
 
Beyond the cilium 
Since the aetiology of BBS was pinpointed to the cilium in 2003, the field has 
focussed its attention purely on ciliary roles for ciliopathy proteins such as BBS.  
However, it is likely that these proteins have roles outside of the cilium, due to the 
deployment of microtubule-based transport in the cytoplasm.  Processes such as 
fast-axonal transport are similar in mechanism to IFT.  BBS proteins such as 
BBS4 have been associated with cytoplasmic microtubules and organisation in 
cochlear hair cells (unpublished data from our laboratory).  BBS proteins have 
been implicated in diverse functions, from proteosomal degradation, vesicle 
trafficking, sensory neuron function, cell cycle regulation, and intracellular 
signalling.  It is therefore likely that these proteins function outside of the cilium 
as well, and identifying these roles will be a task for the future. 
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Primer name 
 
Sequence (5’ to 3’) Use of primers 
Ptc-1 F CTCCAAGTGTCGTCCGGTTT 
Ptc-1 R CTGTACTCCGAGTCGGAGGAA 
Amplifying mouse Ptc1 for 
qRT-PCR 
Gli-1 F TGGATATGATGGTTGGCAAGTG 
Gli-1 R ACAGACTCAGGCTCAGGCTTCT 
Amplifying mouse Gli1 for 
qRT-PCR 
Shh F TCCAAAGCTCACATCCACTGTT 
Shh R CAGAGAACTCCGTGGCGGCCAAAT 
Amplifying mouse Shh for 
qRT-PCR 
Bbs8 F GCGCTGACAGAGATGGTGTA 
Bbs8 R ATCGGGACTTGTAAGCATGG 
Amplifying mouse Bbs8 for 
qRT-PCR 
hsGli1 F GAACCCTTGGAAGGTGATATGTC 
hsGli1 R GGCAGTCAGTTTCATACACAGAT 
Amplifying human GLI1 for 
qRT-PCR 
hsPtc1 F GACCGGGACTATCTGCACC 
hsPtc1 R GAGGCCCACAACCAAGAACTT 
Amplifying human PTC1 for 
qRT-PCR 
hsGAPDH F ATGGGGAAGGTGAAGGTCG 
hsGAPDH R GGGGTCATTGATGGCAACAATA 
Amplifying human GAPDH 
as control for qRT-PCR 
hsShh F CTCGCTGCTGGTATGCTCG 
hsShh R ATCGCTCGGAGTTTCTGGAGA 
Amplifying human SHH for 
qRT-PCR 
hsBBS8 rt F TGGGAACGGCTTTGTTTGAGT 
hsBBS8 rt R CACAGGTTGATCCAATGAGACA 
Amplifying human BBS8 for 
qRT-PCR 
zfPtc1 rt F CCAACTTTTACCCCCATCCT 
zfPtc1 rt R GGGGTAGCCATTGGGATAGT 
Amplifying fish ptc1 for qRT-
PCR 
zfGli1 rt F CCTGTCCTGGGCAGTGTAAT 
zfGli1 rt R ACTCTTTGCTGCAGCTCTCC 
Amplifying fish gli1 for qRT-
PCR 
zfShh rt F AAAGCCCACATTCATTGCTC 
zfShh rt R GATGAAGTCGCTGAACACCA 
Amplifying fish shh for qRT-
PCR 
zfEF1a rt F TGGGTGTTGGACAAACTGAA 
zfEF1a rt R CAACACCACCAGCAACAATC 
Amplifying fish ef1a as 
control for qRT-PCR 
zfBBS8splF 1 GCGGATATCTGCTCCACACT 
zfBBS8splR 1 GACGCCTCAGTGATGTTCCT 
Validating splice bbs8 splice 
blocking MO 
zfBBS8splF 2 ATTGATGAGGTGGAGGTGGA 
zfBBS8splR 2 GTCGACCTGACTGGGTCATC 
Validating bbs8 splice 
blocking MO 
IFT80spliceF 1 GTGAGCGGAAAGAAACAAGC 
IFT80spliceR 1 AGGCATCCCTTGTTGAGCTA 
Validating ift80 splice 
blocking MO 
IFT80spliceF 2 GAAGAGTGTGGAGGCCCATA 
IFT80spliceR 2 AGGCATCCCTTGTTGAGCTA 
Validating ift80 splice 
blocking MO 
zBactinF 1 CTCTTCCAGCCTTCCTTCCT 
zBactinR 1 CTTCTGCATACGGTCAGCAA 
Amplifying fish beta-actin as 
qRT-PCR control 
zBactinF 2 CTCTTCCAGCCTTCCTTCCT 
zBactinR 2 CACCGATCCAGACGGAGTAT 
Amplifying fish beta-actin as 
qRT-PCR control 
hBBS8 F  ClaI        ATTGCAATCGATATGAGCTCGGAGAT
GGAGCCG 
hBBS8 R XhoI   ACATGACTCGAGTCAGAGCATAGCA
AAATGCTGC 
Cloning human BBS8 for 
rescue of the fish morphant 
phenotype 
mouse IFT80F 
ClaI      
ATTGCAATCGATATGAGACTGAAGAT
ATCTCTC 
Cloning mouse Ift80 for 
morphant rescue 
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mouse IFT80R 
XhoI     
ACATGACTCGAGTTAGTGCTTTAAGC
CCACAC 
 
zPEPCK F GAGAATTCTCACACACAC 
ACACGTGAGCAGTA 
zPEPCK R GTAAAAGCTTTCCGCCATAACATCTC
CAGCAGAA 
Amplifying fish pepck for 
qRT-PCR 
zINSa F AGTGTAAGCACTAACCCAGGCACA 
zINSa R TGCAAAGT CAGCCACCTCAGTTTC 
Amplifying fish insa for qRT-
PCR 
mFTO xhoI F ATCTGACTCGAGATGAAGCGCGTCCA
GACCGC 
mFTO salI R ATCTGAGTCGACATCTAGGATCTTGC
TTCCAGCAGCTG 
Amplifying mouse Fto for 
zebrafish injection 
mFTO EcoRI F ATCTGAGAATTCATGAAGCGCGTCCA
GACCGC 
mFTO XhoI R ATCTGACTCGAGCTAGGATCTTGCTT
CCAGCAGCTG 
Amplifying mouse Fto for 
GST-tagged protein 
production 
zFTOprobe F1 CATGCACGTGTCATACACCA 
zFTOprobe R1 CCTTCATTCTTTGGCTCTGC 
zFTO probe F2 TTTCAGGACCTGTGGGACTC 
zFTO probe R2 CCATGTCTGTCTGTGCTGCT 
Production of zebrafish fto in 
situ probe 
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Gene Dose  MO sequence mRNA for rescue 
Acat1 ATG 2ng TGAAATACTGTACTCAATAAAGCGC  
Acat1 SPL 1-4ng AGAGGAAGACCTGCATGAGGAAAAC 100pg 
Bbs1 ATG 8ng GGCTGGCAAATAAGCTGTCCACAG  
Bbs4 ATG 4ng GAAAAAGATCACTACTGTAAAGCAT 50pg 
Bbs4 ATG mis n/a GAAtAAGAgCcCTtCTGaAAAGCAT  
Bbs6 ATG 4ng GCTTCTTCTTACTAATGCGAGACAT 50pg 
Bbs8 ATG 2-4ng TCTCACCGGAGAAACACCACACACA 100pg 
Bbs8 SPL* n/a AGCTGTATACTCACGAGCCACCTGA  
Ftm ATG 1-4ng TTCAGGATGGCCACCAAGTTGATCC  
Fto ATG** n/a GTTTACGCTGCCTCGGTTTCATAGC 100pg 
Fto SPL 2ng CACTTTTGACCTCTCACCTTCATTC  
Gli2 ATG 2ng GGATGATGTAAAGTTCGTCAGTTGC  
Gli3 ATG 8ng GGATGATGTAAAGTTCGTCAGTTGC  
Ift80 ATG* n/a TGAAGGATGCGATTGAAAACATCGT  
Ift80 SPL1 4ng AGGTGTATGTGGAACCTGTGATAAG 100pg 
Ift80 SPL2 4ng  TAGGTGGAAAGGTTACCATCAGAGC  
Ift80 SPL2 mis 4ng TAcGTGcAAAGcTTAgCATCAcAGC  
Ihh ATG 4ng GGAGACGCATTCCACCGCAAGCGGC  
Kcnj10 ATG 0.5ng AGGGATAGGAGAGAGATGTTCATTT 50pg 
Kcnj10 SPL 1-2ng AATTGTGAGAGCTATACCTTGGCGA  
Mks1 SPL 2ng CTCTTACACTAATCACCTACCTGAC  
Mks3 SPL 2ng GTAAAAATGACAAGCGCCTACCCAG  
Nphp2 ATG** n/a CATTGCCTGATGCACACACACACAC  
Nphp2 SPL 4ng GAGCAGCTTCCTAAAATGTATAAAC 50pg 
Nphp5 ATG 2ng ATTTCGTCTCCTGAAGGACCCATTG  
Nphp5 SPL 3ng CAAGACGGCACTGCAAAAACAAGGG  
Nphp6 ATG** n/a TCTCAGAATCATCTGCTTTTAGGTC  
Nphp6 SPL 3ng GCCTGCTGCTGCCTATAAAACCATC  
Ofd1 ATG* n/a GCAGCAAACACATTTACATTCAGTC  
Ofd1 SPL 3ng CGGGATATGACCTAAAGTCAAAACC  
P53 *** GCGCCATTGCTTTGCAAGAATTG  
Ptc1 ATG 1ng CATAGTCCAAACGGGAGGCAGAAGA  
 
* These MOs did not yield any phenotype. 
** These MOs were toxic and killed embryos 
*** p53 MO used in some experiments to control for possible non-specific cell 
death.  Used at the same concentration of the MO under test. 
Table 13.  Morpholino oligonucleotide sequences 
 
MOs designated “mis” are 5-base pair mismatch MOs used as controls against the 
gene of interest.  None of mis-pair MOs yielded any phenotype when injected at 
the same concentration as its gene-specific MO.
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Appendix 3: development of a zebrafish model for a new 
human syndrome causing epilepsy and renal tubulopathy 
 
Mutations in KCNJ10 underlie a new human syndrome 
In the latter months of my PhD project, I was approached by paediatric 
nephrologists (Drs. Detlef Bockenhauer and Robert Kleta) at Great Ormond Street 
Hospital, who had identified a new autosomal recessive human syndrome in a 
single consanguineous family.  They wanted some functional assays performed in 
zebrafish embryos.  This syndrome was characterised by renal tubulopathy and 
epileptic seizures.  Using homozygosity mapping on 10k SNP chips, they 
identified a region containing a single gene encoding a potassium channel, 
KCNJ10.  Sequencing revealed non-sense mutations in the patients occurring in 
the membrane-spanning domain of the channel. 
 
KCNJ10 (also called KIR4.1) encodes a slow inward rectifier potassium ion 
channel (Kir) exclusively expressed in human and mouse brain, ear, and kidney 
tissue.  Kir channels pass potassium ions (positive current) from the outside to the 
inside of the cell.  When the membrane potential is below the resting potential, Kir 
channels pass potassium ions back into the cytoplasm to restore the resting 
potential.  Therefore, they regulate the resting potential in neurons.  Because the 
maintenance of resting potential is affected by KCNJ10 mutation, spontaneous 
action potentials result in involuntary epileptic seizures. 
 
Maintenance of resting membrane potential is important for other cell types 
besides neurons.  In the kidney tubule, Kir channels are involved in filtration in the 
nephron.  Here, they reabsorb K+ ions from the filtrate back into the body, or they 
excrete excess K+ into the urine, thus regulating plasma potassium concentration.  
This is why mutation to KCNJ10 in the kidney causes tubulopathy. 
 
There is a mouse knockout of Kcnj10, but it dies perinatally and never lives 
beyond around two weeks post-partum (unpublished data).  The pups are runtish 
and the cause of death tends to be starvation, as before they die, they suffer 
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seizures and malcoordinated movement and so are unable to suckle properly.  
Because of the lack of a conditional mouse model to knock out Kcnj10 in the 
kidney, it is difficult to assess the function of the gene from the mouse model.  In 
order to validate the function of the gene, I produced a zebrafish kcnj10 morphant.  
 
Kidney and motion defects in morphant zebrafish 
I designed ATG and splice blocking MOs against zebrafish kcnj10, which shares 
71% identity with the human orthologue at the protein level.  Kcnj10 had not yet 
been annotated on the zebrafish genome.  Injection of between 2 and 8ng of 
kcnj10 ATG MO, or 4 to 8ng of SPL MO, caused severe morphological defects.  
Injection of 1ng kcnj10 ATG MO, or 2ng of the splice blocking MO (kcnj10 
SPL), did not yield any morphological phenotype at 24hpf.   
 
By 72hpf, around 50% of embryos injected with 1ng ATG or 2ng splice MO had 
oedema in the body cavity and a swollen pronephric duct.  This probably 
represents tubulopathy in the kidney.  Because the zebrafish body tissue is salty, 
but the fish lives in fresh water, failure to regulate potassium secretion and uptake 
in the urine will result in osmotic imbalance and fluid uptake, resulting in oedema.  
Figure 92 shows an embryo injected with 1ng ATG blocking MO. 
 
 
 
 
 
 
 
 
 
Figure 92.  kcnj10 morphant phenotype. 
1ng kcnj10 ATG MO was sufficient to cause oedema of the kidney and swelling of the 
pronephric duct, a sign of tubulopathy. 
 
kcnj10 ATG 1ng 
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To prevent such gross oedema of the body, I reduced the amount of ATG MO 
injected to 0.5ng.  At this dosage, the embryos did not develop oedema.  
However, although morphologically grossly normal, these embryos showed a 
striking movement disorder.  Control embryos at 5dpf swam in smooth circles 
around their dish (Fig. 93, left panel).  Kcnj10 morphants exhibited two unusual 
swimming behaviours that to my knowledge, have never been documented in 
other morphants.  Firstly, they had seizures resulting in tremors of the whole 
body, due to rapid, involuntary muscle contraction.  These seizures were 
impossible to record due to the lack of a videomicroscope of high-speed.  
Secondly, instead of the embryos swimming in smooth lines, morphant embryos 
swam in tight loops (Fig. 93 right panel).  Some embryos even circled around 
their own body axis.  This looping behaviour was observed in over 15 separate 
embryos from different injections and was never seen in controls. 
 
In order to document this phenotype and analyse it, I collaborated with Dr 
Anukampa Barth at UCL.  We used a digital infrared camera that tracks the 
motion path of an embryo in a dish against a white background.  The computer 
then draws a line representing the movement of the fish.  We made 3-minute 
recordings for each embryo and compared the traces from control and morphant 
embryos.  From the motion-captured images, it is clear that morphant embryos 
tend to swim in tight loops, often turning back on themselves.  This is in contrast 
to controls, which swam in large circles, never looping back on their own tracks. 
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Figure 93.  Movement analysis of kcnj10 morphants. 
Left side: 5.5dpf control embryos swim in large loops around the dish, often sticking to 
the margins.  There are no small loops or sudden erratic changes of direction.  Right side: 
morphant embryos swim in very tight loops, turning on their own axes.  In some cases, 
the embryos pivoted around their own axis in tight spirals or on the spot. 
 
To test the renal function of morphant embryos I injected 0.5ng of ATG MO, 
which did not result in oedema and performed the same functional assay used for 
the drug testing on ciliopathy morphants (Fig. 94A-B’’). Fluorescence was 
reduced by 91% in controls (n=10) but by only 26% in morphants (n=15) (Fig. 
94C).  This shows that renal filtering function is impaired in these morphants.   
 
Mutant human mRNA is unable to rescue the movement phenotype 
Collaborators at the Royal Free Hospital in London working on this project tested 
the function of the mutant KCNJ10 allele by injecting wild type and mutant 
mRNA (R65P substitution) into Xenopus oocytes.  They then performed whole 
cell  electrophysiological recordings with an electrode.  They found that channel 
function in the mutant was reduced to 30% of the wild type level.  They proved 
specificity by treating the oocytes with barium, which specifically blocks Kir 
control kcnj10 
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channels.  In this case, membrane potentials were the same in mutant and wild 
type oocytes. 
 
To see if this reduction in channel function affected whole-organism physiology, I 
injected these wild type and mutant forms of mRNA into kcnj10 morphants.  To 
objectively and quantitatively assay function, I counted the number of body flexes 
dechorionated 30hpf embryos made in a random 30-second period.  The embryos 
were placed in individual wells of a 12 well plate and left to equilibrate for 3 
minutes before counting.  Between 15 and 20 embryos were counted for each 
treatment.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0hr 
control 
24hr 
kcnj10 
A B 
B
’ 
B’’ 
A
’ 
A’’ 
C 
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Figure 94.  Kidney function assay on kcnj10 morphants. 
A-A’: immediately after fluorescent dextran injection, the control embryo is brightly 
fluorescent.  24 hours later, this fluorescence has largely dispersed.  A’’: An image of the 
whole embryo shows it has been excreted from the systemic circulation.  B,B’: kcnj10 
morphants retain much of the original fluorescence 24hpi.  B’’: the fluorescence persists 
in the circulation and in the pronephros.  C: quantification of the amount of fluorescence 
in the heart at 0hpi shows the same amount of fluorescence in controls and morphants.  
24hpi, control fluorescence has reduced by 91% of the original amount but only by 26% 
in morphants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 95.  Effect of human kcnj10 mutation on zebrafish body movements. 
The number of body twitches was counted in a random 30-second period for each embryo 
placed in its own well.  Morphants twitched around 6-times more frequently than 
controls.  This excessive body movement was rescued by injection of 50pg wt human 
mRNA, but not by the mutant mRNA. 
 
These data show that control embryos flexed an average of 1.6 times in each 
period (Figure 95).  In contrast, morphants flexed 10.4 times, a 6.5-fold increase.  
Injection of 50pg or 100pg of wild type mRNA restored this movement defect to 
just 1.4 and 1.1-fold over control levels respectively.  In contrast, injection of 
50pg or 100pg of mutant mRNA resulted in no rescue of the excessive body 
twitching, with 5.9 and 6.1-fold more twitches compared to controls (Figure 95).  
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Together, the oocyte and zebrafish data suggest that the mutant mRNA is 
diminishing channel activity resulting in hyperactivity of the neurons in the brain 
and uncontrollable body seizures. 
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